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Background: Lung cancer is the leading cause of cancer death worldwide. There are 
evident health inequalities in lung cancer mortality, with those from more deprived groups 
more likely to be diagnosed with lung cancer and die of the disease. Understanding the 
factors associated with cancer screening uptake is vital to implementing an effective and 
efficient UK lung cancer screening programme in the future. This thesis aimed to explore 
the socioeconomic and psychosocial factors associated with lung cancer screening 
participation.  
 
Methodology: This thesis used a mixed methods approach. A systematic review, of the 
public perceptions and awareness of lung cancer and lung cancer screening, used an 
integrative methodology, exploring both quantitative and qualitative literatures. Two 
secondary analyses of data from an early detection of lung cancer trial were conducted (n = 
11,164). The first of the two quantitative studies examined the demographic and 
psychosocial differences across socioeconomic groups among trial participants, while the 
second study looked to explore any demographic or psychosocial differences of those who 
were recruited to participate in the trial by their GP and those recruited via the community. 
Data from both studies were analysed using univariate and multivariate analyses. Finally, a 
qualitative study (n = 8) used semi-structured interviews to examine the barriers to 
attendance among people who initially arranged a lung cancer screening appointment but 
did not attend. Two analytic approaches were applied to the data. First, data were analysed 
using a thematic framework approach to generate themes, this was then followed by a 
theoretical framework approach using two different behavioural models (the Health Action 
Process Approach and the Common-Sense Model of Self-Regulation) in order to identify 
overlap and gaps in the models. 
 
Main Findings: The findings of these studies suggest that beliefs about lung cancer and 
lung cancer screening vary by socioeconomic status, with those from more deprived 
backgrounds more likely to report barriers to screening, less likely to perceive that their 
actions can impact the development of lung cancer and more likely to feel upset when they 
think about lung cancer. The secondary analyses highlight the need to consider how best to 
measure deprivation if it is to be used as a criterion in targeted cancer screening, and 
further consider how we optimise the way we invite high risk people to participate in lung 
cancer screening. Results of the secondary analyses of recruitment type in the ECLS trial 




people from less deprived backgrounds, and therefore might not be the best method to 
reach those at high risk of lung cancer and living in more deprived areas. Results of the 
qualitative study indicate that people experience both practical and emotional barriers to 
attending lung cancer screening. Those who agreed to participate, but did not attend their 
appointment, were more likely to first cite practical barriers, such as competing priorities 
or ill-health. However, the reasons for not making another appointment were often more 
emotive, with lung cancer fear and fatalism high among non-attenders. The study also 
identified significant overlap between the HAPA model and CSM, particularly with regard 
to the role coping strategies play in a group of people who already have positive intentions. 
Coping planning and coping appraisal seem to be significant problem areas for non-
attenders, with the time between invitation and appointment vital to whether or not they 
attend their appointment. 
 
Conclusions: There are sociodemographic and psychosocial factors associated with 
participation in lung cancer screening. It is important to identify the barriers to lung cancer 
screening and provide solutions if a lung cancer screening programme is to be 
implemented in the UK. Further work is required in order to explore the development of 
targeted interventions to support those at high risk of lung cancer, particularly those from 






Table of contents 
Abstract ........................................................................................................... 2 
List of tables .................................................................................................. 11 
List of figures ................................................................................................ 13 
Acknowledgements ....................................................................................... 14 
Author’s declaration ..................................................................................... 15 
Abbreviations ................................................................................................ 16 
Chapter 1 : Lung cancer epidemiology and lung cancer screening ......... 18 
1.1 The problem: a cancer of substantial unmet need ................................................. 18 
1.2 Lung cancer epidemiology ....................................................................................... 19 
1.2.1 Lung cancer presentation ................................................................................. 19 
1.2.2 Incidence and mortality of lung cancer ............................................................ 19 
1.2.3 ... Demographic characteristics associated with lung cancer incidence and mortality
 ......................................................................................................................................... 20 
1.2.3.1 Sex ............................................................................................................ 20 
1.2.3.2 Socioeconomic status ............................................................................... 20 
1.2.4 Risk factors ...................................................................................................... 21 
1.2.4.1 Smoking ................................................................................................... 21 
1.2.4.2 Age ........................................................................................................... 22 
1.2.4.3 Pre-existing lung disease or lung condition ............................................. 22 
1.2.4.4 Environmental exposure .......................................................................... 23 
1.2.4.5 Family history .......................................................................................... 23 
1.3 Screening for lung cancer ........................................................................................ 23 
1.3.1 Definition of screening and screening criteria ................................................. 23 
1.3.2 Existing national cancer screening programmes in the UK ............................. 24 
1.3.3 Cancer screening uptake in Scotland ............................................................... 25 
1.3.4 Screening tests for lung cancer ........................................................................ 26 
1.3.4.1 Chest x-ray ............................................................................................... 26 
1.3.4.2 Low-dose computed tomography ............................................................. 26 
1.3.4.3 Biomarker detection ................................................................................. 28 
1.3.4.4 Sputum analysis ....................................................................................... 30 
1.3.5 Potential harms of lung cancer screening ........................................................ 31 
Chapter 2 : Achieving equitable uptake - psychosocial predictors of 
cancer screening uptake ............................................................................... 33 
2.1 Challenges for lung cancer screening ..................................................................... 33 
2.1.1 Selecting a target population ............................................................................ 33 
2.1.2 Sociodemographic predictors of uptake ........................................................... 34 
2.1.3 Sex .................................................................................................................... 34 
2.1.4 Age ................................................................................................................... 35 
2.1.5 Ethnicity ........................................................................................................... 36 




2.2 Barriers to lung cancer screening ........................................................................... 38 
2.2.1 Practical barriers .............................................................................................. 38 
2.2.1.1 Financial barriers ...................................................................................... 39 
2.2.1.2 Geographic barriers .................................................................................. 39 
2.2.1.3 Competing priorities ................................................................................ 40 
2.2.2 Psychological barriers ...................................................................................... 41 
2.2.2.1 Knowledge and awareness ....................................................................... 41 
2.2.2.2 Attitudes ................................................................................................... 42 
2.2.2.3 Perceived risk ........................................................................................... 43 
2.2.3 Emotional barriers ............................................................................................ 44 
2.2.3.1 Fear ........................................................................................................... 44 
2.2.3.2 Fatalism .................................................................................................... 45 
2.2.3.3 Cancer stigma ........................................................................................... 47 
2.3 Interpersonal determinants of screening participation: GP endorsement .......... 49 
2.4 Theories of health behaviour and cancer screening participation ....................... 50 
2.4.1 Health behaviour theories and construct overlap ............................................. 50 
2.4.2 Intention-behaviour gap ................................................................................... 51 
2.4.3 Dual process models ........................................................................................ 52 
2.5 Thesis aims and research questions ........................................................................ 53 
2.5.1 Aim of thesis .................................................................................................... 53 
2.5.2 Overview of thesis ........................................................................................... 54 
2.6 Chapter summary ..................................................................................................... 56 
Chapter 3 : Public perceptions and awareness of lung Cancer and lung 
cancer screening in different socioeconomic groups: an integrative 
systematic review .......................................................................................... 57 
3.1 Introduction .............................................................................................................. 57 
3.2 Aim of review and research questions .................................................................... 57 
3.3 Methodology .............................................................................................................. 58 
3.3.1 Protocol and registration .................................................................................. 58 
3.3.2 Eligibility criteria and scope of review ............................................................ 58 
3.3.3 Information sources .......................................................................................... 59 
3.3.4 Search strategy ................................................................................................. 59 
3.3.5 Data management ............................................................................................. 61 
3.3.6 Article selection and quality assessment process ............................................. 61 
3.3.7 Data synthesis .................................................................................................. 62 
3.4 Results ........................................................................................................................ 64 
3.4.1 Description of included studies ........................................................................ 64 
3.4.2 Quantitative and mixed method study results .................................................. 65 
3.4.3 Qualitative study results ................................................................................... 83 
3.4.4 Qualitative thematic analysis ........................................................................... 92 
3.4.4.1 Qualitative thematic framework – lung cancer ........................................ 92 
3.4.4.2 Qualitative thematic framework – lung cancer screening ...................... 102 
3.4.5 Synthesis matrix – lung cancer ...................................................................... 106 
3.4.6 Synthesis matrix – lung cancer screening ...................................................... 112 
3.4.7 Further synthesis: reflecting on research question ......................................... 115 
3.4.7.1 Do public perceptions and awareness level of lung cancer differ between 
socioeconomic groups? ............................................................................................. 115 




3.4.7.1.2 Stigma ................................................................................................ 116 
3.4.7.1.3 Lung cancer and symptom awareness ............................................... 116 
3.4.7.1.4 Risk perception .................................................................................. 117 
3.4.7.2 Do the public perceptions and awareness level of lung cancer screening 
differ between socioeconomic groups? .................................................................... 118 
3.4.7.2.1 Barriers to screening .......................................................................... 118 
3.4.7.2.2 Smoking status and smoking cessation .............................................. 118 
3.4.7.2.3 Lung cancer (screening) awareness and beliefs ................................. 119 
3.5 Discussion ................................................................................................................ 121 
3.5.1 Overview of findings ..................................................................................... 121 
3.5.2 Comparison with other literature ................................................................... 122 
3.5.3 Methodological strengths and limitations ...................................................... 122 
3.5.4 Gaps in literature ............................................................................................ 123 
3.5.5 Review strengths and limitations ................................................................... 124 
3.6 Chapter summary ................................................................................................... 124 
Chapter 4 : Socioeconomic status and lung cancer beliefs among 
participants of a lung cancer screening trial ............................................ 126 
4.1 Introduction ............................................................................................................ 126 
4.1.1 Socioeconomic status and health inequalities ................................................ 126 
4.1.2 Health inequalities in Scotland ...................................................................... 127 
4.1.3 Socioeconomic status and cancer screening uptake ....................................... 127 
4.1.4 Socioeconomic status and cancer beliefs ....................................................... 128 
4.1.4.1 Positive and negative attitudes ............................................................... 129 
4.1.4.2 Fatalism and cancer fear ........................................................................ 129 
4.1.4.3 Perceived risk ......................................................................................... 130 
4.1.5 Measurement of socioeconomic status .......................................................... 131 
4.1.5.1 Individual-level measures ...................................................................... 131 
4.1.5.2 Composite measures .............................................................................. 132 
4.2 Aim and research questions ................................................................................... 133 
4.3 Methodology ............................................................................................................ 135 
4.3.1 Study design ................................................................................................... 135 
4.3.1.1 ECLS trial design and participants ......................................................... 135 
4.3.1.2 GP recruitment ....................................................................................... 136 
4.3.1.3 Community recruitment ......................................................................... 136 
4.3.1.4 ECLS procedure – baseline questionnaire ............................................. 137 
4.3.2 The present study: data access ....................................................................... 137 
4.3.2.1 Ethical approvals .................................................................................... 138 
4.3.2.2 Participants ............................................................................................. 138 
4.3.2.3 Measures ................................................................................................ 138 
4.3.2.4 Analysis .................................................................................................. 143 
4.4 Results ...................................................................................................................... 144 
4.4.1 Demographic characteristics of the sample ................................................... 144 
4.4.2 Univariate analysis of the demographic characteristics of the ECLS trial 
participants by the Scottish Index of Multiple Deprivation (Table 4-3) ....................... 144 
4.4.2.1 Sex .......................................................................................................... 144 
4.4.2.2 Age ......................................................................................................... 144 
4.4.2.3 Marital status .......................................................................................... 145 
4.4.2.4 Ethnicity ................................................................................................. 145 




4.4.3 Univariate Analysis of the psychosocial measures of the ECLS trial 
participants by the Scottish Index of Multiple Deprivation .......................................... 145 
4.4.3.1 Health state (Table 4-4) .......................................................................... 145 
4.4.3.2 Revised Illness Perception Questionnaire (Table 4-5) ........................... 145 
4.4.3.3 Smoking status (Table 4.5) .................................................................... 146 
4.4.4 Multivariate analysis of the demographic and psychosocial measures of the 
ECLS trial participants by the Scottish Index of Multiple Deprivation ........................ 151 
4.4.4.1 . Model 1 - demographic characteristics of ECLS participants by SIMD (Table 
4-7) ............................................................................................................................ 152 
4.4.4.1.1 Sex ..................................................................................................... 152 
4.4.4.1.2 Marital status ...................................................................................... 152 
4.4.4.1.3 Region ................................................................................................ 153 
4.4.4.1.4 Age ..................................................................................................... 153 
4.4.4.2 Model 2 - demographics and psychosocial characteristics of ECLS 
participants by SIMD (Table 4-8) ............................................................................ 153 
4.4.4.2.1 Health state (Table 4-8) ..................................................................... 153 
4.4.4.2.2 Revised Illness Perception Questionnaire (Table 4-8) ....................... 153 
4.4.4.2.3 Smoking status (Table 4-8) ................................................................ 154 
4.4.5 Univariate analysis of the demographic characteristics of the ECLS trial 
participants by individual socioeconomic status measure (Table 4-9) .......................... 158 
4.4.5.1 Sex .......................................................................................................... 158 
4.4.5.2 Age ......................................................................................................... 158 
4.4.5.3 Marital status .......................................................................................... 158 
4.4.5.4 Ethnicity ................................................................................................. 158 
4.4.5.5 Region .................................................................................................... 158 
4.4.6 Univariate Analysis of the Psychosocial Measures of the ECLS trial 
participants by Individual Socioeconomic Status Measure ........................................... 159 
4.4.6.1 Health state (Table 4-10) ........................................................................ 159 
4.4.6.2 Revised Illness Perception Questionnaire (Table 4-11) ......................... 159 
4.4.6.3 Smoking status (Table 4-11) .................................................................. 160 
4.4.7 Multivariate analysis of individual-level socioeconomic status .................... 165 
4.4.7.1 Model 1- demographic characteristics of ECLS participants by 
Individual-level SES (Table 4-13) ............................................................................ 166 
4.4.7.1.1 Marital status ...................................................................................... 166 
4.4.7.1.2 Region ................................................................................................ 166 
4.4.7.1.3 Age ..................................................................................................... 167 
4.4.7.1.4 Ethnicity ............................................................................................. 167 
4.4.7.2 Model 2 - psychosocial measures of ECLS trial participants by 
individual-level SES (Table 4-14) ............................................................................ 167 
4.4.7.2.1 Health state ........................................................................................ 167 
4.4.7.2.2 Revised Illness Perception Questionnaire .......................................... 167 
4.4.7.2.3 Smoking status ................................................................................... 168 
4.5 Discussion ................................................................................................................ 173 
4.5.1 Summary of main findings ............................................................................. 173 
4.5.2 Comparison with other literature ................................................................... 178 
4.5.3 Strengths and limitations ................................................................................ 179 
4.6 Chapter summary ................................................................................................... 180 
Chapter 5 : Do recruitment methods to cancer screening impact uptake 
across socioeconomic groups?  A comparison of GP and community 




5.1 Introduction ............................................................................................................ 182 
5.1.1 Alternative invitation methods to increase uptake of screening .................... 182 
5.1.2 Phone and text-based invitations .................................................................... 182 
5.1.3 GP endorsement ............................................................................................. 183 
5.1.4 Opportunistic invitations ................................................................................ 184 
5.1.5 Community-based invitations ........................................................................ 185 
5.1.6 Demographic and psychosocial differences impacting uptake ...................... 186 
5.2 Aim and research questions ................................................................................... 187 
5.3 Methodology ............................................................................................................ 188 
5.3.1 Study design ................................................................................................... 188 
5.3.1.1 ECLS trial design and participants ......................................................... 188 
5.3.1.2 GP recruitment ....................................................................................... 189 
5.3.1.3 Community recruitment ......................................................................... 189 
5.3.1.4 ECLS Procedure – baseline questionnaire ............................................. 190 
5.3.2 The present study: data access ....................................................................... 190 
5.3.2.1 Ethical approvals .................................................................................... 191 
5.3.2.2 Participants ............................................................................................. 191 
5.3.2.3 Measures ................................................................................................ 191 
5.3.2.4 Analysis .................................................................................................. 196 
5.4 Results ...................................................................................................................... 197 
5.4.1 Demographic characteristics of the sample ................................................... 197 
5.4.2 Univariate analysis ......................................................................................... 197 
5.4.2.1 Demographic characteristics of GP recruited vs. community recruited 
participants (Table 5-3) ............................................................................................ 197 
5.4.2.1.1 Sex ..................................................................................................... 197 
5.4.2.1.2 Age ..................................................................................................... 197 
5.4.2.1.3 Marital status ...................................................................................... 197 
5.4.2.1.4 Ethnicity ............................................................................................. 198 
5.4.2.1.5 Region ................................................................................................ 198 
5.4.2.1.6 SIMD ................................................................................................. 198 
5.4.2.1.7 Individual SES ................................................................................... 198 
5.4.2.2 Psychosocial measures by recruitment source ....................................... 201 
5.4.2.2.1 Health state (Table 5-4) ..................................................................... 201 
5.4.2.2.2 Revised Illness Perception Questionnaire (Table 5-4) ....................... 201 
5.4.2.2.3 Smoking status (Table 5-5) ................................................................ 202 
5.4.3 Multivariate analysis ...................................................................................... 205 
5.4.3.1 Demographic characteristics .................................................................. 206 
5.4.3.1.1 Sex ..................................................................................................... 206 
5.4.3.1.2 Region ................................................................................................ 206 
5.4.3.1.3 Marital status ...................................................................................... 206 
5.4.3.1.4 SIMD & individual SES .................................................................... 206 
5.4.3.2 Psychosocial measures ........................................................................... 206 
5.5 Discussion ................................................................................................................ 210 
5.5.1 Summary of main findings ............................................................................. 210 
5.5.2 Comparison with other literature ................................................................... 212 
5.5.3 Strengths and limitations ................................................................................ 213 
5.6 Chapter summary ................................................................................................... 214 
Chapter 6 : What barriers and beliefs lead to non-attendance in the 




6.1 Introduction ............................................................................................................ 216 
6.1.1 Decision-making about cancer screening ...................................................... 216 
6.1.1.1 Inclined abstainers .................................................................................. 217 
6.1.1.2 Cognitive and practical barriers to screening ......................................... 217 
6.1.1.3 Theoretical models for cancer screening ............................................... 218 
6.1.1.4 Common-Sense Model of Self-Regulation ............................................ 219 
6.1.1.5 Health Action Process Approach ........................................................... 220 
6.1.1.6 Using two models to explain cancer screening participation ................. 221 
6.2 Aim and research question .................................................................................... 221 
6.3 Methodology ............................................................................................................ 222 
6.3.1 Context ........................................................................................................... 222 
6.3.2 Design and sample of present study ............................................................... 222 
6.3.3 Procedure ....................................................................................................... 222 
6.3.4 Data analysis .................................................................................................. 224 
6.3.5 Ethical considerations and approvals ............................................................. 225 
6.4 Results ...................................................................................................................... 227 
6.4.1 Demographics ................................................................................................ 227 
6.4.2 Reasons for non-attendance ........................................................................... 227 
6.4.3 Related themes and CSM & HAPA constructs .............................................. 227 
6.4.4 Identified themes mapped against the constructs of CSM and HAPA .......... 230 
6.4.4.1 Perceived risk / Cause (CSM)/ Risk perception (HAPA) ...................... 230 
6.4.4.2 ... Perceived Severity / Consequences (CSM) / Outcome expectancies (HAPA)
 .................................................................................................................................. 232 
6.4.4.3 Lung cancer vs. other cancers / Identity (CSM) .................................... 234 
6.4.4.4 Stoicism / Coping strategies (CSM) / Coping planning (HAPA) .......... 235 
6.4.4.5 Co-morbidity .......................................................................................... 236 
6.4.5 CSM & HAPA constructs not identified in initial identification of themes .. 236 
6.4.5.1 CSM constructs ...................................................................................... 236 
6.4.5.1.1 Timeline ............................................................................................. 236 
6.4.5.1.2 Cure/control ....................................................................................... 237 
6.4.5.1.3 Coherence .......................................................................................... 237 
6.4.5.1.4 Emotional representations .................................................................. 238 
6.4.5.1.5 Coping (not including stoicism) ........................................................ 238 
6.4.5.1.6 Active coping ..................................................................................... 239 
6.4.5.1.7 Denial and avoidance ......................................................................... 239 
6.4.5.1.8 Illness outcome .................................................................................. 240 
6.4.5.2 HAPA constructs .................................................................................... 243 
6.4.5.2.1 Intention ............................................................................................. 243 
6.4.5.2.2 Task self-efficacy ............................................................................... 243 
6.4.5.2.3 Maintenance self-efficacy .................................................................. 244 
6.4.5.2.4 Recovery self-efficacy ....................................................................... 244 
6.4.5.2.5 Action planning .................................................................................. 245 
6.4.5.2.6 Coping planning (not including stoicism) ......................................... 245 
6.4.5.2.7 Self-monitoring .................................................................................. 246 
6.5 Discussion ................................................................................................................ 247 
6.5.1 Summary of main findings ............................................................................. 247 
6.5.2 Comparison with other literature ................................................................... 252 
6.5.3 Strengths and limitations ................................................................................ 254 
6.6 Chapter summary ................................................................................................... 255 




7.1 Introduction ............................................................................................................ 256 
7.2 Overview of main findings ..................................................................................... 256 
7.2.1 Do public perceptions of lung cancer and lung cancer screening differ between 
socioeconomic groups? ................................................................................................. 256 
7.2.2 Do the demographic and psychosocial characteristics of ECLS trial 
participants vary by socioeconomic status? .................................................................. 259 
7.2.3 Do socioeconomic status, beliefs and attitudes towards lung cancer and lung 
cancer screening differ by invitation type? ................................................................... 262 
7.2.4 What are the perceived barriers and beliefs about lung cancer and lung cancer 
screening held by screening non-attenders? .................................................................. 265 
7.3 Strengths and limitations ....................................................................................... 269 
7.3.1 Exploration of an unmet research need .......................................................... 269 
7.3.2 Mixed methods approach ............................................................................... 269 
7.3.3 Generalisability of screening trial .................................................................. 270 
7.3.4 Secondary data set .......................................................................................... 271 
7.3.5 Recruitment challenges .................................................................................. 272 
7.4 Implications for future research, policy and practice ......................................... 272 
7.4.1 Future research ............................................................................................... 272 
7.4.2 Implications on policy and practice ............................................................... 274 
7.5 Conclusions .............................................................................................................. 276 
Appendix 1: PROSPERO systematic review registration ...................... 278 
Appendix 2: Systematic review search strategy ....................................... 281 
Appendix 3: Systematic review data extraction form ............................. 282 
Appendix 4: NHS ethics application approval correspondence ............. 283 
Appendix 5: Participant information sheet .............................................. 286 
Appendix 6: Participant consent form ...................................................... 290 
Appendix 7: Non-attender interview schedule ......................................... 291 
Appendix 8: ECLS sub-study protocol submitted for NHS ethics ......... 293 






List of tables 
Table 2-1: Thesis Research Questions ................................................................................. 53 
Table 3-1: Eligibility Criteria ............................................................................................... 59 
Table 3-2: Reason for Exclusion from Systematic Review ................................................. 60 
Table 3-3: Article Selection Questions ................................................................................ 62 
Table 3-4: Summary of Included Studies ............................................................................ 64 
Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15)
 .............................................................................................................................................. 65 
Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods 
Studies (n = 7) ...................................................................................................................... 76 
Table 3-7: Data Extraction - Lung Cancer Qualitative Studies (n = 6) ............................... 83 
Table 3-8: Data Extraction - Lung Cancer Screening Qualitative Studies (n = 2) .............. 89 
Table 3-9: Thematic Framework Analysis of Qualitative Lung Cancer Studies ................. 92 
Table 3-10: Thematic Framework Analysis of Qualitative Lung Cancer Screening Studies
 ............................................................................................................................................ 102 
Table 3-11: Thematic Synthesis Matrix for Lung Cancer Studies ..................................... 106 
Table 3-12: Thematic Synthesis Matrix for Lung Cancer Screening Studies .................... 112 
Table 3-13: Summary of Review Findings ........................................................................ 121 
Table 4-1: ECLS Participants Eligible for this Analysis ................................................... 138 
Table 4-2: Measures ........................................................................................................... 139 
Table 4-3: Demographic Characteristics by SIMD 5 ......................................................... 147 
Table 4-4: Mean Health State Score by SIMD 5 (One-way ANOVA) ............................. 148 
Table 4-5: Psychosocial Measures by SIMD 5 .................................................................. 149 
Table 4-6: Test for Multicollinearity ................................................................................. 152 
Table 4-7: Multinomial Logistic Regression of SIMD 5 (Model 1: Demographics) ........ 155 
Table 4-8: Multinomial Logistic Regression of SIMD 5 (Model 2: Demographic & 
Psychosocial Measures) ..................................................................................................... 156 
Table 4-9: Demographic Characteristics by Individual SES Score ................................... 161 
Table 4-10: Mean Health State Score by Individual SES Score (One-way ANOVA) ...... 162 




Table 4-12: Test for Multicollinearity ............................................................................... 166 
Table 4-13: Multinomial Logistic Regression of Individual SES (Model 1: Demographic 
Variables) ........................................................................................................................... 169 
Table 4-14: Multinomial Logistic Regression of Individual SES (Model 2: Demographic 
and Psychosocial Variables) .............................................................................................. 170 
Table 4-15: Area-level SES (SIMD) Findings ................................................................... 174 
Table 4-16: Individual-level SES Findings ........................................................................ 175 
Table 5-1: ECLS Participants Eligible for this Analysis ................................................... 191 
Table 5-2: Measures ........................................................................................................... 192 
Table 5-3: Demographic Characteristics by Recruitment Source ...................................... 199 
Table 5-4: Mean Health State Score by Recruitment Source ............................................ 202 
Table 5-5: Psychosocial Measures by Recruitment Source ............................................... 203 
Table 5-6: Test for Multicollinearity ................................................................................. 205 
Table 5-7: Multiple Logistic Regression (0 = GP recruitment; 1 = community recruitment)
 ............................................................................................................................................ 208 
Table 5-8: Summary of Findings ....................................................................................... 211 
Table 6-1: Patterns of Intention - Behaviour (adapted from Orbell & Sheeran, 1998) ..... 217 
Table 6-2: Participant Characteristics & Reasons for Non-attendance .............................. 228 
Table 6-3: Quotes Illustrating Developed Themes and Related CSM & HAPA Constructs
 ............................................................................................................................................ 229 
Table 6-4: Summary of Findings - How do Different Beliefs Influence Non-attendance or 
Reappointing to a Cancer Screening Trial? ....................................................................... 249 
Table 6-5: Summary of Findings - HAPA Constructs ....................................................... 250 











List of figures 
Figure 1-1: Incidence and Mortality Rates by SIMD (2016) Deprivation Quintile (Public 
Health Scotland, 2020) ......................................................................................................... 21 
Figure 1-2: ECLS Trial Consort Flowchart (Sullivan et al., 2020) ...................................... 30 
Figure 3-1: PRISMA Chart .................................................................................................. 60 
Figure 3-2: Outline of Data Synthesis Method .................................................................... 63 
Figure 4-1: Inclusion Criteria of the ECLS Trial ............................................................... 136 
Figure 5-1: Inclusion Criteria of the ECLS Trial ............................................................... 189 
Figure 6-1: Common-Sense Model of Self-Regulation (Leventhal, 2003) ....................... 220 
Figure 6-2: Health Action Process Approach (Schwarzer, 1992; Schwarzer, 2008) ......... 221 

























This PhD has most definitely been a marathon, and not a sprint. I am very grateful to all of 
those who provided me with support and guidance along the way. 
 
My PhD supervisors, Dr Katie Robb and Dr Sara Macdonald, have provided me with their 
time, guidance and expertise. More than this, Katie and Sara have shown me great 
understanding and compassion. Without them I do not think I would have persisted. I am 
grateful to have worked with such inspiring women. I thank them both for their 
unwavering support. 
 
A large component of this PhD involved working with the ECLS trial. I show a huge debt 
of gratitude to the study participants and to the ECLS trial team. Without them this thesis 
would not be possible. 
 
I have been fortunate to have worked with some excellent colleagues in IHW, in particular, 
Dr Marie Kotzur and Lauren Gatting. I have been extremely lucky to have worked 
alongside them and am thankful for the excellent advice they have given me throughout 
this journey. It has been a true pleasure to get to know them. 
 
Finally, I would like to thank my family, who have been with me every step of the way. I 
would like to my Mum, Lesley, for her unconditional support. She might not know exactly 
what I do, but her support and encouragement are unwavering. My daughter, Isobel, was 
not around when I started this PhD. She has always provided me with a light at the end of 
the tunnel and I love her infinitely. Undoubtedly, I would have finished this PhD much 
sooner if it was not for her, but I thank her for her patience and love. Finally, I would like 
to thank my husband, Jamie. He has pushed me along for the last six years and believed in 
me when I did not. I cannot begin to explain how much his support has meant to me. None 














Author’s declaration  
 
I declare that, except where explicit reference is made to the contribution of others, that 
this thesis is the result of my own work and has not been submitted for any other degree at 


































ABC Awareness and Beliefs about Cancer measure 
CAM Cancer Awareness Measure 
CHI Community Health Index 
COPD Chronic Obstructive Pulmonary Disease 
CRUK Cancer Research UK 
CSM Common-Sense Model of Self-Regulation 
CT Computed Tomography  
CXR Chest X-ray 
DANTE 
Detection and Screening of Early Lung Cancer with Novel 
Imaging Technology trial  
DNA Did Not Attend 
ECLS Early detection of Cancer of the Lung Scotland trial 
FIT Faecal Immunochemical Test 
FOBT Faecal Occult Blood Test 
GP General Practitioner  
HAPA  Health Action Process Approach 
HBM Health Belief Model  
HINTS Health Information Trends Survey 
IMD Index of Multiple Deprivation 
ISD Scotland Information Services Division Scotland 
ITALUNG Italian Lung Cancer Screening trial 
LDCT Low-dose Computed Tomography 
LLP Liverpool Lung Project 
MILD Multicentric Italian Lung Detection trial 
NCI National Cancer Institute  




NLST National Lung Screening Trial 
NSCLC Non-small Cell Lung Cancer 
PAPM Precaution Adoption Process Model  
PLCO Prostate, Lung, Colorectal and Ovarian Screening trial 
RCT Randomised Controlled Trial 
RIPQ-LC Revised Illness Perception Questionnaire – Lung Cancer 
SCLC Small Cell Lung Cancer 
SCT Social Cognitive Theory 
SEP  Socioeconomic Position 
SES Socioeconomic Status 
SIMD Scottish Index of Multiple Deprivation 
TB Tuberculosis 
TCTU Tayside Clinical Trials Unit 
TPB Theory of Planned Behaviour  
TRA Theory of Reasoned Action 
TTM Transtheoretical Model  
UK NSC UK National Screening Committee 
UKLS UK Lung Screening trial 
USPSTF US Preventative Services Task Force 
VIF Variance Inflation Factor  










Chapter 1 : Lung cancer epidemiology and lung 
cancer screening 
The aim of this chapter is to set lung cancer and lung cancer screening in context and 
provide a clear rationale for the studies described in this thesis. This will be achieved by 
describing the epidemiology of lung cancer and the current position of lung cancer 
screening, including reported barriers to uptake. The chapter will also highlight the body of 
literature that explores cancer inequalities and discusses the mechanisms surrounding the 
variation in uptake in lung cancer screening. 
 
1.1 The problem: a cancer of substantial unmet need 
Lung cancer is the leading cause of cancer death worldwide (World Health Organisation 
(WHO), 2020). It is a disease of high symptom burden, psychological distress and is 
associated with poor quality of life (Mazières et al., 2015; Yang et al., 2012). Despite the 
burden lung cancer places on individuals, and the association with very poor outcomes, 
lung cancer research is severely underfunded (Carter & Nguyen, 2012). Lung cancer has 
been described as a cancer of substantial unmet need by Cancer Research UK (CRUK), 
and there have been calls for prioritisation of lung cancer to ensure that progress in 
research is akin to other types of cancer (CRUK, 2015). While overall cancer survival has 
doubled since the 1970’s, the survival rate of lung cancer has only shifted marginally, with 
5-year survival being around 9% in the UK (CRUK, 2015). 
 
Health inequalities exist in lung cancer incidence and mortality. Lung cancer 
disproportionately impacts those from deprived groups. Those from more deprived groups 
are not only more likely to be diagnosed with lung cancer, but they are also more likely to 
die from it when compared to their less deprived counterparts (Powell, 2019). The 
mechanisms behind this health inequality are also under-researched, which is evident by 
the dearth of literature when compared to other types of cancer (Powell, 2019). 
 
It is clear that there is much work to be done to improve lung cancer outcomes and our 






1.2 Lung cancer epidemiology  
1.2.1 Lung cancer presentation 
Lung cancer develops from the abnormal growth of cells within the lungs, bronchi or 
trachea. Lung cancer can be categorised into two main types: small cell lung cancer 
(SCLC) and non-small cell lung cancer (NSCLC). The distinction between these types of 
lung cancer is important for management, prognosis, and screening efficacy (Nanavaty, 
Alvarez & Alberts, 2014). 
 
SCLC accounts for 15-20% of all lung cancers diagnosed. Although a smaller proportion 
of the total lung cancers diagnosed, it is described as aggressive and characterised by rapid 
doubling time and early metastasis, making it more challenging to detect during the early 
stages (CRUK, 2020; Nanavaty, Alvarez & Alberts, 2014). NSCLC is the most common 
form of lung cancer, accounting for 80-85% of all lung cancers (CRUK, 2020). There are 
three main types of NSCLC, including adenocarcinoma, squamous cell carcinoma and 
large cell carcinoma. These types of lung cancer behave and respond to treatment in a 
similar way. Significantly, in contrast to SCLC, NSCLC are easier to detect at an earlier 
stage using screening. 
 
1.2.2 Incidence and mortality of lung cancer  
Lung cancer is both the most commonly diagnosed type of cancer, and the leading cause of 
cancer death worldwide. In 2018, lung cancer accounted for over two million diagnoses of 
cancer. Lung cancer accounts for 18.4% of all cancer deaths, which is double that of bowel 
cancer (9.4%), the second highest cause of cancer death (WHO, 2020).  In the UK, lung 
cancer accounts for 13% of all new cancer cases and 21% of all cancer deaths. Lung cancer 
mortality rates are significantly higher in Scotland when compared to the UK average 
(CRUK, 2020).  
 
Lung cancer is the most common type of cancer in Scotland, with 15.8% of all cancers 
diagnosed attributed to lung cancer (Public Health Scotland, 2020a). A quarter of all deaths 
from cancer in Scotland are attributed to lung cancer. The number of deaths owing to lung 
cancer are more than double that of colorectal cancer, which is the next most common 





Lung cancer mortality is higher than other forms of cancer, often because of late stage 
diagnosis. Almost half of those with lung cancer (46%) are diagnosed when the cancer has 
already metastasised to other areas of the body, making it more difficult to treat (Public 
Health Scotland, 2020). Late stage lung cancer diagnosis (Stage IV) can, in some cases, be 
attributed to an absence of any recognisable symptoms (such as a persistent cough or 
unexplained weight loss) until the later stages of the disease (Public Health Scotland, 
2020a). 
 
Lung cancer mortality in Scotland reduced by 18.5% between 2008 and 2018 (Public 
Health Scotland, 2020a). However, mortality rates are predicted to increase as a response 
to restrictions to some healthcare services throughout the COVID-19 pandemic. This is the 
result of a reduction in the number of people seeking help for lung cancer symptoms and 
the reduced availability of diagnostic services. It is estimated that there will be a 4.8% 
increase in 5-year lung cancer death in the UK, compared to pre-COVID (Maringe, Spicer, 
Morris, Purushotham, Nolte, Sullivan, Rachet & Aggarwal, 2020). 
 
1.2.3 Demographic characteristics associated with lung cancer 
incidence and mortality 
1.2.3.1 Sex  
In contrast to other UK nations, the incidence of lung cancer in Scotland is slightly higher 
among women than men (Public Health Scotland, 2020b). This reflects a change in both 
incidence and mortality rates between men and women over the past 10 years. Lung cancer 
mortality rates in men have decreased by 25% in the past decade when compared to 
women, whose mortality rate has decreased by 10%. The difference in the rates of 
reduction, between men and women, is a result of historic trends in smoking behaviour 
prevalence (Public Health Scotland, 2020b).  
 
1.2.3.2 Socioeconomic status  
There is a clear association between lung cancer incidence and deprivation (Fig. 1-1). In 
Scotland, the incidence rate is three times higher in the most deprived areas (Scottish Index 
of Multiple Deprivation (SIMD) 1) when compared to those in the least deprived areas 
(SIMD 5) (Public Health Scotland, 2020c). This social gradient can also be seen in lung 
cancer mortality rates, which indicate that those from the most deprived areas of Scotland 




deprived areas of Scotland (Public Health Scotland, 2020c). This association, between 
incidence and mortality and deprivation level, is not unique to Scotland; it is also evident 
in other countries of the UK (National Cancer Intelligence Network, 2014) and 
internationally (Mihor, Tomsic, Zagar, Lokar & Zadnik, 2020). 
 
Higher incidence of lung cancer among those from the most deprived groups is correlated 
with the increased prevalence of smoking in these groups (Hiscock, Bauld, Amos, Fidler & 
Munafo, 2012). Smoking is more common in deprived areas of Scotland (32% prevalence) 
when compared to the least deprived areas (9% prevalence) (Public Health Scotland, 
2020a). Further, those from more deprived groups are less likely to successfully quit 
smoking compared to more affluent groups, despite being just as likely to attempt to stop 
(Hiscock et al., 2012). 
 
Figure 1-1: Incidence and Mortality Rates by SIMD (2016) Deprivation Quintile 
(Public Health Scotland, 2020) 
  
 
1.2.4 Risk factors 
1.2.4.1 Smoking 
Tobacco smoking is the most significant contributor to lung cancer incidence, responsible 
for 72.2% of all lung cancers diagnosed in the UK (Brown et al., 2018). Risk of lung 
cancer death is around 15 times higher in current smokers compared with never-smokers 
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consumption of cigarettes, longer duration and starting smoking at a younger age (Doll et 
al., 2005; Lubin & Caporaso, 2006; Kenfield et al., 2010). Around 1% of all lung cancers 
in the UK are the result of environmental tobacco smoke, and account for 15% of lung 
cancer diagnosis that occur in never-smokers (Brown et al., 2018). Smoking cessation is 
the most effective way to decrease risk of lung cancer and improve life expectancy (Pirie, 
Peto, Reeves, Green and Beral, 2013). 
 
Smoking prevalence in Scotland has declined significantly since 2003, with adult smoking 
rates declining from 28% to 19% in 2018 (Scottish Government, 2020c). Changes in policy 
may have had significant implications on the reduction in smoking rates in Scotland. For 
example, the Smoking, Health and Social Care (Scotland) Act 2005 prohibited smoking in 
most enclosed public places, and more recently, the Scottish Governments five-year action 
plan set out interventions and policies to help reduce the use of and associated harms from 
using tobacco in Scotland (Scottish Government, 2018a). However, despite the proactive 
approach to reduce smoking related harm, smoking prevalence in Scotland is still higher 
than England and Wales (Office of National Statistics, 2020). 
 
1.2.4.2 Age 
There are a number of risk factors associated with the development of lung cancer. Age is 
associated with the development of lung cancer, with higher incidence of lung cancer being 
found in people over the age of 60 (Public Health Scotland, 2020b). 
 
1.2.4.3 Pre-existing lung disease or lung condition 
A person’s medical history may also play a role in the risk of developing lung cancer. Risk 
of lung cancer increases significantly with a history of lung disease (such as COPD). Lung 
cancer risk is 104-144% higher in smokers with a history of emphysema, and 47-52% 
higher in smokers with a history of chronic bronchitis (Brenner et al., 2012).  
 
Pre-existing lung conditions have been found to be correlated with socioeconomic status, 
with those from more deprived groups disproportionately affected by COPD (Pleasants, 
Riley & Mannino, 2016). This is the result of higher rates of tobacco use and also 





1.2.4.4 Environmental exposure 
There are significant associations between environmental and occupational exposure and 
the development of lung cancer. Around 8% of all lung cancer cases are caused by air 
pollution and 13% are caused by occupational exposure, such as asbestos exposure (Brown 
et al., 2018).  
 
Those from lower socioeconomic groups are historically more likely to have been exposed 
to harmful environmental and occupational carcinogenic toxins (Hovanec et al., 2018). 
This is the result of traditional occupation types carried out by those from lower 
socioeconomic groups, such as metal production and processing, construction, mining, the 
chemical production and occupations working with asbestos, have significantly higher 
carcinogenic risk (Hovanec et al., 2018). 
 
1.2.4.5 Family history 
A family history of lung cancer significantly increases risk of developing lung cancer. 
Lung cancer risk is 50% higher in people who have a family history of lung cancer. There 
is a significant association between having a sibling who has had lung cancer and 
developing lung cancer. This association is stronger in siblings compared to risk based on 
lung cancer history of parents (Coté et al., 2012).  
 
A family history of lung cancer does not appear to be related to SES. Evidence suggests 
that this type of risk is associated with genetic factors that contribute to susceptibility to 
lung cancer (Cassidy, Myles, Duffy, Liloglou & Field, 2006). 
 
1.3 Screening for lung cancer 
 
1.3.1 Definition of screening and screening criteria  
The UK National Screening Committee (UK NSC) defines screening as “the process of 
identifying healthy people who may have an increased chance of a disease or condition. 
The screening provider then offers information, further tests and treatment. This is to 
reduce associated problems or complications. Screening should always be a personal 
choice” (UK NSC, 2017). National screening programmes target large population groups 




is to lower incidence and improve early diagnosis and health outcomes for patients (NHS 
England, 2019). 
 
The WHO published a set of criteria to determine whether a condition or disease should be 
considered a population screening programme (Wilson & Jugner, 1968). The initial criteria 
were first developed in 1968 and argued that national screening programmes should only 
be considered for implementation if the condition is an important public health problem, 
with an identifiable early stage at which treatment is demonstrably more effective. The 
screening test itself must be acceptable, with adequate infrastructure for follow-up, and any 
risk of harm from the test must be outweighed by the likelihood of benefit (Wardle, Robb, 
Vernon & Waller, 2015). The UK NSC last updated their screening criteria in 2015 (NHS 
England, 2019). In the UK, screening for cervical, breast and bowel cancer are considered 
to meet the criteria for national cancer screening programmes (UK NSC, 2017). 
 
1.3.2 Existing national cancer screening programmes in the UK 
The UK currently has three organised cancer screening programmes for breast, cervical 
and bowel cancer. Breast screening is offered to women aged 50-70 in all UK nations. The 
screening uses a test called mammography which involves taking x-rays of the breasts. 
Mammography is offered every three years.  
 
Cervical screening is offered to women aged 25-64 in the UK. It is offered every three 
years for women aged 25-49, and every five years for women 50-64. The test aims to pick 
up cell changes that could develop into cancer if left untreated and involves taking a 
sample of cells from the cervix. 
 
Bowel screening is offered to men and women aged 60-74 in England, Wales and Northern 
Ireland. In Scotland, men and women aged 50-74 are offered screening. The screening 
programme sends a bowel cancer testing kit every 2 years to people eligible to take part. 
The kits sent out in the UK vary depending on country as each has its own bowel screening 
programme – those in England, Wales and Scotland are offered faecal immunochemical 
test (FIT), while those in Northern Ireland are offered faecal occult blood (FOB) tests. 
Both types of test involve collecting a sample of bowel movement at home and returning it 




In order to be invited to be screened for breast, cervical or bowel cancer in the UK, you 
must be registered with a GP. At present all invitations for breast and bowel screening are 
sent centrally, whereas invitations for cervical screening are sent via primary care.  
1.3.3 Cancer screening uptake in Scotland  
Uptake of the screening programmes vary. In Scotland, 71.2% of women invited to take 
part in breast screening attended their screening appointment (ISD Scotland, 2019a), 
73.1% attended cervical screening (ISD Scotland, 2019b), and among men and women 
eligible for bowel screening 63.9% completed screening (ISD Scotland, 2019c). Analysis 
of Scottish uptake of cancer screening indicates that screening participation is lower for 
those in lower socioeconomic status groups across all of the cancer screening programmes 
offered. Of those eligible to take part, those who fall into the lowest SIMD group (SIMD 1) 
uptake for bowel screening is 46.5%, compared to those in the least deprived group (SIMD 
5) who have an uptake rate of 68.9% (ISD Scotland, 2019c). Similarly, in Scotland’s 
cervical screening programme, women from the most deprived areas are also less likely to 
take part in the screening programme (67% of those living in the most deprived areas 
attend, compared to 78% from the least deprived areas; ISD Scotland, 2019b). Breast 
screening uptake was 58.5% in the most deprived group, compared to 79.1% in the least 
deprived group (ISD Scotland, 2019a). 
 
The difference in screening uptake contributes to widening health inequality in Scotland, 
with the cancer mortality rates between Income-Employment Index1 group one and 
Income-Employment Index group ten being significantly different (Scottish Government, 
2018). Of people in the 45-74-year age group, those in Scotland’s most deprived areas are 
more than twice as likely to die of cancer than those in the least deprived (567.1 deaths per 
100,000 population compared to 257.1 per 100,000 population, in 2017; Scottish 
Government, 2018). 
 
There are a number of barriers to screening for deprived groups (Lo et al., 2013; Smith et 
al., 2016) and the way in which people are invited to screen may impact whether they 
choose to take part.  
 
 
1 Income-Employment Index is a ‘sub-measure’ of SIMD, which includes the income and employment 
domains of the index only. The reasoning behind this was that income / poverty / employment are felt to 




1.3.4 Screening tests for lung cancer 
Early diagnosis of lung cancer is challenging because it can often be asymptomatic in early 
stages (Blandin Knight, Crosbie, Balata, Chudziak, Hussell and Dive, 2017). Most patients 
(75%) are therefore diagnosed when the disease is in advanced stages (stage III/IV) 
(Walters et al., 2012) and the window for successful treatment reduces as the disease 
advances (Blandin Knight et al., 2017). This highlights the significant need for the 
implementation of strategies for detecting lung cancer at an early stage. 
 
The development of early detection screening for lung cancer has progressed rapidly in the 
last decade, with promising advances in low-dose computed tomography (LDCT) and 
alternative forms of screening such as lung cancer antibody detection (Blandin Knight et 
al., 2017). 
 
1.3.4.1 Chest x-ray  
Chest X-Ray (CXR) was the first form of lung cancer screening, with a number of trials 
evaluating the effectiveness of x-ray as a tool for early diagnosis in the 1970s, and the first 
large-scale randomised controlled trials (RCT) being carried out in the 1980s. Early trials 
all produced null findings, with CXR not making any significant difference in mortality 
(Frost et al., 1984; Kubik & Polak, 1986; Melamed et al., 1984). More recently the 
Prostate, Lung, Colorectal and Ovarian Cancer Screening trial (PLCO) found that there 
was no mortality benefit to annual screening with CXR compared to usual care (Oken et 
al., 2011). The results of these studies indicate the limited effectiveness of CXR as an early 
diagnosis screening test. 
 
1.3.4.2 Low-dose computed tomography  
Computed tomography (CT) produces more detailed images of the chest compared to CXR 
alone by combining x-ray equipment with advanced computer technology in order to 
generate multiple cross-sectional images of the inside of the body. The 3D scan images are 
interpreted by radiologists in order to identify potential pulmonary nodules that could be 
cancer. 
 
The radiation dose of CT scanning is about 100 times higher than CXR (Blandin Knight et 
al., 2017). This is too high for the benefits of early diagnosis to outweigh the risks of 




radiation doses has made LDCT scanning a promising technique for the early diagnosis of 
lung cancer. LDCT has 22% of the effective radiation dose of a standard CT, making it 
more viable as a screening tool (Larke et al., 2011). 
 
There have been a number of trials that have explored the effectiveness of LDCT in the 
detection of lung cancer, with a significant proportion of these studies carried out in 
Europe. So far, all of these trials have focused on at-risk populations, with eligibility 
commonly defined by age and smoking history (i.e. 20-30 pack years) (Blandin Knight et 
al., 2017). Unfortunately, a number of the studies did not have adequate statistical power to 
detect an effect on lung cancer mortality. Three Italian studies (Multicentric Italian Lung 
Detection Trial (MILD; n = 4099); Italian Lung Cancer Screening Trial (ITALUNG; n = 
3206); and the Detection and Screening of Early Lung Cancer with Novel Imaging 
Technology trial (DANTE; n = 2472) all reported no mortality benefit to LDCT when 
compared to control groups (Infante et al., 2008; Lopes Pegna et al., 2013; Pastorino et al., 
2012). Similar trials have been carried out in France (DEPISCAN; n = 765), Denmark 
(DLCST; n = 4104) and the UK (UKLS; n = 4055) but did not report on mortality as the 
focus was on the number of cancers detected at an early stage (Blanchon et al., 2007; Field 
et al., 2015; Saghir et al., 2012).The UKLS trial did, however, report that LDCT screening 
can be used to detect lung cancer at an early stage in over 80% of cases (Field et al., 2015). 
 
There have also been some successes in reducing lung cancer mortality with the use of 
LDCT. At 10-year follow up of the Dutch-Belgian trial (NELSON; n =15,822) results 
indicated that lung cancer related mortality was 24% lower among current and former 
smokers who underwent LDCT, compared to those who underwent no screening (de 
Koning et al., 2020). The National Lung Screening Trial (NLST), carried out in the United 
States, conducted the largest LDCT RCT to date (n =53,454; The National Lung Screening 
Trial Research Team, 2011). Participants at high risk of lung cancer (aged 55-74; 30-pack 
year history; smoked within the past 15-years) were randomised to annual LDCT or CXR 
over three years. After follow-up, there was found to be a significant reduction in lung 
cancer mortality (20%), as well as a reduction in late-stage diagnosis in the LDCT group 
compared to the CXR group. 
 
Despite the apparent success of the NLST, there has been some criticism, including 
overdiagnosis (Infante et al., 2012). Overdiagnosis is the term used when a condition is 




2010). Overdiagnosis is estimated to account for 18% of cancers in the NLST and could be 
an explanation for the higher detection rates in the LDCT group. The NLST also reported a 
high number of false positives in the LDCT arm (96%) compared to CXR (94%) (National 
Lung Screening Trial Research Team, 2011). This was thought to be the result of the trial 
criteria to refer any nodule more than 4mm in diameter for further investigation (Blandin 
Kinght et al., 2017).  
 
However, as a direct result of the NLST, the US Preventative Services Task Force 
(USPSTF) have been supportive of the findings and made recommendations that annual 
screening for lung cancer with LDCT in asymptomatic people at high risk of lung cancer is 
beneficial. They further advised that the upper age limit be extended to 80 years (USPSTF, 
2013). However, population screening using LDCT is yet to be recommended in the UK by 
the UK NSC. The UK NSC do not consider there to be enough evidence that a screening 
programme would be effective at improving lung cancer outcomes or that there is a 
suitable test for the use in a screening programme (UK NSC, 2007). This recommendation 
is currently under review in light of the recently published findings of the NELSON trial. 
Since the original recommendation in 2007, there have been a number of LDCT screening 
trials in the UK (e.g. UKLS) and the landscape is changing rapidly. Some of the focus is on 
understanding how we can minimise the risk of LDCT by improving our understanding of 
individual risk in a minimally invasive way. For example, in Scotland, the Early detection 
of Cancer of the Lung Scotland (ECLS) trial explored the use of biomarker detection to 
refine the criteria for LDCT screening. 
 
1.3.4.3 Biomarker detection 
Biomarker testing has been posited as a promising development in the early detection of 
lung cancer, providing a form of screening that is not invasive and is cost effective 
(Brambilla et al., 2003). Biomarker detection can be carried out using a number of 
biological sources, including sputum, exhaled breath, urine, saliva and blood. A blood test 
is often the first choice as it is efficient and a minimally invasive way to obtain biomarkers 
(Seijo et al., 2018). 
 
One such biomarker are the autoantibodies (AABs) that develop in response to an 
abnormal tumour antigen that presents in some patients with lung cancer. This AAB 
response often occurs before symptoms present or before image-based detection is possible 




patients with solid tumours up to 3-4 years before symptomatic presentation (Yongliang et 
al., 2005). However, the sensitivity of AAB tests is only around 40%, making test accuracy 
a significant issue (Blandin Knight et al., 2017). It has been suggested that biomarker 
testing could be used to optimise image-based screening, such as LDCT, by providing 
further refinement of screening selection criteria. The use of biomarker testing in this way 
would help with risk management of LDCT and reduce the overall costs of lung cancer 
screening (Seijo et al., 2018). 
 
The ECLS trial (n = 12,208) was a randomised controlled trial that aimed to use an 
enzyme-linked immunosorbent assay (EarlyCDT-Lung) that measures seven different 
AABs to identify those at high risk of lung cancer (Sullivan et al., 2020). Participants of 
the trial provided a blood sample before being randomised to the intervention arm or 
control arm (figure 1.2). Participants allocated to the intervention arm were tested with the 
EarlyCDT-Lung test. If this was positive, they received a baseline CXR (in order to 
prioritise access to CT for patients with positive findings on CXR) and chest LDCT-scan 
followed by 6-monthly LDCT scans up to 24 months post randomisation. Participants 
allocated to the control arm, and those who tested negative, received standard clinical care 
in the NHS in Scotland following national guidelines for identification and management of 
symptoms suggestive of lung cancer with no further study investigations. After a two-year 
follow-up, a total of 127 lung cancers were detected in the study population across both 
control and intervention arms. Those in the intervention arm were detected at an earlier 
stage, compared to those in the control arm. Participants in the intervention arm were 
diagnosed with lung cancer, on average, 87.3 days earlier compared to the control arm. 
However, there were no significant differences in lung cancer mortality between the 
intervention and control groups. 
 
The ECLS trial has indicated that biomarker detection can be effective in detecting lung 
cancer at an earlier stage. Further investigation is required to determine the long-term 
impact of the EarlyCDT-Lung test on mortality, with additional follow-up analysis planned 










Figure 1-2: ECLS Trial Consort Flowchart (Sullivan et al., 2020) 
 
1.3.4.4 Sputum analysis 
There is an association between abnormal sputum cytology and lung cancer (Prindiville et 
al., 2003). Sputum cytology is a non-invasive and non-radiological test that could be used 
for the early detection of lung cancer. The test does not require any specialist equipment, 





However, early studies have failed to reduce lung cancer mortality (Blandin Knight et al., 
2017; Fontana et al., 1975). More recently, a randomised controlled trial in the UK aimed 
to use a sequential screening approach to target those with COPD by using a combination 
of sputum cytology, LDCT and autofluorescence bronchoscopy to detect lung cancer. 
LungSEARCH (n = 1568) randomised participants into either a control arm (usual care) or 
surveillance arm. The surveillance arm included five annual sputum screenings, with 
further investigation with LDCT and autofluorescence bronchoscopy if sputum cytology 
indicated abnormalities. After five-year follow-up there were 42 lung cancers among 785 
screened individuals and 36 lung cancers among 783 controls. There was found to be no 
significant difference in the detection of early stage lung cancers or lung cancer mortality 
(Spiro et al., 2019). 
 
1.3.5 Potential harms of lung cancer screening  
The benefits of cancer screening are clear, with screening enabling the early detection of 
cancers, as well as supporting earlier treatment and decreasing cancer mortality. However, 
there are a number of risks associated with cancer screening that must be considered to 
ensure that participants of cancer screening are able to make an informed decision about 
taking part. 
Informed decision-making is fundamental to the ethical implementation of organised 
cancer screening programmes. Informed decision-making involves providing participants 
with adequate information about screening in order to weigh up and use the information to 
make decisions consistent with their values (Marteau, Dormandy & Michie, 2001). In 
practical terms, this includes providing screening candidates with standardised information 
material, ensuring both benefits and risks of screening are presented in a balanced way. 
As indicated by previous RCTs, lung cancer screening can miss cancers and can produce 
false negative results, with cancers often developing during screening intervals (Pinsky, 
2014; The National Lung Screening Trial Research Team, 2011). In addition to the harm 
caused by false negatives, false positives can also cause significant challenges. In LDCT, 
there has been found to be a high rate of false positives, where screening detected nodules 
that are harmless or benign. A systematic review of lung cancer LDCT trials found that 
nodules were detected in 20% of screening participants, with 90% of these being benign 




positives, can cause further harm, as well as psychological distress. A matched cohort 
study of the Dutch Lung Cancer Screening Trial participants found that receiving a false 
positive result in lung cancer screening was more likely to lead to higher rates of negative 
short-term psychosocial consequences, compared to those in the control group and the 
true-negative group (Rasmussen, Siersma, Malmqvist & Brodersen, 2020). 
Overdiagnosis has been highlighted as a potential risk of lung cancer screening, with 
cancers detected that would not have become symptomatic or caused death. Overdiagnosis 
can lead to unnecessary and harmful treatments causing negative physical and 
psychological adverse effects (Welch & Black, 2010). 
The screening test can also cause potential harm, although most are non-invasive. LDCT 
and CXR have risks associated with radiation exposure, with exposure increasing with the 
repeated scans that are often required to monitor abnormal screening results (Bach et al., 
2012). All radiation poses the risk of causing cancer, including the radiation produced by 
cancer screening. Modelling, using the NLST data, predicts approximately one cancer 
death is caused per 2500 people screened (Bach et al., 2012). The risk of radiation caused 
by lung cancer screening typically presents 10-20 years later, therefore the benefit of 
preventing lung cancer deaths is greater than the risk of radiation for those over the age of 
55 (Bach et al., 2012). The risk posed by radiation highlights the need for ‘triage’ before 
using LDCT as a tool for screening, with the developments in biomarker and sputum 





Chapter 2 : Achieving equitable uptake - 
psychosocial predictors of cancer screening 
uptake 
2.1 Challenges for lung cancer screening 
2.1.1 Selecting a target population 
Optimal delivery of lung cancer screening requires the targeting of those individuals most 
at risk. Screening programmes in the UK, such as bowel, cervical and breast screening, set 
eligibility for screening by age. However, it is unclear if those not in high risk categories 
for lung cancer screening would benefit from lung cancer screening. For example, there is 
limited evidence of the benefit of lung screening for never-smokers (Blandin Knight, 
2017). Further analysis of the NLST data, stratified by lung cancer risk, indicated that 
screening with LDCT prevented the greatest number of deaths among participants who 
were at highest risk and prevented very few deaths in those at lowest risk. Further, the 
study also found that there was a significant decrease in the number of false positives as 
participant risk level increased, decreasing the need for unnecessary diagnostic and 
invasive test procedures (Kovalchik et al., 2013). As a result, it might be more appropriate 
to have a more refined, risk-based eligibility criteria if a screening programme was to be 
implemented. 
 
Currently, there is only one widely implemented lung cancer screening programme. The 
US screening programme is based upon the eligibility criteria of the NLST with an 
increased upper age limit (see section 1.3.4.2), however this has been criticised for not 
having a more risk-based approach by only including age and pack-year history (Marcus, 
Raji & Field, 2015). Other lung cancer screening trials have had variable criteria for 
eligibility, with some taking an individual risk-based approach. The UK based Liverpool 
Lung Project (LLP), in addition to the standard age and smoking history criteria, developed 
a risk prediction model that incorporated family history of lung cancer, previous cancer 
diagnoses, history of respiratory conditions (such as COPD, bronchitis, emphysema and 
pneumonia) and work place exposure to asbestos (Cassidy et al., 2008). It is suggested that 
this more advanced individual risk-based model could predict approximately two-thirds of 
lung cancers within 5-years, screening only 30% of the population. This more restricted 
screening criteria could reduce the cost of a screening programme while also screening 




must also be addressed if this approach was implemented. There is a substantial risk of 
missing a proportion of lung cancers in individuals who do not meet the strict eligibility 
criteria. 
 
Regardless of eligibility criteria of implemented screening programmes or screening trials, 
evidence suggests that there are observable inequalities in the uptake of cancer screening. 
It is unclear how an individual risk-based approach to eligibility criteria would impact 
screening uptake in those who are eligible. 
 
2.1.2 Sociodemographic predictors of uptake  
The sociodemographic characteristics of people who do and do not attend cancer screening 
are important to the understanding of possible health inequalities that may exist. Failing to 
acknowledge the possible inequalities in cancer screening, and addressing the potential 
causes, further exacerbates and widens the health inequality gap that exists between some 
groups. The identification of health inequalities allows for positive action to be taken to 
reduce disadvantage and improve health outcomes. Like many health behaviours, distinct 
inequalities exist in screening participation.  
 
Age, sex, ethnicity and socioeconomic status are all predictors of uptake of cancer 
screening (Sarma, Silver, Kobrin, Marcus & Ferrer, 2019). Understanding and monitoring 
uptake across different demographic groups helps us to understand the variation in uptake 
and target interventions towards certain groups where uptake is low.  
 
There is only one functioning lung cancer screening programme worldwide, so there is 
limited opportunity to explore the sociodemographic predictors of this type of screening. 
As a result, we can draw on evidence from other, more developed, cancer screening 
programmes and screening trials to help us further understand what could be expected with 
regard to uptake if lung cancer screening was widely implemented. 
 
2.1.3 Sex 
There is an underlying assumption that men are less willing to engage with healthcare 
services, and subsequently, are less likely to also participate in cancer screening. However,  
research examining the sex differences in the participation of bowel cancer screening has 




differences in uptake of flexible sigmoidoscopy screening for bowel cancer concluded that 
attendance rates are significantly higher in men, compared to women (Wardle, Miles & 
Atkin, 2005). This result is contrary to the expectation that men are considerably less likely 
to utilise health services or be convinced of the value of preventative behaviours (Wardle 
et al., 2005). However, further bowel cancer screening literature also indicates that women 
are more likely to take part in home-based faecal occult blood testing (von Wagner et al., 
2011). 
 
The limited literature available on the uptake of lung cancer screening indicates that men 
are more likely to participate. In the UKLS trial, women who were at high risk of lung 
cancer, were less likely to participate compared to high risk men (Ali et al., 2015). 
Similarly, a systematic review of participation in lung cancer screening programmes also 
indicated that men are more likely than women to participate, with the mean participation 
rate for men being approximately 56% (Schütte et al., 2018). However, research from the 
US indicates that there is no sex difference in uptake of lung cancer screening. A cross-
sectional study of the sociodemographic variables associated with lung screening 
behaviour in Indiana found that there was no significant difference in sex between 
screeners and non-screeners (n =438) (Carter-Harris et al., 2018). This is further supported 
by analysis of the LDCT screening programme in the US, which also indicates that there is 
no difference in uptake between males and females (Yong et al., 2020). Overall, the uptake 
of lung screening in the US is low (<6%) and this analysis of the lung screening 
programme is limited to only three states (Florida, Nevada and Georgia). Further extensive 
analysis is required to ensure generalisability of these findings.  
 
2.1.4 Age 
Across existing cancer screening programmes, the evidence of difference in uptake by age 
is varied. There is no apparent difference in uptake by age in breast screening, but younger 
women are less likely to participate in cervical screening (Wardle et al., 2015). Uptake of 
bowel cancer screening is lowest among adults aged 60 to 64 years (Sarma et al., 2019) 
with uptake increasing with age (von Wagner et al., 2011). 
 
Within the current lung cancer screening literature, the UKLS trial found that older age is 
associated with non-uptake of lung screening (Ali et al., 2015). However, uptake of lung 






There are differences in uptake of cancer screening by ethnicity. In the UK, participation is 
higher in those who are White in breast, cervical and bowel screening (Wardle et al., 
2015). A recent study of bowel cancer screening uptake in Scotland reported complex 
patterns of variation in screening by ethnic groups. Those from South Asian groups had 
significantly lower uptake in screening compared with the White Scottish population, but 
there was higher uptake among Chinese and other White British populations (Campbell et 
al., 2020). In the US, African Americans have lower bowel cancer screening rates but 
similar rates of breast and cervical screening to non-Hispanic white Americans, with 
Hispanics reporting lower rates of breast, cervical and bowel cancer screening compared to 
non-Hispanics (Sarma et al., 2019). 
 
Low uptake among non-white groups is also evident in lung cancer screening. A study (n = 
675) exploring the racial differences in lung cancer screening uptake and follow-up 
adherence in the US indicate disparities between white and African American study 
participants (Lake et al., 2020). Black patients were significantly less likely to undertake 
LDCT screening and have longer follow-up time intervals compared to white participants. 
The authors were unable to identify reasons for this disparity but highlight potential biases 
in the healthcare system that could account for issues in uptake and follow-up. This study 
did not undertake analysis of other ethnic group uptake beyond participants who were 
white or African American. This is a clear limitation given the ethnic diversity of the US 
population and does not provide insight into other underserved groups, such as Hispanic 
Americans.  
 
It is markedly clear that the picture with regard to variation in lung cancer screening by 
ethnicity is not complete and is an area that requires further research. 
 
2.1.6 Socioeconomic status 
Socioeconomic status (SES) has been found to be a significant predictor of cancer 
screening uptake. In general terms, low SES leads to low uptake of screening behaviour 
and increased health inequalities (Weller & Campbell, 2009). SES acts as a measure of a 
person’s access to social and economic resources and is usually determined by markers 




SES can also be described as socioeconomic position or socioeconomic group, and these 
three terms are often used interchangeably (Conway, McMahon, Brown & Leyland, 2019). 
SES is commonly used as an indicator of socioeconomic deprivation level, with lower SES 
equating to higher levels of deprivation (Galobardes, Lynch & Smith, 2007).  
 
There are a number of ways to measure SES, but it is frequently measured with individual 
measures of SES (such as, income, education level, occupation and household indicators), 
or composite measures of SES (a combination of individual measures) (Galobardes, Lynch 
& Smith, 2007). Composite measures can be used to determine the SES of individuals or 
groups and capture multiple dimensions of SES. Composite measures are commonly used 
to measure area-level SES, such as SIMD (Scottish Government, 2020b). 
 
Moser, Patnick & Beral (2009) studied the relationship between women’s reported use of 
breast and cervical screening in the UK and their sociodemographic characteristics and 
concluded that indicators of wealth were important for predicting uptake of breast 
screening, but not cervical screening. Those who had a higher economic position based on 
markers of wealth (vehicle ownership and house ownership) were more likely to attend 
breast screening, with this group also significantly more likely to be inclined to be 
screened for breast cancer before, or at the onset, of symptoms. Similarly, cervical 
screening uptake in England was found to be lower in those from more deprived areas 
(Bang, Yadegarfar, Solijak & Majeed, 2012). In the US, the proportion of women who 
attended breast and cervical screening increased with increasing education and income 
level, with uptake lowest in those who did not have healthcare insurance (White et al., 
2017). A similar pattern is evident in bowel cancer screening, with uptake lowest in the 
most deprived groups in the UK (Joseph et al., 2012; von Wagner et al., 2011). 
 
Other contributing factors might also play a role in why those from lower SES groups are 
less likely to participate in cancer screening. For example, health literacy could act as a 
mediating factor that helps to explain the relationship between SES and inequalities in 
screening uptake (Stormacq, Van den Broucke & Wosinski, 2019; Kobayashi, Wardle & 
von Wagner, 2014). Those from lower SES groups are more likely to have lower levels of 
health literacy, and therefore knowledge about cancer and cancer screening (Peterson et al., 
2007). 
 
Similarly, variation in other individual beliefs may also act as mediators between SES and 




uptake, with those from lower SES groups being more fatalistic and less positive about 
early detection (Beeken, Simon, von Wagner, Whitaker & Wardle, 2011). Dispositional 
optimism has also been found to play a mediating role in health, with those with from 
lower SES groups more likely to view the future as containing more negative events (e.g. 
more pessimistic) (Robb, Simon & Wardle, 2009). However, it is unclear whether 
optimism plays specific a role in cancer screening uptake. 
 
Overall, those with higher SES appear to be overrepresented in lung cancer screening 
programmes, with those from more deprived backgrounds less likely to participate (Schütte 
et al., 2018). This is problematic for the development of a national screening programme. 
Lower SES is associated with smoking status and lung cancer risk. Without sufficient 
uptake from those from deprived groups, a national lung cancer screening programme 
could further widen lung cancer mortality inequalities. 
 
2.2 Barriers to lung cancer screening  
With cancer screening rates being less than optimal, exploring the motivational and 
volitional factors associated with uptake of screening is becoming increasingly relevant in 
public health (Eiser & Cole, 2002). Practical, cognitive and emotional barriers can impede 
uptake and understanding the variation in barriers experienced by different groups helps us 
to identify modifiable variables as targets for intervention. Significant variation in uptake 
by demographic characteristic indicates that there is much to be done to support high-risk 
groups overcome the barriers they experience when invited to participate in cancer 
screening.  
 
Research exploring the barriers to lung cancer screening is sparse, but insight gained from 
our existing knowledge of barriers to other types of cancer screening, and work exploring 
the uptake of lung cancer screening trials, have assisted in building a better understanding 
of the common barriers experienced. 
 
2.2.1 Practical barriers  
Practical barriers play a significant role in the uptake of cancer screening and have been 
found to be predictive of screening uptake in other forms of cancer screening (Waller, 




2.2.1.1 Financial barriers 
Financial constraints are a barrier to screening in countries where healthcare is not covered 
by the state. The LDCT screening for lung cancer in the US is covered by the Government 
insurers, Center for Medicare and Medicaid Services, as preventative service for eligible 
beneficiaries. However, this form of insurance coverage only covers the cost of the 
screening and does not cover the costs associated with the monitoring of detected nodules. 
In short, eligibility ceases when a person receives an abnormal screening result and 
therefore it is no longer deemed to be a preventative service (Li et al., 2018). Despite the 
‘universal’ insurance coverage of lung cancer screening, uptake is lowest among those who 
have no insurance coverage, or those with government-based health insurance (Yong et al., 
2020). In a cross-sectional study that aimed to understand lung cancer screening behaviour 
there was a significant difference between screeners and non-screeners by insurance status. 
Participants in receipt of government-based insurance were less likely to be screened and 
were more likely to be unaware of lung cancer screening (Carter-Harris et al., 2018). The 
association between insurance coverage and income in the US are well known, with 
government-based health insurance predominantly providing coverage for low income 
populations (Pezzi et al., 2020). As a result, those who do not have a higher level (i.e. 
private insurance) of coverage might find the constraints of their insurance plan to be a 
barrier to screening causing further exacerbation of health inequalities between high and 
low SES groups. 
2.2.1.2 Geographic barriers 
The geographic location of screening test facilities can be a barrier to uptake of cancer 
screening, with those required to travel further from home less likely to attend a screening 
appointment (Onitilo et al., 2014). As a consequence, distance from healthcare services can 
have an adverse impact on cancer outcomes, with increased travel requirements being 
associated with later stage cancer diagnosis and increased cancer mortality (Ambroggi, 
Biasinim Giovane, Fornari & Cavanna, 2015). The effect that geography has on cancer 
outcomes is even more evident in countries with a high proportion of rural and remote 
communities, such as Australia (Tracey, McCaughan, Badgery-Parker, Young & 
Armstrong, 2015). Screening appointments can be difficult to get to geographically as they 
are often held in hospitals, and require significant travel (Carter-Harris, Brandzel, Wernli, 





The inaccessibility of some screening services means that those from rural or remote areas 
are required to travel long distances to be screened (Bobridge et al., 2017). However, it is 
not a barrier that is unique to those from rural or remote areas, it is also a barrier reported 
to those living in urban areas (das Nair, Orr, Vedhara & Kendrick, 2014). Lung cancer 
screening using LDCT usually require people to travel to larger hospitals, which can be 
located in central urban locations or sometimes on the outskirts of cities. For those living in 
larger towns and cities, without access to a vehicle, this can be problematic and requires 
some to rely upon public transport. A study exploring the impact of car ownership, and 
public transport usage, in cancer screening coverage in England, indicates that car 
ownership is significantly associated with improved breast and cervical cancer screening 
uptake. Public transport use was associated with reduced breast screening uptake, but not 
cervical screening uptake because this type of screening is usually performed in primary 
care settings (Wang, 2016).  
 
Mobile screening units, such as those used in breast screening in the UK, have been 
proposed as a way to increase uptake in areas where uptake is low. Mobile screening units 
for breast cancer screening appear to increase access to services for under-screened groups 
(Greenwald, El-Zein, Bouten, Ensha, Vazquez & Franco, 2017). However, it is uncertain if 
offering this type of service for lung cancer screening will reflect the success of mobile 
mammography units. A pilot study that aimed to explore the difference in lung health 
check uptake between mobile and hospital-based (fixed) CT units in London found that 
there were similar levels of participant uptake at both mobile and hospital-based screening 
facilities (Bartlett et al., 2020). Similar pilot studies in Manchester have indicated that 
providing lung health checks in the proximity of local shopping centres is effective and 
engages high-risk populations in deprived areas (Balata et al., 2019; Crosbie et al., 2019). 
 
2.2.1.3 Competing priorities  
Competing priorities are often cited as a barrier to screening. This includes work 
commitments, caring responsibilities and co-morbidities (Ali et al., 2015). Often 
scheduling and attending a cancer screening appointment is not convenient or perceived to 
be a priority compared to other aspects of individuals’ lives (NHS England, 2019). For 
example, screening appointments for breast and cervical cancer are offered to those who 
are of working age in the UK, as is the LDCT screening offered in the US. As screening 
appointments are predominately offered during daytime working hours, those wishing to 




knock-on financial consequences (Travis, Ashley, Pownall & O’Connor, 2020). In 
response to this, a recent review of adult screening programmes in England, conducted by 
Professor Sir Mike Richards, recommended financial incentives for screening providers to 
promote out of hours and weekend appointments (NHS England, 2019). 
 
Those with caring responsibilities also often find it difficult to find time to attend their 
screening appointment. Rearranging appointments to a more convenient time can also be 
problematic as there can be a lack of flexibility built into healthcare booking systems 
(Travis et al., 2020).  
 
Living with two or more health conditions could also be perceived to be a barrier to cancer 
screening. Comorbidity negatively impacts cancer screening uptake, and in some cases is 
associated with more advanced stage cancer at time of diagnosis (Renzi et al., 2019). A 
European cross-section study of the impact of comorbid conditions on participation in an 
organised bowel cancer screening programme reports that having three or more chronic 
diseases was associated with lower uptake of screening (Guiriguet et al., 2017). Having to 
manage multiple conditions can be challenging, with some individuals having to prioritise 
their existing conditions over attending early detection screening appointments (Ali et al., 
2015). 
 
2.2.2 Psychological barriers  
Cognitive barriers, such as knowledge, perceived risk and attitudes, are significant 
determinants of cancer screening uptake (Sarma et al., 2019). The cognitive constructs are 
commonly described within health behaviour theories, some of which have been used to 
explain cancer screening participation, namely: Health Belief Model (HBM), Theory of 
Planned Behaviour (TPB), Precaution Adoption Process Model (PAPM), and the 
Transtheoretical Model (TTM) (Wardle et al., 2015). It is believed that these cognitive 
determinants of screening uptake are modifiable and, therefore, could be the focus of 
future interventions. 
2.2.2.1 Knowledge and awareness  
Knowledge and awareness of cancer and cancer screening are important factors in the 
uptake of early detection screening. An understanding of cancer risk, risk factors, cancer 




informed decision about their participation. The more knowledge or awareness a person 
has about cancer and cancer screening increases the likelihood that they will be screened 
(Berkowitz et al., 2008; Rakowski et al., 2006). This has been well exemplified in the case 
of bowel cancer screening, with lack of knowledge about bowel cancer and bowel cancer 
screening commonly reported as a barrier to screening adherence (Garcia, Buvlla, Nicolas-
Perez & Quintero, 2014). Health literacy is associated with level of knowledge, with those 
with lower levels of health literacy having less knowledge about cancer and cancer 
screening (Peterson et al., 2007) and being less likely to attend cancer screening (Sarma et 
al., 2019; Kim & Han, 2015). This may also help us to understand the contribution that 
level of knowledge makes to socioeconomic differences in uptake. For example, an 
analysis of the Health Information National Trends Survey (HINTS) in the US indicates 
that those from higher SES groups are more likely to have better knowledge about 
prevention of lung cancer and lung cancer screening (Rutten, Hesse, Moser, McCaul & 
Rothman, 2009). Education level is often used as an indicator of SES, with those from 
more deprived groups more likely to have lower educational attainment (Conway et al., 
2019).  
 
Level of knowledge is a modifiable behaviour, making health education a target for 
intervention development. Patient education has been found to be somewhat successful in 
increasing knowledge of cancer and cancer screening. A meta-analysis of the effect 
cervical cancer education has on screening rates indicates that women who received 
educational interventions were significantly more likely to screen for cervical cancer, 
compared with women in control groups (Musa et al., 2017).  
 
2.2.2.2 Attitudes 
Public perceptions of cancer screening are generally very positive (Wardle et al., 2015). A 
study exploring enthusiasm for cancer screening in the UK (n = 2024) indicates that 
attitudes towards cancer screening are overwhelmingly positive, with almost 90% of 
survey respondents believing that cancer screening is ‘almost always a good idea’ (Waller 
et al., 2015). This belief is not unique to people from the UK, with similar results reported 
from the US (Schwartz, Woloshin, Fowler & Welch, 2004). A stronger belief about the 
effectiveness of cancer screening is associated with increased participation (Berkowitz et 
al., 2008). Conversely, negative beliefs about cancer screening, such as fatalism and fear, 





Despite the overall positivity towards cancer screening, there are concerns that individuals 
might overemphasise the benefits of screening and underestimate the potential limitations 
and harms of screening (Schwartz et al., 2004; Waller et al., 2015). A systematic review 
exploring the expectations of the benefits and harms of treatments, tests or screening 
indicates that over 50% of participants overestimate the benefits of cancer screening, and 
only between 9-20% of participants could correctly identify the potential harms of cancer 
screening (Hoffman & Del Mar, 2015). 
2.2.2.3 Perceived risk 
Perceived risk is a construct that features in many theoretical models that have been used 
to explain screening behaviour (Wardle et al., 2015). Perceived risk is often divided into 
three distinct dimensions: perceived likelihood of developing the disease; perceived 
susceptibility/vulnerability to the disease, and perceived severity of the disease (Brewer et 
al., 2007). These dimensions collectively contribute to the formation of a person’s overall 
view of their perceived risk. However, perceived risk is often not an accurate reflection of 
true risk (Ferrer & Klein, 2015). For example, those who incorrectly consider themselves 
to be at low risk of developing cancer can be said to have ‘unrealistic optimism’ 
(Weinstein, 1980). This form of bias is common across different health protective 
behaviours, including cancer screening, with individuals underestimating their risk, 
particularly when they compare their own risk to other peoples’ (Ferrer & Klein, 2015). It 
is, therefore, evident that the formation on accurate risk perceptions has important 
consequences for health outcomes. However, the association between risk perception and 
screening participation is unclear (Wardle et al., 2015).  
 
For some forms of cancer screening, such as breast screening, higher perceived risk is 
positively associated with increased participation. A meta-analysis exploring the predictors 
of perceived breast cancer risk, and the relation between perceived risk and breast cancer 
screening, found a consistent association between mammography participation and 
perceived risk, although the study did report a small effect size (Katapodi, Lee, Facione, & 
Dodd, 2004).  However, there is no clear consensus about the association between risk 
perception and participation in other forms of screening (Vernon, 1999).  
 
More recent work on lung cancer screening suggests that worry and perceived seriousness 
of a lung cancer diagnosis are strongly associated with the desire to participate in lung 




occur among high risk participants (such as current smokers) of lung cancer screening 
trials who report either accurate or overly pessimistic perceived risk (Park et al., 2009; van 
den Bergh et al., 2009). Although, in contradiction, non-participants in the UKLS trial who 
perceived themselves to be at high risk of lung cancer, indicated lower intention to be 
screened (Ali et al., 2015). The picture of the impact perceived risk has on participation in 
screening is unclear; it can act as both a barrier and a motivator that is dependent on how 
the individual responds emotionally to their risk. 
 
2.2.3 Emotional barriers 
Cancer is an emotive topic, and quite rightly individuals often have an emotional response 
to cancer and cancer screening, which might influence their participation in screening. 
Negative responses such as fear, fatalism and perceived stigma can adversely impact the 
decision people make about cancer screening and can lead to some maladaptive coping 
mechanisms such as avoidance and denial (Sarma et al., 2019). 
 
It is recognised that the beliefs about lung cancer and beliefs about lung cancer screening 
can be different (see section 2.2.2.2). Lung cancer as a disease may evoke negative 
psychological responses, while lung cancer screening, as an early detection medical 
procedure, may not. For this reason, a distinction between lung cancer and lung cancer 
screening is made and are identified as distinct beliefs. Despite being distinct concepts, it is 
understood that beliefs about one (e.g. lung cancer) might significantly impact beliefs 
about the other (e.g. lung cancer screening) and therefore act as a determinant of screening 
uptake. 
2.2.3.1 Fear 
Like perceived risk, the association between cancer fear and cancer screening uptake has 
been mixed. Fear of cancer can be both a barrier and a facilitator of cancer screening 
(Consedine, Magai, Krivoshekova, Ryzewicz & Neugut, 2004). Despite improvements in 
prognosis and treatment, cancer worry remains consistently high, enduring for decades 
(Wardle et al., 2015). In the 1960’s 31% of adults in the US considered cancer to be a 
significant worry in their lives (Kirscht, Haefner, Kegeles, & Rosenstock, 1966). More 
recently, a large community-based study in the UK (n = 7, 971) found that more than half 
(59%) of this older adult sample reported cancer as their greatest health fear (Vrinten et al., 
2014). Cancer fear in this sample was found to be higher in women, those with lower 




Further, those with cancer fear are more likely to be fatalistic about cancer and avoid 
cancer information (Miles, Voorwinden, Chapman & Wardle, 2008). This association 
between fear and avoidance of cancer information could perpetuate negative beliefs about 
cancer. 
 
Studies exploring the relationship between fear and cancer screening participation have 
been contrasting (Hay, Buckley & Ostroff, 2005). Some studies indicate that fear increases 
participation in breast and bowel cancer screening (Moser et al., 2007; Hay et al., 2006), 
while others indicate that fear is a barrier to screening in some ethnic groups (Good, 
Niziolek, Yoshida & Rowlands., 2010; Vrinten et al., 2016). Variation in results about the 
association between fear and cancer screening participation might be because of the way in 
which studies measure cancer fear or worry (Consedine et al., 2004). It is hypothesised that 
variation is the result of the relationship between cancer worry and screening participation 
appear to be an ‘inverted U-shape’ (Hay et al., 2005; Consedine et al., 2004). This means 
that moderate levels of worry facilitate screening participation, while both high and low 
levels of fear inhibit cancer screening participation. 
 
Cancer fear research, exploring the association with lung cancer and lung cancer screening, 
is not as well developed, but early research into what individuals fear about lung cancer 
offers some insight into whether fear is a barrier or motivator to this form of screening. 
Commonly reported fears include fear of a cancer diagnosis (Delmerico, Hyland, 
Celestino, Reid & Cummings, 2014) and concerns about having a CT scan as part of 
screening (Cataldo, 2016; Jonnalagadda et al., 2012) with both of these reported fears 
being associated with lower intention to screen for lung cancer. Non-participation in lung 
cancer screening is associated with fatalistic beliefs, and avoidance, leading us to speculate 
whether fear will also play a similar role in lung cancer screening (Patel et al., 2012). Lung 
cancer screening is unique from other forms of cancer screening because it is only used in 
those who are high risk, meaning that fear among this group towards this form of 
screening, may vary considerably from other types of cancer. 
2.2.3.2 Fatalism 
Cancer fatalism, or the belief that a cancer diagnosis is out of individual control or that 
cancer always leads to death, can be an emotional barrier to cancer screening. Fatalism has 
been associated with lower cancer screening uptake in a number of cancer screening 




Valdez, 1997; Powe & Finnie, 2003; Vernon, 1997). A cross-sectional study that compared 
the barriers to bowel cancer screening with the barriers of breast and cervical screening 
results indicates that cancer fatalism is a significant barrier associated with general non-
participation in screening to cancer screening (Lo et al., 2013). Avoidance, a maladaptive 
coping mechanism, was often cited by people who did not attend any form of cancer 
screening indicating a general negative perception to all cancer screening (Lo et al., 2013). 
Fatalistic beliefs are associated with delayed presentation and diagnosis and are more 
common in those from more deprived groups, those with lower education levels and health 
literacy levels (Agustina et al., 2018; Kobayashi & Smith, 2016; Niederdeppe & Levy, 
2007). 
 
Cancer fatalism has also been found to be a barrier to lung cancer screening. A qualitative 
study (n = 60) embedded within the Lung-SEARCH trial, explored the attitudes towards 
participation of lung cancer screening. Themes of fatalism, worry, and avoidance in those 
who declined to be screened were reported (Patel et al., 2012). Those who held fatalistic 
beliefs about lung cancer were all current smokers that considered that lung cancer was 
either inevitable or predetermined (e.g. outside their control) and, therefore, taking part in 
screening was pointless. Fatalism, as a barrier to lung cancer screening, is supported by 
similar studies from the US (Jonnalagadda et al., 2012). 
 
Often, as a response to fatalistic beliefs, people put coping mechanisms in place to help 
deal with these feelings. However, not all coping mechanisms are applied effectively and 
often individuals will adopt maladaptive coping mechanisms, such as avoidance or denial 
(Patel et al., 2012). Stoicism and other forms of avoidance are a possible explanation for 
non-attendance of cancer screening. A stoic attitude – a belief that controlling emotions 
leads to less suffering and a view that death is inconsequential – is often considered to be a 
deliberate life choice (Moore, Grime, Campbell, & Richardson, 2013; Pathak, Wieten, & 
Wheldon, 2017). In the context of cancer, choosing not to worry and avoiding information 
about cancer is a way to cope with what they feel they have no control over. Stoicism is 
associated with an indifference to, and tolerance of, adversity – having a “stiff upper lip”. 
It is most commonly associated with older men and it is hypothesised that stoicism is a 
coping strategy that they adopt because they find it more difficult to identify and express 
their emotions (Cairncross, Magee, & Askham, 2007; Calderón et al., 2017). Asking for 
help can be perceived as a weakness, therefore, stoicism has been linked with reduced 




reliably associated with heightened levels of distress and a reduction in quality of life in 
cancer patients (Aguirre‐Camacho, González‐Márquez, & García‐Borreguero, 2017; 
Gillanders, Sinclair, MacLean, & Jardine, 2015). Stoicism has been identified in research 
as a coping strategy used by men in their response to prostate cancer (Chambers, 
Zajdlewicz, Youlden, Holland, & Dunn, 2014; Gannon, Guerro‐Blanco, Patel, & Abel, 
2010). However, there is limited literature exploring how stoicism impacts other forms of 
cancer and cancer screening. One study, exploring the uptake of breast cancer preventative 
therapy in the UK, indicates that stoicism within the family influenced women’s beliefs 
towards taking regular medication and reduced the likelihood of discussing tamoxifen2 
with family members (Hackett et al., 2018).  Similarly, stoicism has been found to 
influence the uptake of bowel cancer screening in men with those with more stoic attitudes 
less likely to attend (Oster, McGuniness & Turnbull, 2015). 
 
2.2.3.3 Cancer stigma  
Lung cancer, unlike some other types of cancer, often carries a stigma that can be 
detrimental to those who are diagnosed with the disease and can slow the diagnosis 
(Chapple, Ziebland & McPherson, 2004). A fundamental definition of stigma is an 
‘attribute that is deeply discrediting’ which can reduce an individual from a ‘whole and 
usual person to a tainted, discounted one’ (Goffman, 1963). Those attributes considered to 
be negative within a society are those that contradict the ‘social norms’ of that society. 
Individuals who do not conform to societal norms are likely to be discriminated against 
(Turner, 1991). A diagnosis of lung cancer can be associated with attributes perceived to 
be negative - for example, smoking. As a result, individuals with lung cancer may be 
stigmatised or blamed for their own illness (Weiss, Stephenson, Edwards, Rigney & 
Copeland, 2014). There are two distinguishable types of stigma: public/social stigma and 
self-stigma (Corrigan, 2004). Public, or social, stigma can be defined as the stigmatising 
ideas of one group about another group - for example, society’s general belief about lung 
cancer. When asked, participants in a number of studies believed that individuals with lung 
cancer are partially or fully to blame for their illness (Weiss et al., 2014; Gulyn & Youssef, 
2010; Chapple, Ziebland & McPherson, 2004). Johnson, Brodsky & Cataldo (2014) 
consider this stigma and blame to be felt equally by smokers, past-smokers and never-
 
2 Tamoxifen – a hormone therapy for breast cancer, sometimes used in women who have a high risk of 





smokers. This follows the common misconception that those with lung cancer are all 
current smokers (Carter-Harris, 2014).  
 
‘Self-stigma’ occurs when a member of the stigmatised group internalises the beliefs held 
by wider society (Barney, Griffiths, Jorm & Christensen, 2006; Corrigan, 2004). Vogel, 
Wade & Hackler (2007) considers there to be a direct relationship between public and self-
stigma, concluding that one’s perceptions of public stigma may play a role in the 
development of self-stigma. Moreover, self-stigma and attitudes towards help-seeking have 
a mediating effect between perceived public stigma and actual help-seeking behaviour 
(Vogel et al., 2007). Those with higher stigma scores are significantly more likely to delay 
medical help-seeking for lung cancer symptoms, compared to those with illnesses with less 
stigma attached (Carter-Harris et al., 2014; Chapple, Ziebland & McPherson, 2004). A 
delay in medical help-seeking was found to be as a result of the anticipation of stigma as a 
result of a lung cancer diagnosis (Scot, Crane, Lafontaine, Seale & Currow, 2015).  
 
When lung cancer is compared to other types of cancer, it appears that the stigma 
experienced by those with lung cancer is unique because of the clear causal relationship 
with smoking. Conversely, other forms of cancer (e.g. bowel, breast, cervical and prostate) 
often do not have a clear cause and have less stigma attached to diagnosis. Patients with 
lung cancer have higher levels of perceived cancer related stigma than patients with 
prostate or breast cancer (LoConte et al., 2008) and head and neck cancer (Lebel et al., 
2013). A randomised survey study (n = 1,205), which aimed to explore stigma between 
lung cancer and four other cancer types, found that lung cancer attracted higher stigma 
scores than breast cancer, cervical cancer and bowel cancer. Lung cancer was deemed 
similar to skin cancer on personal responsibility measures but attracted higher stigma than 
skin cancer (Marlow, Waller & Wardle, 2010).  
 
The implications of lung cancer stigma are far reaching. In addition to delayed help-
seeking behaviour, individuals who experience stigma associated with lung cancer also 
have reduced quality of life scores (Johnson et al., 2014; Chambers et al., 2012), increased 






2.3 Interpersonal determinants of screening 
participation: GP endorsement 
Given that certain types of people are more likely to attend cancer screening, a concerted 
effort must be made to assess the best way to reach ‘hard-to-reach’ groups. Evidence 
indicates that individuals are more likely to attend screening appointments if it has been 
recommended by their doctor (Brawarsky, Brookes, Mucci & Wood, 2004). A meta-
analysis exploring the impact cervical cancer education and provider recommendation has 
on screening rates indicates that endorsement by health care provider improves uptake 
(Musa et al., 2017). Similarly, GP-endorsed invitations were also found to consistently 
improve participation in screening among those from more deprived groups (Duffy, Myles, 
Maroni & Mohammad, 2017).  
 
Previous research in lung cancer screening trials indicates that there are significant 
differences between participants who are invited to take part, and those who self-select. 
Participants in the US NLST, who were recruited by the media, appeared to be younger, 
higher educated and less likely to be current smokers (The National Lung Screening Trial 
Research Team, 2011). Similarly, in the NELSON trial, respondents to the initial invitation 
that self-selected were somewhat younger, and less likely to be a current smoker. In 
addition, those responding to the national screening invitation were more likely to be 
categorised as ‘healthy volunteers’, and more likely to be ineligible for participation in the 
trial (van der Aalst et al., 2012). Similar results can also be found outside lung cancer 
screening trials. In the Oslo Health Study, respondents to community and media 
advertisement were associated with older age, higher education levels, being married, and 
also not in receipt of benefits (Søgaard, Selmer, Bjertness & Thelle, 2004). When 
comparing the respondents of community invitations and personal invitations, Manjer, 
Elmstahl, Janzon & Berglund (2002) found that community respondents were older, and 
more often females, than participants recruited using personal invitations. Furthermore, 
participants recruited through community advertisement had a comparably more 
favourable situation with regard to sociodemographic and lifestyle factors. They also had a 
lower frequency of prevalent disease, lower incidence of cancer and lower mortality 




2.4  Theories of health behaviour and cancer screening 
participation  
Identifying how people make choices is important to understanding why they might make 
risky health decisions. Psychological theories and their application to cancer screening 
have helped us to further understand the behavioural mechanisms that contribute to non-
participation. Theory-driven approaches to the design and evaluation of interventions can 
increase our ability to identify strategies that change behaviour and have the potential to be 
implemented successfully (Bartholomew & Mullen, 2011). 
2.4.1 Health behaviour theories and construct overlap  
A large number of theories have been used to try and explain cancer screening 
participation. In a review of the use of health behaviour theory in National Cancer Institute 
(NCI) grant applications between 1998 and 2009, the authors report that all but one grant 
that met the criteria included a conceptual model in their research (Kobrin et al, 2015). A 
total of six theories were used in the 38 grant proposals that met the criteria of the review: 
Transtheortical model (TTM); Health belief model (HBM); Social cognitive theory (SCT); 
Precaution adoption process model (PAPM); Theory of reasoned action (TRA); and 
Theory of planned behaviour (TPB). Beyond the grant proposals reviewed by Kobrin et al, 
(2015), these theories also commonly feature in public health intervention literature (Glanz 
& Bishop, 2010). However, there are some criticisms of the use of theory in behavioural 
science and the challenges of how theory is applied. It is argued that the constructs within a 
given theory are often not applied consistently and sometimes omitted without rationale or, 
conversely, add constructs that are not part of the conceptual model in question. The 
addition of extra constructs was found in all the NCI grant applications, with an average of 
nearly three non-related constructs for each proposal (Kobrin et al., 2015). 
 
There is significant overlap between the theories frequently used to describe cancer 
screening participation. For example, the HBM (Rosenstock et al., 1988) and PAPM 
(Weinstein & Sandman, 1992) both discuss perceived barriers, perceived severity, 
perceived susceptibility and self-efficacy as constructs of the behavioural models. As a 
result of the lack of distinct theories and constructs it is a challenge to find the best model 






Behavioural models applied less frequently to cancer screening but, commonly used to 
explain other health behaviours, such as the Common-Sense Model of Self-Regulation 
(CSM) (Leventhal, 2003) and the Health Action Process Approach (HAPA) (Schwarzer, 
1992; Schwarzer, 2008) could be used to explain screening behaviour and provide insight 
that other models cannot. The CSM and HAPA have been previously used to understand 
individuals’ response to illness and explore both cognitive and emotional representations 
of illness. The CSM and HAPA models provide a unique perspective on screening 
behaviour not yet considered, particularly when exploring the screening behaviour of those 
with positive intentions to screen (see section 2.4.2 and section 6.1.1). The models both 
account for how emotional and cognitive representations form and change after intention 
and allow for individuals to reassess their decision to participate in a given health 
behaviour. This is of particular benefit if we wish to explore the reasons why people might 
change their mind after they agree to participate in cancer screening.  
 
There is some overlap between the CSM and HAPA, but each model has components that 
makes them significant to developing our understanding of screening behaviour. For 
example, the CSM describes a parallel process that accounts for the development of both 
cognitive and emotional representations occurring simultaneously, while also considering 
the interaction between cognitive and emotional representations. Critically, the CSM 
model includes a ‘feedback’ loop that allows for individuals to reappraise their decisions 
(e.g. change their mind). 
 
The HAPA, in contrast, is a staged model of behaviour, with individuals progressing 
through each stage in order to encourage long term behaviour change. The model includes 
both motivational and volitional phases, and also describes the formation of action and 
coping planning. These components are of particular importance to understanding any 
potential intention-behaviour gap that might be evident in cancer screening.  
 
2.4.2 Intention-behaviour gap 
Cancer screening is often unique to other health behaviours as the majority of people think 
it is a good idea and attitudes towards screening are overwhelmingly positive (Waller et al., 
2015). However, we still witness obvious intention-behaviour gaps in cancer screening 
participation, with positive attitudes and intent not always converting into action. While 
some behavioural theories address this gap (TPB) (Ajzen, 1991) and TTM (Prochaska & 




motivational mechanisms that play a role in cancer screening participation. It can be 
argued that future theory-driven research should look to address the intention-behaviour 
gap by exploring the volitional factors that play a role in cancer screening decision-
making. 
 
Orbell and Sheeran (1998) state that the intention-behaviour gap is caused by individuals 
not being consistent with their intentions, either positive or negative. In particular, Sheeran 
(2002) considers there to be two groups of people that explain the intention-behaviour gap: 
inclined abstainers and disinclined actors. In the area of risky decision-making, inclined 
abstainers are of significant interest. This group of people have positive intentions to carry 
out a given health behaviour, but fail to act, unlike disinclined actors who initially have 
negative intentions but carry out the behaviour anyway (Orbell & Sheeran, 1998). 
Participants who change their minds pose a considerable issue for public health 
programmes. This is supported by research conducted in the area of cancer screening. In a 
study exploring unscreened women in a campaign that aimed to increase participation in 
cervical cancer screening, it was found that 57% percent of women who said that they 
intended to attend cervical screening within a year failed to do so (n =166) (Orbell & 
Sheeran, 1998). Similar results were found with intention to use condoms (57%; n =447) 
(Gallois, Kishima, Terry, McCamish, Timmins & Chauvin, 1992) and intention to exercise 
(54%; n =163) (Sheeran & Orbell, 2000). 
 
2.4.3 Dual process models  
The way in which inclined abstainers make decisions can partly be explained by the 2-
system model of decision-making. There has been a growing interest in Dual Process 
Models in recent years, and their potential to have practical application in increasing the 
uptake of cancer screening (Wardle et al., 2015). The model states that there are two 
distinct systems of information processing: System 1 is an impulsive, fast and effortless 
process of decision-making, based on an individual’s perceptions, schema and emotions. In 
contrast, System 2 is a slower decision-making process, based on logic, and reasoning 
(Kahneman, 2003; Strack & Deutsch, 2004). For example, those who positively intended 
to take part in screening, but did not attend, may use System 1 to make their initial positive 
decision to take part in the programme. However, after engaging System 2, more complex 






This insight into the decision-making processes we engage in helps us develop 
interventions that may improve participation. In some cases, it might be more appropriate 
to target System 1, capitalising on people making a fast, intuitive decision because of their 
positive attitude towards cancer screening (Wardle, 2015). Some interventions that target 
System 1 decision-making, such as physician endorsement, have been found to efficiently 
encourage people to make default decisions to attend, removing the need for them to 
evaluate the risks and benefits themselves (Brawarsky et al., 2004). Interventions that 
focus on engaging System 2 include providing information to improve informed decision-
making, particularly when trying to explore the risks and benefits of cancer screening 
(Wardle et al., 2015). 
 
To date, there has been no theoretical exploration of the mechanisms behind participation 
in lung cancer screening. Understanding the mechanisms to decision-making in lung 
cancer screening will help us to engage with and target intervention development to high 
risk groups, ensuring optimal uptake and reducing cancer inequalities. 
 
2.5 Thesis aims and research questions 
2.5.1 Aim of thesis 
The aim of this thesis is to use an integrative mixed methods approach to holistically 
explore the factors associated with the uptake of lung cancer screening. In order to achieve 
this objective, the thesis includes four studies, each with individual research questions that 
help create an overall picture of lung cancer screening participation. 
 
A description of the studies included in this thesis, alongside corresponding research 
questions, are described in Table 2-1. 
 
Table 2-1: Thesis Research Questions 




Do public perceptions of 
lung cancer and lung cancer 
screening differ between 
socioeconomic groups? 
I. Do public perceptions and 
awareness level of lung 
cancer differ between 
socioeconomic groups? 
 
II. Do public perceptions and 
awareness level of lung 







Table 2-1: Thesis Research Questions 







status in the 
ECLS trial 
Do the demographic and 
psychosocial characteristics 
of lung screening trial 
participants vary by 
socioeconomic status? 
I. Do the demographic 
characteristics of ECLS trial 
participants vary by area-
based SIMD or individual 
SES? 
 
II. Do the psychosocial 
characteristics of ECLS trial 









in the ECLS 
trial  
Do socioeconomic status, 
beliefs and attitudes towards 
lung cancer and lung cancer 
screening differ by invitation 
type? 
I. Are socioeconomic status 
and demographic 
characteristics different 
between self-referrers or GP 
invited ECLS trial 
participants? 
 
II. Do the beliefs and 
attitudes towards lung cancer 
and lung cancer screening 
differ between self-referrers 












What are the perceived 
barriers and beliefs about 
lung cancer and lung cancer 
screening held by screening 
non-attenders? 
I. What are the perceived 
barriers to participating in a 
lung cancer screening trial? 
 
II. What beliefs do non-
attenders hold about lung 
cancer and lung cancer 
screening? 
 
III. Do the Common-Sense 
Model of Self- Regulation 
and the Health Action 
Process Approach help to 
explain the processes behind 
those who intend to 
participate in screening but 
do not attend? 
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2.5.2 Overview of thesis 
In this section I present an overview of the thesis. 
 
Chapters 1 and 2 introduce the thesis and the rationale for the studies. This includes setting 
out the current picture of lung cancer rates in the UK and Scotland and explores the uptake 




cancer screening uptake and cancer mortality. The chapters also set out the body of 
literature that explores the mechanisms surrounding the variation in uptake including the 
common barriers to cancer screening, highlighting the variation across socioeconomic 
groups. 
 
Chapter 3 reviews the current literature that exists surrounding the difference in lung 
cancer beliefs across SES. The systematic review looks at both quantitative and qualitative 
literature to synthesise the evidence that variation in lung cancer beliefs exist across 
different socioeconomic groups and describes what these differences are. The review 
discusses how these differences in beliefs might impact uptake of lung cancer screening 
and, therefore, mortality. The review concludes that cancer fear and fatalism are significant 
emotive barriers to cancer screening, particularly among those with lower SES. 
 
Chapter 4 displays the methodology and results of a secondary quantitative analysis that 
looks to explore the demographic and psychosocial differences of participants in the ECLS 
trial and compares the differences across SES. A secondary aim of this study was to 
investigate how best to measure SES. To do so, two distinct measures were used; area-
level and individual-level SES. The use of two measures helps us to ascertain whether 
either method of measuring SES is more appropriate when SES is used as a criterion for 
cancer screening trials. The study concluded that those from more deprived groups are less 
likely to be aware of their risk of lung cancer or understand that their own health 
behaviours might impact their chance of getting lung cancer. This was found to be the case 
for both measures of SES. 
 
Chapter 5 describes the results of a further secondary quantitative analysis that looks to 
explore the demographic and psychosocial differences of ECLS trial participants who were 
invited to participate in two distinct ways; via their GP or via the community. It is 
hypothesised that those who self-selected for community recruitment have more positive 
beliefs about lung cancer and have more awareness of the risk factors associated with lung 
cancer. Results indicate that this is the case, and that those recruited via the community are 
less deprived than those recruited via their GP. 
 
Chapter 6 qualitatively investigates the lung cancer beliefs and barriers to attending a lung 
cancer screening trial among people who initially accepted their invitation to screening but 




structured interviews elicited the views of people at high risk of lung cancer. A framework 
analysis was used to map data onto two theoretical models: Health Action Process 
Approach and the Common-Sense Model of Self-Regulation. The results of the study 
indicate that participants cited two distinct types of barrier to attending their cancer 
screening appointment – practical and emotional. Practical barriers, such as competing 
priorities, were often cited first, before emotional barriers, such as cancer fear were 
introduced. The results mapped onto the concepts of the HAPA and CSM models, but 
neither fully captured the reasons for non-attendance of a lung cancer screening 
appointment in isolation, highlighting the argument for the use of multiple models to 
explain cancer screening behaviour. 
 
Chapter 7 brings together and discusses the results of all four included studies and 
compares the results with the existing body of literature and describes the extent to which 
the studies have addressed the aims of the thesis. Overall, the findings of the studies are 
supportive of the broader cancer screening literature. However, as there are few studies on 
barriers to lung cancer screening, this thesis contributes novel findings. The chapter also 
outlines the strengths and limitations of the studies, proposes areas for future study and 
discusses implications for policy and practice. 
 
Chapter 7 also draws conclusions of the thesis and highlights the novel contribution the 
study has made to the field of behavioural medicine, in particular our understanding of 
perceptions of lung cancer and how they may influence the uptake of any future lung 
cancer screening programme implemented nationally. 
 
2.6 Chapter summary  
This chapter presented an overview of the epidemiology of lung cancer, and the 
development of lung cancer screening. This chapter also described the sociodemographic 
predictors of cancer screening and explored the common practical, cognitive and emotional 
barriers involved in non-participation.  
  
The next chapter will present an integrative systematic review that further explores the 






Chapter 3 : Public perceptions and awareness of 
lung cancer and lung cancer screening in 
different socioeconomic groups: an integrative 
systematic review 
3.1 Introduction 
The previous chapter described the literature surrounding public perceptions of lung cancer 
and lung cancer screening. The variability in lung cancer mortality across socioeconomic 
groups emphasises existing health inequalities. Differences in beliefs about lung cancer 
and lung cancer screening could go some way to explain this variability. 
 
In order to understand the role deprivation level plays in awareness of, and beliefs about, 
lung cancer and lung cancer screening, it is important to examine what has already been 
explored and identified in the literature. This chapter presents a systematic review of both 
quantitative and qualitative literature that explores beliefs about lung cancer and lung 
cancer screening and investigates if those beliefs vary by SES. The systematic review 
approach was chosen to explore the subject holistically and draw conclusions that provide 
a more comprehensive understanding of public perceptions of lung cancer and lung cancer 
screening. Integrative systematic review is a form of mixed-methods approach to 
synthesising literature (Pearson, White, Bath-Hextall, Salmond, Apostolo & Kilpatrick, 
2015) which allows for the inclusion of diverse methodologies in order to draw 
conclusions that provide a more comprehensive understanding of a given phenomenon 
(Sutton, Clowes, Preston & Booth, 2019). 
 
3.2 Aim of review and research questions 
The aim of this systematic review is to explore and synthesise the current literature 
surrounding the public perceptions of lung cancer and lung cancer screening in different 
socioeconomic groups.  
 
The review will answer the following questions: 
I. Do public perceptions and awareness level of lung cancer differ between 
socioeconomic groups? 
II. Do public perceptions and awareness level of lung cancer screening differ 





This section details the methodology of the systematic review. 
 
3.3.1 Protocol and registration 
A protocol was created, and the review registered on PROSPERO, the International 
Prospective Register of Systematic Reviews (CRD42015025259) (Appendix 1). 
 
3.3.2 Eligibility criteria and scope of review  
Studies exploring beliefs and awareness of lung cancer and lung cancer screening were 
searched for. An exhaustive search strategy was deemed suitable, as the aim was to 
summarise all the relevant literature on this topic. Limitations of English language and year 
of publication 1990 and onwards were set. There were no geographical restrictions. Study 
types included in the review were mixed methods, qualitative, descriptive and RCTs. 
 
As lung cancer literature is diverse, and often clinical in nature, it was agreed that as well 
as literature related to public views, studies that include primary care practitioner beliefs 
and/or awareness would also be included in the review. Studies that included the views of 
lung cancer patients were also deemed appropriate, however were only included if beliefs 
were about lung cancer and lung cancer screening in general and excluded if the focus of 
the study was about the diagnostic process or treatment of lung cancer. 
 
Studies that do not have lung cancer or lung cancer screening as the sole focus, such as 
those that compare different types of cancer were considered to be eligible for inclusion if 
there was sufficient lung cancer content and results reported related to lung cancer or lung 
cancer screening. Only the results relating to lung cancer or lung cancer screening are 
presented in the review unless cancer comparison is directly relevant to the review. 
 
As the review focuses on the beliefs and awareness of different socioeconomic groups, 
included studies were required to report an individual or composite measure of SES but 
SES did not have to be the primary focus of the study. Eligibility criteria for paper 






Table 3-1: Eligibility Criteria 
 Studies Included Studies Excluded 
Language English language Non-English language 
Geography No geographical restrictions N/A 
Timescale 1990-2020 Papers published before 1990 
Study type 
Mixed method studies; 
qualitative studies; descriptive 
studies; randomised 
controlled trials 
Reviews (including systematic 
reviews); economic analyses 
Paper topic 
Comparisons of cancer type; 
public awareness of lung 
cancer / screening; general 
beliefs about lung cancer / 
screening 
Palliative care in lung cancer 
patients; views on the diagnostic 
process of lung cancer; views on 
the treatment of lung cancer; 




Public; primary care 
practitioners; patients of lung 




Socioeconomic status – 
individual (such as income, or 
employment) or composite 
(such as an area-based 
deprivation measure or a 
composite measure composed 
of individual measures) 
No measure of socioeconomic 
status 
 
3.3.3 Information sources 
The electronic databases of Medline, Pubmed, Cinahl, EMBASE, IBSS, PsychINFO and 
Web of Science Core Collection were searched to provide published literature. 
 
3.3.4 Search strategy 
Scoping searches were carried out to identify key literature and to familiarise reviewers 
with key terms. A formal database search strategy was subsequently developed by the 
reviewers with the assistance of a subject librarian (Appendix 2). Individual key words 
were combined to narrow the search and identify the most relevant references. 
 
The keywords used as part of the search strategy produced 14,326 references. A total of 
2,691 duplicates were removed before title and abstract screening using EndNote reference 




stage as a result of title and abstract review. A total of 441 went to full paper review, with 
30 of these included in the final review. Fig. 3-1 displays the PRISMA chart to describe the 
inclusion and exclusion process for the review. Reasons for exclusion are included in Table 
3-2. 






Table 3-2: Reason for Exclusion from Systematic Review 
Reason for exclusion 
Number 
excluded 
Not about lung cancer or lung cancer screening  6944 
Not about public perceptions or awareness of lung cancer or lung 
cancer screening  
4250 
Duplicate  92 
Other  319 





3.3.5  Data management  
The review was conducted by utilising two computer-based aids. EndNote (EndNote 
Team, 2013) was used to extract references from electronic databases and to identify and 
exclude duplicate references. DistillerSR (Evidence Partners, Ottawa, Canada) was used to 
manage the remaining references after duplicates were removed. 
 
3.3.6 Article selection and quality assessment process 
The search of all databases was carried out in December 2015 and updated in June 2020. A 
three-step process in article selection was adopted: title, abstract and full paper screening. 
The relevance of the study to the review question was assessed at each stage using the 
questions displayed in Table 3-3. If the relevance was uncertain, studies moved on to the 
next stage of the review in order to ensure that it was not incorrectly excluded. 
 
One reviewer (HS) carried out the title, abstract and full paper screening with a percentage 
(20%) of these second reviewed by the other review team members (KR/SM). Data were 
extracted from the papers included in the full paper review (n = 30) using data extraction 
(Appendix 3) and quality assurance tools. A number of quality assurance tools were used 
for the different methodologies that were used across the 30 papers in the final review. 
Quantitative studies were assessed using an adapted version of the NIH study quality 
assessment tool (NIH, 2014); mixed methods studies were assessed using an adapted 
version of O’Caithan, Murphy & Nicholl (2008); and qualitative studies were assessed 
using the Critical Appraisal Skills Programme (CASP) Qualitative checklist (2018). 
 
All tools used considered a number of aspects of quality such as rigour, validity and 
transparency. Each paper was given a rating of ‘Good’ (2), ‘Fair’ (1), or ‘Poor’ quality (0). 
A paper was awarded a ‘Good’ if they received no ‘Poor’ scores (a zero) on any aspect of 
the assessment tool. A ‘Fair’ was awarded if they received one ‘Poor’ score on any aspect 
of the assessment tools. A paper is deemed ‘Poor’ if it was awarded two or more ‘Poor’ 
scores on any aspect of the assessment tool. 
 
Studies were not excluded based on quality and data was extracted regardless of rating. 





Table 3-3: Article Selection Questions 
Stage of Review Assessment Question Possible Answers 
Title Review  Could this paper be relevant 
to lung cancer or lung 
cancer screening? 
 
Could this paper be relevant 
to perceptions or awareness 





Abstract Review  Is this paper relevant to 
perception or awareness of 
lung cancer or lung cancer 
screening? 
 
Is this paper relevant to 
perceptions or awareness of 











3.3.7 Data synthesis 
The review includes papers on both beliefs and awareness of lung cancer and lung cancer 
screening. It was decided that, although the beliefs about lung cancer and lung cancer 
screening are often distinct from one another, it was appropriate to integrate them in the 
review in order to provide a comprehensive understanding of the awareness and beliefs 
across both lung cancer as a disease, and lung cancer screening as an early detection 
procedure. In order to highlight the differences and overlap between the beliefs about the 
disease, and beliefs about the screening test, they are synthesised and presented separately 
within the results.  
 
An outline of the synthesis method is presented in Fig. 3-2. A convergent design was used 
to synthesise findings. In a convergent design, qualitative and quantitative evidence is 
collated and analysed in a parallel, as opposed to sequential synthesis design, where the 
collation and analysis of quantitative and qualitative evidence takes place in a sequence 
with one synthesis informing the other (Noyes, Booth, Moore, Flemming, Tunçalp and 





The first step in the synthesis process was to extract data. The data from quantitative and 
mixed methods studies (n = 22) were extracted separately from qualitative studies. 
Figure 3-2: Outline of Data Synthesis Method 
 
 
The data were extracted, summarised and displayed in tables. Tables 3-5, 3-6, 3-7 and 3-8 
present study characteristics including study population, study design, aims, main findings, 
and assessed quality rating. Studies relating to lung cancer and lung cancer screening are 
presented separately. Quantitative and qualitative papers were presented separately for 
each. 
 
The systematic review identified eight papers that used qualitative methodologies. These 
papers were used to carry out an additional analysis.  A thematic synthesis was used to 
synthesise qualitative research (Thomas & Harden, 2008). In order to thematically 
synthesise the findings of all qualitative papers, a three-step procedure was adopted in line 
with that of Thomas & Harden (2008). The first step was to code text of the studies, 
followed by developing descriptive themes, and finally generating analytical themes in 
order to draw out the cross-cutting analytical themes contained in all qualitative studies 
included. The text was coded, and initial descriptive themes were developed by HS. The 
analytical themes were developed by HS and discussed with KR and SM to ensure 
agreement of themes. 
 
A thematic synthesis matrix was created to integrate the quantitative and qualitative 
syntheses. This allowed all studies to be plotted against the themes generated in the 
qualitative thematic synthesis. The matrix displays areas of crossover in the findings of all 
Review Question: Public perceptions and 
awareness of lung cancer and lung cancer 
screening across socioeconomic groups
Quantitative & mixed methods data 
extraction 
Qualitative data extraction
Thematic synthesis of results using 
framework analysis 
Integration and synthesis of quantitative and 





papers, and also helps identify gaps in literature. The matrix, which displays the included 
studies in rows and generated themes in columns, was created by HS. 
 
3.4 Results  
This section presents the results of the systematic review.  
 
3.4.1 Description of included studies  
The review included a total of 30 papers. This included quantitative (n = 19), mixed 
methods (n = 3) and qualitative research (n = 8). The focus of the research was broken 
down into two categories, those about lung cancer (n = 21) and those about lung cancer 
screening (n = 9). Of all the papers included in the review, eight included only low SES 
groups, and 22 included both low and high socioeconomic groups. Included papers came 
from six countries including: Australia (n = 3), Denmark (n = 1), France (n = 1), Nigeria (n 
= 1), UK (n = 13) and USA (n = 11). Publication dates spanned from 1994 to 2019, with a 
clear publication cluster between 2014 and 2016 (n = 18). The majority of papers were 
considered to be of good quality (n = 28). 
 
A summary of included studies is displayed in Table 3-4. 
 

































































3.4.2 Quantitative and mixed method study results  
The following tables describe the quantitative and mixed methods studies exploring the perceptions and awareness of lung cancer and lung cancer 
screening respectively.  
 
Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 





















knowledge of risk 
factors and 
symptoms 
suggestive of lung 
cancer in New 
South Wales and 
explore attitudes 







measure of SES; 
Area based SES. 
Focus groups – Smoking 
status was associated with 
low SES. Perceived risk 
was low amongst those at 
risk with current smokers 
preferring to deny their 
risk while former smokers 
were generally unaware 
of any ongoing risk. 
Current smokers 
perceived there to be 
stigma associated with 
smoking.   
Survey –  
The majority of 
participants were able to 
identify smoking as a risk 
Good 
 
3 Lung-CAM - The Cancer Awareness Measure (CAM) is a validated questionnaire designed to measure the public’s awareness of the symptoms and risk factors of cancer as well as 




Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 
Study type Study aims Measures Findings Assessed quality 
score  
factor for lung cancer 
(90.6 %). Age (<65 
years), sex (female), and 
high SES contributed to a 









Nigeria  Participants 
(n=1125) were 
taken from a 
random sample of 
households in the 
Ilorin West and 
East Local 
Government Area 
of Kwara State, 
Nigeria. The mean 
age of the 
respondents was 
33 years.  
Cross-
sectional  
To determine the 
awareness about 
the warning signs 
of and risk factors 
for lung cancer and 










measure of SES. 
The demographic 
correlates of a good 
awareness score and 
recognition of risk factors 
were higher educational 
level and higher income. 
Males and those with 
lower education level and 
income were more likely 
to wait 2 weeks or more 








Denmark A total of 3,000 
participants were 
recruited to the 
study. n =1,000 
respondents aged 

















measures of SEP 
(education, 
occupation and 
Overall, across all 
cancers, there was a 
strong socioeconomic 
gradient in cancer 
awareness. People with a 
low educational level and 
a low household income 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 
Study type Study aims Measures Findings Assessed quality 
score  




the Danish Civil 
Registration 
System. 
cancer in a Danish 
population sample 








a lower awareness of 
cancer symptoms, cancer 
risk factors and the 
growing risk of cancer 
with age. There was no 
clear association between 
knowledge of 5-year 











postcodes in the 
UK. Mean age of 





of blame for five 
common cancers 
and two conditions 









measure of SES 
(education level). 
Attributions of blame 
were higher for lung 
cancer than any other 
cancer type. Higher 
education level was 
associated with greater 










France  A representative 






To evaluate the 
perception of lung 











lung cancer, and 
how they 
evaluated their 
own level of 
Lung cancer was 
identified as a severe 
disease (82%) with a 
worse prognosis than 
other cancers but overall 
survival of patients with 
lung cancer (32%) was 
overestimated. When 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 







measure of SES 
(education level 





cancer, lung cancer was 
associated with a loss of 
autonomy or seen as a 
punishment. 
The most common words 
participants associated 
with lung cancer include: 
Death, Cure, Black, 
Fatigue and Pollution. 
Negative word 
associations (such as 
death or black) were 
associated with high 
education level and those 
in employment. Positive 
words (such as cure) were 
associated with those 
outside of employment 









Men and women 
over the age of 50 









impact on public 
awareness and the 
number of patients 
presenting to 
general practitioner 






hoarseness/coughing as a 
symptom of lung cancer 
increased after the 
campaign (41% - 50%). 
There was a pre to post 
campaign increase in 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 





was also obtained 
from GP practices 
to cross-check GP 
attendance 
(n=486).  
highlighted in the 
campaigns on 
samples of the 
population sub-
grouped by sex, 
age and a measure 
of SES. 
and women and a greater 
increase in GP 
attendances for practices 





USA A total of n=1184 
women were 





New Jersey. The 
mean age of the 





perceptions of the 
health-related risks 
of smoking among 
women smokers. 
Lifetime risk of 
lung cancer; 
individual 
measures of SES 
(income and 
education level). 
The rating of perceived 
lifetime risk for 
developing lung cancer 
differed significantly 
among never smokers, 
former smokers, and 
current smokers. There 
was no difference in 













based survey that 
sampled n=35,308 
from 25 primary 




This study aimed 
to identify how 
cancer symptom 
awareness and 
barriers to help 
seeking vary by 
small geographical 




based on the 
income domain 




awareness and barriers 
scores varied greatly 
between geographical 
regions in England, with 
the lower cancer symptom 
awareness and more 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 




levels of awareness 
and barriers are 
associated with 
cancer survival at 
the PCT level. 
socioeconomically 
deprived parts of East 
London. Low cancer 
awareness score was 
associated with poor 
cancer survival at trust 
level. There were no 
statistically significant 
associations between 
survival from lung cancer, 
and the awareness score 
or recognition of each 
cancer symptom. There 
was no association 
between the barriers score 
or individual barriers and 






The sample were 
randomly selected 




over a two-month 
period in 2010 (n= 




Test the prediction 
that there would be 
greater awareness 














seeking help and 
cancer 
experience; 
Participants from 2012 
were significantly more 
likely to be able to recall 
‘cough’ or ‘hoarseness’ as 
a symptom of lung cancer 
compared to those asked 
in 2010. Recognition of 
lung cancer symptoms 
was much higher in 2012. 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 









survey year and sex, age, 
ethnicity, occupation or 
cancer experience in the 
changes in lung symptom 





USA  A random sample 
of Ohio residents 
(n=500) with an 
income <$18,000 




census data. Mean 
age of the sample 







of lung cancer and 
smoking by 















measures of SES 
(education level). 
Those with the highest 
level of education knew 
more about lung cancer 
than either the middle 
level or lowest level of 
educated respondents. 
The least educated 
respondents perceived 
themselves as more 
susceptible to developing 
lung cancer than those 
with higher education 
levels, considered lung 
cancer to be more severe, 
and perceived fewer 
benefits to quitting 
smoking. No significant 
difference was found 
across education levels 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 
Study type Study aims Measures Findings Assessed quality 
score  


























Use data from a 
large population-
based survey to 
compare beliefs 












measure of SES 
(education level). 
 Current smokers are 
more pessimistic, 
fatalistic and avoidant of 
cancer and its outcomes 
Current smokers were 
significantly more 
pessimistic about cancer 
outcomes and early 
detection than former- or 
never smokers. More 
negative perceptions of 




SES), self-rated health 









USA A random, 
stratified sample 
of who had been 
seen at least once 
in the past year at 




















measures of SES 
Individuals most likely to 
perceive that they were 
unlikely to get cancer 
were more often black, 
with low incomes or less 
than a high school degree. 
Those with lower incomes 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 





aged between 18 











between racial and 
socioeconomic 
groups among 
Indiana residents in 









had a lung scan in the last 
year. Those with some 
college education were 
also less likely to have 
had a lung scan. 
Knowledge about 
appropriate ages to start 
lung screening did not 








UK A total of n=1484 
participants were 
recruited as part 











CAM) and presents 
results from a 
population survey 




measure of SES 
(occupation or 
‘social grade’). 
 People in the highest 
social grade had higher 
symptom awareness than 
those in the lower grades. 
Familiarity with cancer 
was associated with 
higher recognition of risk 
factors. People with the 
highest social grade had 
greater risk factor 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 
Study type Study aims Measures Findings Assessed quality 
score  
recall (p<.05) than those 













selected using a 
random digit dial 
sample (n=1071). 
Participants were 

















Most participants felt that 
lung cancer was 
principally caused by 
external factors (78%), 
that it could be cured if 
caught early (73%), and 
that lung cancer patients 
were at least partly to 
blame for their illness 
(59%). ‘Supporters’ of the 
efforts against lung cancer 
were have higher income. 
Stigmatization of lung 









UK Data were 
collected from 
n=2018 adults 








Use data from a 
British population 
sample to compare 
estimated survival 
for three common 
cancers distributed 








measure of SES 
(occupation). 
 
There was a tendency to 
overestimate lung cancer 
survival. Respondents 
correctly recognised that 
5-year survival for breast 
cancer was higher than for 
colorectal cancer, which 
in turn was recognised to 





Table 3-5: Data Extraction - Lung Cancer Quantitative & Mixed Methods Studies (n = 15) 
Author / Year Location Participants (n, 
age, sampling) 
Study type Study aims Measures Findings Assessed quality 
score  
respondents (aged 






 cancer. Similarly, 
curability was perceived 
to be higher for breast 
cancer than colorectal 
cancer, and both were 
perceived to be more 
curable than lung cancer. 
Awareness of survival 
differences did not vary 
by sex, age or 















Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods Studies (n = 7) 












Field & Brain 
(2015) 




and of these n=434 
provided comments in the 
optional free-text field. 
Participants were high-
risk individuals aged 50–
75years residing in six 
primary care trusts in the 




Use a mixed 
methods approach 
to identify the 


















associated with lung 
cancer screening uptake. 
Individuals in the lowest 
quintile were almost 
twice as likely to decline 
screening compared 
with those in the highest 
quintile. Reasons for 
non-participation 
include: Practical 
Barriers (e.g. travel, 
comorbidities, caring 
responsibilities); 
Emotional Barriers (e.g. 
avoidance of lung 
cancer information, 
fear); Trial acceptability, 
Age (e.g. too old); 
Dislikes (e.g. hospitals 
or healthcare) and Low 
Perceived Risk. 
Good 
Cataldo (2016) USA Smokers, over the age of 
55 (n=338) were recruited 
as part of the larger 
Cross-
sectional  




beliefs about lung 
cancer and lung 
Over 82% of the sample 
believed that a person 





Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods Studies (n = 7) 




Study aims Measures Findings Assessed 
quality 
score  
Tobacco Attitudes and 
Beliefs Study. Mean age 














related to whether 
a smoker would 








after the age of 40 has at 
least a 25% chance of 
developing lung cancer 
and 77.3% would “agree 
to a LDCT today”. None 
of the demographic 
variables were 
significantly associated 
with the decision to have 
a LDCT, including SES. 





Triplette, Meza & 
Elmore (2016) 
USA A total of n=6 focus 
groups were carried out, 
and n=45 patients 
participated (mean age of 
61 years). Participants 
were recruited from an 
urban county hospital 












based and paper 








measures of SES 
(income and 
education level). 
Participants, from a low-
incomes sample 
demonstrated improved 
knowledge about lung 
cancer screening after 
reviewing two decision 
aids and spending 1.5 
hours in a discussion 
group. There was no 
significant change in 
subjects’ perception of 





Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods Studies (n = 7) 








benefits of lung 
cancer screening. 
risk or the feelings of 
worry that would result 
from an abnormal 
LDCT scan. Few 
participants agreed that 
if they had a normal 
LDCT scan they could 
“continue to smoke 
without worrying’. The 
focus groups highlighted 
that participants were 
not aware of the purpose 
of lung cancer 
screening. Participants 
expressed surprise that 
the magnitude of their 
lung cancer risk and 
benefits of screening 
were lower than 
anticipated. No SES 
comparisons presented 
as all participants were 




USA Patients (n=108) were 
recruited from the primary 





(SRM) to assess 
Survey based on 
SRM domains 
(identity, cause, 
Beliefs reflecting main 






Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods Studies (n = 7) 










large urban academic 
medical centre. The study 
cohort consisted of 
asymptomatic individuals 
with a ≥10 pack-year 
cigarette smoking history, 
with a mean age of 62.3 
years. 
the influence of 













with intention to screen. 
Beliefs reflecting 
fatalism and spirituality 
were endorsed more 
often by minority and 
low-income groups in 
addition to fear and 
anxiety. Cost of 
screening, fatalism and 
fear of radiation 
exposure from screening 
were perceived barriers 
for minority groups and 
those with low incomes. 
Quaife, Vrinten, 
Ruparel, Janes, 
Beeken, Waller & 
McEwan (2018) 
UK A total of n=1445 
participants from a 
number of geographical 
areas England were 
recruited to participate in 
the Attitudes, Behaviour 
and Cancer UK Survey 
(ABACUS). Mean age of 








early detection of 
lung cancer might 










worry about lung 
cancer risk; 
individual 
measure of SES 
(education level). 
Current smokers had a 
lower level of education. 
48% of participants 
considered a lung cancer 
diagnosis to be a death 
sentence. Worry about 
lung cancer risk was 
most common among 
smokers (48%). The 
large majority of current 
and former smokers 





Table 3-6: Data Extraction - Lung Cancer Screening Quantitative & Mixed Methods Studies (n = 7) 













for lung cancer. The 
proportion of intenders 
was highest if 
recommended by a GP. 
Sex, age, ethnicity, level 
of education, marital 
status and cancer 
experience were not 
associated with 
screening intentions. No 
SES differences were 
reported. 
Rutten, Hesse, 
Moser, McCaul & 
Rothman (2009) 
USA The data analysed was 
obtained the HINTS 2005. 
A representative sample 
(n=5586) was achieved by 
using random digit dial of 
all tele- phone exchanges 
in the United States. 
Cross-
sectional  
Evaluate what the 
current public 
understanding of 
colon, lung, and 






















18.1% of respondents 
believed that there was 
not much that can be 
done to lower chances of 
getting lung cancer. 
Prevention knowledge 
was associated with 
higher education level. 
87.4% of respondents 
agreed that screening 
increases chances of 
finding lung cancer 
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screening beliefs and 
demographic 
characteristics. Only 
17.3% of respondents 
accurately reported that 
25% or fewer people 
would survive at least 5 
years. No significant 
association between 







USA US veterans (n=209) were 
recruited in a healthcare 
setting where they were 
being treated as 
outpatients. Adults over 
the age 18 were 
approached to participant, 
with participant mean age 
being 56.2 years. 87.1% 
of participants were male. 
Cross-
sectional  
Assess the role of 
beliefs and 
attitudes toward 
LC screening in 
US veterans. 
Knowledge about 
and willingness to 
be screened for 
lung cancer; 
individual 







more likely than never 
smokers to be less 
educated, have a lower 
income, and report 
poorer health. 80% of 
current smokers believe 
that they were at 
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Study aims Measures Findings Assessed 
quality 
score  
cancer. 50% believed 
that early detection of 
lung cancer results in a 
good chance of survival. 
No SES differences 
reported, but smoking 
status is associated with 





















3.4.3 Qualitative study results 
The following tables describe qualitative studies exploring the perceptions and awareness of lung cancer and lung cancer screening respectively.  
 
Table 3-7: Data Extraction - Lung Cancer Qualitative Studies (n = 6) 















Adults with lung cancer 
diagnosis (n=11) and adults’ 
high risk of lung cancer (n=14) 
recruited from healthcare 
settings were situated in an area 
of high economic deprivation on 
the outskirts of a major (UK) 





Investigate the social 
factors which 
influence symptom 
recognition and help 
seeking behaviour. 
Fatalism - Both patients and 
high-risk individuals had 
fatalistic views of lung cancer. 
Participants in both groups 
reported that acknowledging and 
looking for symptoms was 
something they chose not to 
think about 
Awareness of smoking risk - 
Those in the diagnosed group 
who continued to smoke 
believed that ‘the damage was 
done’. Smokers in both groups 
would actively avoid lung cancer 
media campaigns.  Participants 
could identify smoking as a risk 
but were ambivalent about the 
effects of smoking. 
Social Network and help 
seeking - All male participants in 
the study said they tended to 





Table 3-7: Data Extraction - Lung Cancer Qualitative Studies (n = 6) 
Author / Year Location Participants (n, SES, sampling) Study type Study aims Findings / Reported Themes Assessed 
quality 
score 
any reason and were usually 
pressurised into it by a spouse or 
family member. Many reported 
that they would have to be in 










Adults with lung cancer 
diagnosis (n=22), aged between 
42-82 years.  Participants were 
recruited from two cancer 
centres in the South and North 
of England. For participants 
where occupational status was 
relevant, 13 described 
themselves as having or having 
had manual occupations, five 




Examine whether any 
or all types of delay 
were factors in the 
timing of diagnosis 
among patients with 
lung cancer, and to 
understand more fully 
how processes of delay 
occur. 
Disconnected interpretations of 
bodily changes - Delay in help 
seeking occurred because 
symptoms were not important 
enough to warrant making a GP 
appointment. Most were not in 
regular contact with primary care 
services and did not consider the 
GP as someone to go to about 
their health or any bodily 
changes. Bodily changes put 
down to age, or incorrectly 
attributed to co-morbid illness. 
Unworthy of treatment – Delay 
to help seeking occurred as a 
result of stigma attached to 
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Two-part study which recruited 
people with no cancer history 
(n=32) and current lung cancer 
patients (n=10). 
Participants were aged 35+, and 
self-identified as African 
American. Participants were 
recruited from a subsidised 
housing community in an 











recognised factors that 
may account for 
differences in care and 
medical outcomes of 
African Americans 
with lung cancer. 
Smoking as a risk factor – Both 
lung cancer patients and those 
who had no cancer history were 
aware of the link between 
smoking and lung cancer, 
common symptoms and possible 
poor prognosis. However, the 
majority of participants from the 
patient group did not think 
smoking was the cause of their 
current cancer diagnosis. 
Race or SES as a risk factor 
Most participants considered 
insurance status and other 
socioeconomic factors were 
more likely to impact diagnosis 
and treatment of lung cancer 




Yang & Fong 
(2015) 
Australia Aboriginal and Torres Strait 
Islander peoples (n=67) 
including community members 
and Indigenous health workers. 
Participants were from 
communities of lower 
socioeconomic status.  
Structured 
interviews  
Survey the level of 
lung cancer awareness 
in rural and remote 




barriers to timely 
Lung cancer knowledge -
Around half of participants had a 
low level of awareness/ 
knowledge of lung cancer but 
had some awareness of smoking 
as a cause. Participants were able 
to identify some symptoms of 
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treatment of lung 
cancer. 
Accessibility - The main barrier 
to early diagnosis was thought to 
be accessibility – travel to 
specialist doctors located in 
urban areas was difficult and 
costly. Many would not even 








Australia Culturally and Linguistically 
Diverse communities (n=51) - 
Mandarin (n=7); Cantonese 
(n=13); Vietnamese (n=16); 
Arabic (n=15). Aged between 
44 and 65 years old. Participants 
were recruited from 
underserved communities that 




attitudes and beliefs 
about lung cancer in 
three CALD 
communities in NSW. 
Perceived susceptibility - 
Smokers’ idea of susceptibility 
varied across the different 
CALD groups. This was clear in 
the Arabic-smokers group, who 
did not believe the risk was any 
different to non-smokers and that 
healthy behaviours outweigh 
smoking behaviour. 
Perceived severity – There was 
some awareness that early 
diagnosis of lung cancer is 
beneficial, but all groups thought 
survival rates were poor. There 
was limited knowledge of lung 
cancer and groups believed that 





Table 3-7: Data Extraction - Lung Cancer Qualitative Studies (n = 6) 
Author / Year Location Participants (n, SES, sampling) Study type Study aims Findings / Reported Themes Assessed 
quality 
score 
stage. All groups reported 
fatalistic views of lung cancer. 
Awareness of symptoms -   
Responses across the CALD 
groups were mixed. Levels of 
trust in participants GP appears 
to influence help-seeking 
behaviour.  
Tod, Craven & 
Allmark 
(2008) 
UK Adults with lung cancer 
diagnosis (n=18) and adults 
previously diagnosed and 
survived lung cancer (n=2), 
aged between 47 and 81 years 
old. Participants were recruited 
from a health board in the North 





Explore and explain 
delay, particular pre-
diagnostic delay, in 
lung cancer and to 
consider the 
implications for public 
education and nursing. 
Symptom experience – Many 
participants believed their 
symptoms to be minor or 
unspecific leading them to delay 
diagnosis. A recurring belief that 
non-smokers and ex-smokers 
would not get lung cancer. As a 
result, there was a lack of 
symptom vigilance and belief 
that any symptoms were not 
attributed to lung cancer but 
another illness. 
Fear – Fear was fostered by a 
lack of knowledge of treatments 
and strong fatalistic beliefs. Fear 
of death and a cancer diagnosis 





Table 3-7: Data Extraction - Lung Cancer Qualitative Studies (n = 6) 
Author / Year Location Participants (n, SES, sampling) Study type Study aims Findings / Reported Themes Assessed 
quality 
score 
Blame and Stigma – The 
findings revealed a prevailing 
expectation that people with lung 
cancer would experience blame 
and stigma. Non- or ex-smokers 
delayed in reporting symptoms 
because of an expectation, based 
on previous experience, that they 
would be stigmatized as a 
smoker and blamed for their 
illness. 
Culture - Cultural factors such 
as stoicism in older males and 
non-standard patterns of health 
care utilization. Often, 
participants would not use GP’s 
at all having previously used 
‘pit’ doctors and fear that they 






Table 3-8: Data Extraction - Lung Cancer Screening Qualitative Studies (n = 2) 
Author / Year Location Participants (n, SES, 
sampling) 
Study type Study aims Findings / Reported Themes Assessed 
quality 
score 






Adults high risk of lung 
cancer (n=32), aged between 
50 and 75 years old. 
Participants recruited from 
the most disadvantaged areas 





and facilitators in 
early lung cancer 
detection trials. 
Invitation to participate - 
Participants from Glasgow 
considered GP invitations a 
good idea for recruitment; 
however, some were 
sceptical that the GP would 
be willing to give the time. 
Participants suggested that 
word of mouth might be the 
best way to recruit to the 
lung cancer screening trial. 
Understanding 
randomisation and issues 
related to the control group 
- Participants all struggled 
with the concepts of 
randomisation and control 
groups. When explained, 
participants understood that 
they were a good idea, but 
would still want to be in the 
‘treatment’ arm 
Perceived barriers and 
facilitators to participation - 
Many participants identified 
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Author / Year Location Participants (n, SES, 
sampling) 




felt stigmatized because of 
their smoking status and the 
targeted nature of the 
screening trial. They 
considered that smokers 
should not be singled out as 





Reinke & Au 
(2015)  
USA  US Veterans high risk of 
lung cancer (n=37), aged 






Aim to learn from 
patients who were 
offered screening 







Screening and Smoking - 
current smokers exaggerated 
the personal benefits of lung 
cancer screening. 
Participants were very 
positive about screening – it 
was considered very easy to 
do, compared to stopping 
smoking which was seen as 
much more difficult. Many 
believed that screening 
meant that there was less 
urgency to stop smoking. 
Participants felt ‘protected’ 
from lung cancer because 





Table 3-8: Data Extraction - Lung Cancer Screening Qualitative Studies (n = 2) 
Author / Year Location Participants (n, SES, 
sampling) 
Study type Study aims Findings / Reported Themes Assessed 
quality 
score 
a screening programme was 
available. 
Screening and Self-
reflection About Smoking - 
Lung cancer screening 
stimulates a period of self-
reflection and induced 
‘emotional arousal’. Many 





















3.4.4 Qualitative thematic analysis  
A framework approach was used to generate analytical themes for qualitative lung cancer and lung cancer screening studies. The frameworks of 
identified themes, including extracts from the included studies, are displayed in Tables 3-9 and 3-10. 
 
3.4.4.1 Qualitative thematic framework – lung cancer  
The table below displays a thematic framework based on the findings of the qualitative lung cancer studies. The table includes extracts from the included 
studies. 
Table 3-9: Thematic Framework Analysis of Qualitative Lung Cancer Studies 












A strong thread with our 
diagnosed participants was a 
kind of fatalistic attitude 
towards post diagnosis 
processes 
 
Elements of fatalism, where 
they were apparent, were more 
akin to resignation about having 
to go through a potentially 
painful and ultimately tenuous 
(in terms of possible outcomes) 
treatment process 
This gave us the opportunity to 
explore the issue of smoking 
related stigma […] In our data, 
however, negative issues such 
as these were not strongly 
evident, even among those who 
had non-smoking related lung 
cancer. Work by De Nooijer et 
al. has suggested that shame 
and embarrassment about 
symptoms actively hinders early 
presentation and diagnosis, but 
again, this was not the case in 
the people we interviewed. 
There was often the admission 
that looking out for, or 
acknowledging the appearance 
of worrying symptoms was 
something that people chose not 
to think about in any formalised 
way 
 
its [symptom] appearance might 
be attributed to any number of 
other lung problems apart from 
cancer 
 
Most participants said they’d go 
to their doctor if they started 
They regarded the damage as 
having already being done [with 
regard to smoking]. 
 
On the one hand, participants 
would readily admit that there 
was a real risk of lung cancer 
(or other health implications) if 
they continued to smoke. But on 
the other, the reasons they cited 





Table 3-9: Thematic Framework Analysis of Qualitative Lung Cancer Studies 
 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
noticing persistent symptoms 
such as coughing, or ‘a different 
kind of coughing’. However, as 
outlined already, these wouldn’t 
necessarily be attributed to 
cancer, or the possibility that 





Participants did not appear to 
have consciously ‘delayed’ 
seeking help for symptoms 
through fear, neither did we 
find obvious evidence of 
‘denial’ among participants who 
were smokers or former 
smokers that the symptoms they 
were experiencing might be due 
to lung cancer, although this 
warrants further study. 
There was evidence in the 
account of one woman that she 
felt because she smoked she 
may not have the right to 
professional care 
 
The woman’s account accords 
with recent work […] which 
reveals the stigma experienced 
by people with lung cancer 
because the disease is so 
strongly associated with 
smoking and led some to 
conceal their illness, while 
others worried that diagnosis, 
access to care and research into 
lung cancer might be adversely 
affected by the stigma attached 
to the disease and to those who 
smoke. 
For many, symptoms were not 
perceived as important enough 
to warrant making an 
appointment. They were 
uncertain as to what should be 
considered normal, or they felt 
what they were experiencing 
was probably a minor problem. 
For example, a man who had 
been very active describes how 
he had experienced profound 
tiredness for 18 months prior to 
his diagnosis, yet it took him 
over 1 year to go to his doctor 
about it 
 
Knowing what was ‘normal’ 
and knowing what was 
reasonable, or bad enough to 
warrant making an appointment 
Most of the participants were 
smokers or former smokers, a 
number had even given up 
smoking as a result of the health 
changes they were 
experiencing, but none seemed 
to have considered the 
possibility of lung cancer or 
they had suppressed the 
possibility of a connection. 
There is no evidence in the 
interviews that individuals had 
considered that they may have 
lung cancer until after they had 
been referred by their doctor for 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
was an issue for some and 
worrying that they might be 
wasting their doctor’s time or 
that they might be criticised for 
this, seemed to be a common 
preoccupation. 
 
‘Carrying on’ in the face of 
growing ill-health was common 
place and was driven by the 
need to hold down a job, or to 
keep up familiar roles and 
responsibilities 
 
Since the symptoms participants 
experienced were not 
considered to be matters 
relating to health, or for that 
matter ill-health, but were 
bound up in their experience of 
everyday life, it had not 
occurred to them that they 
might seek help from anyone 
and this is possibly the most 
important factor underlying the 
health-related behaviours 
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Symptoms were attributed to 
bodily functions or changes and 
therefore were experienced as 
part of the everyday 
fluctuations one experiences of 
one’s body and its functioning 
 
They were uncertain as to what 
should be considered normal, or 
they felt what they were 









Participants seemed well aware 
of treatment options for lung 
cancer, including surgery, 
radiation, and chemotherapy. 
Several spoke specifically about 
chemotherapy, focusing on its 
side effects. Although some 
participants believed it was 
effective, others believed it 
could be fatal. 
 
Participants overwhelmingly 
reported that they did not fear 
All participants believed that 
others assume lung cancer 
patients are smokers and that 
many use it to judge their 
character. 
 
Focus group and lung cancer 
participants alike discussed the 
stigma associated with a lung 
cancer diagnosis and the lack of 
attention lung cancer gets in 
relation to other diseases in 
African American communities. 
Most participants were aware 
that cigarette smoking was the 
main environmental exposure. 
Several also mentioned that 
some patients are diagnosed 
with lung cancer without a 
smoking history and that other 
environmental agents can also 
cause lung cancer. Asbestos, 
second-hand smoke, and air 
pollution were all mentioned as 
possible causes. 
 
Most participants were aware 
that cigarette smoking was the 
main environmental exposure. 
Several also mentioned that 
some patients are diagnosed 
with lung cancer without a 
smoking history and that other 
environmental agents can also 
cause lung cancer. Asbestos, 
second-hand smoke, and air 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
the treatments but had different 
reasons. Some expressed 
confidence in the environment, 
whereas other noted their age 
and life experience. 
The lethality of lung cancer was 
also discussed, but a majority of 
participants maintained a 
positive outlook on their 
personal circumstances. 
When asked what they would 
do if diagnosed with lung 
cancer, participants most 
commonly responded that they 
would seek information about 
treatment options from their 
doctor. Only one participant 
reported that he would not seek 
treatment because of his 
father’s experience. 
 
Most did not suspect that they 
had lung cancer prior to 
diagnosis. A few reported that 
the initial shock they 
experienced made it difficult to 
interact with their care team or 
to recall their initial 
conversations. 
 
All but one participant felt that 
lung cancer was not viewed a 
prevalent issue among African 
Americans and that there was 
more emphasis on other 
illnesses and cancers. 
Most focus group participants 
worried about getting lung 
cancer as a result of their 
smoking history. 
 
Most participants felt that 
African Americans were at high 
risk for lung cancer because 
they smoked more cigarettes. 
The targeting of African 
Americans in tobacco 
advertising was a key theme 
that emerged. 
 
Although 9 of the 10 
participants had a smoking 
history, only 2 identified 
smoking as the sole or primary 
cause of their lung cancer. Four 
male participants believed 
occupational exposure to 
hazardous chemicals may have 
also been a contributing factor, 
and two female participants 
noted that they had quit 
smoking decades earlier. Three 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
that non-smokers can also 
develop lung cancer, and one 
suggested that heredity was an 
additional factor because not 
everyone who smokes develops 
lung cancer. Nevertheless, most 
reported wishing they had quit 






In reply to the question: ‘what 
do you know about lung 
cancer?’ 18% (n=9) of 
community members and 28% 
(n=4) Indigenous health 
workers mentioned lung cancer 
mortality. Responses included 
words such as ‘death’ or ‘kills’. 
 The following question was 
‘What do you think causes lung 
cancer?’ Forty-six of 51 (46%) 
community members and 14/14 
Indigenous health workers cited 
smoking. Four of 51 (8%) 
community members, and four 
of 14 (28%) Indigenous health 
workers also cited toxic fumes, 
including gas, petrol, paints and 
pesticides as a cause of lung 
cancer. 
 
All participants identified at 
least one warning symptom of 
lung cancer from the list in 
Table 3. Thirty-five of 51 
(69%) community participants 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
Indigenous health workers said 
they would seek health- care 
promptly if they developed one 
of these warning symptoms. 
 
Traditional medicine was used 
(but not regularly or 
exclusively) by 17 community 
members (33%) and six 
Indigenous health workers 
(43%). All participants reported 
seeking conventional treatment 
when ill. 
 
We found a low level of lung 
cancer awareness in this survey 











All groups thought survival 
rates would be very poor for 
people with lung cancer. 
Arabic-speaking smokers 
generally believed that a person 
would die six months after 
diagnosis, and the groups could 
not recall any cases where lung 
Arabic-speaking groups also 
expressed a cultural perception 
and stigma towards cancer, 
whereby the more one talks and 
thinks about cancer the higher 
the risk. 
As well as smoking, other 
perceived risk factors for lung 
cancer were suggested, 
including stress, lifestyle, 
environmental factors and 
genetics. Environmental risk 
factors and agricultural food 
production 
Participants accurately reported 
that a person diagnosed with 
lung cancer was more likely to 
be male than female, over 40 
years of age and be a regular 
long-term or heavy smoker. 
While smoking was the most 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
cancer treatment was 
successful. 
 
There was limited knowledge of 
lung cancer, however generally 
it was felt diagnosis would 
occur in a late stage. Further, 
fatalistic views towards cancer 
in general were apparent across 
all three CALD groups. 
 
Compared with other illnesses 
Arabic-speaking smokers felt 
that cancer was of greater 
concern as participants believed 
other diseases could be 
managed and some cured, 
whereas cancer could not be. 
 
Overall, a greater sense of fear 
was articulated in the Arabic-
speaking groups in relation to 
help-seeking for health 
concerns. Participants discussed 
reluctance to go to the doctor 
for fear of bad news, 
particularly if one is referred to 
were discussed in the Cantonese 
and Mandarin-speaking smoker 
groups. 
 
Arabic-speaking smokers were 
less knowledgeable about 
symptoms than non-smokers 
and advised they would not be 
concerned by a cough that 
changes/new cough or 
persistent cough as they were 
not seen to be symptoms of 
lung cancer. 
 
In the Arabic-speaking smoker 
group there was a sense of 
denial towards the risk of 
developing lung cancer, and 
cancer more generally, as well 
as the link between smoking 
and lung cancer. 
 
There was some awareness of 
the importance of early 
diagnosis of lung cancer 
(primarily amongst Cantonese-
speaking smokers), however all 
general concept of risk factors 
was not clearly understood. 
 
As well as smoking, other 
perceived risk factors for lung 
cancer were suggested, 
including stress, lifestyle, 
environmental factors and 
genetics. Environmental risk 
factors and agricultural food 
production were discussed in 
the Cantonese and Mandarin-
speaking smoker groups. 
 
Further, smokers in all three 
CALD groups were mixed in 
their views of whether smoking 
increased their risk of lung 
cancer; some felt they had no 
greater risk of lung cancer than 
ex-smokers or non- smokers. 
Some of those in the Arabic-
speaking smoking group felt 
they were not at increased risk 
compared with non-smokers 
due to their healthy lifestyle 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
a specialist, with associated 
stress and anxiety when waiting 
for a diagnosis. 
groups thought survival rates 
would be very poor for people 
with lung cancer. 
 
Opinion on early diagnosis was 
also not consistent, as some in 
the Cantonese non-smoking 
group thought diagnosis was 
not possible in the early stages 
of lung cancer. 
 
There was a mixed response 
between the groups regarding 
awareness of symptoms 
consistent with lung cancer 
than their smoking or that their 
bodies were immune. 
 
Arabic-speaking groups also 
expressed a cultural perception 
and stigma towards cancer, 
whereby the more one talks and 







Fear was fostered by a lack of 
knowledge of treatments and 
strong fatalistic beliefs. Fear of 
death and a cancer diagnosis 
delayed reporting of symptoms. 
 
Current information campaigns 
were seen to contribute to 
fatalistic views as they focused 
on death rather than treatment. 
 
The findings revealed a 
prevailing expectation that 
people with lung cancer would 
experience blame and stigma. 
 
Non- or ex-smokers delayed in 
reporting symptoms because of 
an expectation, based on 
previous experience, that they 
would be stigmatized as a 
smoker and blamed for their 
illness. 
There was wide variation in 
symptoms and therefore no 
clear symptom profile emerged. 
Symptoms were often minor 
and unspecific 
 
Some participants thought that 
lung cancer was different from 
other cancers which had clear 
symptoms detectable through 
physical self-examination 
 
Participants did not have 
accurate knowledge of lung 
cancer risk and saw themselves 
as more at risk of other cancers. 
 
Two participants believed that 
after they gave up smoking their 
risk of lung cancer would be nil. 
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 Fatalism and Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
Great value was placed on 
stoicism, not complaining and 
‘‘putting on a brave face’’. 
 
Fear of a medical consultation 
and being seen as a time- waster 
further prompted delay, 
especially where people had 
previous bad experiences. 
 
Stoicism was present in older, 
male participants and those who 
had worked in traditional 
industries such as coal mining 
and steel, and at the railway 
plant. 
There was a tendency to 
attribute symptoms to other 
acute and chronic conditions 
[…] This tendency was 
exaggerated in those who did 
not smoke. 
 
Knowledge and awareness of 
lung cancer symptoms and 
treatments was poor, and 
available information focused 
on other cancers. Any lung 
















3.4.4.2 Qualitative thematic framework – lung cancer screening 
The table below displays a thematic framework based on the findings of the included qualitative lung cancer screening studies. The table includes 
extracts from the included studies. 
Table 3-10: Thematic Framework Analysis of Qualitative Lung Cancer Screening Studies 









We class the perceived barriers as practical 
barriers and psychosocial barriers. Of the 
former, the main obstacle 
to participation appeared to be the need for 
flexible appointments that were local to 
participants 
 
While most of the respondents were retired, 
work commitments among some of the 
younger participants were seen as a 
potential barrier and so the need for flexible 
appointments was perceived to be greatest 
for this demographic (under 60s) 
 
With regard to perceived psychosocial 
barriers, participants felt stigmatized 
(because of their smoking status) by some 
of the language used in the PILs (such as 
targeting smokers, because of their higher 
risk of developing lung cancer). Some 
strong views were expressed that cancer 
Indeed, some participants believed that by 
taking part in the trial and finding out that 
they had lung cancer may force people to 
stop smoking, even though they did not 
want to […]Such views were, however, 
contrasted with equal numbers of 
participants who said that they would 
continue to smoke, regardless of what the 
test found 
 
With regard to perceived psychosocial 
barriers, participants felt stigmatized 
(because of their smoking status) by some 
of the language used in the PILs (such as 
targeting smokers, because of their higher 
risk of developing lung cancer). Some 
strong views were expressed that cancer 
could affect anyone and smokers should not 
be made to feel singled out or challenged: 
 
With regard to perceived psychosocial 
barriers, participants felt stigmatized 
(because of their smoking status) by some 
of the language used in the PILs (patient 
information leaflet) (such as targeting 
smokers, because of their higher risk of 
developing lung cancer). Some strong views 
were expressed that cancer could affect 
anyone and smokers should not be made to 
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 Barriers to screening Smoking status and cessation Lung cancer (screening) awareness and 
beliefs 
could affect anyone and smokers should not 
be made to feel singled out or challenged 
 
One possible barrier to recruitment was the 
perception held by some participants that 
the trial is designed to encourage people to 
stop smoking 
 
Altruism was perceived to be a motivator 
for participants, particularly for those in the 
control group who saw their role in 
participating in the research, even to the 
extent that they viewed the blood they were 
giving (which was not going to be tested for 










They described lung cancer screening as 
much simpler than other cancer screening 
tests. One participant described the test as 
“no fuss, no muss.” 
 
Many study participants expressed that 
offering screening was a highly valuable 
service because everyone who undergoes 
screening will receive a benefit from it 
 
Many participants wanted to undergo 
screening to 
The emotional arousal induced by screening 
was strongly influential to some 
participants. Notably, 3 participants 
reported having quit smoking for at least 30 
days because of screening 
 
One participant indicated that he quit after 
being offered screening because the 
conversation caused him to think differently 
about his health and smoking. One 
participant who reported quitting described 
Participants described the offer of lung 
cancer screening as stimulating a period of 
self-reflection.  
 
Most participants described the availability 
of screening very positively; however, some 
participants described being anxious for 
many days thinking about smoking and lung 
cancer during the entire screening process, 
from the time of being offered the test, 
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 Barriers to screening Smoking status and cessation Lung cancer (screening) awareness and 
beliefs 
see “how much damage” they had done to 
their lungs 
 
Most participants described the availability 
of screening very positively; however, some 
participants described being anxious for 
many days thinking about smoking and lung 
cancer during the entire screening process, 
from the time of being offered the test, 
scheduling it, and waiting for the results. 
how suspicious findings provided 
motivation for quitting 
 
Other participants described being 
motivated to consider quitting by results of 
their tests, although most ultimately 
commented that now was not a good time to 
try quitting, said they could wait to see if 
the findings on their LDCT scan progressed, 
or provided other reasons why they were 
not likely to take immediate action to quit. 
 
The exasperated and hopeless tone about 
quitting contrasted strongly with the 
language used to describe the ease and 
effortlessness of screening 
They described lung cancer screening as 
much simpler than other cancer screening 
tests. One participant described the test as 
“no fuss, no muss.” Although no 
participants directly stated that they saw 
screening as a substitute for cessation, most 
were extremely enthusiastic about how 
simple the screening process was while 
earlier in the interview they had spent a 
They described lung cancer screening as 
much simpler than other cancer screening 
tests. One participant described the test as 
“no fuss, no muss.” Although no 
participants directly stated that they saw 
screening as a substitute for cessation, most 
were extremely enthusiastic about how 
simple the screening process was while 
earlier in the interview they had spent a 
significant amount of time recounting the 
futility of trying to quit smoking.  
 
Many study participants expressed that 
offering screening was a highly valuable 
service because everyone who undergoes 
screening will receive a benefit from it. 
Although patients were provided with 
education about the limited absolute benefit 
of screening, nearly all participants 
mentioned the belief that everyone who is 
screened will benefit in some way.  
 
Several patients used future-looking phrases 
to describe how they felt protected from 
lung cancer just knowing that a screening 
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 Barriers to screening Smoking status and cessation Lung cancer (screening) awareness and 
beliefs 
significant amount of time recounting the 
futility of trying to quit smoking.  
In interviews conducted after patients had 
received the results of their scan, some 
participants reported feeling they should be 
more motivated to quit. However, when 
asked in more depth to describe those 
feelings, several patients described a lack of 
urgency for quitting linked with plans to 
follow their findings with additional 
imaging. 
 
Many participants wanted to undergo 
screening to see “how much damage” they 
had done to their lungs, a theme that arose 
both in interviews prior to knowing the 
LDCT results as well as interviews after 
results were known. 
 
Several participants indicated that they were 
expecting bad news; so, when they were 
told the findings were not urgent and did not 
require immediate action, they expressed 
relief 
 
Interestingly, even participants who were 
identified with nodule findings described 
feeling that their smoking had not yet 
harmed them because they were not told 













3.4.5 Synthesis matrix – lung cancer  
The following table displays a thematic synthesis matrix of quantitative and qualitative lung cancer studies, in order to identify overlap and gaps in the 
identified literature. 
 
Table 3-11: Thematic Synthesis Matrix for Lung Cancer Studies 
 Fatalism & Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
Chatwin et al. (2014) 
(Low SES) 
Both patients and high-risk 
individuals (from low SES 
areas) had fatalistic views 
of lung cancer. 
 Poor awareness among 
participants of the 
symptoms of lung cancer. 
Participants could identify 
smoking as a risk but were 
ambivalent about the 
effects of smoking. 
Corner et al. (2006) 
(Low and High SES) 
Participants did not appear 
to have consciously 
‘delayed’ seeking help for 
symptoms through fear. 
Delay to seek help 
occurred as a result of 
stigma attached to smoking 
in both low and high SES 
areas.  
Delay in help seeking 
occurred because 
symptoms where not 
important enough to 
warrant making a GP 
appointment across SES. 
 
Crane et al. (2016)  
(Low and High SES) 
A sense of fatalism 
amongst both current and 
former smokers about their 
current and future health 
was also evident. 
Current smokers would not 
go to their doctor about 
symptoms because of 
feelings of stigma 
associated with smoking. 
The majority of 
participants were able to 
identify smoking as a risk 
factor for lung cancer. 
Higher socioeconomic 
status contributed to a 
higher recognition of 
symptoms. 
Perceived risk was low 
amongst those at most risk. 
Desalu et al. (2016) 
(Low and High SES) 
  Those with lower education 
level and income were 
more likely to wait 2 weeks 
Good awareness and 
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awareness 
Risk Perception 
or more before seeking 
help for symptoms 
were higher educational 
level and higher income. 
Hvidberg et al. (2014) 
(Low and High SES) 
  People with a low 
educational level and a low 
household income were 
more likely to have a lower 
awareness of cancer 
symptoms. 
People with a low 
educational level and a low 
household income were 
more likely to have a lower 
awareness of cancer risk 
factors.  
Lathan et al. (2015) 
(Low SES) 
 Stigma associated with a 
lung cancer diagnosis. 
Participants believed that 
others assume lung cancer 
patients are smokers and 
that many use it to judge 
their character.  
Both lung cancer patients 
and those who had no 
cancer history were aware 
of common symptoms and 
possible poor prognosis of 
lung cancer.  
Both lung cancer patients 
and those who had no 
cancer history were aware 
of the link between 
smoking. The majority of 
participants from the 
patient group did not think 
smoking was the cause of 
their current cancer 
diagnosis. 
Marlow et al. (2010) 
(Low and High SES) 
 Higher education level was 
associated with greater 
blame attribution for lung 
cancer. 
  
Mazieres et al. (2015) 
(Low and High SES) 
Lung cancer was identified 
as a severe disease with a 
worse prognosis than other 
cancers but overall survival 
Lung cancer was associated 
with a loss of autonomy or 
seen as a punishment. 
Negative word associations 
were associated with high 
education level and those 
in employment. Positive 
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 Fatalism & Fear Stigma Lung cancer and symptom 
awareness 
Risk Perception 
of patients with lung cancer 
was overestimated. 
those outside of 
employment and low 
education level. 
Moffat et al. (2015) 
(Low and High SES) 
  Awareness of 
hoarseness/coughing as a 
symptom of lung cancer 
increased after the 
campaign – there was no 
significant difference 
across deprivation groups. 
There was a greater 
increase in GP attendances 
for practices in less-
deprived areas. 
 
Moran et al. (2003) 
(Low and High SES) 
   Current smokers rated their 
lifetime risk for developing 
as average or below 
average. There was no 
difference in perceived risk 
across education levels. 
Niksic et al. (2016) 
(Low and High SES) 
  Cancer symptom 
awareness and barriers 
scores varied greatly 
between geographical 
regions in England, with 
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Page, et al. (2015) 
(Low SES) 
Participant responses to 
lung cancer were often 
negative and included 
words such as ‘death’ or 
‘kills’. 
 Around half of participants 
had a low level of 
awareness/ knowledge of 
lung cancer but had some 
awareness of smoking as a 
cause. Participants were 
able to identify some 
symptoms of lung cancer. 
 
Power & Wardle (2015) 
(Low and High SES) 
Being too scared and being 
worried about what the 
doctor might find were 
cited as barriers to help 
seeking but reduced 
significantly between the 
two campaigns. SES 
differences not reported. 
 There were no significant 
interactions between 
survey year and sex, age, 
ethnicity, occupation or 
cancer experience in the 
changes in symptom recall 
or symptom recognition. 
 
Price & Everett (1994) 
(Low and High SES) 
The least educated 
respondents considered 
lung cancer to be more 
severe. 
 Those with the highest 
level of education knew 
more about lung cancer 
than either the middle level 
or lowest level of educated 
respondents. 
The least educated 
respondents perceived 
themselves as more 
susceptible to developing 
lung cancer than those with 
higher education levels. 
Quaife et al. (2015) 
(Low and High SES) 
Current smokers are more 
pessimistic, fatalistic and 
avoidant of cancer and its 
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perceptions of cancer 




Rawl et al. (2019) 
(Low and High SES) 
  Those with lower incomes 
were less likely to have had 
a lung scan in the last year. 
Individuals most likely to 
perceive that they were 
unlikely to get cancer were 
more often black, with low 
incomes or less than a high 
school degree. 
Scott et al. (2014) 
(Low SES) 
All groups reported 
fatalistic views of lung 
cancer. 
Only Arabic-speaking 
groups expressed a 
perceived stigma towards 
cancer. 
There was limited 
knowledge of lung cancer 
There was some awareness 
that early diagnosis of lung 
cancer is beneficial, but all 
groups thought survival 
rates were poor.  
Perceived susceptibility 
varied across the different 
cultural groups. 
Simon et al. (2012) 
(Low and High SES) 
  People in the highest social 
grade had higher symptom 
awareness than those in the 
lower grades. 
People with the highest 
social grade had greater 
risk factor recognition and 
recall than those in the 
lowest social grade 
Tod et al. (2008) 
(Low SES) 
Fear was fostered by a lack 
of knowledge of treatments 
and strong fatalistic beliefs. 
An expectation that people 
with lung cancer would 
experience blame and 
Symptom awareness was 
poor, and symptoms 
experienced were seen as 
Knowledge of lung cancer 
risk was poor, with 
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awareness 
Risk Perception 
Fear of death and a cancer 
diagnosis delayed reporting 
of symptoms. 
stigma. Non- or ex-
smokers delayed in 
reporting symptoms 
because of an expectation, 
based on previous 
experience, that they would 
be stigmatized as a smoker 
and blamed for their 
illness. 
minor and not attributed to 
lung cancer.  
would be more at risk of 
other types of cancer. 
Weiss et al. (2014) 
(Low and High SES) 
 Stigmatization of lung 
cancer negatively 
influenced support for lung 
cancer initiatives. 
Participants believed that 
lung cancer patients were 
at least partly to blame for 
their illness.  
Participants perceived that 
lung cancer was caused by 
external factors, and that it 
could be cured if caught 
early. ‘Supporters’ of lung 
cancer initiatives were 
more likely to be employed 
and have higher income. 
 
Whitaker et al. (2012) 
(Low and High SES) 
Lung cancer perceived to 
be more fatal when 
compared to other cancers. 
 There was a tendency to 
overestimate lung cancer 
survival, however 
awareness of survival 
differences did not vary by 









3.4.6 Synthesis matrix – lung cancer screening  
The following table displays a thematic synthesis matrix of quantitative and qualitative lung cancer screening studies, in order to identify overlap and 
gaps in the identified literature. 
 
Table 3-12: Thematic Synthesis Matrix for Lung Cancer Screening Studies 
 Barriers to screening  Smoking Status and Smoking 
Cessation 
Lung cancer (screening) awareness 
and beliefs 
Ali et al. (2015) 
(Low and High SES) 
A number of perceived barriers to 
the lung cancer screening trial were 
cited including practical barriers, 
emotional barriers, trial 
acceptability, and low perceived 
risk. Practical barriers are more 
likely to be perceived by those with 
lower SES. Smokers were more 
likely to report emotional barriers to 
participation. 
Smokers were less likely to 
participate in the lung cancer 
screening trial.  
Older age, female gender, smoking 
status, low SES, and higher 
perceived risk were significantly 
associated with non-uptake of lung 
cancer screening. 
Cataldo (2016) 
(Low and High SES) 
 Older smokers are aware of the 
risks of smoking and were 
interested in smoking cessation. 
Older smokers are interested in and 
positive about lung cancer 
screening. Demographic variables 
were not significantly associated 
with the decision to have lung 
cancer screening. 
Crothers et al. (2016) 
(Low SES) 
 Current smokers wanted to learn 
about lung cancer but believed that 
other risk factors deserved more 
emphasis. Smokers felt a sense of 
Participants were not aware of the 
purpose of lung cancer screening, 
wanted to know about the benefits 
and harms and believed physicians 




Table 3-12: Thematic Synthesis Matrix for Lung Cancer Screening Studies 
 Barriers to screening  Smoking Status and Smoking 
Cessation 
Lung cancer (screening) awareness 
and beliefs 
stigmatisation because of their 
smoking status. 
effectively. Participants expressed 
surprise that the magnitude of their 
lung cancer risk and benefits of 
screening were lower than 
anticipated. 
Das Nair et al. (2014) 
(Low SES) 
Cited potential barriers include lack 
of flexibility for appointments and 
smoking related stigma.  
Participants felt stigmatized 
because of their smoking status and 
the targeted nature of the screening 
trial. They considered that smokers 
should not be singled out as non-
smokers can also get lung cancer. 
Participants were concerned that 
they would be forced to stop 
smoking. 
 
Jonnalagadda et al. (2012) 
(High and Low SES) 
Cost of screening, fatalism and fear 
of radiation exposure from 
screening were perceived barriers 
for minority groups and those with 
low incomes.  
 Minority groups were more likely 
to report difficulty understanding 
lung cancer and to hold 
misconceptions about lung cancer 
cause. Beliefs reflecting fatalism 
and spirituality, fear and anxiety 
were endorsed more often by 
minority groups compared to non-
minority subjects. 
Quaife et al. (2018) 
(High and Low SES) 
 Current smokers were found to 
have lower level of education. 
Worry about lung cancer risk was 
most common among smokers. The 
Participants had fatalistic beliefs 
about lung cancer. Sex, age, 
ethnicity, level of education, marital 




Table 3-12: Thematic Synthesis Matrix for Lung Cancer Screening Studies 
 Barriers to screening  Smoking Status and Smoking 
Cessation 
Lung cancer (screening) awareness 
and beliefs 
majority of current and former 
smokers intended to be screened for 
lung cancer. 
not associated with screening 
intentions. 
Rutten et al. (2009) 
(High and Low SES) 
  Lung cancer prevention knowledge 
was associated with higher 
education level. There were no 
significant associations between 
screening beliefs and survival 
beliefs and demographic 
characteristics.  
Tanner et al. (2013) 
(Low and High SES) 
 Smokers were significantly more 
likely to be less educated, have a 
lower income, and report poorer 
health. 
Current smokers believe that they 
were at increased risk of lung 
cancer. Half of participants believed 
that early detection of lung cancer 
results in a good chance of survival. 
Nearly all surveyed would have a 
CT scan for lung cancer screening. 
Zeliadt et al. (2015)  
(Low SES) 
 Current smokers exaggerated the 
personal benefits of lung cancer 
screening. Many believed that 
screening meant that there was less 
urgency to stop smoking. Lung 
cancer screening stimulates a period 
of self-reflection and induced 






3.4.7 Further synthesis: reflecting on research question 
The following section describes the evidence from the included studies using the identified 
themes with the aim to answer the research questions.  
 
3.4.7.1 Do public perceptions and awareness level of lung cancer differ 
between socioeconomic groups? 
3.4.7.1.1 Fatalism & fear 
Eleven studies contained elements of fear and fatalism (Chatwin et al., 2014; Corner et al., 
2006; Crane et al., 2016; Mazieres et al., 2015; Page, et al., 2015; Power & Wardle, 2015; 
Price & Everett, 1994; Quaife et al., 2015; Scott et al., 2014; Tod et al., 2008; Whitaker et 
al., 2012). 
 
Fear of lung cancer and its consequences was assessed in three studies (Power & Wardle, 
2015; Quaife et al., 2015 & Tod et al., 2008). In studies where lung cancer fear was 
reported, it was not found to vary by SES. 
 
Lung cancer fatalism was discussed in nine studies (Chatwin et al., 2014; Crane et al., 
2016; Mazieres et al., 2015; Page, et al., 2015; Price & Everett, 1994; Quaife et al., 2015; 
Scott et al., 2014; Tod et al., 2008; Whitaker et al., 2012). Cancer fatalism was reported in 
all but one of these studies, which concluded that the survival of lung cancer was 
significantly overestimated by participants (Page et al., 2015). A fatalistic view of lung 
cancer was also found to delay help-seeking for lung cancer symptoms (Tod et al., 2008). 
The association of fatalism and SES was mixed. Low SES was associated with fatalistic 
beliefs of lung cancer in four studies (Chatwin et al., 2014; Page et al., 2015; Price & 
Everett, 1994; Tod et al., 2008). However, fatalism was not associated with SES in the 
remaining four studies fatalism was identified in (Crane et al., 2016; Quaife et al., 2015; 
Scott et al., 2014; Whitaker et al., 2012). Smoking status was also associated with fatalistic 
views of lung cancer, with current smokers more likely to hold fatalistic beliefs (Crane et 
al., 2016; Quaife et al., 2015). 
 
The studies reviewed reveal that fear and fatalism are commonly held beliefs about lung 




3.4.7.1.2 Stigma  
Perceived stigma was discussed in eight studies (Corner et al.,2006; Crane et al., 2016; 
Lathan et al., 2015; Marlow et al., 2010; Mazieres et al., 2015; Scott et al., 2014; Tod et al., 
2008; Weiss et al., 2014). 
 
Stigma was directly associated with smoking status in all studies; current smokers were 
more likely to believe that there is a stigma associated with lung cancer. A level of blame 
is also attributed to a diagnosis of lung cancer (Lathan et al., 2015; Marlow et al., 2010; 
Mazieres et al., 2015; Scott et al., 2014; Tod et al., 2008; Weiss et al., 2014). Blame was 
described as personal (i.e. the individual would blame themselves for a lung cancer 
diagnosis) and also attributed by others (i.e. other people would blame them for a lung 
cancer diagnosis). The result of perceived lung cancer stigma was a delay in help-seeking 
for symptoms of lung cancer (Corner et al., 2006; Crane et al., 2016; Tod et al., 2008). 
 
The association of lung cancer stigma and SES was mixed. No differences in perceived 
stigma and SES were reported in four studies (Corner et al., 2006; Crane et al., 2016; 
Lathan et al., 2015; Scott et al., 2014). Perceived stigma was found to be higher in low SES 
groups (Tod et al., 2008; Weiss et al., 2014), while those in higher SES groups were more 
likely to attribute blame to smokers (Marlow et al., 2010; Mazieres et al., 2015). 
 
The studies reveal that smokers perceive a high level of stigma attached to lung cancer but 
the association between stigma and SES varies. 
 
3.4.7.1.3 Lung cancer and symptom awareness 
Lung cancer and symptom awareness was discussed in eighteen studies (Chatwin et 
al.,2014; Corner et al., 2006; Crane et al., 2016; Desalu et al., 2016; Hvidberg et al., 2014; 
Lathan et al., 2015; Mazieres et al., 2015; Moffat et al., 2015; Niksic et al., 2016; Page, et 
al., 2015; Power & Wardle, 2015; Price & Everett, 1994; Rawl et al., 2019; Scott et al., 
2014; Simon et al., 2012; Tod et al., 2008; Weiss et al., 2014; Whitaker et al., 2012). 
 
Lung cancer knowledge, including perceived severity and cause, was discussed in nine 
studies (Lathan et al., 2015; Mazieres et al., 2015; Page, et al., 2015; Price & Everett, 
1994; Rawl et al., 2019; Scott et al., 2014; Weiss et al., 2014; Whitaker et al., 2012). Lung 
cancer knowledge was associated with SES in all but two studies (Lathan et al., 2015; 





Lung cancer symptom awareness and recognition was discussed in eleven studies (Chatwin 
et al., 2014; Corner et al., 2006; Crane et al., 2016; Desalu et al., 2016; Hvidberg et al., 
2014; Lathan et al., 2015; Moffat et al., 2015; Niksic et al., 2016; Power & Wardle, 2015; 
Simon et al., 2012; Tod et al., 2008).  
 
Symptom awareness was found to be associated with delay in help-seeking, with those 
with lower lung cancer recognition scores more likely to wait longer to seek medical help 
for symptoms (Corner et al., 2006; Desalu et al., 2016).  Symptom awareness varied by 
SES in the majority of studies, with those with low SES having poorer lung cancer 
symptom recognition (Chatwin et al, 2014; Crane et al., 2006; Desalu et al., 2016; 
Hvidberg et al., 2014; Niksic et al., 2016; Simon et al., 2012; Tod et al., 2008). However, 
four studies indicated that that there was no difference in symptom awareness across SES 
groups. 
 
The studies reveal a clear association between SES and lung cancer knowledge, and a 
suggestion that symptom recognition is related to SES. Results indicate that those from 
lower SES groups have poorer knowledge and recognition. 
 
3.4.7.1.4 Risk perception 
Risk perception was discussed in eleven studies (Chatwin et al., 2014; Crane et al., 2016; 
Desalu et al., 2016; Hvidberg et al., 2014; Lathan et al., 2015; Moran et al., 2003; Price & 
Everett, 1994; Rawl et al., 2019; Scott et al., 2014; Simon et al., 2012; Tod et al., 2008). 
 
Lung cancer risk factor recognition varied across studies. Smoking was a well-recognised 
risk factor (Chatwin et al., 2014; Lathan et al., 2015), although, patients with lung cancer 
who smoked were unlikely to attribute their diagnosis to their smoking status (Lathan et 
al., 2015). Risk factor awareness and recognition was better in higher SES groups (Desalu 
et al., 2016; Hvidberg et al., 2014; Simon et al, 2012). 
 
Perceived risk of lung cancer varied by smoking status; smokers perceived their risk as 
average or below average (Moran et al., 2003). Perceived risk also varied by cultural group 
in one study (Scott et al., 2014). In some studies, perceived risk was associated with SES 
(Crane et al., 2014; Price & Everett, 1994; Rawl et al., 2019; Tod et al., 2008). Three 
studies reported that those from lower SES groups perceived themselves to be at lower risk 




study reported that those from low SES groups were more likely to perceive themselves at 
higher risk of lung cancer (Price & Everett, 1994), and one found that there was no 
difference in risk perception across SES groups (Moran et al., 2003). 
 
The studies reveal a mixed picture of lung cancer risk perception. Risk factor recognition 
was higher in high SES groups. However, the studies indicate the link between perceived 
risk and SES is not as transparent. General trends indicate that those from lower SES 
groups perceive themselves at lower risk of lung cancer. 
 
3.4.7.2 Do the public perceptions and awareness level of lung cancer 
screening differ between socioeconomic groups? 
3.4.7.2.1 Barriers to screening  
Barriers and motivators to attending lung cancer screening were discussed in three studies 
(Ali et al., 2015; das Nair et al., 2014; Jonnalagadda et al., 2012). All studies cited both 
practical and emotional barriers. Practical barriers include travel to, and flexibility of 
appointments (Ali et al., 2015; das Nair et al., 2014), the presence of comorbidities and 
caring responsibilities (Ali et al., 2015), and cost of lung cancer screening in health care 
systems that require private insurance (Jonnalagadda et al., 2012). Emotional barriers cited 
include lung cancer fear (Ali et al., 2015), lung cancer and smoking stigma (das Nair et al., 
2014), and lung cancer fatalism (Jonnalagadda et al., 2012). 
 
Low SES groups reported more barriers to screening (Jonnalagadda et al., 2012). Those 
from low SES groups were more likely to report practical barriers to screening, compared 
to those in higher SES groups (Ali et al., 2015; Jonnalagadda et al., 2012). Smokers were 
more likely to report emotional barriers like fear, fatalism and stigma (Ali et al., 2015). 
 
The studies indicate that both practical and emotional barriers play a role in non-uptake of 
lung cancer screening. Those from lower SES groups are more likely to report more 
barriers to screening. 
 
3.4.7.2.2 Smoking status and smoking cessation  
Seven studies discussed smoking status and smoking cessation in relation to lung cancer 
screening (Ali et al., 2015; Cataldo, 2016; Crothers et al., 2016; das Nair et al., 2014; 




The perceptions of lung cancer screening varied by smoking status. Smoking status was 
associated with intention to attend lung cancer screening, with smokers less likely to 
participate in lung cancer screening, or lung cancer screening trials despite positive 
intentions (Ali et al., 2015; Quaife et al., 2018). Lung cancer worry was highest among 
smokers (Quaife et al., 2018). Smokers were also likely to report perceived stigma because 
of their smoking status (Crothers et al., 2016; das Nair et al., 2014). 
 
Smoking cessation was discussed in three studies (Cataldo et al., 2016; das Nair et al., 
2014; Zeliadt et al., 2015). Results across the studies were mixed. Older smokers reported 
being interested in smoking cessation as a result of lung cancer screening (Cataldo et al., 
2016). However, another indicated that smokers would be concerned that they would be 
forced to stop smoking if they attended lung cancer screening (das Nair et al., 2014). The 
remaining study indicated that smokers were less likely to stop smoking as a result of lung 
cancer screening because participants overestimated the protective benefits of screening 
(Zeliadt et al., 2015). 
 
Smokers were found to be more likely from lower SES groups (Quaife et al., 2018; Tanner 
et al., 2013). SES differences went unreported in all but two studies that indicate that there 
were no differences in beliefs across SES groups (Cataldo et al., 2016; Quaife et al., 2018). 
 
The studies indicate that smokers are more likely to be from lower SES groups, less likely 
to attend screening, are more worried and perceive greater stigma because of their smoking 
status. However, the gaps in SES comparison mean potential difference in beliefs across 
SES are inconclusive. 
 
3.4.7.2.3 Lung cancer (screening) awareness and beliefs 
Lung cancer and lung cancer screening beliefs were discussed in seven studies (Ali et al., 
2015; Cataldo, 2016; Crothers et al., 2016; Jonnalagadda et al., 2012; Quaife et al., 2018; 
Rutten et al., 2009; Tanner et al., 2013). 
 
There were a number of misconceptions about lung cancer screening, including the 
purpose of lung cancer screening and overestimating the benefits of lung cancer screening 






Those from lower SES groups were less likely to attend lung cancer screening (Ali et al., 
2015), despite positive intentions (Tanner et al., 2013). Fear, anxiety and fatalism were 
commonly reported by those from lower SES groups (Jonnalagadda et al., 2012) and those 
from lower SES groups were more likely to overestimate the benefits of screening and 
underestimate their own risk (Crothers et al., 2016). Those from high SES groups were 
more likely to have better knowledge about lung cancer and lung cancer screening (Rutten 
et al., 2009). Three studies indicated that there was no difference in lung cancer screening 
beliefs across SES groups (Cataldo, 2016; Quaife et al., 2018) or beliefs about lung cancer 
survival (Rutten et al., 2009). 
 
The studies indicate that the evidence about differing beliefs about lung cancer screening 
across SES groups is mixed. Those from lower SES groups appear to hold greater 
misconceptions about lung cancer screening and have more emotional barriers. However, 
results about the association between SES and lung cancer screening beliefs are 


































3.5 Discussion  
3.5.1 Overview of findings  
This systematic review identified evidence that indicates that there is some variation in the 
public perception and awareness of lung cancer and lung cancer screening across different 
socioeconomic groups. The evidence explored suggests that those from lower SES groups 
have poorer knowledge of lung cancer and its symptoms, are more likely to perceive 
themselves at lower risk of lung cancer and report more barriers to lung cancer screening. 
However, we cannot conclude that there are stark differences in fear and fatalism, stigma, 
smoking status and cessation and lung cancer screening awareness and beliefs. The results 
of these aspects were mixed and therefore do not offer a clear picture about potential 
socioeconomic differences. An overview of the review findings can be found in Table 3-
13. 
Table 3-13: Summary of Review Findings 
Area of focus Identified Theme Conclusion 
Lung Cancer Fear and fatalism  Differences not clear – results 
are mixed 
 
Lung Cancer Stigma  Differences not clear – results 
are mixed 
 
Lung Cancer Lung cancer and symptom 
awareness  
Those from lower SES 
groups have poorer 
knowledge and symptom 
recognition. 
 
Lung Cancer  Risk perception  General trends indicate that 
those from lower SES groups 
perceive themselves at lower 




Barriers to screening  Those from lower SES 
groups are more likely to 










Lung cancer (screening) 
awareness and beliefs 
 
Differences not clear – results 





3.5.2 Comparison with other literature 
There are currently no other systematic reviews that explore the variation in lung cancer 
and lung cancer beliefs or awareness across SES. There are a significant number of 
reviews that explore the treatment of lung cancer, and mortality rates across socioeconomic 
groups, but these do not illuminate the differences in beliefs, knowledge and awareness of 
lung cancer and lung cancer screening. However, these reviews provide important detail on 
the potential outcomes of differences in beliefs and awareness. For example, a systematic 
review exploring the sex and socioeconomic differences in participation in lung cancer 
screening programmes concluded that men and those with high SES are over-represented 
in screening programmes (Schütte, Dietrich, Montet & Flahault, 2018).  
 
Overall, excepting the studies included in the review, studies that explore the differences in 
beliefs by SES are limited. Within the studies included in the review, only four studies 
mentioned socioeconomic differences as a primary aim of the study (Hvidberg et al., 2014; 
Moffat et al., 2015; Price & Everett, 1994; Rawl et al., 2019), despite the clear and well 
discussed health inequalities in cancer mortality rates across socioeconomic groups.  
 
3.5.3 Methodological strengths and limitations  
 
The studies included in the review were broadly assessed to be of good quality, with only 
two assessed to be of ‘fair’ quality (Page et al., 2015; Scott et al., 2014).  
 
There was a great amount of variability in outcome variables in the included studies. This 
might account for the inconclusive nature of the review results. As mentioned, very few 
studies had differences in SES as the primary aim of the study. As a result, the reporting of 
differences by SES was often lacking in detail. 
 
There was a lack of consistency in the measurement of beliefs, knowledge and awareness, 
with a number of different measures used across the included studies. As a result, drawing 
conclusions about the differences in beliefs and awareness was challenging and did not 
allow for further in-depth quantitative analysis.  
 
 Similarly, there was also a lack of standardisation in the measurement of SES. SES was 
measured using a number of different components that reflect socioeconomic position, for 




individual measure. This was most frequently education level. Individual measures of SES 
can be indicative of current SES level but cannot account for other aspects of SES that 
might be associated with screening behaviour. The use of composite measures or area-
based measures can create a more reliable measure of SES (Galobardes, Lynch & Smith, 
2007). 
 
It is evident that there is limited literature about the beliefs and awareness of lung cancer 
screening as a result of the lack of national lung cancer screening programmes 
internationally. As a result, this review included studies using lung cancer screening trials. 
It is acknowledged that these are not ‘true’ cancer screening programmes, but they reflect 
the conditions of screening programmes. 
 
3.5.4 Gaps in literature 
 
The integrated synthesis of quantitative and qualitative evidence allowed for the 
identification of gaps in the current literature. It is evident that there is a difference in 
studies that explore the beliefs about the physical aspects of lung cancer, and those 
exploring the emotional beliefs surrounding lung cancer. There appears to be more 
concentrated study of symptom awareness in quantitative studies, but these detailed very 
little about emotional representations of lung cancer or lung cancer screening. Conversely, 
qualitative studies were more likely to discuss emotional representations of lung cancer in 
a more in-depth manner. 
 
Very few studies explored the barriers to lung cancer screening. This might be the result of 
lung cancer screening not being widely implemented. However, this gap in knowledge has 
practical implications if a lung cancer screening is to be implemented in the UK; optimal 
uptake is fundamental to the successful introduction of a screening programme. 
 
Overall, the included studies did not sufficiently articulate the differences in beliefs and 
awareness of lung cancer and lung cancer screening across socioeconomic groups. 






3.5.5 Review strengths and limitations  
The review had a broad research question and inclusion criteria. This resulted in the 
inclusion of studies with diverse methodologies, aims and outcomes. The inclusion of both 
qualitative and quantitative methodologies allowed for a comprehensive exploration of the 
perceptions and awareness of lung cancer and lung cancer screening, not limited by 
methodology.  
 
To overcome the challenges of synthesising a diverse body of literature an integrative 
approach was adopted.  The integrative review method has been criticised (Whittemore & 
Knafl, 2005) as incorporating diverse methodologies may to contribute to lack of rigour, 
inaccuracy, and bias (Whittemore & Knafl, 2005). This review aimed to overcome these 
criticisms by carrying out the review using a systematic methodology throughout, 
including study criteria, data extraction and method of synthesis and the inclusion of a 
strong review team. This helped to ensure that the review had limited bias and improved 
the accuracy of the conclusions. 
 
The review included studies from different countries, and therefore, different health care 
systems and relative levels of SES. As a result, the findings of the review are difficult to 
truly compare. For example, the barriers to lung cancer screening might vary by health 
system when comparing insurance-based health systems, and those that have national 
health care, such as the NHS. However, where appropriate, the review distinguishes 
between the barriers of different health systems within the presentation of the results. 
 
As SES is often relative to the geographical context, there is also a challenge when 
comparing SES across different countries. The review included papers from six different 
countries. While some are directly comparable, others may not be. For example, measures 
of income and education might not be as relevant in some contexts as it is on others. There 
is an underlying assumption that SES is the same across different international contexts, 
and as a result, it is important to highlight that this is not always the case. 
 
3.6 Chapter summary  
This chapter presented an integrative systematic review exploring the perceptions and 




groups. This systematic review provides a novel integrative synthesis of lung cancer 
literature. 
 
The review synthesised 30 studies, including both qualitative and quantitative 
methodologies. The integrative synthesis concluded that the literature in this area is mixed, 
with only clear socioeconomic differences in symptom knowledge and recognition, 
perceived risk and barriers to lung cancer screening. There is a considerable gap in 
knowledge with regard to emotional representations of lung cancer and lung cancer 
screening across socioeconomic groups, with this review finding mixed results. 
 
The next chapter will present a quantitative study that comprehensively explores the 
differences in lung cancer beliefs across socioeconomic groups and attempts to address 






Chapter 4 : Socioeconomic status and lung cancer 




4.1.1 Socioeconomic status and health inequalities  
Health inequalities are the unfair and avoidable differences in health between people of 
different social groups and can be linked to forms of disadvantage such as poverty, 
discrimination and lack of access to services or goods (WHO, 2013). There are a number 
of social determinants of health inequalities including a person’s socioeconomic position 
within society. 
 
Socioeconomic status (SES) is a term used to describe a person’s social and economic 
position in society (Galobardes et al., 2006). The determinants of this position in society 
are debated (Economic Commission for Europe, 2019) but usually it is understood in terms 
of access to social and economic resources (Adler and Newman, 2002). 
 
Low SES is a predictor of mortality for many diseases (Kivimäki et al., 2020). Mortality 
and negative health outcomes are significantly higher for those in more deprived groups – 
this trend persists globally (Mackenbach, Stirbu, Roskam et al, 2008). Kivimäki et al. 
(2020) carried out a multi-cohort study exploring associations between SES and the 
development of mental and physical health conditions in adulthood, using data from two 
Finnish prospective cohort studies: The Health and Social Support study and the Finnish 
Public Sector study. Results of the study indicated that low SES is a risk factor for a wide 
range of disorders including both physical and mental health issues. The authors also 
reported that the health inequalities that result from variation in SES create a ‘lifelong 








4.1.2 Health inequalities in Scotland 
In Scotland, the premature mortality rate in the most deprived groups is four times higher 
than the mortality rate in the least deprived groups (Scottish Government, 2020a).  It is 
evident that deprivation impacts life expectancy and healthy life expectancy in Scotland. 
National records indicate that there is a significant gap in life expectancy between the most 
and least deprived areas of Scotland. The difference in life expectancy between those in 
SIMD decile one and ten has grown from 12.2 to 13.1 years for men and 8.6 to 9.8 years 
for women since 2016 (National Records of Scotland, 2019). For Healthy Life Expectancy 
(the number of years they might live in a 'healthy' state), the difference between the most 
and least deprived areas is even greater. For men, there is a difference of 23.0 years 
between SIMD decile one and SIMD decile ten and for women, there was a difference of 
23.9 years (National Records for Scotland, 2019). 
 
In line with this trend, cancer incidence and mortality are highest in the most deprived 
areas of Scotland. Of people aged between 45 and 75 years old, those in the most deprived 
groups are more than twice as likely to die of cancer than those in the least deprived 
groups.  The biggest gap in incidence and mortality between the most and least deprived 
areas is largest for cancer of the trachea, bronchus and lung (Scottish Government, 2020a). 
The overall SES differences in cancer mortality are fundamentally driven by variations in 
screening uptake in the existing cancer screening programmes (e.g. breast, cervical and 
bowel). This leads to socially patterned rises in cancer incidence and, in turn, cancer 
survival for some types of cancer in the least deprived areas (Scottish Government, 2020a). 
Although cancers of the trachea, bronchus and lung do not currently have national 
screening programmes in the UK, we should anticipate these challenges if a screening 
programme is implemented. 
 
4.1.3 Socioeconomic status and cancer screening uptake 
There is variation in participation that exists both within and between national screening 
programmes. It has been recognised that people at higher risk of cancer are significantly 
less likely to participate in cancer screening (NHS England, 2019). Level of deprivation 
has been identified as an important determinant of cancer screening uptake, with uptake of 






In Scotland, the uptake of the three national screening programmes varies significantly by 
deprivation level. Women from the most deprived areas are less likely to attend breast 
screening, with 59.9% of women from deprived areas attending screening, compared to 
79.7% of women from the least deprived areas of Scotland (Public Health Scotland, 2020). 
Similarly, women from the most deprived areas of Scotland are less likely to attend 
cervical screening (67%) compared to women from the least deprived areas (78%). This 
trend is also reflected in Scotland’s national bowel screening programme with uptake being 
21.2% lower among people from the most deprived groups of Scotland (51.8%) compared 
to those from the least deprived areas (72.9%) (Public Health Scotland, 2020b). 
 
Although the variation in uptake of cancer screening among different socioeconomic 
groups are multilevel, differences in cancer beliefs may offer a potential malleable target 
for future interventions 
 
4.1.4 Socioeconomic status and cancer beliefs  
Certain beliefs and attitudes about cancer can impact cancer screening uptake. Lower 
uptake is often associated with beliefs such as cancer fatalism (Powe & Finnie, 2003; 
Schueler et al., 2008; Jonnalagadda et al., 2012), low perceived risk (Katapodi et al., 2004) 
and cancer worry (Good et al., 2010; Vrinten et al., 2014).). Overall, those from more 
deprived groups are likely to report more barriers to cancer screening (Ali et al., 2015) 
 
As discussed in Chapter 3, there is some variation in beliefs across SES that partially 
explain difference in uptake of cancer screening across SES. The findings of the systematic 
review indicate that those from lower SES groups having lower knowledge, perceived risk 
and are more likely to report more barriers to lung cancer screening. 
  
Existing literature exploring the variation of attitudes towards cancer and cancer screening, 








4.1.4.1 Positive and negative attitudes 
Robb, Simon, Miles & Wardle (2014) indicate that people are in ‘two minds’ about cancer, 
with positive and negative beliefs coexisting. Participants of the qualitative study would 
often respond in a negative way when discussing cancer (for example, articulate fear of 
cancer) but would also describe the great improvements in treatments in a positive way. As 
a result of this duality, whether positive or negative beliefs about cancer impact the uptake 
of cancer screening is debated. Positive beliefs about cancer might increase uptake by 
viewing screening as an opportunity to undertake preventative behaviour (Quaife et al., 
2017; Sarma et al., 2019). Negative beliefs about cancer might create barriers to cancer 
screening or encourage people to take part. This duality of beliefs exists across SES 
(Quaife et al., 2017). 
 
A population-based study that aimed to assess SES differences in positive and negative 
attitudes towards cancer in the UK found that those with lower SES were significantly 
more likely to hold negative beliefs about cancer compared to those from higher SES 
groups (Quaife et al., 2015). Similarly, a study exploring inequalities in bowel cancer 
screening participation also indicates that negative attitudes towards bowel cancer are 
strongly associated with education level (Smith et al., 2016). Those with lower education 
levels were likely to perceive more emotional and practical barriers, and have lower levels 
of perceived benefit of screening. 
 
4.1.4.2 Fatalism and cancer fear 
Cancer fatalism - the negative belief that cancer has fatal consequences - is cited as both a 
barrier and an encouraging factor in cancer screening uptake (Wardle et al., 2015; Vrinten 
et al., 2015). A systematic review and meta-synthesis exploring cancer fears in the general 
population found that cancer fear is founded on the view that cancer is severe, 
unpredictable and indestructable.  It is often described as an ‘enemy’ and this negative 
belief is believed to impact cancer screening uptake, acceptance of cancer early detection 
and the effectiveness of prevention messages (Vrintern et al., 2016). 
 
Exitising literture on the variation of cancer fear and fatalism across SES groups is 
fragmented, as indicated in the review of literature in Chapter 3. In some cases, levels of 
cancer fear and fatalism have been found to be higher in those from more deprived groups. 




smokers from socioeconomically deprived communities in England, respondents perceived 
lung cancer to be an uncontrollable disease that is self-inflicted and untreatable indicating a 
high level of fatalism (Quaife et al., 2017). On the other hand, studies also indicate that 
there is no differences in fatalism across SES groups (Chatwin et al., 2014; Quaife et al., 
2015). 
 
4.1.4.3 Perceived risk 
Perceived risk is a complex construct that can be divided into three distinct dimensions: 
perceived likelihood of developing the disease; perceived susceptibility/vulnerability to the 
disease; and perceived severity of the disease (Brewer et al., 2007). The combination of 
these distinct forms of risk perception leads to the development of overall perceived risk of 
cancer. The development of perceived risk of cancer can be based on a number of factors 
including family history (Robb, Miles, & Wardle, 2007), and awareness of cancer risk 
factors and symptoms of cancer (Wardle et al., 2015).  
 
The association between perceived risk and screening uptake is unclear. Like cancer fear, it 
can be seen as both a barrier and a motivator to cancer screening (Warlde et al., 2015). A 
meta-analysis exploring whether bowel cancer risk perceptions are associated with 
screening behaviour indicates that greater perceived risk positively predicts bowel cancer 
screening uptake (Atkinson et al., 2015). Similarly, another meta-analysis exploring the 
predictors of perceived breast cancer risk also found a positive assocation between 
perceived risk and breast screening participation (Katapodi et al., 2004). However, other 
studies point to there being no clear association between risk perception and screening 
participation (Vernon, 1999). 
 
Perceived risk of cancer has been shown to vary by socioeconomic deprivation level. A 
quantitative study that investigated participants’ lay beliefs of cancer risk factors in a 
French population (n = 3359) found that those with higher SES scores were more likely to 
emphasise behavioural factors in the development of cancer and were more aware of risk 
factors in general (Peretti-Watel, Fressard, Bocquier & Verger, 2016). Those with higher 
SES, particularly those with a higher education level, were more aware of behavioural risk 
factors for cancer (Pretti-Watel et al., 2016). This was also found to be the case in some of 
the studies reviewed in Chapter 3, with more deprived groups more likely to have lower 
perceived risk of lung cancer (Crane et al., 2016) and lower awareness of cancer risk 




that income (as a measure of SES) can also predict perceived risk (Hawkins, Berkowitz & 
Peipins, 2010). 
 
4.1.5 Measurement of socioeconomic status 
There are a number of ways to measure SES, with each providing benefits and limitations. 
SES is a multifaceted construct that means that there is not one standardised measure.  
 
4.1.5.1 Individual-level measures 
Individual determinants of SES are often used to measure the level of deprivation 
experienced by individuals or groups (Conway et al., 2019). Measures such as income, 
education level, occupation and household indicators can act as individual measures but 
are often highly correlated (Darin-Mattsson, Fors & Kåreholt, 2017). 
 
Income, used as a measure of SES, often refers to access to material resources and 
services. Income is also a reliable measure of SES (Conway et al., 2019). In order to 
predict SES, income is usually measured as household gross income per number of persons 
dependant on the income (Galobardes et al., 2007). A related measure of SES is wealth, 
which includes income and all accumulated material resources such as land, property and 
car ownership (Galobardes et al., 2007; Conway et al., 2019). 
 
Education level has successfully been used as an indicator of SES. An individual’s highest 
attained level of education, or the age at which they left school, reflects early-life SES and 
usually remains stable across the life course (Conway et al., 2019; Darin-Mattsson, Fors & 
Kåreholt, 2017). It is a strong determinant of employment and income. 
 
Similarly, occupation can also act as a measure of SES and is a strong determinant of 
income and can be predicted by educational attainment. Occupation can be measured in a 
number of ways such as employment or job history (e.g. blue or white collar; manual or 
non-manual worker) or type of work contract and job security (Conway at al., 2019). 
 
Certain aspects of a person’s living condition can also indicate level of deprivation. 
Housing quality, overcrowding and house ownership all relate to individual material 





Another less commonly used measure of SES is subjective SES. This relates to an 
individual’s perception of his or her socioeconomic standing (Conway et al., 2019). 
Subjective measures of SES relate to objective indicators (Nobles, Weintraub, & Adler, 
2013), and can uniquely reflect the social norms of a given society (Oakes & Rossi, 2003). 
 
Overall, individual measures of SES are a straightforward way to indicate a person’s level 
of deprivation. However, on their own, might not be as useful in providing a holistic view 
of deprivation level. For example, using just one measure, such as income, might limit our 
understanding of individual experience of deprivation. Deprivation is multifaceted, and the 
absence of one indicator of deprivation does not mean that another does not exist. 
 
4.1.5.2 Composite measures 
Composite measures are used to capture multiple dimensions of SES that can be used at an 
individual or an area-level (Galobardes et al., 2007).  
 
Composite measures are typically made up of multiple individual measures (such as 
income, education and occupation) and a composite score is created by the presence or 
absence of the given individual measures. However, composite measures can mask certain 
relationships and mechanisms which individual SES measurements provide (Conway et al., 
2019).  The selection and weighting of the individual measures used to create composite 
measures of SES are not standardised and can be misinterpreted if poorly constructed 
(Organisation for Economic Co-Operation and Development, 2008). 
 
A composite, standardised measure of deprivation often used in Scotland is the Scottish 
Index of Multiple Deprivation (SIMD). SIMD is used as a tool for identifying area-level 
deprivation across 6,505 areas of Scotland, broken up by postcode. It is a relative measure 
of deprivation which indicates whether one area of Scotland is more deprived than another 
(Scottish Government, 2013).   
 
SIMD combines seven different aspects of deprivation: employment; income; health; 
education, skills and training; geographic access to services; crime; and housing. These 
seven ‘domains’ are measured using a number of indicators which are combined to form 
overall SIMD. This overall SIMD allows us to rank all areas of Scotland, ranging from 1 to 
6,505. As there is no natural cut-off between ‘more deprived’ and ‘less deprived’ the 






By measuring area-level deprivation, it can help improve our understanding of the 
outcomes and circumstances of people who live in the most deprived areas of Scotland, 
allowing for local and national governments to target policies and funding toward areas of 
high multiple deprivation (Scottish Government, 2020b). 
 
There are a number of limitations to using SIMD as a measure of deprivation; the measure 
ranks groups from most to least deprived, it does not indicate how deprived one area is 
compared to another.  
 
Of even more significance, SIMD identifies deprived areas, not people. Around two thirds 
of people on low income do not live in the 20% most deprived areas in Scotland. 
Conversely, not all of those living in deprived areas experience deprivation, with only 
around one third of people living in deprived areas being on a low income (Scottish 
Government, 2020b).  A further issue with SIMD is how areas of Scotland are divided into 
‘data zones’ using postcodes. Postcode areas in rural and remote parts of Scotland cover 
large areas of land that might not reflect an accurate picture of the level of deprivation 
some people face (Scottish Government, 2020b). 
 
Given the social gradient that exists in cancer screening uptake and cancer mortality, it is 
evident that the way in which SES is measured is important to understanding the scale of 
the issue. This is particularly significant to the use of individualised risk scores that have 
been proposed for use in the development of lung cancer screening (see section 2.1.1). 
Understanding SES as a construct and the most effective way to measure it will provide 
insight into how we should move forward to reduce screening inequalities. 
 
4.2 Aim and research questions 
The systematic review presented in Chapter 3 highlighted that there are still significant 
gaps in our knowledge when looking at the differences in beliefs about lung cancer and 
lung cancer screening across SES groups, with a number of the findings being 
inconclusive. In an attempt to create a clearer, more robust picture of variation of beliefs 
across SES groups further investigation is essential. It is hoped that the use of a large, 
deprived sample, as well as the use of two distinct measures of SES will provide insight 





The aim of this chapter is to explore the differences in demographic and psychosocial 
characteristics of ECLS trial participants across socioeconomic groups using two different 
measures of SES; area-level SES (SIMD) and individual-level SES.  
 
To meet this aim, this chapter will answer the following research questions: 
 
I. Do the demographic characteristics of ECLS trial participants vary by area-based 
SIMD or individual SES? 
II. Do the psychosocial characteristics of ECLS trial participants vary by area-based 
SIMD or SES? 
 
The next section describes the methodology of the secondary analysis of the ECLS trial 




































This section describes the methodology of the ECLS Trial and the secondary analysis of 
the trial data. 
4.3.1 Study design 
4.3.1.1 ECLS trial design and participants  
The Early Detection Lung Cancer Screening Trial aimed to develop a new form of lung 
screening that uses a blood test to identify antibodies that indicate lung cancer. The 
EarlyCDT-Lung Test is a novel autoantibody diagnostic test for the early detection of lung 
cancer that helps identify those most at risk of lung cancer. The test leads to a targeted 
approach to CT scanning for early lung cancer detection which may be a more cost-effective 
and potentially less harmful approach to population lung screening. The primary research 
question for the ECLS trial was: ‘Does using the EarlyCDT-Lung Test, followed by X-ray 
and CT scanning, to identify those at high risk of lung cancer reduce the incidence of patients 
with late-stage lung cancer or unclassified presentation at diagnosis, compared to standard 
clinical practice?’. 
 
This thesis will not describe the randomisation of the RCT as the focus of this chapter is the 
recruitment of participants to the trial and the pre-randomisation baseline questionnaire. 
More detail of the ECLS trial can be found in section 1.3.4.3. 
 
The trial aimed to recruit 12,000 high-risk participants from deprived areas of Scotland. 
Participants had to be adults aged 50 to 75, and at risk of developing lung cancer to be 
eligible for trial participation. High risk was  defined as those who were current or former 
cigarette smokers with at least 20 pack-years4, or have a history of cigarette smoking less 
than 20 pack-years plus a family history (mother, father, brother, sister) of lung cancer which 
gives an individual a personal risk similar to a smoking history of 20 pack years. The 










Figure 4-1: Inclusion Criteria of the ECLS Trial 
Figure 4-1: Inclusion Criteria of ECLS Trial 
1 Participant is willing and able to give informed consent for participation in the 
study 
 
2 Male or female aged 50 years to 75 years 
 
3 Current or ex-smoker with at least 20-year pack history 
 
4 or Less than 20-year pack history but with family history of lung cancer in a 1st 
degree relative (mother, father, sister, brother, child) 
 
5 ECOG Status: 0, 1 and 2 (Eastern Co-operative Oncology Group)5 
 
6 Geographical postal sectors of: 
 
Tayside – DD1 – DD11, PH1–PH3, PH6-PH8, PH10, PH11, PH13, PH15 & 
PH16, KY13 
 
Greater Glasgow & Clyde – G1-G5, G11 –G15, G20-G22, G31-34, G40 –G46, 
G51- G53, G60-G62 &G64, G66 & G69, G72 & G73, G76-G78, G81-G83, PA1–
PA8 (except PA6), PA11-PA16 & PA19 
 
Lanarkshire – G33, G65, G67, G69, G71-75, ML1-12 
 
 
4.3.1.2 GP recruitment  
In order to recruit participants for the trial, GP practices within the lowest quintile of 
deprivation (measured using the SIMD) in NHS Tayside, NHS Greater Glasgow & Clyde 
and NHS Lanarkshire were engaged. A total of 170 GP practices within these areas agreed 
to partner with the trial. GP practices were used to help identify eligible patients, and 
subsequently send out invitations to those identified as eligible. 
  
4.3.1.3 Community recruitment 
The trial also used a significant amount of community-based advertisement and media 
campaigns to recruit participants to the trial. These alternative recruitment methods such as 
adverts on TV and radio, posters, flyers, beer mats and other community-based interactions 
(such as stalls in local hospitals) aimed to increase the awareness of the trial and encouraged 
people to make contact if they believed they met the trial inclusion criteria. 
 
5 ECOG is a measure used to describes a patient’s level of functioning in terms of their ability to 






All interested individuals not recruited via GP practices were assessed in relation to 
inclusion/exclusion criteria including residing within the selected geographical post codes.  
4.3.1.4 ECLS procedure – baseline questionnaire 
On receipt of an invitation to take part in the trial, potential participants made an appointment 
with a research nurse for an initial consultation. These appointments took place in local 
hospitals and health centres across Greater Glasgow & Clyde, Tayside and Lanarkshire.  
 
The aim of the consultation was to ensure that the participant was eligible and met the 
inclusion criteria. If they were eligible, consent was taken followed by providing a blood 
sample and subsequently randomised into a treatment arm. Before randomisation took place, 
participants were asked to provide some information on their medical history and complete 
the baseline questionnaire. The research nurse provided active support to complete the 
questionnaire ensuring that questions were understood. When required, the research nurse 
would scribe on behalf on the participant. 
 
The medical data collected, such as smoking history (pack year) and current medications 
were manually entered into the patient management system by the research nurse. 
Participants were also asked where they had heard about the trial in order to collect 
recruitment method. The baseline questionnaire data was initially handwritten and then 
uploaded onto a patient management system manually. Participant records and baseline 
questionnaire data were aligned using a unique cohort ID assigned to them, as well as 
Community Health Index (CHI). 
 
4.3.2 The present study: data access  
The secondary analysis reported in this thesis included analysis of the baseline questionnaire 
that ECLS trial participants completed prior to being randomised. Data were obtained via 
the Tayside Clinical Trials Unit (TCTU). In order to transfer data, an access agreement was 
developed and agreed upon. Training on good practice in clinical trial procedures was a 
prerequisite of the data being transferred. 
 
Data was accessed via an NHS Safe Haven hosted by NHS Tayside. A Safe Haven is a secure 




safeguard for confidential information which is being used for research purposes. The Safe 
Haven was accessed remotely via the internet. 
 
The data uploaded to the Safe Haven included all baseline questionnaire data. 
Supplementary to this, demographic data including date of birth, SIMD and CHI were 
provided. Data were merged using the participants’ cohort ID and CHI. 
 
4.3.2.1 Ethical approvals 
The secondary analysis used ECLS trial data, which was carried out in conjunction with 
the NHS. As a result, ethical permission was sought from NHS Scotland East of Scotland 
Research Ethics Service. Ethical approval was sought based on an amendment to the 
original ECLS trial ethical approval. Ethical approval for the amendment was granted by 
the committee in December 2015 (Appendix 4). 
 
4.3.2.2 Participants  
In order to be included within the statistical analyses for this study, participants were 
required to have taken part in the ECLS trial and completed the baseline study 
questionnaire. Of the 12,243 ECLS trial participants, 11,164 completed the baseline 
questionnaire. As a result, 1079 ECLS trial participants were excluded from this analysis 
(Table 4-1). 
 
Table 4-1: ECLS Participants Eligible for this Analysis 










2039 1943 96 (95.3%) 
GP letter 
recruitment  
10204 9220 984 (90.4%) 
Total 12243 11164 1079 
 
4.3.2.3 Measures  





Table 4-2: Measures 
Measure Description Questions  Scale 
Recruitment Method An indicator of how participants were recruited to the ECLS 
trial. This was established by trial records which indicated if a 
postal invitation was sent by a GP or not. In the absence of a 
postal invitation being sent, recruitment was assumed to be 
via the community methods employed. This was cross-
checked with the participants self-report of recruitment 
method. In cases (n=30) where there was a disparity between 
trial records and self-report, trial record of recruitment method 
was used.  
N/A 1– No GP 
letter sent  
0 - GP Letter 
Sent  
Sex An indicator of the sex. This was not included in the baseline 
questionnaire. A person’s sex was established by their CHI 
linked to NHS records. 
N/A 1-Male 
2-Female  
Age  A measure of chronological age. This was calculated by date 
of birth, and then grouped into age groups.  
Date of Birth  1 - 50-60 
2 - 61-70 
3 - 71-75 
Marital Status  An indicator of current marital status.  Marital Status  1 - Married 






Table 4-2: Measures 
Measure Description Questions  Scale 
Ethnicity  An indicator of the ethnicity identified with. These were then 
grouped into three categories. 
I would describe my ethnic origin as … 
 
1 - White 
2 - Other 
Ethnic 
Group 
0 - Prefer 
Not to Say  
 
Geographic Region  An indicator of the geographic location that they live. This 
was not included in the baseline questionnaire but was 
established by their CHI linked with NHS records. 
N/A 1 - Greater 
Glasgow 
2 - Tayside  
3 - 
Lanarkshire 
Scottish Index of 
Multiple Deprivation 
(SIMD) (2012) 
A standard measure of deprivation in a given geographical 
area. A persons SIMD score is determined by their postcode. 
The most current record of SIMD was used at the time the 
trial was initiated in 2013. SIMD was calculated based on 
participants NHS record. The data used was split into 
quintiles and analysed as five distinct groups. 










Table 4-2: Measures 
Measure Description Questions  Scale 
Individual measure of 
socioeconomic 
deprivation (SES) 
A measure of socioeconomic status. This is calculated based 
on three indicators of socioeconomic status: educational 
qualifications (left school after 16 years of age); car 
ownership; and home ownership. The presence of any one of 
these indicators provided respondents with a score of one. The 
score for each indicator was summed to create an overall 
socioeconomic status score. Scores can range from zero to 
three. Composite measures such as this have been used 
successfully in previous studies (Robb, Simon, & Wardle, 
2009). 
Age at which you left full-time education  
 
How many cars or vans are available for use 
by one or more members of your household?  
 
Do you own or rent your home? 
 










(Rabin & de Charro, 
2001) 
 
Measure of perceived current health status that asks 
participants to rate their health out of 100.  
To help people say how good or bad a health 
state is, we have drawn a scale (rather like a 
thermometer) on which the best state you can 
imagine is marked 100 and the worst state you 
can imagine is marked 0. 
 
We would like you to indicate on this scale how 
good or bad your own health is today, in your 
opinion. Please do this by drawing a line from 
the box below to whichever point on the scale 







Table 4-2: Measures 
Measure Description Questions  Scale 
Revised Illness 
Perception 




Moss-Morris et al. 
(2002)  
 
A measure of illness perception adapted for lung cancer.  The 
Illness Perception Questionnaire was developed to provide a 
quantitative assessment of the five components of the illness 
representation – identity, consequences, timeline, control/cure 
and cause in Leventhal’s Self-Regulatory Model. This 
iteration of the IPQ, adapted for the ECLS trial, consists of 
seven items. Each component is given a score of 1– 5. Items 
were recoded to dichotomise into ‘agree’ and ‘disagree’. 
Those who answered, ‘Strongly Disagree’, ‘Disagree’ or 
‘Neutral’ were recoded as ‘Disagree’, while those who 
answered, ‘Strongly Agree’ or ‘Agree’ were recoded as 
‘Agree’. 
What I do can affect my risk of getting lung 
cancer (personal control) 
 
When I think about my risk of getting lung 
cancer, I get upset (emotional response) 
 
I do not know how likely it is that I might get 
lung cancer (illness coherence) 
  
Finding lung cancer early can improve my 
chances of survival (treatment control) 
 
Lung cancer would have a big impact on my 
life (consequences) 
  
Lung cancer lasts for a long time (timeline) 
 
A blood screening test can accurately detect 





2 - Disagree  
3 - Neutral 
4 - Agree 




0 – Disagree  
1 – Agree  
Smoking Behaviour  A measure of smoking status. Have you smoked any cigarettes or tobacco in 






4.3.2.4 Analysis  
The secondary quantitative analysis included descriptive analysis of all ECLS Trial 
participants who completed the baseline questionnaire data. This descriptive analysis 
including frequencies and means examined the differences between demographic and 
psychosocial measures across both area-level SES (SIMD) and individual- level SES groups. 
Univariate statistical tests conducted included chi-square for categorical variables and one-
way ANOVA for continuous variables. Univariable and multivariable multinomial logistic 
regression analyses were conducted to examine the associations between demographic and 
psychosocial factors and SIMD and SES groups. Only those variables found to be significant 
in the univariate analysis were entered into the multinomial logistic regression analyses. Data 





4.4 Results   
4.4.1 Demographic characteristics of the sample 
A total of 11,164 trial participants completed the baseline questionnaire. As displayed in 
Table 5-3, of those who completed the questionnaire, 50.6% were male (n = 5645) and 
49.4% female (n = 5510). Over half of the participants were aged between 50 – 60 (53.6%) 
and were married or in a civil partnership (52.9%). The majority of participants identified 
as white (99.1%), with only 0.6% identifying with another ethnic group. Participants were 
primarily from Greater Glasgow (67.4%), followed by Tayside (22.8%) and Lanarkshire 
(9.8%). 
 
The majority of participants were from the most deprived SIMD groups, groups 1 and 2 
(40.7% and 20.0% respectively). Those from group 5 (least deprived) accounted for 10.5% 
of participants. However, when using the individual measure of socioeconomic deprivation 
just under one third were considered least deprived (SES group 3) (32.8%) and those in the 
most deprived group (SES group 0) accounted for 10.5% of trial participants. A 
spearman’s rho analysis indicated that there was a significant positive correlation between 
SIMD and the individual measure of SES (rs= .420, p<.001). 
 
4.4.2 Univariate analysis of the demographic characteristics of 
the ECLS trial participants by the Scottish Index of 
Multiple Deprivation (Table 4-3) 
4.4.2.1 Sex 
There was a significant difference between the number of men and women across SIMD 
quintiles (Table 4-3). There was little variation in SIMD groups one to four but there were 
significantly more men in the most affluent quintile (SIMD 5) (55.8%) relative to the most 
deprived quintile (50.6%; c2(1) = 6.48, p = .011). Conversely, there were significantly 
fewer women in the most affluent quintile (SIMD 5) (44.2%) compared to the most 
deprived quintile (SIMD 1) (49.4%) 
 
4.4.2.2 Age 
The number of participants aged 50-60 decreased as deprivation level increased (Table 4-
3). There were more participants aged 50-60 in the most deprived quintile (SIMD 1) 




4.4.2.3 Marital status  
The number of people who were married or in a civil partnership increased as deprivation 
level decreased (c2(1) = 588.91, p <.001). There were fewer participants who were married 
or in a civil partnership in the most deprived quintile (SIMD 1) (41.6%) compared to those 
from the most affluent quintile (SIMD 5) (74.2%).  
 
4.4.2.4 Ethnicity  
There was no significant association between ethnicity and SIMD (c2(1) = .796, p = .372).  
 
4.4.2.5 Region  
Participants from Greater Glasgow were significantly more likely to be in the most 
deprived quintile SIMD 1 (78.1%) compared to those from Tayside or Lanarkshire (Table 
4-3). The number of participants from Tayside or Lanarkshire generally increased as 
deprivation level decreased (c2(1) = 218.30, p <.001). 
 
4.4.3 Univariate Analysis of the psychosocial measures of the 
ECLS trial participants by the Scottish Index of Multiple 
Deprivation 
4.4.3.1 Health state (Table 4-4) 
There was a significant difference in health state across SIMD groups. Health state 
improved as deprivation levels decreased (F (1) = 347.15, p <.001). 
 
4.4.3.2 Revised Illness Perception Questionnaire (Table 4-5) 
“What I do can affect my risk of lung cancer” (Personal Control) 
There were significantly more participants who agreed that their actions could control their 
risk of lung cancer among those in the least deprived SIMD 5 (91.8%) compared to the 
most deprived SIMD 1 (88.6%; c2(1) = 18.59, p<.001).  
 
“When I think about lung cancer, I get upset” (Emotional Response) 
Participants in the most deprived quintile SIMD 1 were significantly more likely to agree 
that they get upset when they think about lung cancer (46.2%) compared to those in the 




“I don’t know how likely it is that I might get lung cancer” (Illness Coherence) 
There were no significant differences across SIMD groups for illness coherence (c2(1) = 
6.47, p = .11). 
 
“Finding lung cancer early can improve my chances of survival” (Treatment Control) 
There were no significant differences across SIMD groups for treatment control (c2(1) = 
2.39, p = .122). 
 
“Lung cancer would have a big impact on my life” (Consequences) 
Significantly more participants in the least deprived quintile SIMD 5 agreed that lung 
cancer would have a big impact on their lives (97.3%) compared to the most deprived 
quintile SIMD 1 (95.4%; c2(1) = 10.46, p =.001). 
 
“Lung cancer lasts for a long time” (Timeline) 
Significantly more participants in the most deprived quintile SIMD 1 agreed that lung 
cancer lasts a long time (65.5%) compared to the least deprived quintile SIMD 5 (59.8%; 
c2(1) = 10.78, p<.001). 
 
“A blood test can accurately detect lung cancer “(Treatment Control) 
Participants in the most deprived quintile SIMD 1 were significantly more likely to agree 
that a blood test can accurately detect lung cancer (67%) compared to the least deprived 
quintile SIMD 5 (53.2%; c2(1) = 101.19, p <.001). 
 
4.4.3.3 Smoking status (Table 4.5) 
“Have you smoked any cigarettes or tobacco in the last 7-days?” 
Participants in the most deprived quintile SIMD 1 were significantly more likely to say that 
they had smoked cigarettes or tobacco in the last seven days (64%) compared to people in 







Table 4-3: Demographic Characteristics by SIMD 5 
 
  
All (n = 11,130) 
SIMD 1  
Most 
Deprived 
(n = 4534) 
SIMD 2  
(n = 2231) 
SIMD 3  
(n = 1578) 
SIMD 4  
(n = 1614) 
SIMD 5  
Least 
Deprived  
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Table 4-5: Psychosocial Measures by SIMD 5 
 All 
(n=11,164) 
SIMD 1  
Most 
deprived 
(n = 4534) 
SIMD 2 
(n = 2231) 
SIMD 3 
(n = 1587) 
SIMD 4 




(n = 1173) 
Sig. 
Revised Illness Perception Questionnaire         
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Table 4-5: Psychosocial Measures by SIMD 5 
 All 
(n=11,164) 
SIMD 1  
Most 
deprived 
(n = 4534) 
SIMD 2 
(n = 2231) 
SIMD 3 
(n = 1587) 
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Sig. 























= 101.19, p 
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Smoking Status        
 
Have you smoked any cigarettes or tobacco in the 










































4.4.4 Multivariate analysis of the demographic and 
psychosocial measures of the ECLS trial participants by 
the Scottish Index of Multiple Deprivation 
Ordinal logistic regression was planned to ascertain the independent effects of 
demographic and psychosocial characteristics of the ECLS trial participants by the SIMD. 
A full likelihood ratio test comparing the fit of the proportional odds model to a model 
with varying location parameters suggested that the assumption of proportional odds was 
violated: c2 (36) = 192.68, p < 0.001.  
 
If the assumptions of ordinal logistic regression are violated, a multinomial logistic 
regression can be conducted (Laerd, 2020). A multinomial logistic regression was 
therefore used to ascertain the independent effects of demographic and psychosocial 
characteristics of the ECLS trial participants by the SIMD. 
 
Prior to carrying out the multinomial logistic regression analysis, a test for 
multicollinearity was conducted. This was done by running a linear regression using SIMD 
as the predictor variable in order to obtain tolerance and Variance Inflation Factor (VIF) 
statistics. Tolerance values less than 0.1 (Menard, 1995) and VIF values greater than 10 
(Myers, 1990) indicate a problem with multicollinearity. The table below displays the 
tolerance and VIF statistics for each of the variables. These indicate that the assumptions 
of the regression analysis were not violated.  
 
Only those variables found to be significant in univariate analyses were included in the 
multivariate analyses. It was decided to conduct the analysis in two stages in order to 
understand the contribution of each distinct factor in relation to SIMD. The first model 
included demographic variables only and the second model included both demographic 
variables and psychosocial variables. The model explained 16.1% (Nagelkerke R2) of 











Table 4-6: Test for Multicollinearity 



























What I do can affect my risk of getting lung cancer 
 
.964 1.038 
When I think about my risk of lung cancer, I get upset 
 
.936 1.069 
Lung cancer would have a big impact on my life 
 
.956 1.046 
Lung cancer lasts a long time 
 
.901 1.110 
A blood screening test can accurately detect lung cancer 
 
.907 1.103 




4.4.4.1 Model 1 - demographic characteristics of ECLS participants by 
SIMD (Table 4-7) 
4.4.4.1.1 Sex  
The model indicated that there was no significant difference in sex between those in the 
most deprived quintile (SIMD 1) compared to those in SIMD 5 (OR =.90, 95% CI 0.79 – 
1.03). The likelihood of a participant being male increased in SIMD 2 (OR = .79, 95% CI 
0.69 – 0.92), SIMD 3 (OR = .86, 95% CI 0.74 – 1.00) and SIMD 4 (OR= .86, 95% 0.74 – 
0.99).  
 
4.4.4.1.2 Marital status  
It was more likely that a participant in the most deprived quintile (SIMD 1) was not 
married compared to those in the least deprived quintile (SIMD 5) (OR = 3.87, 95% CI = 






The likelihood of a participant being from Greater Glasgow was significantly higher if they 
were in the most deprived quintile (SIMD 1) compared to least deprived quintile (SIMD 5) 
(OR = 1.76, 95% CI = 1.39 – 2.21). A participant from Tayside was less likely to be in 
SIMD 1 compared to SIMD 5 (OR = .76, 95% CI .59 – .97). 
 
4.4.4.1.4 Age 
Participants aged between 50 – 60 were significantly more likely to be in the most 
deprived quintile (SIMD 1) compared to the least deprived quintile (SIMD 5) (OR = 1.46, 
95% CI = 1.14 – 1.87). There was no significant difference in SIMD in the age group 61 – 
70. 
 
4.4.4.2 Model 2 - demographics and psychosocial characteristics of ECLS 
participants by SIMD (Table 4-8) 
4.4.4.2.1 Health state (Table 4-8) 
There was marginal variation in health state across SIMD groups. Those with lower health 
state scores were more likely to from the most deprived quintile (SIMD 1) compared to the 
least deprived quintile (SIMD 5) (OR = 0.98, 95% CI = .97 - .98). 
 
4.4.4.2.2 Revised Illness Perception Questionnaire (Table 4-8) 
“What I do can affect my risk of lung cancer” (Personal Control) 
The likelihood of disagreeing with the statement was significantly higher in those from the 
most deprived quintile (SIMD 1) compared to the least deprived quintile (SIMD 5) (OR = 
1.69, 95% CI 1.29 – 2.19). Similarly, the odds of disagreeing with the statement was 
significantly higher in those from SIMD 2 compared to SIMD 5 (least deprived quintile) 
(OR = 1.72, 95% CI 1.31 – 2.28). There was no significant difference SIMD 3 and SIMD 4 
compared to SIMD 5.  
 
“When I think about my risk of lung cancer, I get upset” (Emotional Response) 
A participant was significantly less likely to disagree with the statement if they were in the 
most deprived quintile (SIMD 1) compared to the least deprived quintile (SIMD 5) (OR = 
.83, 95% CI .71 - .96). There was no significant difference across SIMD 2, SIMD 3 and 





“Lung cancer would have a big impact on my life” (Consequences) 
A participant was significantly more likely to disagree with the statement if they were in 
the most deprived quintile (SIMD 1) compared to the least deprived quintile (SIMD 5) (OR 
= 1.69, 95% CI 1.11 – 2.59). There was no significant difference across SIMD 2, SIMD 3 
and SIMD 4 compared to SIMD 5.   
 
“Lung cancer lasts for a long time” (Timeline) 
There was no significant difference across SIMD groups in perceptions of how long lung 
cancer lasts.  
 
“A blood test can accurately detect lung cancer” (Treatment Control) 
Most participants agreed with this statement. However, they were significantly less likely 
to be in the most deprived quintile (SIMD 1) than in the least deprived quintile (SIMD 5) if 
they disagreed with the statement (OR = .56, 95% CI .48 - .66).  
 
4.4.4.2.3 Smoking status (Table 4-8) 
“Have you smoked any cigarettes or tobacco in the last 7-days?” 
A participant was more likely to respond ‘no’ to the question ‘Have you smoked any 
cigarettes or tobacco in the last 7 days?’  if they were in the most deprived quintile (SIMD 
1) than in the least deprived quintile (SIMD 5) (OR = 1.93, 95% CI 1.67 – 2.25). As SIMD 
increased the odds of having smoked a cigarette in the past seven days increased. However, 











Table 4-7: Multinomial Logistic Regression of SIMD 5 (Model 1: Demographics) 
 
 
SIMD 1 (Most Deprived) vs. 
SIMD 5 (Least Deprived) 
SIMD2 vs. SIMD 5 SIMD3 vs. SIMD 5 SIMD4 vs. SIMD 5 
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Table 4-8: Multinomial Logistic Regression of SIMD 5 (Model 2: Demographic & Psychosocial Measures) 
 SIMD 1 vs. SIMD 5 SIMD2 vs. SIMD5 SIMD3 vs. SIMD 5 SIMD4 vs. SIMD5 
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Table 4-8: Multinomial Logistic Regression of SIMD 5 (Model 2: Demographic & Psychosocial Measures) 
 SIMD 1 vs. SIMD 5 SIMD2 vs. SIMD5 SIMD3 vs. SIMD 5 SIMD4 vs. SIMD5 
When I think about my 
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4.4.5 Univariate analysis of the demographic characteristics of 
the ECLS trial participants by individual socioeconomic 
status measure (Table 4-9) 
4.4.5.1 Sex 
There was no significant association between sex and individual SES (c2(1) = .914, p = 
.339). 
 
4.4.5.2 Age  
There was a significant association between age and SES (c2(1) = 243.06, p <.001). The 
number of participants aged between 50 – 60 increased as SES increased; 39% of 
participants in the most deprived group (SES 0) were aged between 50 – 60, this increased 
to 66.4% in SES 3. There were fewer participants aged between 61 – 70 as SES increased; 
61 – 70-year olds accounted for 50.7% of those in SES 0 (most deprived), and 28.5% of 
those in SES 3 (least deprived). 
 
4.4.5.3 Marital status  
There was a significant association between marital status and SES (c2(1) = 1367.74, p 
<.001). The number of participants who were married or in a civil partnership increased 
with SES. Those in SES 3 (least deprived) were more than three times as likely to be 
married (69.2%) compared to those in SES 0 (most deprived) (21.4%). 
  
4.4.5.4 Ethnicity  
There was a significant association between ethnicity and SES (c2(1) = 5.78, p =.016). As 
SES increased so too did the number of participants in an ‘Other Ethnic Group’. In SES 0 
(most deprived) 0.3% of participants said they were part of an ‘Other Ethnic Group’, this 
increased to 1.2% of participants in SES 3 (least deprived). However, it must be noted that 
in two categories there were fewer than five participants which violates the assumptions of 
a chi-square test. 
 
4.4.5.5 Region 
There was a significant difference between the number of participants from Greater 




98.48, p<.001). Conversely, the proportion of participants from Tayside and Lanarkshire 
increased as SES increased. 
 
4.4.6 Univariate Analysis of the Psychosocial Measures of the 
ECLS trial participants by Individual Socioeconomic 
Status Measure  
4.4.6.1 Health state (Table 4-10) 
The mean score of perceived health state significantly increased with SES (F(1) =761.08, p 
<.001).  
 
4.4.6.2 Revised Illness Perception Questionnaire (Table 4-11) 
“What I do can affect my risk of lung cancer” (Personal Control) 
There were significantly more participants in the least deprived group (SES 3) (92%) that 
agreed that their actions could control their risk of lung cancer compared to those in SES 2 
(88.3%), SES 1 (88.2%) and SES 0 (most deprived) (88.6%; c2(1) = 21.53, p<.001).  
 
“When I think about lung cancer, I get upset” (Emotional Response) 
Participants in the most deprived group (SES 0) (52%) were significantly more likely to 
agree with this statement than those in least deprived group (SES 3) (36.8%; c2 (1) = 
104.76, p <.001).  
 
“I don’t know how likely it is that I might get lung cancer” (Illness Coherence) 
Those in most deprived group (SES 0) (69.2%) were significantly more likely to not know 
their risk of getting lung cancer compared to those in the least deprived group (SES 3) 
(63.6%; c2(1) = 8.93, p = .003).  
 
“Finding lung cancer early can improve my chances of survival” (Treatment Control) 
There was no significant association between SES and participants’ tendency to agree with 
the statement (c2(1) = 0.66, p = .42).  
 
“Lung cancer would have a big impact on my life” (Consequences) 
Those in the least deprived group (SES 3) (97.2%) were significantly more likely to agree 
that lung cancer would have a big impact on their life compared to those in most deprived 




“Lung cancer lasts for a long time” (Timeline) 
Those in the most deprived group (SES 0) (71.1%) were significantly more likely to agree 
that lung cancer lasts a long time compared to those in least deprived group (SES 3) 
(60.7%; c2(1) = 44.44, p <.001). 
 
“A blood test can accurately detect lung cancer” (Treatment Control) 
Those in the most deprived group (SES 0 (76.3%) were significantly more likely to agree 
that a blood test could accurately detect lung cancer compared to those in the least 
deprived group (SES 3) (51.3%; c2(1) = 265.78, p <.001).  
 
4.4.6.3 Smoking status (Table 4-11) 
“Have you smoked any cigarettes or tobacco in the last 7-days?” 
Those in the most deprived group (SES) 0 (70.7%) were significantly more likely to have 
smoked cigarettes or tobacco in the last seven days than those in the least deprived group 





Table 4-9: Demographic Characteristics by Individual SES Score 
 
  All  (n = 11,164) 
SES 0  
Most Deprived  
(n = 1166) 
SES 1  
(n = 2551) 
SES 2  
(n =3761) 
SES 3 
Least Deprived  
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c2(1, 11027) = 5.78, p 
=.016 
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Table 4-10: Mean Health State Score by Individual SES Score (One-way ANOVA) 
 
 All 
(n = 11,164) 
SES 0 
Most Deprived 
(n = 1166) 
SES 1 
(n = 2551) 
SES 2 
(n = 3761) 
SES 3 
Least Deprived 
(n = 3647) 
Sig. 
Health State Mean 





























Table 4-11: Psychosocial Measures by Individual SES Score 
 All (n = 11,164) SES 0 
Most deprived 
(n = 1166) 
SES 1 
(n = 2551) 
SES 2 
(n = 3761) 
SES 3  
Least deprived 
(n = 3647) 
Sig. 
Revised Illness Perception Questionnaire       




















c2(1, 11011) = 
21.53, p<.001 




















c2(1, 10974) = 
104.76, p <.001 
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8.93, p = .003 
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c2(1, 11004) = 
19.17, p < .001 
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Table 4-11: Psychosocial Measures by Individual SES Score 
 All (n = 11,164) SES 0 
Most deprived 
(n = 1166) 
SES 1 
(n = 2551) 
SES 2 
(n = 3761) 
SES 3  
Least deprived 
(n = 3647) 
Sig. 
 

































c2(1, 10998) = 
265.78, p <.001 
Smoking Status 
Have you smoked any cigarettes or tobacco 
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4.4.7 Multivariate analysis of individual-level socioeconomic 
status 
Ordinal logistic regression was used to ascertain the independent effects of demographic 
and psychosocial measures on SES. A full likelihood ratio test comparing the fit of the 
proportional odds model to a model with varying location parameters suggested that the 
assumption of proportional odds was violated: c2 (30) = 214.39, p < 0.001.  
 
If the assumptions of ordinal logistic regression are violated, a multinomial logistic 
regression can be conducted (Laerd, 2020). A multinomial logistic regression was 
therefore used to ascertain the independent effects of demographic and psychosocial 
measures have on SES. 
 
Prior to carrying out the multiple logistic regression analysis, a test for multicollinearity 
was conducted. This was done by running a linear regression using SIMD as the predictor 
variable in order to obtain tolerance and Variance Inflation Factor (VIF) statistics. 
Tolerance values less than 0.1 (Menard, 1995) and VIF values greater than 10 (Myers, 
1990) indicate a problem with multicollinearity. The table below displays the tolerance and 
VIF statistics for each of the variables. These indicate that the assumptions of the 
regression analysis were not violated.  
 
Only those variables found to be significant in univariate analyses were included in the 
multivariate analyses. It was decided to conduct the analysis in two stages in order to 
understand the contribution of each distinct factor in relation to SES. The first model 
included demographic variables only and the second model includes both demographic 
variables and psychosocial variables. The model explained 27.7% (Nagelkerke R2) of 









Table 4-12: Test for Multicollinearity 
























Ethnicity (Dummy variable) 
Not white 














What I do can affect my risk of getting lung cancer 
 
.962 1.040 
When I think about my risk of lung cancer, I get upset 
 
.898 1.113 
I do not know how likely it is that I might get lung cancer 
 
.931 1.074 
Lung cancer would have a big impact on my life 
 
.954 1.048 
Lung cancer lasts a long time 
 
.899 1.113 
A blood screening test can accurately detect lung cancer 
 
.902 1.109 




4.4.7.1 Model 1- demographic characteristics of ECLS participants by 
Individual-level SES (Table 4-13) 
4.4.7.1.1 Marital status  
The likelihood of being not married decreased as SES increased. It was more likely that a 
participant in SES 0 (most deprived) was not married compared to those in SES 3 (least 
deprived) (OR = 10.32, 95% CI = 8 .74– 12.17).  
 
4.4.7.1.2 Region 
The likelihood of a participant being from Greater Glasgow was significantly higher if they 
were from the most deprived group (SES 0) (1.86, 95% CI 1.43 – 2.42) compared to the 






Participants aged between 50 – 60 were significantly less likely to be in the most deprived 
group (SES 0) compared to the least deprived group (SES 3) (OR = .21, 95% CI = .16 – 
.27). There was found to be no significant difference in SES in the age group 61 – 70. 
 
4.4.7.1.4 Ethnicity 
The likelihood of a participant being white and in SES 1 was significantly higher compared 
to SES 3 (least deprived) (OR = 3.12, 95% CI = 1.08 – 9.06).  
 
4.4.7.2 Model 2 - psychosocial measures of ECLS trial participants by 
individual-level SES (Table 4-14) 
4.4.7.2.1 Health state 
The general trend indicated that as SES increased so too did perceived health state; SES 0 
(most deprived) (OR= .96, 95% CI .96 – .97)), SES 1 (.97, 95% CI = .96 - .97), SES 2 (OR 
= .98, 95% CI .98 - .99).  
 
4.4.7.2.2 Revised Illness Perception Questionnaire 
“What I do can affect my risk of lung cancer” (Personal Control) 
Participants in SES 0, SES 1 and SES 2 were significantly more likely to disagree that their 
actions could affect their risk of lung cancer.  The likelihood of disagreeing with the 
statement was significantly higher in those from SES 1 compared to SES 3 (OR = 1.87, 
95% CI 1.51 – 2.31).  
 
 “When I think about my risk of lung cancer, I get upset” (Emotional Representations) 
A participant was significantly less likely to disagree with the statement if they were in 
SES 0 (most deprived) compared to SES 3 (least deprived) (OR = .62, 95% CI .52 - .74).  
 
“I don’t know how likely it is that I might get lung cancer” (Illness Coherence) 








“Lung cancer would have a big impact on my life” (Consequences) 
The belief that lung cancer would have a big impact on life increased with SES. A 
participant was significantly more likely to disagree with the statement if they were in SES 
0 (most deprived) compared to SES 3 (least deprived) (OR = 1.98, 95% CI 1.31 – 3.02).  
 
“Lung cancer lasts for a long time” (Timeline) 
There was no significant difference across SES groups for the perception that lung cancer 
lasts for a long time. 
 
“A blood test can accurately detect lung cancer” (Treatment Control) 
The likelihood of participants disagreeing with this statement decreased as SES increased. 
A participant was significantly more likely to disagree with the statement if they were in 
SES 0 (most deprived) than if they were in SES 3 (least deprived) (OR = .40, 95% CI .33 - 
.48).  
 
4.4.7.2.3 Smoking status 
“Have you smoked any cigarettes or tobacco in the last 7-days?” 
As SES increased the odds of having not smoked a cigarette in the past seven days 
decreased. A participant was more likely to have responded ‘no’ to the question ‘Have you 
smoked any cigarettes or tobacco in the last 7 days?’ if they were in SES 0 (most 






























Table 4-13: Multinomial Logistic Regression of Individual SES (Model 1: Demographic Variables) 
 SES 0 (Most Deprived) vs. SES 3 
(Least Deprived) 
SES 1 vs. SES 3 SES 2 vs. SES 3 
Variable OR 95% CI OR 95% CI OR 95% CI 
Marital Status 
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.31 - .45 
.72 – 1.07 
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.41 – 8.29 






.18 – 2.89 






.37 – 3.68 
2.12 – 8.14 




Table 4-14: Multinomial Logistic Regression of Individual SES (Model 2: Demographic and Psychosocial Variables) 
 SES 0 (Most Deprived) vs. SES 3 
(Least Deprived) 
SES 1 vs. SES 3 SES 2 vs. SES 3 
Variable OR 95% CI OR 95% CI OR 95% CI 
Marital Status 
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.77 – 1.19 
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Table 4-14: Multinomial Logistic Regression of Individual SES (Model 2: Demographic and Psychosocial Variables) 
 SES 0 (Most Deprived) vs. SES 3 
(Least Deprived) 
SES 1 vs. SES 3 SES 2 vs. SES 3 
Variable OR 95% CI OR 95% CI OR 95% CI 
When I think about my 
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I don’t know how likely it 
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Lung cancer would have 


























1.23 – 2.19 
 



























.89 – 1.12 
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Table 4-14: Multinomial Logistic Regression of Individual SES (Model 2: Demographic and Psychosocial Variables) 
 SES 0 (Most Deprived) vs. SES 3 
(Least Deprived) 
SES 1 vs. SES 3 SES 2 vs. SES 3 
Variable OR 95% CI OR 95% CI OR 95% CI 
Smoking Status 
Have you smoked any 
cigarettes or tobacco in 
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4.5 Discussion  
4.5.1 Summary of main findings  
The primary aim of this study was to explore the differences in beliefs about lung cancer 
across different SES groups. However, it also looked to discuss the different ways in which 
we can measure SES. This opens up some considerations on how we should measure level 
of deprivation, particularly if it is used as a criterion in cancer screening trials, such as the 
ECLS trial. 
 
The aim of this chapter was to explore the differences in demographic and psychosocial 
characteristics of ECLS trial participants across socioeconomic groups using two different 
measures of SES.  
 
To meet this objective, this chapter aimed to answer the following research questions: 
 
I. Do the demographic characteristics of ECLS trial participants vary by SIMD or 
SES? 
 
II. Do the psychosocial characteristics of ECLS trial participants vary by SIMD or 
SES? 
 
An overview of the findings for area-level (SIMD) and individual-level SES are displayed 
















Table 4-15: Area-level SES (SIMD) Findings 
 Conclusion 
Demographics Those from the most deprived group (SIMD 1) were more 
likely to be women, unmarried and from Glasgow compared to 
those from the least deprived group (SIMD 5). There was no 
difference in ethnicity across SIMD. 
  
Health State  Health state appeared to increase as SIMD increased, but the 
differences between the most and least deprived groups were 
marginal. 
Illness Perception  Those from the most deprived group (SIMD1) had lower 
perceived control over lung cancer risk, were more likely to 
have an emotional response to their risk and less likely to 
believe that lung cancer would have a big impact on their life. 
The perceived efficacy of the ECLS trial screening test was 
high across the board but those from the least deprived group 
were marginally less likely to believe lung cancer can be 
detected by a blood test. 
 
Smoking Status  Smoking status increased by SIMD, with those from the least 
deprived group (SIMD5) more likely to have smoked in the 












Table 4-16: Individual-level SES Findings 
 Conclusion 
Demographics Those from lower SES groups were more likely to be 
unmarried, and from Glasgow compared to those in higher 
SES groups. There was found to be no difference in sex across 
different SES groups.  
 
Health State  Health state appeared to increase as SES increased, but the 
differences between the most and least deprived groups were 
marginal. 
 
Illness Perception  Those from more deprived groups (SES 0) were more likely to 
have lower perceived control over their risk of lung cancer, 
have a greater emotional response to their risk of lung cancer 
and less likely to believe that lung cancer would have a big 
impact on their life compared to those in less deprived groups 
(SES 3). The perceived efficacy of the ECLS trial screening 
test was high across the board but those from the least 
deprived group were marginally less likely to believe lung 
cancer can be detected by a blood test.  There was no 
difference in perceived risk or the timeline of lung cancer 
across SES groups.  
Smoking Status  Smoking status increased as SES increased, with those from 
the least deprived group (SES 3) more likely to have smoked 
in the last seven days. 
 
Using two measures of SES also highlighted some differences in the ECLS trial participant 
sample. The SIMD measure used in the ECLS trial indicated that the majority of 
participants were from the most deprived groups, with 60% of participants being from 
group one or two. However, when using a composite measure of individual SES, the 
sample did not appear to be as deprived as first indicated – over 65% of participants were 
from the least deprived groups - groups two and three. The inconsistency is a result of how 
we measure SES. SIMD is an area based, composite measure and cannot indicate 
individual level of deprivation. This means that a person can be from an area that is 




participant sample in this study. This discrepancy opens up some considerations on how 
we should measure level of deprivation, particularly if it is used as a criterion in cancer 
screening trials, such as the ECLS trial.  
 
There was some variation in demographic characteristics at both area- and individual-level 
SES. Of particular note, marital status appears to be a predictor of SES, at both area- and 
individual-levels. Those who were married or in a civil partnership were significantly more 
likely to be from more affluent groups (SIMD 5 or SES 3), compared to those who were 
not married or in a civil partnership.  
 
Sex of a participant was found to be a predictor of area-level SES (SIMD), but not of 
individual-level SES. When SES is measured using SIMD, women were significantly more 
likely to be from the most deprived group (SIMD 1) compared to men. Significantly more 
men were found to be in the least deprived quintile (SIMD 5) compared to women. 
 
Those recruited from Glasgow were significantly more likely to be from the most deprived 
groups of both area-level SES (SIMD 1) and individual-level SES (SES 0). This was not 
particularly surprising as it is a result of the ECLS trial’s successful recruitment strategy, 
that looked to recruit those from the most deprived groups. Recruitment predominantly 
focused on Greater Glasgow and Clyde in the first instance and recruitment numbers were 
highest in this location compared to Tayside and Lanarkshire. The high level of low SES 
participants in Glasgow does however indicate that the recruitment strategy put in place 
was relatively successful. 
 
Univariate analysis indicated that SES was positively associated with perceived health 
state, with perceived health increasing as deprivation level decreased. This was found to be 
the case at both area-level and individual-level SES. However, when controlling for other 
variables, there was very little variation in perceived health state across both area and 
individual-level SES in multivariate analysis. Although, there does appear to be a more 
obvious gradient when looking at individual-level SES. 
 
There was some variation in lung cancer illness perception across both area- and 
individual-level SES. Those from more deprived groups (SIMD 1 and SES 0) were more 
likely to have low perceived control over the risk factors of lung cancer, as well as a more 




groups (SIMD 5 and SES 3). This might indicate a level of fatalism about lung cancer (e.g. 
it is not something they can control or that it is inevitable) and a high level of fear that 
evokes an emotional response. Those from more deprived groups were also less likely to 
understand the long-term consequences of having lung cancer, at both area and individual-
level SES. This might be indicative of having lower level of knowledge about lung cancer 
and lung cancer symptoms. 
 
Univariate analysis indicated that those from affluent groups were significantly less likely 
to have smoked in the past week. However, when controlling for other variables, the 
results indicated that those recruited from affluent groups were actually more likely to have 
smoked in the past week. This was the case at both area- and individual-level SES. There 
could be a number of explanations for this unexpected result, including bias in self-report. 
Another possible explanation is that those from more affluent groups might be more likely 
to see screening as an opportunity to stop smoking or as an opportunity to reassure 
themselves that they do not have cancer despite their smoking status. 
 
As we can see, there was only a small variation between the measures of SES. This would 
indicate that both area-level and individual-level measures of SES in the ECLS trial were 
successful in measuring the SES of the trial participants. It can be argued that individual 
measures of SES can be more sensitive to different types of deprivation not measured at 
area-level, for example, health state. When considering the use of SES to calculate 
individual cancer risk or as a criterion of cancer screening trials, it might be more 
appropriate to use individual measures of SES. Area-based measures of SES (such as 
SIMD), despite being more convenient, have some drawbacks. For example, area-based 
measures cannot account for individual wealth or access to services.  
 
Our understanding of the socially graded nature of lung cancer beliefs is important to 
ensuring optimal uptake of any lung cancer screening programme in the UK. As a result of 
our understanding of lung cancer beliefs in the most deprived groups, it would be 
appropriate to target areas such as personal control over risk and the emotional response to 
lung cancer, when developing interventions to improve screening uptake in deprived 
groups. For example, the use of mass media campaigns, or the development of appropriate 
screening information materials that address lung cancer risk and the control individuals 





4.5.2 Comparison with other literature 
This study indicates that being married or in a civil partnership was associated with higher 
level of SES. Existing research would suggest that being in a long-term relationship is also 
an indicator of cancer screening participation (van Jaarsveld, Miles, Edwards & Wardle, 
2006; Hanske et al., 2016; Saghari et al., 2015). The mechanisms behind this variation 
might be the result of having a more ‘stable’ lifestyle (including housing and income) 
(Petrelli et al., 2018) and also the social support provided by a spouse when married or in a 
civil partnership (Hanske et al., 2016). 
 
Participants’ beliefs about lung cancer reflect the findings of existing literature. Perceived 
lack of control of risk factors and emotional response to perceived risk in those from 
deprived groups has been found in other forms of cancer screening (Peretti-Watel et al., 
2016). These negative responses to lung cancer suggest a level of lung cancer fatalism 
among those from low SES groups (Quaife et al., 2017). The emotional response to 
perceived lung cancer risk, as well as less understanding of the consequences of lung 
cancer could be as a result of lower levels of knowledge about lung cancer and lung cancer 
symptoms. Those from more deprived groups have been found to have lower level of 
knowledge about lung cancer (Rutten et al., 2009). However, these findings do, to some 
extent, contradict the findings of the review presented in Chapter 3 which concluded that 
there was no evident variation on fatalism or fear across different SES groups. Conversely, 
the review does support the conclusion that level of knowledge about cancer is socially 
graded. The corresponding construct in the Revised Illness Perception Questionnaire 
(Illness Coherence) does not appear to differ by SES. 
 
Findings surrounding smoking status were unexpected, and contradictory to our knowledge 
of smoking uptake across SES - that smoking rates are commonly higher in those from 
more deprived groups (Hiscock, Bauld, Amos, Fidler & Munafò, 2012). In this study, 
those from the least deprived groups were more likely to have smoked in the past seven 
days. It is unclear why ECLS trial participants would go against this trend but there is 
some evidence to suggest that lung cancer screening and lung cancer screening trials can 
be used as an intervention to promote smoking cessation (Taylor et al., 2007; Pistelli et al., 
2020). Although, these interventions are usually as a result of participating in screening, 





4.5.3 Strengths and limitations 
The study used data from both the ECLS trial and NHS patient data in order to explore the 
demographic and psychosocial characteristics of the ECLS trial participants. As a result of 
this robust analysis, the study has provided a holistic exploration of SES and lung cancer 
beliefs.  The use of a large sample in this study, from predominately deprived groups, has 
provided insight into lung cancer beliefs that previous studies have not. Further, this is the 
first study exploring lung cancer beliefs in a Scottish population. The ECLS trial screening 
test is a novel form of screening, and this study also provides insight into the perceived 
efficacy and acceptability of this form of cancer screening. 
 
To my knowledge, there have been no previous studies that have explored the predictors of 
uptake of a lung cancer screening trial by two different measures of SES. This study 
therefore makes a novel contribution to cancer screening literature. This study, alongside 
the systematic review presented in Chapter 3, contribute to our knowledge of 
socioeconomic variation in lung cancer beliefs and provides insight into how we might 
effectively reduce the social gradient of screening uptake that might occur if lung cancer 
screening is implemented in the UK.  
 
There are some limitations to the study. Firstly, the study was a secondary data analysis 
which means that there was a lack of control over the variables used in the analysis. This 
somewhat limited the development of the individual-level measure of SES. In order to 
create the composite measure three individual indicators of SES were combined (age at 
which they left education, house ownership and car ownership) and an overall SES score 
created. However, given more control over the data collected, a more comprehensive 
measure could have been developed. For example, the inclusion of income or job type 
might be a better indicator of wealth. 
 
A second limitation of the study is the use of self-report, particularly for smoking status 
and health state. There are clear limitations to self-report questionnaires that could reduce 
reliability. An example of this might be social desirability bias, where respondents answer 
questions in a way that they believe to be socially desirable. A way to circumvent issues 
such as this is to triangulate self-report with health records. 
 
The ECLS trial baseline questionnaire used in this analysis adapted a version of the revised 




cancer (Lee et al., 2019; Hagger & Orbell, 2005). However, there is no standardised 
measure for lung cancer and the ECLS trial adapted the original revised questionnaire to 
meet the needs of the trial. As a result, the adapted IPQ used in the analysis has some 
limitations. For example, the questions developed for the trial do not directly map to those 
previously used, which created some challenges when attempting to understand which 
question related to each of the IPQ concepts. Remaining cognisant of the limitations of the 
measure used in the analysis, and a potential ceiling effect is important when attempting to 
interpret the results of the study. Similarly, it is important to recognise that a small effect 
size, as result of the trials large sample size, might produce statistically significant results. 
 
4.6 Chapter summary  
This chapter has presented the results of the secondary quantitative analysis of the ECLS 
trial data that explored the demographic and psychosocial differences across different 
socioeconomic groups using two distinct measures of SES. 
 
The findings of this analysis indicate that lung cancer beliefs do vary by SES, with those 
from lower SES groups having lower perceived control of risk, higher emotional response 
to risk and less likely to perceive lung cancer as having long term consequences than those 
in less deprived groups.  
 
This chapter also opened up methodological discussion on what the most effective way to 
measure SES and compared the findings of area-level and individual-level SES measures. 
The findings indicate that there is little variation in the differences in lung cancer beliefs 
between the two different measures. There is no clear conclusion on which is the most 
effective measurement, but it is thought that perhaps individual SES measures can be used 
to explore more complex indicators of SES, such as health state, and therefore might be 
more helpful when using SES as a measure of individual cancer risk, or as a criterion for 
cancer screening trials. On the other hand, the study also indicates that the differences in 
results between individual- and area-level SES are slight, providing some reassurance of 
the effectiveness of both forms of SES measurement. With area-level SES, such as SIMD, 
being more readily available it is evident that they are also an efficient way to measure 
SES. 
 
This study has clear implications for any future cancer screening programme implemented 




ensuring that appropriate interventions and mitigating actions can be put in place in 
advance of any programme implementation. 
 
The next chapter describes and presents the results of another secondary analysis of the 
ECLS trial that explores the differences in demographic characteristics and beliefs about 




Chapter 5 : Do recruitment methods to cancer 
screening impact uptake across 
socioeconomic groups?  A comparison of GP 
and community recruitment 
5.1 Introduction 
5.1.1 Alternative invitation methods to increase uptake of 
screening 
Previous research has explored how different invitation types encourage participation in 
screening. Traditionally, in the UK, screening invitation letters are sent to those eligible by 
post. These invitations are sent on behalf of an NHS board by a centralised administration 
function. In Scotland, letters are automatically generated based on the population register 
Community Health Index (CHI). CHI Index contains details of all Scottish residents and 
exists to ensure that patients can be correctly identified, and that relevant information 
pertaining to a patient’s health is available to providers of care. The CHI number is a 
unique 10-character numeric identifier, allocated to each patient on first registration with 
the system. For screening purposes, this is how eligible screeners are identified by age and 
sex. This is a simple way to identify and invite eligible persons but given the inequalities in 
uptake this approach does not appear to effectively engage the most deprived compared to 
the most affluent.  Consideration of alternative methods of invitation to improve access to 
screening among those at highest risk (the most deprived groups) is vital if inequalities are 
to be addressed.  
 
Alternative types of invitation have been explored in order to ascertain if they support 
increased uptake in health behaviours in underserved groups. 
 
5.1.2 Phone and text-based invitations 
Phone or text-based invitations are suggested to be an effective means of increasing 
participation in screening. A systematic review conducted by Rat et al. (2018) indicated 
that telephone contacts and the involvement of ‘navigators’ led to higher uptake of bowel 
screening tests compared to standard postal invitation, but concluded that this type of 
invitation is more resource-intensive and may be difficult to implement in the usual 




A study exploring the uptake of cervical screening in Portugal developed an intervention 
that invited women to undertake the screening through automated, customised text 
messages and phone calls, followed by text message reminders before the arranged 
appointment (Firmino-Machado et al., 2018). This intervention was compared to standard 
care – a written letter received in the post. The study found that automated and customised 
text messages, phone calls and reminders increased adherence to cervical screening by 
13.3%, when compared to standard care. However, the RCT did not address the 
socioeconomic barriers to access screening services this way, with those in deprived 
groups less likely to have access to a mobile phone. Kerrison et al. (2015) discussed this in 
relation to text reminders for routine breast screening in the UK and concluded that lack of 
access to mobile phones is a significant barrier to this type of invitation. However, for 
those in the most deprived groups who do have access to a mobile, this type of intervention 
is effective in increasing uptake. The study by Kerrison et al. (2015) further concluded that 
text message reminders increased uptake in women living in the most deprived quintile 
area by 13.6% despite poor mobile records within this group when compared to usual care 
(a letter with no reminder text). 
 
5.1.3 GP endorsement  
Research indicates that GP-endorsed invitations are particularly successful in increasing 
uptake across the board, including those from more deprived groups. A review and 
evaluation of interventions that improve participation in cancer screening services carried 
out by Duffy et al. (2017), concluded that GP endorsement was found to consistently 
improve participation in cancer screening, including in underserved populations. GP 
endorsement includes recommending screening, and in the case of the UK, having a GP’s 
name on a screening invitation or recall letter. Such a technique has been found to increase 
participation in bowel cancer screening. Hewitson et al. (2011) explored whether a general 
GP’s letter encouraging participation and an enhanced procedural leaflet explaining how to 
complete faecal occult blood test (FOBT) included with the English Bowel Cancer 
Screening Programme invitation materials would improve uptake. GP endorsement and an 
explicit leaflet were both found to increase uptake of bowel screening by 5.8% and 6% 
respectively. This was further supported by Raine et al. (2016) who reported that the 
addition of a simple statement of endorsement from GPs to the standard English bowel 
cancer screening invitation letter increased the likelihood of participation in FOBT 
screening programme by 7%. GP-endorsed reminder letters for people who did not respond 




by 1.7%. However, GP endorsement did not have a significantly stronger effect in lower 
versus higher socioeconomic groups (Raine et al., 2016). In a study carried out in England, 
GP-endorsed reminders, sent three months after the original invitation, increased uptake by 
3% when compared to those in a standard reminder letter control group (Benton et al., 
2017). Studies exploring the uptake of breast and cervical screening in Italy and the 
Netherlands also found that receiving a GP-endorsed screening invitation increased uptake, 
when compared to non-GP endorsed invitations (Giorgi et al., 2000; de Nooijer et al., 
2005; Hermens et al., 2000) 
 
5.1.4 Opportunistic invitations 
There is limited research exploring the effectiveness of increasing uptake of screening by 
using opportunistic or community-based invitations. This is a result of it not being a 
frequently employed invitation strategy. In the UK, opportunistic screening refers to tests 
that are recommended for certain groups but do not involve actively inviting people for a 
test. Chlamydia screening is the most common form of opportunistic screening (NHS 
England, 2019). This type of screening in the NHS is embedded into other health services 
(primary, secondary and local authority funded) and is offered when attending services for 
other healthcare needs. 
 
Similarly, in the United States, health care providers are directly involved in 
recommending screening to patients. This type of opportunistic screening, with 
endorsement from a trusted healthcare professional has been found to be an effective way 
to increase cervical screening uptake in the United States (Balas et al., 2000). Although, 
opportunistic screening methods in the US differ slightly from the UK. The majority of 
cancer screening in the US is opportunistic. It is reliant on a physician recommendation or 
the individual’s request to be screened. As a result, it is often more appropriate to target 
behavioural interventions at healthcare providers, ensuring that they prompt patients to 
consider cancer screening (Wardle et al., 2015).  
 
Studies indicate that the use of opportunistic screening creates a widening of screening 
inequality with those from more deprived groups less likely to screen when invited in this 
way. Differences in screening participation were observed in opportunistic screening of 
breast and cervical cancer in a study exploring screening programmes in EU-15 countries 
(Walsh, Silles & O’Neill, 2011). The study indicated that opportunistic cervical screening 




based screening programmes did not result in significant differences in screening 
participation across SES (Walsh et al., 2011). A similar study by Palència and colleagues 
(2010) also found that socioeconomic inequalities in the uptake of cancer screening were 
exacerbated in countries that did not have population-based breast and cervical screening 
programmes.  
 
5.1.5 Community-based invitations  
Community-based screening invitations are even less frequently used than opportunistic 
screening. Community-based invitations refer to passive advertisement of screening in 
local communities where the expectation is that those eligible for screening will make 
contact with the relevant healthcare professional (e.g. ‘self-select’). Advertisement of the 
screening test might include posters, leaflets or stalls.  
 
One Swedish study concluded that community-based invitations to an RCT more 
successfully encouraged participation in a cohort study in those from the least deprived 
groups (Manjer et al., 2002). Manjer et al. (2002) described how those who responded to 
community directed invitations (for example, posters or pamphlets) in the Malmo Diet and 
Cancer Study were more likely to be older, female, have higher SES and were overall, 
healthier when compared to those who were recruited using personal invitations (i.e. 
letter). Other studies have found that community advertisement for cancer screening is 
more likely to attract those who are not high-risk candidates for cancer (das Nair et al., 
2014). 
 
This type of community-based recruitment or invitation has not been employed by cancer 
screening programmes in the UK to date. However, it has been used to recruit participants 
to cancer screening trials. The ECLS trial used a mix of both GP-endorsed invitation letters 
and community-based recruitment to recruit over 12,000 participants to a RCT. Pre-trial 
focus groups, with people at high-risk of lung cancer, highlighted the desire for an 
alternative invitation type other than a letter from their GP, including word of mouth 
within the community (das Nair, 2014). Different forms of media, especially local papers 
and the radio, were also seen as a valid form of raising awareness about the study and 
increasing participation. There was a view among focus group participants that they would 
not respond to an invitation to the lung screening trial from their GP. This was related to 
their trust in their GP practice as well as viewing letters from their GP as junk mail because 




‘Not through the GP. I wouldn’t bother contacting them and asking them to do it, 
‘cause they’re hopeless.’  
‘Well, the first thing you would do with that [GP letter and reply slip] is bin it.’  
The insight gained from the focus groups significantly influenced the recruitment method 
of the lung cancer screening trial. As a result of the feedback, a particular focus was given 
to community advertisement as a method of recruitment. 
5.1.6 Demographic and psychosocial differences impacting 
uptake 
In order to understand what the most effective invitation strategy to encourage 
participation in screening we must also explore the individual determinants of cancer 
screening participation. As presented in Chapters 3 and 4, beliefs about lung cancer and 
lung cancer screening vary by SES. The efficiency of the invitation may vary depending on 
a person’s beliefs and attitudes towards cancer screening. Investigating the population 
subgroups most likely to engage with different types of recruitment (e.g. GP or 
community-based recruitment) could support the development of interventions that 
encourage participation in those least likely to participate. 
 
We know that participation in screening not only varies by SES, but also other 
demographic characteristics. Sex, age and ethnicity are all predictors of cancer screening 
uptake. Uptake by sex varies for different types of screening (Wardle et al., 2015). 
Preliminary studies on the uptake of lung cancer screening in men and women is mixed, 
with some indicating men are more likely to participate than women (Ali et al., 2015), and 
others indicating that there is no difference in participation in lung cancer screening 
(Carter-Harris et al., 2018; Yong et al., 2020). Similarly, variation in uptake by age also 
varied from screening to screening (Sarma et al., 2019). Conversely, literature exploring 
variation in screening uptake by ethnicity is much clearer, with participation higher in 
those who identify as white, compared to other ethnic groups (Wardle et al., 2015).  
 
As previously discussed, variation in beliefs can lead to differences in uptake of cancer 
screening. For example, existing literature indicates that a person’s knowledge about 
cancer, cancer symptoms or cancer screening impacts their participation in screening 
programmes (Wardle et al., 2015). The more knowledge a person has about cancer and 
cancer screening increases the likelihood that they will be screened (Berkowitz et al., 




with those with greater knowledge of lung cancer and lung cancer screening more likely to 
be from higher SES groups and more likely to participate in lung cancer screening. Other 
beliefs that predict screening uptake are positive attitude (Power, Miles, von Wagner, Robb 
& Wardle, 2009) and perceived risk (Walsh, 2006; Sarma et al., 2019). Other individual 
determinants of cancer screening include current health state or the presence of 
comorbidity. Poor health is also barrier to screening (Constantinou, Dray-Spira & 
Menvielle, 2016). 
 
Understanding the variation in demographic characteristics and beliefs between those who 
engage with different forms of screening invitation, such as GP recruitment and 
community recruitment, will provide insight into how to best optimise screening uptake in 
high risk groups. 
 
5.2 Aim and research questions 
Overall, the aim is to understand how GP and community-based recruitment might attract 
different types of people and to quantitatively explore the demographic and psychosocial 
differences between people who respond to screening invitations in different ways. It is 
hypothesised that those who respond to GP-endorsed screening invitations may differ 
significantly from those who ‘self-select’ via community-based recruitment in a number of 
ways, including SES, sex, age and health status, and health beliefs. 
To meet this objective this chapter aims to answer the following research questions: 
 
I. Are socioeconomic status and demographic characteristics different between self-
referrers or GP invited ECLS Trial participants? 
II. Do the beliefs and attitudes towards lung cancer and lung cancer screening differ 













This section describes the methodology of the ECLS Trial and the secondary analysis of 
the trial data. It should be noted that the study design and measures presented in this 
section replicate the methodology set out in Chapter 4 but has been included in Chapter 5 
to ensure consistency and to allow the individual chapters to stand alone. 
5.3.1 Study design 
5.3.1.1 ECLS trial design and participants  
The Early Detection Lung Cancer Screening Trial aimed to develop a new form of lung 
screening that uses a blood test to identify antibodies that indicate lung cancer. The 
EarlyCDT-Lung Test is a novel Autoantibody diagnostic test for the early detection of lung 
cancer that helps identify those most at risk of lung cancer. The test leads to a targeted 
approach to CT scanning for early lung cancer detection which may be a more cost-
effective and potentially less harmful approach to population lung screening. The primary 
research question for the ECLS trial was: ‘Does using the EarlyCDT-Lung Test, followed 
by X-ray and CT scanning, to identify those at high risk of lung cancer reduce the 
incidence of patients with late-stage lung cancer or unclassified presentation at diagnosis, 
compared to standard clinical practice?’. 
 
This thesis will not describe the randomisation of the RCT as the focus of this chapter is 
the recruitment of participants to the trial and the pre-randomisation baseline questionnaire. 
More detail of the ECLS trial can be found in section 1.3.4.3. 
 
The trial aimed to recruit 12,000 high-risk participants from deprived areas of Scotland. In 
order to be eligible for the trial, participants had to be adults aged 50 to 75 who were at risk 
of lung cancer. These were defined as those who were current or former cigarette smokers 
with at least 20 pack-years, or have a history of cigarette smoking less than 20 pack-years 
plus a family history (mother, father, brother, sister) of lung cancer which gives an 
individual a personal risk similar to a smoking history of 20 pack years. The inclusion 








Figure 5-1: Inclusion Criteria of the ECLS Trial 
Figure 5-1: Inclusion Criteria of ECLS Trial 
1 Participant is willing and able to give informed consent for participation in the 
study 
 
2 Male or female aged 50 years to 75 years 
 
3 Current or Ex-smoker with at least 20-year pack history 
 
4 or Less than 20-year pack history but with family history of lung cancer in a 1st 
degree relative (mother, father, sister, brother, child) 
 
5 ECOG Status: 0, 1 and 2 (Eastern Co-operative Oncology Group)6 
 
6 Geographical postal sectors of: 
 
Tayside - DD1 - DD11, PH1–PH3, PH6-PH8, PH10, PH11, PH13, PH15 & PH16, 
KY13 
 
Greater Glasgow & Clyde - G1-G5, G11 –G15, G20-G22, G31-34, G40 –G46, 
G51- G53, G60-G62 &G64, G66 & G69, G72 & G73, G76-G78, G81-G83, PA1–
PA8 (except PA6), PA11-PA16 & PA19 
 
Lanarkshire - G33, G65, G67, G69, G71-75, ML1-12 
 
 
5.3.1.2 GP recruitment  
In order to recruit participants for the trial, GP practices within the lowest quintile of 
deprivation measured using the SIMD in NHS Tayside, NHS Greater Glasgow & Clyde 
and NHS Lanarkshire were engaged. A total of 170 GP practices within these areas agreed 
to partner with the trial. GP practices were used to help identify eligible patients, and 
subsequently send out invitations to those identified as eligible.  
5.3.1.3 Community recruitment 
The trial also used a significant amount of advertisement to recruit participants to the trial, 
this included community-based advertisement and media campaigns. These alternative 
recruitment methods including adverts on TV and radio, posters, flyers, beer mats and 
 
6 ECOG is a measure used to describes a patient’s level of functioning in terms of their ability to 





other community-based interactions aimed to increase the awareness of the trial and 
encouraged people to make contact if they believed they met the trial inclusion criteria.  
All interested individuals outwith the GP recruitment strategy were assessed in relation to 
inclusion/exclusion criteria including residing within the selected geographical post codes.  
5.3.1.4 ECLS Procedure – baseline questionnaire 
On receipt of an invitation to take part in the trial, potential participants made an 
appointment with a research nurse for an initial consultation. These appointments took 
place in local hospitals and health centres across Greater Glasgow & Clyde, Tayside and 
Lanarkshire.  
 
The aim of the consultation was to ensure that the participant was eligible and met the 
inclusion criteria. If they were eligible, consent was taken followed by providing a blood 
sample and subsequently randomised into a treatment arm. Before randomisation took 
place, participants were asked to provide some information on their medical history and 
complete the baseline questionnaire. The research nurse provided active support to 
complete the questionnaire ensuring that questions were understood. When required, the 
research nurse would scribe on behalf on the participant. 
 
The medical data collected, such as smoking history (pack year) and current medications 
were manually entered into the patient management system by the research nurse. 
Participants were also asked where they had heard about the trial in order to collect 
recruitment method. The baseline questionnaire data was initially handwritten and then 
uploaded onto a patient management system manually. Participant records and baseline 
questionnaire data were aligned using a unique cohort ID assigned to them, as well as CHI. 
 
5.3.2 The present study: data access  
The secondary analysis reported in this thesis included analysis of the baseline 
questionnaire that ECLS trial participants completed prior to being randomised. Data were 
obtained via the Tayside Clinical Trials Unit (TCTU). In order to transfer data an access 
agreement was developed and agreed upon. Training on good practice in clinical trial 
procedures was a prerequisite of the data being transferred. 
 
Data was accessed via an NHS Safe Haven hosted by NHS Tayside. A Safe Haven is a 




data. It is a safeguard for confidential information which is being used for research 
purposes. The Safe Haven was accessed remotely via the internet. 
 
The data uploaded to the Safe Haven included all baseline questionnaire data. 
Supplementary to this, demographic data including date of birth, SIMD and CHI were 
provided. Data were merged using the participants’ cohort ID and CHI. 
 
5.3.2.1 Ethical approvals 
The secondary analysis used ECLS trial data, which was carried out in conjunction with 
the National Health Service. As a result, ethical permission was sought from NHS Scotland 
East of Scotland Research Ethics Service. Ethical approval was sought based on an 
amendment to the original ECLS trial ethical approval. Ethical approval for the 
amendment was granted by the committee in December 2015 (Appendix 4). 
 
5.3.2.2 Participants  
In order to be included within the statistical analyses for this study, participants were 
required to have taken part in the ECLS trial and completed the baseline study 
questionnaire. Of the 12,243 ECLS trial participants, 11,164 completed the baseline 
questionnaire. As a result, 1079 ECLS trial participants were excluded from this analysis 
(Table 5-1). 
Table 5-1: ECLS Participants Eligible for this Analysis 









2039 1943 96 (95.3%) 
GP letter 
recruitment  
10204 9220 984 (90.4%) 
Total 12243 11164 1079 
 
5.3.2.3 Measures  





Table 5-2: Measures 
Measure Description Questions  Scale 
Recruitment Method An indicator of how participants were recruited to the ECLS 
trial. This was established by trial records which indicated if a 
postal invitation was sent by a GP or not. In the absence of a 
postal invitation being sent, recruitment was assumed to be 
via the community methods employed. This was cross-
checked with the participants self-report of recruitment 
method. In cases (n=30) where there was a disparity between 
trial records and self-report, trial record of recruitment method 
was used.  
N/A 1– No GP 
letter sent  
0 - GP Letter 
Sent  
Sex  An indicator of the sex. This was not included in the baseline 
questionnaire. A person’s sex was established by their CHI 
linked to NHS records. 
N/A 1-Male 
2-Female  
Age  A measure of chronological age. This was calculated by date 
of birth, and then grouped into age groups.  
Date of Birth  1 - 50-60 
2 - 61-70 
3 - 71-75 
Marital Status  An indicator of current marital status.  Marital Status  1 - Married 





Table 5-2: Measures 
Measure Description Questions  Scale 
Ethnicity  An indicator of the ethnicity identified with. These were then 
grouped into three categories. 
I would describe my ethnic origin as … 
 
1 - White 
2 - Other 
Ethnic 
Group 
0 - Prefer 
Not to Say  
Geographic Region  An indicator of the geographic location that they live. This 
was not included in the baseline questionnaire but was 
established by their CHI linked with NHS records. 
N/A 1 - Greater 
Glasgow 






Table 5-2: Measures 
Measure Description Questions  Scale 
Scottish Index of 
Multiple Deprivation 
(SIMD) (2012) 
A standard measure of deprivation in a given geographical 
area. A persons SIMD score is determined by their postcode. 
The most current record of SIMD was used at the time the 
trial was initiated in 2013. SIMD was calculated based on 
participants NHS record. The data used was split into 
quintiles and analysed as five distinct groups. 





5 - Least 
Deprived 
Individual measure of 
socioeconomic 
deprivation (SES) 
A measure of socioeconomic status. This is calculated based 
on three indicators of socioeconomic status: educational 
qualifications (left school after 16 years of age); car 
ownership; and home ownership. The presence of any one of 
these indicators provided respondents with a score of one. The 
score for each indicator was summed to create an overall 
socioeconomic status score. Scores can range from zero to 
three. Composite measures such as this have been used 
successfully in previous studies (Robb, Simon, & Wardle, 
2009). 
Age at which you left full-time education  
 
How many cars or vans are available for use 
by one or more members of your household?  
 
Do you own or rent your home? 
 










(Rabin & de Charro, 
2001) 
 
Measure of perceived current health status that asks 
participants to rate their health out of 100.  
To help people say how good or bad a health 
state is, we have drawn a scale (rather like a 
thermometer) on which the best state you can 
imagine is marked 100 and the worst state you 
can imagine is marked 0. 
 
We would like you to indicate on this scale how 
good or bad your own health is today, in your 





Table 5-2: Measures 
Measure Description Questions  Scale 
the box below to whichever point on the scale 








Moss-Morris et al. 
(2002)  
 
A measure of illness perception adapted for lung cancer.  The 
Illness Perception Questionnaire was developed to provide a 
quantitative assessment of the five components of the illness 
representation – identity, consequences, timeline, control/cure 
and cause in Leventhal’s Self-Regulatory Model. This 
iteration of the IPQ, adapted for the ECLS trial, consists of 
seven items. Each component is given a score of 1– 5. Items 
were recoded to dichotomise into ‘agree’ and ‘disagree’. 
Those who answered, ‘Strongly Disagree’, ‘Disagree’ or 
‘Neutral’ were recoded as ‘Disagree’, while those who 
answered, ‘Strongly Agree’ or ‘Agree’ were recoded as 
‘Agree’. 
What I do can affect my risk of getting lung 
cancer (personal control) 
 
When I think about my risk of getting lung 
cancer, I get upset (emotional response) 
 
I do not know how likely it is that I might get 
lung cancer (illness coherence) 
  
Finding lung cancer early can improve my 
chances of survival (treatment control) 
 
Lung cancer would have a big impact on my 
life (consequences) 
  
Lung cancer lasts for a long time (timeline) 
 
A blood screening test can accurately detect 





2 - Disagree  
3 - Neutral 
4 - Agree 




0 – Disagree  
1 – Agree  
Smoking Behaviour  A measure of smoking status. Have you smoked any cigarettes or tobacco in 







The secondary quantitative analysis included descriptive analysis of all ECLS Trial 
participants who completed the baseline questionnaire data. This descriptive analysis 
included frequencies and means examined the differences between demographic and 
psychosocial measures of those who responded to GP invitations and those who were 
recruited via community advertisement recruitment. Univariate statistical tests conducted 
included chi-square for categorical variables and independent sample t-tests for continuous 
variables. Univariable and multivariable logistic regression analyses were conducted to 
examine the associations between demographic and psychosocial factors and cancer 









































5.4 Results  
5.4.1 Demographic characteristics of the sample 
A total of 11,164 trial participants completed the baseline questionnaire. As displayed in 
Table 5-3, of those who completed the questionnaire, 50.6% were male (n = 5645) and 
49.4% female (n = 5510). Over half of the participants were aged between 50 – 60 (53.6%) 
and were married or in a civil partnership (52.9%). The majority of participants identified 
as white (99.1%), with only 0.6% identifying with another ethnic group. Participants were 
primarily from Greater Glasgow (67.4%), followed by Tayside (22.8%) and Lanarkshire 
(9.8%). 
 
The majority of participants were from the most deprived SIMD groups, groups 1 and 2 
(40.7% and 20.0% respectively). Those from group 5 (least deprived) accounted for 10.5% 
of participants. However, when using the individual measure of socioeconomic deprivation 
just under one third were considered least deprived (group 3) (32.8%) and those in the 
most deprived group (group 0) accounted for 10.5% of trial participants. 
 
5.4.2 Univariate analysis 
5.4.2.1 Demographic characteristics of GP recruited vs. community 
recruited participants (Table 5-3) 
5.4.2.1.1 Sex  
Uptake was significantly higher among women invited by community recruitment (55.2%) 
than by GP letter (48.1%; c2 (1) = 32.37, p <.001). 
 
5.4.2.1.2 Age  
Over half of participants were in the age range 50-60 years for both recruitment sources. 
However, a chi-square test of association between age and recruitment source revealed no 
significant difference: c2(2) = 3.78, p =.151. 
 
5.4.2.1.3 Marital status 
People recruited via the community were significantly more likely to be married (56.2%) 




5.4.2.1.4 Ethnicity  
There was no significant association between ethnicity and recruitment source (c2(2, 
11030) = 2.31, p =.314). 
 
5.4.2.1.5 Region  
People from Greater Glasgow were more likely to be recruited via their GP (72.7%), 
compared to community recruitment (42.5%). Conversely, in Tayside 17.2% of the sample 
were recruited by GP letter compared with 49.7% recruited via community advertisement 
(c2(2, 11163) = 968.3, p <.001). 
 
5.4.2.1.6 SIMD 
Significantly more people from SIMD group 1 (most deprived) were recruited via GP letter 
(43.4%) than community advertisement (28%; c2(1, 11130) = 282.41, p <.001). Those 
recruited from the least deprived group (group 5) were more likely to be recruited via the 
community (18.1%) compared to GP recruited (9.0%). 
 
5.4.2.1.7 Individual SES 
Among those in the most deprived group (group 0), twice as many people were recruited 







Table 5-3: Demographic Characteristics by Recruitment Source 
 
  
All (n = 11,164) GP Recruitment  
(n = 9,920) 
Community Recruitment  

































c2(2, 11163) = 3.78, p =.151 
Marital Status 
Married / Civil Partnership % 











2(1, 11010) = 10.49, p =.001 
Ethnicity  
White % 
Other Ethnic Group % 














c2(2, 11030) = 2.31, p =.314 
Region  




















Table 5-3: Demographic Characteristics by Recruitment Source 
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5.4.2.2 Psychosocial measures by recruitment source 
 
5.4.2.2.1 Health state (Table 5-4) 
Those that were recruited via the community were more likely to have higher health state 
scores (M = 80.31, SD = 17.16) indicating that they perceived themselves to be healthier, 
compared to those recruited via their GP (M = 78.38, SD = 18.3; t (10917) = -4.27, 
p<.001 ; Table 5-4).  
 
5.4.2.2.2 Revised Illness Perception Questionnaire (Table 5-4)  
“What I do can affect my risk of lung cancer” (personal control) 
There were significantly more people who agreed that their actions could control their risk 
of lung cancer among those recruited via the community (92.2%) compared to those 
recruited via their GP (89.0%): c2(1) = 18.15, p <.001). 
 
“When I think about my risk of lung cancer, I get upset” (emotional response) 
Those recruited via their GP were more likely to agree that they would get upset when they 
thought about their risk of lung cancer (43.0%) compared to those recruited via the 
community (39.6%: c2(1) = 7.61, p =.006).  
 
“I don’t know how likely it is that I might get lung cancer” (illness coherence) 
Those recruited via their GP were more likely to not know how likely it is that they might 
get lung cancer (65.2%) compared to those recruited via the community (61.1%). A chi-
square test of association between level of agreement with their understanding of their risk 
of lung cancer and recruitment source revealed a significant association: c2(1) = 11.69, p 
=.001.  
 
“Finding lung cancer early can improve my chances of survival” (treatment control) 
There was a high level of agreement that finding cancer early would improve outcomes 
among those recruited by their GP (97.1%) and those recruited via the community (97.2%) 







“Lung cancer would have a big impact on my life” (consequences) 
There was a high level of agreement that lung cancer would have a big impact on 
participants’ lives:  GP Recruitment (95.9%); Community Recruitment (96.8%; c2(1, 
11022) = 3.36, p =.067). 
 
“Lung cancer lasts for a long time” (timeline) 
Those recruited via their GP were more likely to think that cancer lasts a long time (64.7%) 
compared to those recruited via the community (61.3%; c2(1) = 7.83, p = .005). 
 
“A blood test can accurately detect lung cancer” (treatment control) 
Those recruited via their GP were more likely to believe that lung cancer can be detected 
by a blood test (64.1%) compared to those recruited via the community (55.4%; c2(1) = 
50.99, p <.001). 
 
5.4.2.2.3 Smoking status (Table 5-5) 
“Have you smoked any cigarettes or tobacco in the last 7-days?” 
Those recruited via their GP were more likely to have smoked tobacco products in the last 
seven days (58.3%) compared to those recruited via the community (43.7%;  c2(1) = 
130.55 p <.001).  
 
Table 5-4: Mean Health State Score by Recruitment Source 
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Table 5-5: Psychosocial Measures by Recruitment Source  
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Table 5-5: Psychosocial Measures by Recruitment Source  
 All (n = 11,164) GP Recruitment (n = 9,920) 
Community 
Recruitment 
(n = 1943) 
Sig. 
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5.4.3 Multivariate analysis 
Multiple logistic regression analysis was conducted in order to examine how each variable 
was associated with recruitment source (GP Recruitment = 0; Community Advertisement = 
1). Only those variables found to be significant in univariate analyses were included in the 
multivariate analyses. 
 
Prior to carrying out the multiple logistic regression analysis a test for multicollinearity 
was conducted. This was done by running a linear regression using recruitment source as 
the predictor variable in order to obtain tolerance and Variance Inflation Factor (VIF) 
statistics. Tolerance values less than 0.1 (Menard, 1995) and VIF values greater than 10 
(Myers, 1990) indicate a problem with multicollinearity. The table below displays the 
tolerance and VIF statistics for each of the variables. These indicate that the assumptions 
of the regression analysis were not violated (Table 5-6).  
 
Table 5-6: Test for Multicollinearity 
Variable Tolerance VIF 
Sex 
 .946 1.057 
Marital Status 
 .967 1.034 
Region 
 .967 1.034 
SES 
 .744 1.344 
SIMD 
 .795 1.257 
Health State 
 .595 1.682 
What I do can affect my risk of getting lung cancer 
 .966 1.036 
When I think about my risk of lung cancer I get upset 
 .782 1.279 
I do not know how likely it is that I might get lung cancer 
 .933 1.072 
Lung cancer lasts a long time 
 .911 1.098 
A blood screening test can accurately detect lung cancer 
 
.890 1.124 








It was decided to conduct the analysis in two stages in order to understand the contribution 
each of the distinct factors made in relation to recruitment source. The first model included 
demographic variables only and the second model includes both demographic variables 
and psychosocial variables (Table 5-7). The final model explained 19.5% (Nagelkerke R2) 
of the variance in recruitment source and correctly classified 83.3% of cases. 
 
5.4.3.1 Demographic characteristics  
5.4.3.1.1 Sex 
The multivariate model indicated that women had lower odds of being recruited via the 
community than men (OR 0.75, 95% CI 0.67 – 0.85).   
 
5.4.3.1.2 Region  
Those recruited from Lanarkshire had significantly higher odds of being recruited via the 
community (OR 3.90, 95% CI 3.20 - 4.75) when other demographic factors were 
controlled. 
 
5.4.3.1.3 Marital status 
Those who were married or in a civil partnership were significantly more likely to be 
recruited via the community (OR 1.17 95% CI 1.04 - 1.32) in the multivariate analysis.  
 
5.4.3.1.4 SIMD & individual SES 
Both SIMD and individual SES significantly predicted recruitment groups. The odds of 
being recruited via the community increased as deprivation level decreased in SIMD (OR 
0.67, 95% CI 0.55 - 0.81 for those from the least deprived group compared to the most 
deprived) and individual SES (OR 0.83, 95% CI 0.73 - 0.95 for those from the least 
deprived groups compared to the most deprived). 
 
5.4.3.2 Psychosocial measures  
The model indicated that understanding how behaviour affects risks of lung cancer 
significantly predicted recruitment source. Those who agreed that what they did impacted 





 Participants had higher odds of being recruited via the community if they did not know 
how likely it was that they will get lung cancer (OR 1.18, 95% CI 1.04 - 1.33) and if they 
considered a blood test to be an effective way to screen for lung cancer (OR 1.41, 95% CI 
1.25 - 1.59).  
 
Those who had not smoked in the last week had lower odds of being recruited via the 




Table 5-7: Multiple Logistic Regression (0 = GP recruitment; 1 = community recruitment) 
 Model 1 (Demographic 
Characteristics) 
Model 2 (Demographic Characteristics and Psychosocial 
Measures) 










































.81 [.67, .98] 
3.54 [2.92, 4.30] 
 
 




.826 [.68, 1.00] 
3.90 [3.20, 4.75] 
 
 











.52 [.43, .63] 
.54 [.44, .66] 









.51 [.42, .62] 
.56 [.46, .68] 
.56 [.46, .69] 








0 (Most Deprived) 
1 
2 
3 (Least Deprived) 
 
1 
.41 [.32, .53] 
.54 [.46, .64] 
.76 [.67, .87] 
 
 
p = <.001 
p = <.001 
p = <.001 
 
1 
.49 [.38, .64] 
.60 [.50, .72] 
.81 [.71, .92] 
 
 
p < .001 
p < .001 






   
.99 [.99, 1.00] 
 




Table 5-7: Multiple Logistic Regression (0 = GP recruitment; 1 = community recruitment) 
 Model 1 (Demographic 
Characteristics) 
Model 2 (Demographic Characteristics and Psychosocial 
Measures) 
Variable OR [95% CI] Sig.  OR [95% CI] Sig.  
Revised Illness Perception Questionnaire 
 
    




   









   
.99 [.88, 1.11] 
1 
 
p = .811 
 
I don’t know how likely it is that I might get lung cancer 
Agree 
Disagree 
   
 




p = .009 




   
1.07 [.95, 1.21] 
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p = .253 




   
1.45 [1.28, 1.63] 
1 
 
p < .001 
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5.5 Discussion  
5.5.1 Summary of main findings  
This study offered a valuable opportunity to explore the effectiveness of recruitment 
methods in Scotland’s first lung cancer screening trial to engage high risk groups. 
Although a lung cancer screening trial and not a cancer screening programme, the uptake 
rate and the way in which those from high risk groups engaged with recruitment methods 
could have significant implications on any future lung cancer screening programme if 
implemented. Making sure that the right method of recruitment is employed by a national 
screening programme to reach high risk groups could help to ensure the future 
sustainability of a programme, lower mortality rates in high risk groups, and potentially 
address the stark inequalities in uptake observed in existing cancer screening programmes.  
 
The current analysis explored the differing demographic and psychosocial characteristics 
of people who were recruited to the ECLS trial by their GP compared to those who were 
recruited via the community. The study aimed to address the following questions: 
 
I. Are SES and demographic characteristics different between self-referrers 
(community-based) or GP invited ECLS Trial participants? 
II. Do the beliefs and attitudes towards lung cancer and lung cancer screening differ 
between self-referrers and GP invited ECLS Trial participants? 
 
















Table 5-8: Summary of Findings 
 Conclusion 
Demographics Those from more affluent groups were more likely to be 
recruited via the community, compared to those from more 
deprived groups. Men and those who were married or in a civil 
partnership were also more likely to be recruited via the 
community.  
Health State  Those recruited from the community were more likely to 
report higher perceived health state, compared to those 
recruited via their GP. However, when controlling for other 
variables there was found to be no difference in health state 
between the two recruitment groups. 
Illness Perception  Those who were recruited via their GP were more likely to 
understand their own risk of developing lung cancer, compared 
to those recruited via community advertisement. Those 
recruited via the community were more likely to believe in the 
efficacy of a blood test to screen for lung cancer.  
Smoking Status  Those recruited from the community were more likely to have 
smoked in the past seven days. 
 
The SES of participants did significantly differ between GP recruited and community 
recruited participants. An observable trend in both SIMD and individual SES indicated that 
as deprivation level decreased, the likelihood of community-based recruitment increased. 
Those from more affluent groups were more likely to self-refer via community-based 
recruitment. The availability of two measures of SES provides greater robustness to this 
finding.  It suggests that community-based recruitment does not assist in engaging people 
from more deprived backgrounds in cancer screening as suggested by the pre-trial 
qualitative work (das Nair et al., 2014). However, the pre-trial work was a proactive 
attempt at co-design, and it was important for the ECLS trial to respond to the feedback 
received in the focus groups that indicated that participants would be less likely to respond 
to an invitation from their GP. 
 
There were some demographic differences seen between the two recruitment types. Of 
significance, the sex of the participant was a predictor of recruitment type. Univariate 




however, multivariate analysis indicated that men had higher odds of being recruited via 
the community, when controlling for other variables.  
 
Univariate analysis indicated that those recruited via community advertisement were 
significantly less likely to have smoked in the past week. However, when controlling for 
other variables, the results indicated that those recruited from the community were actually 
more likely to have smoked in the past week. This might be as a result of being more 
motivated to screen for lung cancer because of their smoking status, as indicated by their 
more proactive approach to signing up to join the screening trial as opposed to being 
passively recruited via their GP. 
 
With regard to the perceptions and beliefs about lung cancer, those who were recruited via 
their GP were more likely to understand their own risk of developing lung cancer, 
compared to those recruited via community advertisement. However, they were less likely 
to believe that a blood test can accurately detect lung cancer. Those recruited via the 
community were more likely to believe in the efficacy of a blood test to screen for lung 
cancer. This is not unexpected as they are unlikely to proactively engage with a screening 
trial if they did not believe the test was accurate. 
 
5.5.2 Comparison with other literature  
To my knowledge, there has been no previous research that has directly compared 
community and GP recruitment methods. In light of this, the findings will be discussed and 
compared to previous literature exploring the predictors of uptake in other cancer screening 
programmes and trials. 
 
This study found that being male, married, and affluent were significantly associated with 
community recruitment. With regard to sex, this is not entirely in keeping with previous 
research, that indicate that women are more likely to engage with cancer screening in 
general (von Wagner et al., 2011; Davis, Buchanan, Katz & Green, 2012). However, as 
discussed by Wardle et al. (2005), contrary to common expectation, men are more likely to 
take part in some forms of screening than women. Higher male uptake via community 
methods might be explained by being more affluent or being more likely to be married. 
 
Those recruited from the community were more likely to be married than those recruited 




are more likely to participate in screening than the non-married (van Jaarsveld et al., 2006). 
This might be a result of increased social support, but also the ‘healthy marriage’ effect, 
where spouses monitor their partner’s health behaviours and encourage them to undertake 
positive health behaviours. The consequence of this is that married people lead healthier 
lives because the wellbeing of the family is partly dependent on all members’ good health 
(van Jaarsveld et al., 2006). Participants who were recruited via community engagement 
might be more proactive with their health because of their increased likelihood of being 
married. 
 
Participants’ beliefs about lung cancer and lung cancer screening also reflect the current 
literature. Those recruited via the community were less likely to understand the control 
they might have over their own risk of developing lung cancer but still self-referred to 
participate in the screening trial. Although this group were more affluent and healthier, 
they were also, overall, more worried about lung cancer compared to those recruited via 
their GP. This might be reflective of the ‘worried well’ phenomenon who undertake 
screening to confirm their belief that they are either not at risk of lung cancer or for 
reassurance that they do not currently have cancer (Brodersen, Siersma & Ryle, 2011). 
Conversely, those who were recruited via their GP, who indicate an understanding of their 
own risk of developing lung cancer, might believe so because they have been prompted by 
a GP-endorsed letter that tells them that they are in a high-risk group. Their eligibility to 
participate and the active invitation to the trial confirms their at-risk status. 
 
5.5.3 Strengths and limitations  
There were no previous studies identified that explore the predictors of uptake of a cancer 
screening trial by recruitment. This study, therefore, makes a unique contribution to the 
literature. This study used both ECLS trial and NHS data to explore the demographic and 
psychosocial characteristics of the ECLS trial participants. 
 
A strength of this study is that participants were recruited from multiple regions of 
Scotland, with participation targeted at those who are most at risk of lung cancer. The three 
study sites used in the trial were selected because of their high incidence of lung cancer 
and high levels of deprivation. The representativeness of the study participants (with the 
exception of ethnicity) means that the findings are on the whole generalisable to the people 




best way to recruit BME groups to cancer screening trials and improve our understanding 
of the processes leading to inequalities in cancer screening uptake. 
 
This was a secondary data analysis. As a result, there were limitations relating to the 
control of the design of the questionnaire (previously discussed in Chapter 4).  This 
includes a lack of control over measures used within the baseline questionnaire and 
understanding of the rationale to use unstandardised measures. However, the data used 
were appropriate to answer the research questions of the study, and consistency of data was 
assured as a result of strict RCT protocol guidelines.  
 
The ECLS trial was an RCT to test the effectiveness of a lung cancer screening test. As a 
result, the trial was not a ‘true’ screening test akin to those that have national screening 
programmes in the UK. While it is noted that participating in a cancer screening trial is not 
the same as participating in a screening programme, given that there is no current national 
lung screening programme, it is useful to draw on the findings of this study to understand 
the screening behaviour of high risk groups, with the aim to help shape future screening 
programmes. 
 
There could be ‘study contamination’ across recruitment groups, with people receiving GP 
letters also potentially being exposed to community-based advertisement. Those from the 
GP recruitment group could have been influenced by receiving the letter and seeing posters 
in their community that might further influence participation, compared to those who 
received only a GP letter or community advertisement. In order to understand the true 
effectiveness of different recruitment methods, an alternative study design could be 
implemented. By only using one method of recruitment per area, for example, differences 
in uptake and demographics of those engaging with each method would be clearer. 
 
5.6 Chapter summary  
This chapter has presented the results of the secondary quantitative analysis of ECLS trial 
data that explored the demographic and psychosocial differences between the people 
recruited via a letter from their GP and those recruited via the community. 
 
The findings of this analysis are indicative that community recruitment to screening trials 
attract higher uptake from more affluent groups, when compared to those who receive an 




cancer screening programmes in the UK. It is hypothesised that community-based 
recruitment methods and other opportunistic screening attract those from more affluent 






Chapter 6 : What barriers and beliefs lead to non-
attendance in the ECLS trial? 
6.1 Introduction  
Non-attendance in healthcare is common and can be problematic in a number of ways. 
Repeated missed appointments in primary care settings are associated with poorer health 
outcomes (McQueenie, Ellis, McConnachie, Wilson & Williamson, 2019). Further, non-
attendance at screening appointments has been found to be socially graded, with the 
likelihood of missing an appointment increasing with level of deprivation (Ellis, 
McQueenie, McConnachie, Wilson & Williamson, 2017). There is increased risk that more 
deprived groups miss preventative activities, such as screening, and as a result, existing 
health inequalities are exacerbated by non-attendance.  
 
There are also significant financial implications of non-attendance at health care services. 
It is estimated that each missed hospital outpatient appointment costs the NHS in Scotland 
£120 (Williamson, Ellis, Wilson, McQueenie & McConnachie, 2017). In order to ensure 
the viability of a potential lung cancer screening programme in the UK, we must look to 
minimise non-attendance by developing appropriate evidence-based interventions. 
As discussed in Chapters 3 and 4, beliefs about lung cancer vary by SES. These beliefs 
could provide insight into why people might not to attend their screening appointment. 
While the previous chapters focused on motivational factors associated with cancer 
screening attendance, it is also important to explore the volitional factors. Key to 
understanding non-attendance in deprived groups is exploring how people make decisions 
and why they might change their minds. 
 
6.1.1 Decision-making about cancer screening 
The way in which people make decisions may influence whether or not they attend an 
appointment for cancer screening. Our beliefs about an illness can determine how we 
choose to behave in relation to our health. Previous literature on cancer screening decision-





6.1.1.1 Inclined abstainers 
In order to engage in a behaviour such as cancer screening, you must have the motivation 
to do so in the first instance. McBroom and Reid (1992) set out four distinct groups that 
describe the patterns of motivation and behaviour (Table 6-1). When individuals make an 
appointment for cancer screening, it suggests they are motivated and intend to go to the 
screening appointment. However, this intention to attend does not always translate into 
action (i.e. attending the appointment) and ‘did not attend’ (DNA) status and appointment 
cancellations are frequent outcomes at screening clinics (Sheeran, 2002; Webb & Sheeran, 
2006). The term inclined abstainer is used to describe people with positive intentions who 
fail to act (McBroom & Reid, 1992; Orbell & Sheeran, 1998). 
  
Table 6-1: Patterns of Intention - Behaviour (adapted from Orbell & Sheeran, 1998) 
Screening 
behaviour Inclined to be screened Disinclined to be screened 
Screened Inclined Actor Disinclined Actor 
Not Screened Inclined Abstainer Disinclined Abstainer 
 
Inclined abstainers are a particularly interesting group and, because of their already 
positive intentions, are important in reaching optimal uptake of cancer screening. A meta-
analysis of meta-analyses concluded that intention to carry out a behaviour accounts for 
28% of variance in future behaviour (Sheeran, 2002). Despite this, there are 
inconsistencies in patterns of motivation that result in positive intentions not translating 
into action (McBroom & Reid, 1992). Inclined abstainers differ from other patterns of 
intention because barriers to carry out a given behaviour are volitional, unlike disinclined 
abstainers, who are more likely to have motivational barriers (Orbell & Sheeran, 1998). 
This knowledge allows for interventions to be tailored to both of these groups; 
interventions based upon volitional processes concerning the translation of intention into 
action may be effective for inclined abstainers (Orbell & Sheeran, 1998). 
6.1.1.2 Cognitive and practical barriers to screening 
In order to bridge the intention-behaviour gap, we must first understand the individual 
determinants of cancer screening participation, including the cognitive and practical 
barriers experienced by those invited to cancer screening. As shown in section 2.2, there 
are a number of cognitive (e.g. fear and low perceived risk) and practical barriers (e.g. 




6.1.1.3 Theoretical models for cancer screening   
Currently, there is no one model that can explain the variation in cancer screening, with 
researchers drawing from a range of different models e.g. HBM; TRA /TPB; PMT; PAPM; 
and TTM (Kobrin et al., 2015) (see section 2.4). It is important to consider the theoretical 
underpinnings of behaviour change, allowing us to gain insight into the motivational and 
volitional mechanisms that play a role in participation in cancer screening. A number of 
behavioural models help to explain the process in which inclined abstainers make decisions 
about cancer screening.  
 
The HBM (Rosenstock et al, 1994) is among the most widely used model to explain 
screening behaviour (e.g. Yarbrough & Braden., 2001; Orbell et al., 1996; Savage and 
Clarke, 2003). HBM was originally used to understand the uptake of tuberculosis (TB) 
screening in the early fifties. The theory evolved over time to include a number of key 
components: perceived susceptibility; perceived severity; perceived benefits; perceived 
barriers; cues to action, sociodemographic factors; and self-efficacy. The components of 
the model lend itself well to explorations of other types of screening behaviour, such as 
lung cancer screening. However, limitations of the model mean that the efficacy of the 
model in explaining behaviour has been questioned, with previous studies concluding that 
its predictive capacity is limited when compared to that of other social cognition models 
(Taylor et al., 2007). Overall, the model considers people to be ‘rational actors’ and does 
not account for individuals’ emotional responses to carrying out a health behaviour, such 
as cancer screening. Previous literature has indicated that emotional representations of 
cancer play a significant role in the uptake of cancer screening (Sarma et al., 2019; Kotzur 
et al., 2019; Wardle et al., 2015) 
 
Models such as the HBM, despite being widely used, do not account for either intention or 
emotional representations of cancer screening. However, there are models that do consider 
both of these aspects, and therefore might be useful to explore when considering non-
attenders. The Common-Sense Model of Self-Regulation (CSM) (Leventhal, 2003) and the 
Health Action Process Approach (HAPA) (Schwarzer, 1992; Schwarzer, 2008) have been 
used to understand individuals’ response to illness.  When applied to cancer screening, 
these models both include emotional processes and coping response that can determine 
whether a person will participate in cancer screening.  The CSM and HAPA have rarely 




use in cancer screening is novel, they could provide us with insight into non-attendance 
that other models, such as the HBM, might be unable to provide.  
6.1.1.4 Common-Sense Model of Self-Regulation 
The CSM states that individuals develop representations of illness from information that is 
easily accessible to them. An example of this ‘pool’ of information is social 
communication with others (e.g. friends, family or health professionals) or first-hand 
experience of illness. A change in somatic activity (a new symptom or the introduction of a 
stimulus e.g. an invitation to screening) begins a self-regulation process where individuals 
integrate their existing perceptions about an illness with their current experience of the 
illness. The perception of the illness directly influences coping strategies. Leventhal’s 
model posits that there are two parallel processing pathways – one involves the 
development of illness representations, the other involves the creation of emotional 
representations in relation to a health threat. The two pathways are proposed to interact, as 
the threat develops, via feedback loops and appraisal of coping strategies.  
 
The CSM can provide us with an understanding of the role of emotional representations 
associated with cancer screening and helps to elaborate our existing knowledge of lung 




















Figure 6-1: Common-Sense Model of Self-Regulation (Leventhal, 2003) 
 
 
6.1.1.5 Health Action Process Approach  
The HAPA model (Schwarzer, 1992; Schwarzer, 2008) theorises that the process of 
participating in health behaviours occurs in two stages – motivational phase and volitional 
phase. The motivational phase includes the forming of an intention. This intention is 
formed by individuals’ awareness of risk, outcome expectancies and task self-efficacy. The 
volitional phase is a stage in which individuals plan to act and carry out the action. This 
phase of the model comprises of action planning, coping planning, coping self-efficacy and 
recovery self-efficacy. 
 
The HAPA model is particularly helpful to understanding the intention-behaviour gap, 
which is key to understanding non-attendance. The inclusion of both motivational and 
volitional in phases in the HAPA model will help create a clearer picture of the 
mechanisms that might cause the intention-behaviour gap to occur in those who were 







Figure 6-2: Health Action Process Approach (Schwarzer, 1992; Schwarzer, 2008) 
 
6.1.1.6 Using two models to explain cancer screening participation  
There is significant overlap between behavioural models, including the CSM and HAPA 
model. The aim of this study was to explore the beliefs and perceptions about lung cancer 
and lung screening among people who initially expressed an interest in screening, were 
appointed to be screened, but who later cancelled or did not attend their appointment, and 
in some cases did not attend a reappointment. This study used the CSM and HAPA models 
to provide a comprehensive conceptual understanding of the motivational and volitional 
factors involved in being invited to lung cancer screening and attempt to identify any gaps 
that do not fit either model. 
6.2 Aim and research question 
The aim of this study was to explore the beliefs and perceptions about lung cancer and lung 
screening among people who initially expressed an interest in screening but who later 
declined to participate. 
 
To meet this objective this chapter aims to answer the following research questions: 
I. What are the perceived barriers to participating in a lung cancer screening trial? 
II. What beliefs do non-attenders hold about lung cancer and lung cancer 
screening? 
III. Do the CSM and HAPA model help to explain the processes behind those who 





6.3 Methodology  
6.3.1 Context  
This study, like the secondary analyses described in Chapters 4 and 5, was a sub-study of 
the ECLS trial. A detailed description of the ECLS trial design and recruitment methods 
can be found in sections 4.3 and 5.3. 
 
The trial looked to develop a lung cancer screening test to detect lung cancer at an early 
stage, in order to decrease mortality rates (Sullivan et al., 2020). The test (EarlyCDT-Lung 
Test) involved participants at high risk for lung cancer providing a blood sample to be 
screened for higher levels of autoantibodies, which can be indicative of an immune 
response to antigens produced by solid-tumour cells.  Those found to have a positive blood 
test were invited for a chest x-ray and follow-up computed tomography (CT) scan if 
necessary. Thus, like the existing UK cancer screening programmes of breast, bowel and 
cervical, lung screening aims to detect cancers at an earlier, more treatable stage among a 
supposedly asymptomatic population. 
 
6.3.2 Design and sample of present study 
All participants (n = 123) who were eligible to take part in the ECLS trial, initially 
accepted an appointment but subsequently did not attend or cancelled their screening 
appointment, were invited to participate in the non-attender interviews. Participants were 
contacted by post after they have been identified as a suitable candidate using the ECLS 
Trial patient management system. Participants were identified within the patient 
management system by searching for key phrases, such as ‘did not attend’, ‘DNA’ and 
‘cancelled’. Of those contacted, n = 15 indicated that they would be interested in 
participating and a total of n = 8 agreed to participate. 
 
6.3.3 Procedure 
Interviews were conducted over the telephone (n = 7), with the exception of one which was 
conducted face-to-face - this was most convenient to the participant. Telephone interviews 
were used in order to maximise participation. The use of telephone interviews was thought 
to be an appropriate method in which to conduct interviews with this particular sample. As 
previous non-attenders, the participants were deemed to be a hard-to-recruit group and it 




and telephone interviews were offered to all participants. There are methodological 
implications for utilising telephone interviews. The lack of visual cues during telephone 
interviews is one potential drawback. This might lead to a loss of non-verbal data and 
rapport with the participant as well as loss of contextual data. This, in turn, might lead to 
reduced richness of data (Novick, 2008). However, there are also clear benefits of 
conducting qualitative interviews over the telephone. For example, the convenience of 
telephone interviews is particularly beneficial when conducting research with working age 
adults who might have competing priorities. In addition, participants are more likely to feel 
relaxed in their own environment, experience fewer social pressures and it provides more 
anonymity to answer questions honestly (Novick, 2008). In this study, one participant 
chose to take part in a face-to-face interview. This interview was found to be longer in 
duration but did not produce richer data than that of the telephone interviews.  
 
Participants received the Participant Information Leaflet (Appendix 5) and Informed 
Consent Form (Appendix 6) with their letter of invitation by post before the interview was 
conducted. In the case of telephone interviews, participants were invited to send their reply 
and completed consent form in a prepaid envelope. Prior to the telephone interview, 
participants were asked to confirm their verbal consent. Interviews lasted between 30 
minutes and 1 hour. Interviews were conducted based on a topic guide (Appendix 7) 
developed from the existing screening literature with a particular focus on barriers to lung 
cancer screening. To avoid post-hoc rationalisations of their screening behaviour, 
participants were asked to discuss their general views on screening first before moving on 
to their personal experience.  
 
The interview began with the opening question ‘what do you think about cancer 
screening?’, followed by ‘how do you think people make a decision about whether they 
will take part in screening or not?’. Participants were then asked about their own screening 
behaviour (‘have you ever participated in any other type of cancer screening?’) and their 
family and close friends’ participation in cancer screening (‘do you know anyone else who 
has taken part in any cancer screening?’). Elicitation of cancer and lung cancer beliefs 
followed (‘what comes to mind when you think about cancer?’; ‘what comes to mind when 
you think about lung cancer?’). Subsequent to this, perceptions of lung cancer screening 
(‘what comes to mind when you think about lung cancer screening?’) and their experience 
of being invited to participate in the lung screening trial (‘do you remember receiving an 




their perceived risk of lung cancer (‘how likely do you think it is that you will get lung 
cancer?’). 
 
Interviews were audio-recorded with participants’ permission. Those who participated in 
the interviews were offered a £20 voucher as a token of appreciation for their participation. 
 
6.3.4 Data analysis 
The interviews were transcribed verbatim and checked for accuracy. The data were 
analysed using the `framework approach´, a type of thematic analysis (Ritchie & Spencer, 
1994). Thematic analysis is a method for identifying, analysing, and reporting recurring 
patterns within data, which can then be reported in a detailed way (Braun & Clark, 2006). 
A two-step analytic method was used.  The data were initially analysed with the aim to 
identify recurring themes, and then subsequently analysed using a theoretical framework. 
This ‘bottom up’ approach allowed for greater initial exploration of the data, free from the 
constrains of a theoretical model. This methodology was considered to be appropriate in 
order to truly recognise themes that the models might not account for.  
 
First, the interview transcripts were read multiple times in order to become familiar with 
the data. The data were coded and then placed into a framework where the data were 
collated and organised. The initial thematic analysis of data developed five common 
themes: perceived risk; perceived severity; lung cancer vs. other cancers; stoicism and co-
morbidity. The data were then coded and analysed using the CSM (Leventhal, 2003) and 
the HAPA (Schwarzer, 1992; Schwarzer, 2008). To do so, the conceptual constructs of 
each of the theories were placed within separate frameworks and relevant data were 


















The use of two theoretical models was appropriate for this study as it provided a 
comprehensive conceptual understanding of the motivational and volitional factors 
involved in being invited to lung cancer screening. Utilising more than one theory allows 
for complex data to be explored from different aspects and creates a holistic picture of the 
issue being discussed. The initial thematic analysis was considered to be appropriate in 
order to identify and understand the gaps and overlap in that data with the two theoretical 
models. 
 
In addition to the theoretical analysis, participants reported barriers for attending their lung 
screening trial appointment and demographic characteristics of the participants (including 
age, sex and smoking status) were also described. 
 
6.3.5 Ethical considerations and approvals 
 
Participants were recruited from the ECLS trial, which was carried out in conjunction with 
the National Health Service. As a result, ethical permission was sought from NHS Scotland 
East of Scotland Research Ethics Service. Ethical Approval was granted by the committee 
in December 2015 (Appendix 4). A complete study protocol submitted as part of the ethics 
application can be found in Appendix 8. 
 
There were a number of ethical considerations discussed before commencing the study. 
Participants were invited to participate in the study by writing to them up to a year after 
Framework Analysis
Generated themes: perceived risk; 
perceived severity; lung cancer vs. 
other cancers; stoicism and co-
morbidity




Common Sense Model of Self 
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they had originally engaged with the ECLS Trial. It was possible that individual 
circumstances may have changed between not attending their appointment for the ECLS 
Trial and being invited to participate in the sub-study. In some circumstances it is possible 
that potential participants may have passed away or become unwell. This potential issue 
was mitigated by using the Health Informatics service at the University of Dundee to check 
if participants were still alive using CHI numbers through NHS health records. In addition, 
invitation letters sent to participants included the sentence: ‘We apologise if this letter 
arrives at a particularly difficult time for you.’ 
 
The topic of the study - lung cancer - and the discussion of it can often be a sensitive area. 
It was recognised that the discussion of cancer might cause distress to some participants. 
Although no participants were openly distressed throughout the course of the interviews, a 
few disclosed that cancer was not a comfortable area of discussion for them. Others felt 
that taking part in an interview gave them a chance to talk about something that was 
significant to them and provided an opportunity to talk about their personal experiences. 
Regardless of whether participants believed discussing cancer had a positive or negative 
impact, the researcher was able to react in an empathetic manner. If required, participants 
were signposted to relevant professional organisations and charities that could provide 
advice and support. 
 
Those who participated in the interviews were offered a £20 voucher, however, if the 
participant wished to withdraw from the interview at any point during the interview, the 




















6.4.1  Demographics 
A total of eight participants took part in the interviews (n = 5 female and n = 3 male; mean 
age = 57.5). Among the respondents, four considered themselves past smokers, three 
current smokers and one non-smoker. Three participants reported living with chronic 
health conditions, and three had a family history of lung cancer. Participant characteristics 
are described in Table 6-3.   
 
6.4.2 Reasons for non-attendance 
Participants discussed both practical and psychological reasons for not attending their lung 
cancer screening appointment. Often, the practical barrier faced was initially described as 
the reason for non-attendance but underlying negative perceptions of lung cancer were 
difficult to overcome. Reasons for non-attendance or reappointing are presented in Table 
6-3. 
 
6.4.3 Related themes and CSM & HAPA constructs 
The original five themes identified are presented in Table 6-4. This table shows the 
recurring themes with illustrative quotes. In addition to the original themes, I mapped my 
themes to the corresponding CSM & HAPA constructs. There was significant overlap 
between the themes developed from the data and the theoretical constructs of the CSM and 






Table 6-2: Participant Characteristics & Reasons for Non-attendance 
Participant 
no. Sex Age 
Smoking 





Reason for not 
attending ECLS 
Trial appointment 
Reason for not rescheduling 
ECLS Trial appointment 
1 F 51 Past Smoker Nurse Glasgow 3 No 
Ill-health (minor 
ailment) Had no symptoms; scared 
2 F 55 Past Smoker Nurse Glasgow 2 No 
Competing priorities 
(work) No family history 
3 M 56 Current Smoker Unemployed Glasgow 1 No 
Ill-health (co-
morbidity) Did not want to know; fatalism 
4 M 52 Current Smoker 
Support 
Worker Glasgow 1 Yes 
Ill-health (co-
morbidity) 
Did not want to waste doctor’s 
time 
5 F 60 Past Smoker Accountant Lanarkshire 3 No 
Could not get 
appointment at 
convenient time 
Attempted to make appointment 
but found it too difficult 
6 M 64 Current Smoker Labourer Glasgow 1 No 
Competing priorities 
(work) 
Could not decide if they wanted 
to participate; did not want to 
worry 
7 F 55 Non-smoker Carer Glasgow 1 Yes 
Could not remember 
being invited 
Could not remember being 
invited 
8 F 67 Past Smoker Retired Lanarkshire 1 Yes 
Ill-health (co-
morbidity) 
Attempted to remake 
appointment but could not 






Table 6-3: Quotes Illustrating Developed Themes and Related CSM & HAPA Constructs 
Identified theme Quote CSM Construct  HAPA Construct  
Perceived Risk  
But I think every one of us is a toss of a coin whether we're going to 
get, and I don't care what kind of... money can't... see money? You can 
be the richest guy in the world, you could be Bill Gates and get cancer 
and you're snookered. (Participant 3) 
Cause Risk Perception 
Perceived Severity  
Well, to me, I always thought lung cancer was really a killer. I didn't 
think there was anything could ever be done about that. I thought that 





Lung Cancer Vs. Other Cancers 
If I had a - it's a bit of a... - if I had a choice between lung cancer and 
being diagnosed with breast cancer, I'd rather be diagnosed with 
breast cancer, I think. (Participant 1) 
Identity X 
Stoicism  
I think it's their mind-set. This sense of either not even wanting to face 
up to illness, or, you know, scared of it. Pretending it didn't exist. 
Particularly West of Scotland. (Participant 2) 
Coping Strategies 
& Appraisal  Coping Planning  
Co-morbidity  
[…] it turns out I've got a couple of gastric ulcers, although I didn't 
know that at the time. So, and it's a kind of, the, kind of, that, the sort of 
symptoms of that have sort of dragged on over that - you know, from 
then until pretty much now. So, you know, my lung health, as it were, 
really, I never really thought about it at all. I was so busy with the 
gastric systems that I haven't really - I haven't had any chest symptoms, 





6.4.4 Identified themes mapped against the constructs of CSM 
and HAPA 
The following section describes the themes generated, and the overlap between the themes 
and the constructs of the CSM and HAPA. 
 
6.4.4.1 Perceived risk / Cause (CSM)/ Risk perception (HAPA) 
Participants discussed their own perceived risk of lung cancer, other peoples’ risk of lung 
cancer and potential risk factors of lung cancer.  
 
A number of risk factors were identified by participants. All participants identified 
smoking as a risk factor of lung cancer. However, the importance of smoking was often 
minimised. The impact was minimised in a number of ways, including overemphasising 
the risk of workplace environmental hazards and genetic causes of cancer. This is 
illustrated by participant 7, who considered that exposure to asbestos and an industrial 
work environment are the primary cause of lung cancer: 
 
[…] was it not years ago, I would think, it's the type of job more so that caused a 
lot of problems, wasn't it, with people working with asbestos and in the docks and 
the type of work they done that caused a lot of their lung problems and things. 
(Participant 7, Female) 
 
A number of participants believed genes played a key role in the development of lung 
cancer. 
 
I tend to look sort of at family history and things like that, and I've never - I 
suppose although I was a smoker - I've never really thought that that's what was 
going to get me. (Participant 1, Female) 
 
The concept of lung cancer being hereditary was often tied up with the ‘predetermined’ 
nature of cancer. This was related to the concept that everyone is born with cancer, but 
something can ‘trigger’ it. ‘Triggers’ were considered to be both risk factor-related and 
luck. 
 
You know, on one hand, I think… You know, they say that everybody’s born with a 
cancer in them. […] And it’s just something that triggers it. So, basically, I just 
hope that mine doesn’t get triggered. That’s all. (Participant 6, Male) 
 
When asked how they perceived their own risk of developing lung cancer, most 




categorised as ‘current smokers’, who, when comparing themselves to non-smokers, 
believed they were no more at risk of lung cancer. The existence of lung cancer in non-
smokers was used as evidence to justify minimising the risk smoking posed to their health. 
 
Well, you know, you hear about - I mean, I'm a heavy smoker - and you hear about 
people with lung cancer that never smoked a cigarette in their day, you know, 
which is quite, you know, I don't understand that one (Participant 3, Male). 
 
Participants would also attach considerable weight to their own family history, in 
particular, a lack of lung cancer in their immediate family made them feel less vulnerable 
to lung cancer. Often, participants would identify diseases that were common within their 
family and consider that they are more likely to develop that.  
 
Because all the females in my family older than me, you know, parent, mother, 
aunt, you know, that kind of thing, all of them are smokers, or have been smokers, 
and lung cancer has never - none of them have developed lung cancer. They've 
developed other things, plenty of other things, but never the lung cancer, and I 
think I probably thought 'I'll probably get away with lung cancer. I'll probably get 
a different type of cancer, but I'll probably get away with the lung one.’ 
(Participant 1, Female) 
 
Participants had clear views on who they considered to be a candidate for lung cancer. 
Four participants considered men to be the most at risk of lung cancer. Three participants 
did not consider sex to be a risk factor. 
 
You know, any time you hear of guys having cancer, it’s usually lung cancer…It 
seems to be the norm for males. […] You know, you can't... I just – I just know that 
a lot, lots and lots of females in the past, that I’ve known or heard about, it’s 
always been breast cancer. And I’ve never heard of a guy having it. So… But I’ve 
heard of a lot guys having lung cancer. […] And not a great deal of females. 
(Participant 6, Male) 
 
And it wouldn't really have to matter if it was male or female, it would be an 
older… to me, it's an older person who's smoked all their days that would have it, 
and that's one of the reasons I think my mum doesn't like to go to the doctor's, 
because she probably thinks she's got it. (Participant 7, Female) 
 
One participant could not identify who they believed to be a candidate of lung cancer. 
Participant five had a strong belief that all cancers were the same, and that luck played a 
significant role in the development of lung cancer. This might contribute to their opinion 






I don’t think they look like anything. 
 
They’re just like anybody? 
 
If you lined up twenty cancer patients, they would all look absolutely different. You 
know, you could pick anybody, you know, pretty much any age, I would imagine. 
(Participant 5, Female) 
 
Overall, they perceived someone at risk of lung cancer to be severely unwell. The 
descriptions given were usually highly visual. 
 
I tend to see thin, wrinkled, grey, men and women. They all tend to be around 
about, but not exclusively, around about ten years older than I am now, ten to 
fifteen years older than I am now, so you're probably talking... I tend to see 
someone in their 60s as being thin, they probably smoke more than they eat, and 
they all, and you can see they almost look you know, like, a sort of... as if their face 
has been, you know, it's very leathery and wrinkly and often that's the kind of 
person. Yeah. People who, I tend to, I suppose, the people I visualise are people 
who are heavy smokers. (Participant 1, Female). 
 
I should imagine someone with having to get oxygen and stuff, you know, the tents 
you get in the house and that, and… (Participant 4, Male) 
 
This view of someone at risk of lung cancer was influenced by common lay beliefs and the 
generalised knowledge that all lung cancer is severe, with significant physical 
consequences. These participants believed that the symptoms of lung cancer are so 
significant that oxygen is required to assist breathing. It is unclear whether any less 
‘severe’ breathlessness or wheezing is seen as a symptom. 
 
6.4.4.2 Perceived Severity / Consequences (CSM) / Outcome expectancies 
(HAPA) 
The participants discussed how they felt about lung cancer. All participants perceived lung 
cancer to be severe and survivability to be low. This belief made the interviewees fearful of 
lung cancer. 
 
Because it can very quickly, you know, be serious, or more serious than others. So, 
yeah, I do think that people, if they were worrying about it at all, that would 
probably be the number one. But I do think it’s a bit demonised. Yeah, so I think 
that’s the one that – if people are told that, you know, that they’ve got it, that 
they’re immediately fearful and they think that they’re not going to survive. 







This fear of lung cancer made participants view lung cancer with a level of fatalism. The 
fatalism that the participants experience exhibits itself as both the inevitability of death 
when lung cancer is present, a sense of hopelessness and lack of control over the 
development of cancer.  
 
The inevitability of death when lung cancer is present was a frequent view of participants – 
they considered there to be fewer treatment options and less chance of recovery. 
 
If you did have a diagnosis, initially, I'd imagine 99% of the population think 'This 
means I'm going to die' (Participant 1, Female) 
 
Well, to me, I always thought lung cancer was really a killer. I didn't think there 
was anything could ever be done about that. I thought that was the one that would 
automatically kill you (Participant 7, Female) 
 
The inevitability of death appears to lead to a sense of hopelessness and belief that there is 
nothing that can be done to stop cancer progressing. As discussed previously, many 
participants believed in the idea that cancer is predetermined which adds to the sense of 
hopelessness they experience.  
 
Well, I’ve always had – I’ve always just had the opinion, you’re damned if you do, 
and you’re damned if you don’t, so what’s the point? (Participant 6, Male) 
 
I think we're all stamped when we're born, when we're going to go. (Participant 3, 
Male) 
 
There is a passive belief that we should only concern ourselves with what is in our control 
– this leads to the ‘what’s the point worrying’ attitude. This attitude might be a coping 
mechanism for feeling a lack of control. This coping strategy also extends to the avoidance 
of talking and reading about lung cancer. 
 
I tend, I try not to worry. What’s the point? It’s not going to go anywhere, even if 
you worry about it. You know the old expression, people will worry themselves sick. 
(Participant 6, Male) 
 
You know, certain articles I read, and I buy the papers all the time, but certain 
things I just think 'No, I'm not going to look at that’. I think it'd be dwelling on it 
too much, and at my age you don't want to start dwelling on things too much. 
(Participant 8, Female) 
 
Some participants did recognise advancements in medicine meant that some lung cancers 
can be treated, however the sense of hopelessness persevered. Treatment was not seen as 




who considered that even if treatment was successful cancer would continue to reoccur 
until they died. 
 
Once you've got - whether these drugs... I mean, I've never heard of anybody that's 
got cancer and then totally lived a valued life after it (Participant 3, Male) 
 
6.4.4.3 Lung cancer vs. other cancers / Identity (CSM) 
The criteria to join the ECLS trial required participants to be asymptomatic, and therefore 
participants did not discuss changes in physical functions or any other visible signs and 
symptoms that might be indicative of lung cancer. Participants were stimulated to develop 
cognitive representations by being invited to take part in the lung cancer screening trial. 
Often participants discussed lung cancer in an abstract manner. Lung cancer was 
frequently compared to other cancers. This comparison of types of cancer appeared to 
assist participants to understand, label and define lung cancer. Two clear views of cancer 
emerged – all cancers are the same or some are more severe than others.  
 
Those who did not distinguish between types of cancer had strong views and were more 
likely to be fatalistic about cancer. It is seen as one disease, one type as aggressive as 
another.  
 
I just think cancer is cancer. I just think it's the dirtiest disease on the planet, and I 
don't care what part of cancer it is (Participant 3, Male) 
 
Well, I don't know because, to me, the word 'cancer' just is the whole thing itself. 
You know, it's just the whole thing is just cancer. I don't kind of go 'Oh, it's lung 
cancer.' 'Oh, it's bowel cancer.' 'Oh, it's thingmy cancer.' (Participant 7, Female) 
 
However, this view was often contradictory of their view of survivability of lung cancer, 
where they considered some cancers more treatable than others. This is illustrated by 
Participant 4, who believed all cancers are the same but, some are more treatable. 
 
And I think, I know there is cancers that are more treatable than others. As I say, I 
know a bit about cancer, and I know there is ones that’s – you get ones that’s just 
not curable, if you know what I mean (Participant 4, Male) 
 
This contradiction in some interviewees might connote a feeling of uncertainty about 
cancer in general and may display itself as an ambivalent attitude towards cancer or their 





Participants that viewed cancers differently often discussed them as if on a scale of 
severity, with lung cancer being seen as the most severe and breast cancer as the least.  
 
I think people are more aware now that people can maybe be diagnosed with the 
likes of breast cancer and they know people who've survived that diagnosis. Lung 
cancer, I don't know that most people know someone who's survived lung cancer. 
(Participant 1, Female) 
 
One participant went as far as to describe what type of cancer they would prefer to have: 
 
If I had a - it's a bit of a... - if I had a choice between lung cancer and being 
diagnosed with breast cancer, I'd rather be diagnosed with breast cancer, I think 
(Participant 1, Female) 
 
This hypothetical preference for one type of cancer over another displays that the 
participants had a different attitude towards different types of cancer. It might also be 
indicative of having no close experience of breast or lung cancer but gaining knowledge of 
cancer from an easily accessible general pool of knowledge of cancer from social 
interactions and popular media. 
 
6.4.4.4 Stoicism / Coping strategies (CSM) / Coping planning (HAPA) 
Stoicism was often discussed with regard to lung cancer, and the screening of lung cancer. 
This was used as an avoidant coping response. The possibility of enduring symptoms 
without seeking help and without complaint was seen as a male characteristic, particularly 
seen in those from the West of Scotland.  
 
I think it's their mind-set. This sense of either not even wanting to face up to illness, 
or, you know, scared of it. Pretending it didn't exist. Particularly West of Scotland. 
(Participant 2, Female) 
 
Well, I don't know if it's just him personally, but I think men don't… I think 
they're… how do you say it? They're a lot different to women. Women, I think, have 
got to do these things. Whereas men, they just get up, get ready, go to work and go 
'Ach, don't bother me’. ''Don’t - I can't be bothered’ (Participant 7, Female) 
 
Stoic attitudes often manifest in the feeling of not wanting to make a fuss or bother the 
doctor with their worry. 
 






This attitude is often seen as a deliberate choice – choosing not to worry about cancer and 
just getting on with life. The stoic attitude might also be seen as a mechanism to cope with 
what they feel they have no control over. 
 
I mean, you know, whatever happens, then it’s going to happen anyway. And then 
what happens when they find out something and they’ve worried all that time and 
for nothing. […] So, I tend not to do it anymore. Just get on with it. (Participant 6, 
Male) 
 
6.4.4.5 Co-morbidity  
A number of participants had ongoing health conditions that were discussed during the 
interviews in relation to recognising symptoms of lung cancer and also competing health 
priorities when it comes to attending lung cancer screening. Participants tended to 
concentrate on any ongoing health conditions they had rather than worry about the 
possibility of having lung cancer. 
 
[…] it turns out I've got a couple of gastric ulcers, although I didn't know that at 
the time. So, and it's a kind of, the, kind of, that, the sort of symptoms of that have 
sort of dragged on over that - you know, from then until pretty much now. So, you 
know, my lung health, as it were, really, I never really thought about it at all. I was 
so busy with the gastric systems that I haven't really - I haven't had any chest 
symptoms, and I never really gave it a second thought. (Participant 1, Female) 
 
6.4.5 CSM & HAPA constructs not identified in initial 
identification of themes 
6.4.5.1 CSM constructs 
6.4.5.1.1 Timeline 
The ‘timeline’ of lung cancer was discussed by few participants. This might be the result of 
having little direct experience of lung cancer. When discussed, it was described as fast, 
quick and painful or as slow and painful. 
 
So, I just see that there's less options there, and you're more likely to die from it, 
and it'd be quite a quick cancer. (Participant 2, Female) 
 
But I don’t know […] how long it would, your lungs take to deteriorate, do you 
know what I mean? […] You know whether it, maybe you do that every three fours 
or four years, just depends how long your lungs take, you know, what timescale it 





Other participants did not indicate what they perceived the timeline of lung cancer to be, 
but it was unclear whether this was because they did not know or just that it was not 
considered for discussion. 
 
6.4.5.1.2 Cure/control 
As previously discussed, a number of participants did not believe that they had any control 
over the development of lung cancer. This is tied with the idea that cancer is 
predetermined, and the development of cancer cannot be impacted by changing risk factors 
(i.e. stopping smoking) or by attending cancer screening. There was a passive belief that 
we should only concern ourselves with what is in our control – this leads to the ‘what’s the 
point worrying’ attitude. This attitude might be a coping mechanism for feeling a lack of 
control over their health. This coping strategy also extends to the avoidance of talking and 
reading about lung cancer. 
 
It’s definitely, it’s a word I don’t like to discuss, it’s a subject that I’m not happy 
discussing, because it strikes fear into me. So it’s just... To me, it’s one of those 
taboo things. […]] It strikes fear into people. Human beings. (Participant 6, Male) 
 
6.4.5.1.3 Coherence 
Overall, participants’ knowledge of lung cancer varied greatly. Some participants could 
describe lung cancer, its risk factors and quantify their own risk coherently. Those with 
some knowledge of lung cancer, its causes and treatments were more likely to recognise 
that cancer is not one disease, but cancer comes in many distinguishable forms. However, 
some had little or no knowledge of lung cancer. In general, these participants considered 
cancer to be one indistinguishable disease.  
 
Lack of knowledge was sometimes attributed to lung cancer information not being as 
widely available to the general public, compared to other types of cancer. 
 
And I think, again, that’s back to information. You get bombarded with information 
about breast cancer and these types, but you… Well, most people I know, know 
very little about lung cancer. You know, it doesn’t seem to get the same high profile 
that other ones do. (Participant 5, Female) 
 
With regard to the lung cancer screening trial they were invited to participate in, no 
participants were able to describe the lung cancer screening test they were invited to 




what might be involved in lung cancer screening in general, but overall knowledge was 
poor. 
 
I think it would be - I get a lung function test every year due to another condition, 
and I think it would be the lung function test. Also probably - I don't know if it'd be 
x-ray or a type of scanning, I don't know if that would be maybe certainly part of it, 
or if it would be based on history and... I imagine it would be history and a lung 
function test. (Participant 2, Female) 
 
The poor knowledge of the lung cancer screening test might be attributed to the trial 
information they received. Only one participant understood that they had been invited to 
take part in a RCT and could comprehend what randomisation meant. The trial targeted 
areas of high deprivation, and participants had a varied education level as a result, the 
information they received might not have been accessible to all. 
 
6.4.5.1.4 Emotional representations 
The participants discussed how they felt about lung cancer. All participants perceived lung 
cancer to be severe and survivability to be low. This belief made the interviewees fearful of 
lung cancer. 
 
I'd be scared, I think, of the lung cancer more than anything. (Participant 8, 
Female). 
 
Fear was perceived to be either a motivator or a barrier to lung cancer screening.  
 
There are some people that fear pushes them to investigate, and some people their 
fear is they just don’t want, they'd rather not know. (Participant 1, Female) 
 
Well, I think people would act… I think if you had an immediate fear, you maybe… 
(Participant 4, Male) 
 
Other people shy away because they're scared in case it'll happen to them. 
(Participant 8, Female) 
 
6.4.5.1.5 Coping (not including stoicism) 
Leventhal’s model proposes that people put coping strategies in place in order to protect 
themselves when their health is under threat. Coping strategies guide actions in response to 





6.4.5.1.6 Active coping  
Participants did not often use problem-focused (or active) coping in response to being 
invited to participate in the lung cancer screening trial. All participants indicated that they 
participate in all other cancer screening programmes and their participation would be 
automatic. However, this did not seem to be the case with lung cancer screening. Although 
they stated that their participation would be automatic, their behaviour (i.e. not attending) 
indicates that they did not implement problem focussed coping in this situation. This was 
common amongst most participants. For example, Participant 2 believes strongly that they 
are an active coper: 
 
Generally, I would probably tend to just act immediately and do something about 
it, because I'm a nurse as well, a mental health nurse, so, I tend to be that way, 
that's how my brain functions. I'll tend to - I'm not somebody who'll mull over 
things for a long time. I have an idea about the process of something and I'll just 
get on board with it, get it over and done with, really. (Participant 2, Female) 
 
Participant 2 believes that most other people do not implement active coping in response to 
health issues. The participant distances themselves from this behaviour. However, it is 
clear that having not made an attempt to reappoint they are not problem focused but 
avoidant. This is a result of their cognitive representation of their risk of lung cancer. 
 
I think most people will maybe mull it over and then forget about it. […] Some 
people, I've got people in my family who are of the mind-set that, 'Oh, I'd rather not 
know.' […] And that's how some people think. (Participant 2, Female) 
 
[…]Probably if I had a lot of knowledge and a strong connection to lung cancer, 
then I would have contacted and rearranged, and the fact that I didn't makes me 
think it was more 'Och, I'll just leave it', because maybe what I've got to contribute 
will not really be much. (Participant 2, Female) 
 
Only two out of eight participants attempted to actively remake their missed lung cancer 
screening test. 
 
6.4.5.1.7 Denial and avoidance 
Denial was implemented as a strategy by some participants to cope with the cognitive and 
emotional response to being invited to the lung cancer screening test. All participants of 
the trial were categorised as high risk of lung cancer. However, this status was often 





I don’t think I’m any higher, lower, or anything. I think it’s just your luck. 
(Participant 6, Male) 
 
Participants also implemented avoidance and believed that most others would most likely 
use this strategy.  It was often discussed in relation to older age and being male. 
 
No. It was… Again, just going back to what we said earlier, it was just the fact… 
Oh, God, you know, I hope I don’t have anything and do I want to find out? 
(Participant 6, Male) 
 
I think it's their mind-set. This sense of either not even wanting to face up to illness, 
or, you know, scared of it. […] I think, again, it comes back to a generation thing 
as well, as to how probably men at that age that aren't perceiving... you know, the 
things that they have, have grown up with things that didn't get talked about. 
(Participant 2, Female) 
 
6.4.5.1.8 Illness outcome  
Leventhal’s CSM culminates in a given illness outcome based on the emotional and 
cognitive representations made and how an individual chooses to cope with these 
representations. The model is dynamic and proposes that people reassess their 
representations and coping strategies based on the information they have available to them 
at that time. For this reason, participants in this study may make an initial decision about 
lung cancer screening and subsequently change their mind at a later date. 
 
All participants stated that they did not have to think about their initial decision to take part 
in the lung cancer screening trial and automatically wished to participate. The perception 
of cancer screening in general was positive and all agreed a programme should be in place. 
 
I've got quite a positive view about cancer screening. I believe that it's something 
that should be picked up a lot more by the public. Because of our opportunities to 
identify risk, we've got an opportunity to reduce that risk, to do something about it 
rather than wait until someone's got a diagnosis and then they go down that long 
road of recovery, if recovery is possible. […] I feel quite strongly about screening. 
(Participant 2, Female) 
 
But, no, it’s never a question of I wouldn’t do it. (Participant 5, Female) 
 
Participants often cited practical or situational barriers as reasons for their non-attendance 
to their lung cancer screening test (Table 6-2). Half of the participants cited ill-health as the 




chronic health conditions. The remaining two participants were unwell for a short period of 
time. 
 
I'd totally forgotten. I was feeling so ill so I'd completely forgotten I was supposed 
to go to it […] and I got in the taxi to go to the lung cancer screening thing and I 
just felt so nauseated that I actually just said to the guy half way along, I said, 
"Look, please take me home", because I just felt so sick, and that was the reason I 
didn't go. (Participant 1, Female) 
 
Right, everything was set and I really took… it wasn't really… in a way, it was a 
COP episode but not bad, all my nose and my throat, you know? And I thought 'I 
can't go for that like this.' That's the only reason I cancelled. (Participant 8, 
Female) 
 
A number of participants with ongoing health conditions that were discussed during the 
interviews in relation to recognising symptoms of lung cancer and also competing health 
priorities when it comes to attending lung cancer screening. Participants tended to 
concentrate on any ongoing health conditions they had rather than worry about the 
possibility of having lung cancer. 
 
[…] it turns out I've got a couple of gastric ulcers, although I didn't know that at 
the time. So, and it's a kind of, the, kind of, that, the sort of symptoms of that have 
sort of dragged on over that - you know, from then until pretty much now. So, you 
know, my lung health, as it were, really, I never really thought about it at all. I was 
so busy with the gastric systems that I haven't really - I haven't had any chest 
symptoms, and I never really gave it a second thought. (Participant 1, Female) 
 
Two participants could not attend their appointment because of work commitments. These 
participants prioritised work commitments over being screened for lung cancer. Prioritising 
the screening appointment was not seen as an option and doing so would make their 
everyday lives more difficult. In this sense, it was more practical for them not to attend 
their appointment.  
 
Aye, yeah, I was thinking, ‘I have to go out and earn some money,’ that’s what I 
was thinking. (Participant 6, Male) 
 
I was actually caught up - we do a crisis duty - and I got caught up in a crisis duty 
that day, it just, I never got up to it. And then I forgot all about it. (Participant 2, 
Female) 
 
One participant also found the practicalities of attending their screening appointment 
difficult. The time and location of the screening appointments were seen as problematic, 





But the original date they gave me, I honestly can’t remember what it was I was 
doing but I had somewhere I had to be […] But they didn’t make it easy, put it that 
way. And that’s why I ended up not going […] (Participant 5, Female) 
 
One participant could not recall being invited to take part in the trial, however, it was 
unclear whether this was because of the length of time between being invited to take part in 
the trial and the sub-study interview, or whether this was the reason they did not attend. 
 
Participants had the option to remake the appointment that they did not attend. Two 
participants attempted to reschedule an appointment, six did not. The reasons for not 
remaking their appointment are described in in Table 6-2. 
 
In addition to the practical and situational barriers to their attendance, participants 
discussed in depth their beliefs around lung cancer. These beliefs also impacted 
participants’ attendance to their appointment and the likelihood that they would attempt to 
reappoint. Four participants did not try to rearrange their appointment because they did not 
feel at risk of lung cancer. This is a result of their cognitive representations of lung cancer. 
For example, Participant 2 did not feel the need to reappoint because of a lack of family 
history with lung cancer.  
 
No, I think it's probably a lack of a connection to lung cancer. Maybe about the 
strength of the connection to lung cancer (Participant 2, Female) 
 
Participants were more likely to give an emotive reason for not reappointing compared to 
the reason they originally gave for their non-attendance. This might indicate that the 
participants might have reassessed their representations between their original invite and 
remaking their missed appointment. This was potentially a more deliberative decision 
compared to the automatic decision made when responding to the original invite. 
Participants were more likely to cite fear, worry or not wanting to know as the reason for 
non-attendance at this point. 
 
No, I think I felt a little bit more scared, actually (Participant 1, Female) 
 
But the… at some point, it was one of those ones, again, it was always in the back 
of my head, but I wasn’t sure whether I wanted to… I hadn’t made my mind up 
entirely. […] So, it was lying there, it was just, it was pending in my head. 





6.4.5.2 HAPA constructs 
6.4.5.2.1 Intention 
All participants had intention to attend their lung cancer screening trial appointment. The 
appointments were not automatically allocated, as a result, participants were required to 
make contact with the study team to arrange an appointment. This indicates a positive 
intention to attend and a level of motivation. 
 
I think I must have got it... a few weeks before... It was a few weeks, I think. I'm 
trying to think. I'd went on holiday somewhere, I think it was my brother's down in 
Manchester, so, I must have got it a few weeks before that, and I did contact them 
and I was planning to go. (Participant 1, Female) 
 
I was actually going to do it, and I phoned up. (Participant 4, Male) 
 
One participant could not remember making the appointment, but records obtained from 
the ECLS Trial indicated that an appointment was made. Given the significant time 
between being initially invited to participate in the screening trial and being interviewed 
for the sub-study, it is possible that the participant had forgotten making the appointment. 
 
Overall, participants were very positive about lung cancer screening and screening 
programmes in general. They believed them to be a good idea and necessary. 
 
Well, I'm very supportive of cancer screening. (Participant 1, Female) 
 
The positive support for lung cancer screening was highlighted by participants’ 
descriptions of automatically making an appointment in response to the invitation letter 
No, no. No, I'd soon as… if I get anything through saying 'We'd like you to do this' 
then if it's anything to do with cancer, I do it. ‘Cause my sister-in-law died with 
cancer when she was only thirty-seven. (Participant 7, Female) 
 
6.4.5.2.2 Task self-efficacy 
Participants all believed that they would be able to attend their appointment when they 
initially made it. As a result, we can consider them to have high levels of Task Self-
Efficacy. However, the nature of the screening trial meant that this action self-efficacy was 
not often required. For example, participants’ belief that they had the required resources to 
attend their appointment was heightened because of the proactive recruitment strategies of 
the ECLS trial. The study team covered expenses and travel for participants to attend their 




limitations negligible. Only one person discussed how they had planned to travel to their 
appointment. 
Yeah, and I was all set to go, they told me to get a taxi and everything. I said “No, 
I've got my bus pass.” (Participant 8, Female) 
 
6.4.5.2.3 Maintenance self-efficacy 
Participants did not cope effectively with the barriers that arose before their screening 
appointment, as a result, they can be considered to have low maintenance self-efficacy. 
Strategies were not employed to overcome barriers and participants were not persistent in 
their efforts to overcome barriers. 
 
I did. I was actually caught up - we do a crisis duty - and I got caught up in a crisis 
duty that day, it just, I never got up to it. And then I forgot all about it. (Participant 
2, Female) 
 
But the… at some point, it was one of those ones, again, it was always in the back 
of my head, but I wasn’t sure whether I wanted to… I hadn’t made my mind up 
entirely. So, it was lying there, it was just, it was pending in my head. It was just a 
matter of making my mind up, and at that particular time... again, you know, I 
hadn’t made – I hadn’t made my mind up, and then all of a sudden I got busy at 
work, so it kind of went to the back burner. That’s what happened with that. 
(Participant 6, Male) 
 
6.4.5.2.4 Recovery self-efficacy 
As a result of lack of attendance, it is evident that participants had low levels of recovery 
self-efficacy. Participants were unable to ‘recover’ from barriers to their attendance and 
did not attempt to rearrange their missed appointment. Participants had the option to 
remake the appointment that they did not attend. Two participants attempted to reschedule 
an appointment, four did not. 
 
You know, so, and then I just never rescheduled it. And I think I probably never 
rescheduled it because I thought 'I feel okay, and my lungs, I don't have any 
symptoms. I feel okay', so, you know, I wasn't that worried. (Participant 1, Female) 
 
...on that particular day. And when I had phoned to try and rearrange a time, it was 
really difficult, actually. To – to get them to pick another time. And I do appreciate, 
obviously hundreds of people are getting called. And they can’t possibly re-jig 
everybody’s appointment just to suit one person. But I just felt there wasn’t any 






6.4.5.2.5 Action planning 
Often, participants did not have to put in place any sort of action planning. This might be a 
result of the nature of the screening trial. The trial team provided travel and expenses when 
required to maximise participant attendance. The result of this additional support meant 
that participants were not required to put into place any sort of preparatory strategies.  
 
6.4.5.2.6 Coping planning (not including stoicism) 
Coping planning was not effectively implemented by participants, in contrast, participants 
were more likely to implement maladaptive coping strategies. As with the CSM, 
participants did not often use effective coping in response to being invited to participate in 
the lung cancer screening trial. This is highlighted by the lack of reappointing amongst 
participants - only two out of eight participants attempted to actively remake their missed 
lung cancer screening test. When posed with a barrier (practical or cognitive) they were 
unable to overcome due to ineffective coping planning. If they had put in place plans on 
how to cope if a barrier emerged, they might have successfully attended another 
appointment. 
 
Denial was implemented as a strategy by some participants to cope with the cognitive and 
emotional response to being invited to the lung cancer screening test. All participants of 
the trial were categorised as high risk of lung cancer. However, this status was often 
rejected by participants.  
 
I don’t think I’m any higher, lower, or anything. I think it’s just your luck. 
(Participant 6, Male) 
 
Participants also implemented avoidance and believed that most others would most likely 
use this strategy. It was often discussed in relation to older age and being male. 
 
No. It was… Again, just going back to what we said earlier, it was just the fact… 
Oh, God, you know, I hope I don’t have anything and do I want to find out? 
(Participant 6, Male) 
 
I think it's their mind-set. This sense of either not even wanting to face up to illness, 
or, you know, scared of it. […] I think, again, it comes back to a generation thing 
as well, as to how probably men at that age that aren't perceiving... you know, the 
things that they have, have grown up with things that didn't get talked about. 






Self-monitoring was not required in this screening trial – this was a one-off appointment 


































6.5.1 Summary of main findings 
This study offered the unique opportunity to explore the perceived barriers to lung cancer 
screening and beliefs about lung cancer and lung cancer screening in a group of ECLS trial 
non-attenders. This particular group are of significant interest because of their positive 
intentions to attend their screening appointment. Understanding the barriers and beliefs of 
non-attenders can offer insight into what we must do to encourage attendance in this 
already motivated group. The development of a national cancer screening programme, 
such as lung cancer screening, requires it to be both clinically effective and sustainable. 
Optimising screening attendance among those most at risk of lung cancer is fundamental to 
the success of any potential screening programme. 
 
The qualitative analysis explored the perceived barriers to attending a lung cancer 
screening appointment and the beliefs about lung cancer in a group of non-attenders in the 
ECLS trial. The study aimed to address the following questions:  
 
I. What are the perceived barriers to participating in a lung cancer screening trial? 
II. What beliefs do non-attenders hold about lung cancer and lung cancer 
screening? 
III. Do the CSM and HAPA model help to explain the processes behind those who 
intend to participate in screening but do not attend? 
 
Participants were likely to initially state practical reasons for non-attendance at their lung 
cancer screening appointment, such as ill-health, competing priorities or being unable to 
secure a suitable appointment time. However, all participants also provided psychological 
reasons for not attending. This pattern of discussing practical barriers followed by 
psychological barriers suggests that their underlying beliefs about lung cancer might 
impact the way in which they tackle the practical barriers they face when attending an 
appointment. This idea is supported by participants choosing not to reappoint after missing 
their initial appointment. When the practical barrier they perceived was removed, the 
underlying perceptions of lung cancer were difficult to overcome and resulted in 





The thematic framework analysis generated five distinct themes: perceived risk; perceived 
severity; lung cancer vs. other cancers; stoicism; and co-morbidity. A summary of the 
findings is displayed in Table 6-4. The beliefs about lung cancer that participants held 
influenced their non-attendance at their screening appointment.  
 
Participants’ perceived risk and understanding of risk factors played a role in their non-
attendance. Although participants could identify smoking as a risk factor, they 
underestimated their own risk of getting lung cancer, placing significant weight on external 
factors such as family history. Some participants considered lung cancer to be 
predetermined and seen as something that they had no control over. A low perceived risk, 
or the view that lung cancer is predetermined, meant that non-attenders did not consider it 
necessary to attend their lung cancer screening appointment. 
 
Lung cancer was perceived to be a severe condition with participants holding fatalistic 
beliefs. As a result, participants were often fearful about lung cancer and a feeling of 
hopelessness about the lack of control they have over the development and treatment of 
lung cancer. The emotional response to how serious lung cancer is meant that participants 
were fearful of attending lung cancer screening and of the results of the screening test. The 
fear they feel about lung cancer could perhaps have also lead them to underestimate their 
own risk in order to distance themselves from lung cancer, and lessen their emotional 
response that might occur if they felt at risk. 
 
Lung cancer was often compared to other types of cancer. There were two distinct views 
which emerged; some participants believed all cancers to be the same and others believed 
that some cancers were more severe than others. Those who did not distinguish between 
types of cancer had strong views and were more likely to be fatalistic about cancer. It was 
seen as one disease, one type as aggressive as another. Participants that viewed cancers 
differently often discussed them as if on a scale of severity, with lung cancer being seen as 
the most severe and breast cancer as the least. Both the uncontrollability of cancer and the 
severity of lung cancer induced emotional responses that acted as a barrier to attending or 
remaking a lung cancer screening appointment. 
 
A stoic attitude made some feel they did not want to make a fuss, bother their doctor or 
worry about lung cancer and its symptoms. Those who displayed a stoic attitude often 




information about lung cancer made it easier for them and can be seen as a coping 
mechanism to cope with what they feel they have no control over. This avoidant behaviour 
is a possible explanation for non-attendance of their lung cancer screening appointment. 
This might also indicate that fatalism, often believed to be an irrational response, can be 
employed as a coping mechanism.  
 
A number of participants lived with other health conditions. The existence of an underlying 
condition left participants with competing health priorities. The lung cancer screening 
appointment was not seen as a priority at the time they were invited, with any potential 
symptoms of lung cancer overlooked. Participants tended to concentrate on any ongoing 
health conditions they had rather than worry about the possibility of having lung cancer. 
 
Table 6-4: Summary of Findings - How do Different Beliefs Influence Non-attendance 
or Reappointing to a Cancer Screening Trial? 
Theme Conclusion 
Perceived risk  
Participants underestimated their own risk of getting 
lung cancer 
 
Perceived severity  
Participants perceived lung cancer to be severe and 
survivability to be low 
 
Lung cancer vs other cancers  
Two clear views of cancer emerged – all cancers are the 
same or some cancers are more severe than others. When 
compared to other cancers, lung cancer was perceived to 
be the most severe  
 
Stoicism  
The stoic attitude towards lung cancer displayed by some 
is seen as mechanism to cope with what they feel they 
have no control over 
 
Co-morbidity  
Participants with co-morbidities concentrated on any 
ongoing health conditions they had rather than worry 
about the possibility of having lung cancer 
 
 
The use of two theoretical frameworks provided greater insight into non-attendance and 
helped to identify themes that had not been identified in the initial thematic analysis. 
When comparing the generated themes with the constructs of the HAPA and CSM there 
was found to be significant overlap. The only theme that did not map directly to the CSM 
or HAPA was ‘co-morbidity’. This was identified as a significant barrier to a number of 




compared lung cancer to other types of cancer. However, this mapped directly to the CSM 
construct ‘identity’. 
 
The secondary aim of the study was to explore to what extent HAPA and CSM explained 
non-attenders behaviour. A summary of the findings can be found in Tables 6-5 and 6-6. 
 
Table 6-5: Summary of Findings - HAPA Constructs 
Construct  Conclusion 
Intention  
All participants had intention to attend their lung cancer 
screening trial appointment. 
 
Task self-efficacy  
Participants all had a belief that they would be able to 
attend their appointment when they initially made it. As 
a result, we can consider them to have high levels of task 
self-efficacy. 
 
Outcome expectancies  
All participants perceived lung cancer to be severe and 
survivability to be low. This belief made the 
interviewees fearful of lung cancer. 
 
Risk perception  
Participants underestimated their own risk of getting 
lung cancer 
 
Maintenance self-efficacy  
Participants did not cope effectively with the barriers 
that arose before their screening appointment, as a result, 
they can be considered to have low maintenance self-
efficacy 
 
Recovery self-efficacy  
The lack of attendance indicates that participants had 
low levels of recovery self-efficacy 
 
Action planning  
Participants did not have to put in place any sort of 
action planning because of the nature of the lung 
screening trial procedures 
 
Coping planning  
Coping planning was not effectively implemented by 
participants. Participants often implemented maladaptive 









Table 6-6: Summary of Findings - CSM Constructs 
Construct  Conclusion 
Identity  Participants were stimulated to develop cognitive 
representations by being invited to take part in the lung 
cancer screening trial. Often participants discussed lung 
cancer in an abstract manner and frequently compared to 
other cancers 
 
Cause  The importance of smoking was often minimised. 
Participants overemphasised the risk of workplace 
environmental hazards, genetic causes of cancer and 
often discussed the predetermined and uncontrollable 
nature of cancer 
 
Timeline  Very few discussed the timeline of lung cancer. When 
discussed, lung cancer was described as quick and 
painful or as slow and painful 
 
Consequences  All participants perceived lung cancer to be severe and 
survivability to be low. This belief made the participants 
fearful of lung cancer 
 
Coherence  Participants’ knowledge of lung cancer varied greatly. 
However, no participants were able to describe the lung 
cancer screening test they were invited to  
 
Emotional representations  Participants were fearful of lung cancer and held 
fatalistic beliefs. Fear was perceived to be either a 
motivator or a barrier to lung cancer screening 
 
Coping strategies  Participants did not employ active coping, but instead 
used maladaptive coping strategies such as denial and 
avoidance  
 
Coping appraisal  Participants were unable to appraise the coping strategies 
they employed. This is evidenced by the lack of 
reappointing among participants 
 
Illness outcomes  Participants were likely to cite practical barriers as the 
reason for not attending their screening appointment but 
would cite emotional barriers for the reason not to make 
another appointment. This indicates that the participants 
might have reassessed their representations between their 
original invite and remaking their missed appointment 
 
 
There was not one theoretical model that fully explained non-attendance of the lung cancer 
screening trial. However, each model has important components that go some way to 
explain the behaviour of non-attenders in this context. There was significant overlap 




people who already have positive intentions. Participants were unable to employ action 
focused coping strategies that would help them overcome the initial practical and 
emotional barriers they faced when the time came to attend their appointment. Further, 
they were unable to appraise their maladaptive coping strategies and recover in order to 
make another appointment. Despite there being similarities in the lung cancer beliefs of 
ECLS trial attenders (Chapters 4 and 5) such as perceived lack of control over risk and 
negative emotional responses to lung cancer, coping response might be a key difference 
between attenders and non-attenders. Coping planning and coping appraisal seem to be 
significant problem areas for non-attenders with the time between invitation and 
appointment vital to whether or not they attend their appointment.  
 
6.5.2 Comparison with other literature  
The reported barriers to the cancer screening trial are comparable to those of other cancer 
screening programmes. Both practical and emotional barriers have been previously cited as 
reasons for not taking part in lung cancer screening (Ali et al., 2015). Practical barriers, 
such as competing priorities with regard to work and family commitments, as well as 
ongoing health condition were cited by the participants of this study. A study exploring 
non-participation in the UKLS trial found that alongside emotional barriers, participants 
most commonly cited travel, co-morbidities, caring responsibilities and work commitments 
as the reason they did not participate. This study did not find travel to be a barrier because 
of the proactive recruitment procedures of the ECLS trial, with participants often being 
provided with door-to-door transport. However, outwith a trial setting we could expect this 
to be the case if a national lung cancer screening programme was implemented.  
 
The practical barriers experienced by the participants are legitimate reasons for not 
attending an arranged appointment. Barriers are more likely to be perceived by those of 
lower SES (Ali et al., 2015) and go some way to exacerbate health inequalities. These 
barriers could have been resolved by attempting to make another appointment at a more 
convenient time to them. This would require participants to apply effective coping 
mechanisms and planning. The design of our national screening services could also be 
adapted to help optimise participation; making them accessible by design and ensuring 
flexibility to meet the needs of all communities.  
 
Among the participants, emotional barriers played a significant role in why they chose not 




fear and fatalism. This is also frequently reported in previous studies (Jonnalagadda et al., 
2012; Quaife et al, 2018). This negative association with lung cancer is prevalent, as well 
as the adoption of maladaptive coping mechanisms such as avoidance or denial (Patel et 
al., 2012; Walton et al., 2013). The fear and fatalism experienced by participants also left 
them with a feeling of hopelessness that could have contributed to their non-attendance of 
their appointment. 
  
An important finding of this study is the exploration of what happens between invitation, 
appointment and reappointment. The study found that participants made their choice to 
take part in the screening trial automatically, based on their previous reported screening 
behaviour. However, given time, participants became more reflective in their decision-
making, making their final decision to not attend or reappoint based on their knowledge 
and emotional representations of lung cancer. Dual process models of decision-making 
posit that there are two distinct systems of processing (Kahneman, 2003). System 1 is 
described as intuitive, fast, and emotion-focused, while System 2 is deliberative, slow, 
reflective (Kahneman, 2011). These systems of processing are reflective of how non-
attenders made their decision to participate. Participants engaged System 1 when first 
invited to take part in the trial - a decision to attend was made quickly and based on their 
existing knowledge. Within the period of time between invitation and attending their 
appointment, they engaged the more reflective System 2. Making a deliberative decision 
not to attend their appointment or make another for a later date might be the result of 
having time to ruminate on their emotional representations of lung cancer. When faced 
with practical barriers, there is less inclination to put in place effective coping responses to 
overcome them and a deliberate decision was made not to make another appointment. This 
insight would lead us to believe that interventions for non-attenders could focus on 
reducing the time between engaging System 1 and the appointment date in order to 
encourage more intuitive decision-making. 
 
Exploring non-attenders’ barriers and beliefs has developed the wider understanding of the 
decision-making processes inclined abstainers implement when invited to participate in 
screening. The two-system approach to decision-making adopted by this group will help us 
to identify appropriate interventions to increase screening uptake in not only lung cancer 
screening, but other forms of cancer screening. For example, the use of patient navigators 
to provide emotional and practical support could improve uptake in screening non-




Sheeran, 2006) or the combination of action and coping planning interventions for non-
attenders (Kwasnicka, Presseau, White & Sniehotta, 2013) could also support non-
attenders to overcome some of the barriers they might face when invited to participate in 
cancer screening. 
 
6.5.3 Strengths and limitations  
There were no previous studies that looked at non-attenders of lung cancer screening using 
qualitative methodology. A major strength of the current study is therefore that this unique 
sample provides us with important insight into the cancer screening decision-making 
processes, enabling us to develop interventions to support non-attenders and optimise 
cancer screening.  
 
A further strength of the study is the holistic approach to analysis by exploring two 
theoretical models, allowed for greater understanding of the overlap and gaps in the HAPA 
and CSM. The use of both models highlights the need to move away from the view that 
only one theoretical model can or should be used to describe behaviour. Decision making 
is complex, and by using just one theoretical model we limit our understanding of 
individual experience. Individually, both models provided insight that helps to develop our 
understanding of screening behaviour, but when used in tandem they expand our 
understanding and highlight areas not previously considered, such as the impact underlying 
health conditions have on screening behaviour. It is recognised that each of the models also 
have some limitations in relation to the study. The HAPA did not map directly onto two of 
the identified themes of the initial thematic analysis and as a process model, did not 
account for reappraisal of decisions without starting the decision process again. 
Conversely, the CSM mapped to all identified themes apart from co-morbidity, and also 
includes a feedback loop that accounts for people changing their minds at various stages of 
the process (see table 6-3). As a result, we could conclude that the CSM better explained 
the decision making of non-attenders. However, without examining the qualitative data 
with both models, the gaps in the data would not have been recognised. 
 
A limitation of the study is that the ECLS trial was not a true lung cancer screening 
programme but an RCT. However, as previously discussed, it is useful to draw on the 
findings of this trial to understand the screening behaviour of high-risk groups, with the 
aim to help shape future screening programmes. The majority of participants did not 




experience like they would any other screening programme such as bowel or breast 
screening. Only one participant discussed issues around randomisation, and why this might 
have impacted their decision to participate. 
 
The nature of the sample meant that the recruitment was challenging, and final uptake of 
the study was low. As a result, only eight non-attenders participated in interviews. 
Although a relatively low number, in some ways it can be regarded as a strength that as 
many as eight agreed to be interviewed given they may have been reluctant to speak about 
their non-attendance.  Furthermore, the data that resulted from the interviews were rich and 
allowed for in-depth and holistic analysis. It is evident that non-attenders require extra 
support to encourage actual participation. Future study of this group should aim to reflect 
this in their recruitment strategy. 
 
6.6 Chapter summary  
This chapter has presented the results of a qualitative study exploring the barriers to a lung 
cancer screening trial in a group who initially agreed to participate, but ultimately did not 
attend their arranged appointment. The study also looked to explore to what extent the 
HAPA and CSM help explain the processes behind non-attenders decision-making. 
 
The findings of the study indicate that non-attenders made their initial decision to 
participate instinctively and are motivated to participate. However, they do not effectively 
implement coping mechanisms to overcome practical barriers, such as competing priorities 
or ill-health. When faced with remaking their appointment, participants engaged a more 
reflective and emotive decision-making process, often citing fear and fatalistic beliefs as 
the reason for not reappointing.  
 
There was significant overlap between HAPA and CSM, particularly with regard to the 
role coping strategies play in a group of people who already have positive intentions. 
Coping planning and coping appraisal seem to be significant problem areas for non-
attenders with the time between invitation and appointment vital to whether or not they 
attend their appointment. This insight will help us develop interventions that will minimise 
non-attendance at lung cancer screening. 
 
The next chapter will present the overall discussion of the findings of the thesis and 




Chapter 7 : Discussion and conclusions 
7.1 Introduction  
Lung cancer is the most commonly diagnosed form of cancer, and the leading cause of 
cancer death worldwide. Lung cancer disproportionately impacts those from certain 
groups, including those from more deprived groups. Failing to acknowledge the possible 
inequalities in cancer screening, and addressing the potential causes, can further exacerbate 
existing health inequalities that exists between some groups. By not addressing the 
variation in cancer screening participation there is potential risk that any future lung cancer 
screening programme might not be efficient or sustainable. 
 
This thesis has comprehensively explored lung cancer screening participation. In 
particular, I sought to understand the determinants of lung cancer screening participation, 
including the perceptions and beliefs of lung cancer, and what the implications of these 
perceptions and beliefs might have on screening participation. To address the research 
questions set out, I used a mixed methods approach that allowed me to extensively 
understand the factors associated with lung cancer screening participation. 
 
This chapter aims to integrate the results of the thesis by outlining the main findings, 
discussing the limitations of the thesis and reflecting on future research needs and, policy 
and practice implications. 
 
7.2 Overview of main findings  
This section will provide an overview of the main findings of the thesis and discuss how 
these findings compare to existing literature. 
 
7.2.1 Do public perceptions of lung cancer and lung cancer 
screening differ between socioeconomic groups? 
There is some variation in the public’s perception, and awareness, of lung cancer and lung 
cancer screening across different socioeconomic groups. However, this was not the case 
for all aspects discussed in the literature reviewed in Chapter 3. In general, the evidence 
explored suggests that those from lower SES groups have poorer knowledge of lung cancer 
and its symptoms, are more likely to perceive themselves at lower risk of lung cancer and 




The findings, in relation to poorer knowledge and increased perception of barriers to 
screening among those from lower SES, were not unexpected and are generally reflective 
of the literature exploring other forms of cancer screening (McCutchan et al., 2015; James 
et al., 2008; von Wagner et al., 2011). However, this is not the case with risk perception. 
Existing literature on perceived risk of cancer across SES indicates a confounded picture 
(Wardle et al., 2004; Wardle 2015). Perceived risk of cancer has been found to be both 
higher and lower in more deprived groups. It is surprising that there is an indication that 
lower perceived risk of lung cancer is recurrent in lower SES groups, particularly when 
criteria for participation in lung cancer screening is usually based on risk. This might be an 
example of unrealistic optimism (Weinstein, 1980) among high risk groups, such as 
smokers. A particular bias might be present in the existing literature, including those 
reviewed, that often uses smokers as a sample in lung cancer screening research. This is 
undoubtedly the correct approach, but we must remain mindful of the relationship between 
SES and smoking status when drawing conclusions about perceived risk in different SES 
groups.  
  
No clear conclusions could be made about the SES differences in fear, fatalism, stigma, 
smoking status/cessation, and lung cancer screening awareness. The lack of social gradient 
in the studies, exploring differences in smoking status and smoking cessation, were not 
completely unforeseen given the over representation of smokers in lung cancer screening 
research. Although rates of smoking among those from lower SES groups are higher 
compared to high SES groups, greater variation in beliefs about lung cancer screening can 
be seen by smoking status rather than SES. Similarly, it is not unsurprising that there was 
no variation in lung cancer screening awareness by SES group given the lack of organised 
screening programmes in most countries. Where screening programmes do exist (e.g. 
United States) a lack of awareness of lung cancer screening was made evident by the 
number of misconceptions about lung cancer screening, including believing that the 
purpose of screening is prevention and to act to provide reassurance. A significant number 
of people also overestimate the benefits of lung cancer screening regardless of SES 
(Hoffman & Del Mar, 2015). 
 
Conclusions surrounding the lack of variation in fear, fatalism and stigma were not as 
anticipated. It would be expected that those from lower SES groups would experience 
greater fear, fatalism and perceived stigma with regard to lung cancer. The belief that fear 




greater fear and fatalism would be the result of having less knowledge of lung cancer and 
lung cancer screening. Similarly, the increased uptake of smoking in more deprived groups 
would be expected to be associated with higher levels of perceived stigma. Existing 
literature also supports the hypothesis, with fatalistic beliefs and fear about cancer being 
more common in low SES groups (Beeken et al., 2011; von Wagner et al., 2011; 
Niederdeppe & Levy, 2007; Wardle et al., 2004; McCutchen et al., 2015). Low SES has 
also previously been associated with increased higher lung cancer stigma (Assari et al., 
2019; Chambers et al., 2012).  
 
The inconclusive nature of the findings in Chapter 3 might be explained in a number of 
ways. For example, fear and fatalism might not be as high as anticipated in those from 
lower SES groups, as argued by Blaxter (1997), because they have greater experience of 
having or knowing someone with chronic ill-health. Consequently, they might also have 
greater experience of knowing of someone who has survived despite being high risk, and 
of people who die prematurely despite apparent healthy lifestyles. As a result of these lay 
beliefs, those from lower SES backgrounds might consider ill-health, such as developing 
cancer, to be luck or chance and, therefore, there is nothing within their control that can be 
done to prevent it. This lack of control might come as a relief to some, and potentially 
reduce levels of fear. 
 
Another possible explanation for there being no variation in fear and fatalism across 
socioeconomic groups is that levels of fatalism and fear remain consistent across all 
groups. Cancer fear is generally high across all forms of cancer and is commonly viewed 
as the enemy (Vrinten et al., 2014; Vrinten et al., 2016). However, lung cancer is 
considered to be the most severe form of cancer, and more fatal compared to others 
(Mazières et al., 2015). This persisted in the participants’ views described in Chapter 6, 
who also considered lung cancer to be the deadliest form of cancer and the one they feared 
most. The enduring belief that lung cancer is fatal is perhaps a reflection of the consistently 
high mortality rate of lung cancer, a lack of knowledge about lung cancer, and its 
treatments.   
 
There are evident differences in public perceptions and awareness of lung cancer and lung 
cancer screening between socioeconomic groups and, as a result, this could cause the 





7.2.2 Do the demographic and psychosocial characteristics of 
ECLS trial participants vary by socioeconomic status? 
There were demographic and psychosocial differences at both area (SIMD) and individual-
level SES among ECLS trial participants. Results were generally supportive of existing 
literature. 
 
There were few demographic differences across socioeconomic groups, but the differences 
that were reported highlight some areas of interest. For example, those from more affluent 
groups were more likely to be married than those from more deprived groups at both area 
and individual-level SES. Marital status has been previously associated with breast, 
cervical and bowel cancer screening uptake, with those who are married or in civil 
partnerships more likely to attend (Hanske et al., 2016; Saghari et al., 2015). The 
relationship between SES and marital status, reported in the results of Chapter 4, could 
indicate an area for further research. The social support provided by close relationships, 
such as marriage or civil partnership, has previously found to be beneficial to screening 
behaviour (Hanske et al., 2016). The mechanisms that underlie this relationship between 
social support and screening uptake could provide insight that would be helpful in the 
development of interventions that encourage screening uptake in those less likely to 
participate (e.g. those from deprived groups and those without social support). For 
example, exploring how social norms and relationship interdependencies influence lung 
cancer screening uptake could perhaps be an important direction for future research. 
 
In multivariate analysis (Chapter 4), when controlling for demographics, participants in the 
ECLS trial were more likely to say they are a current smoker if they were from a more 
affluent group at both area and individual-level SES. This was very surprising, as existing 
literature would suggest that smoking rates are higher in those from more deprived groups 
(Hiscock et al., 2012). There could be a number of explanations for this anomaly. First, we 
should consider whether being invited to participate in the trial acted as a ‘teachable 
moment’ for more deprived smokers (Taylor et al., 2007). Participating in lung cancer 
screening has been found to promote smoking cessation (Pistelli et al., 2020). However, 
this is usually as a result of planned intervention and not merely being invited to 
participate. It is unclear whether being invited to participate is enough to encourage people 





 The question asked to participants in the ECLS trial baseline questionnaire (‘Have you 
smoked any cigarettes or tobacco products in the last seven days?’) might not have 
captured any recent changes in smoking status. The question also does not identify the 
number of cigarettes smoked or the number of years of active smoking, both of which are 
key risk factors in lung cancer. Those from more deprived groups have been found to 
smoke more cigarettes and to have started from a much younger age compared to those 
from more affluent groups (Doll et al., 2005; Lubin & Caporaso, 2006; Kenfield et al., 
2010). The self-report approach to the ECLS trial baseline questionnaire might have also 
contributed to under reporting of smoking, perhaps because of smoking-related stigma. 
Another possible explanation for higher smoking rates in more affluent groups could be a 
result of these groups using the opportunity to screen for lung cancer as a reassurance that, 
despite their smoking status, they are ‘safe’ from lung cancer. Results from Chapter 5 
indicate that more affluent participants were more likely to self-select to participate in the 
trial, as well as being healthier. Using screening as a tool to provide reassurance ties in 
with the idea that some of the more affluent participants of the trial could be considered to 
be the ‘worried well’.  
 
There was some variation in illness perception across SES in both area- and individual- 
level SES. Perceived control of individual risk was found to be lower in those from more 
deprived groups at both area- and individual-level SES. Having low perceived control of 
risk factors might indicate a level of fatalism towards lung cancer. Contrary to the results 
of the systematic review presented in Chapter 3, ECLS trial participants from more 
deprived groups may have held more distinct fatalistic beliefs. More deprived participants 
may have tried to minimise the control they have over their own risk as a coping 
mechanism (Lo et al., 2013), or as a response to anticipated smoking-related stigma 
(Johnson et al., 2014). A lack of perceived control over the development of lung cancer 
was an area discussed by non-attenders of the ECLS trial (Chapter 6) who were also from 
high risk, deprived groups. Interview participants underestimated the risk smoking posed 
to them, and also believed they had no control over the development of lung cancer. 
Among these participants, a number considered that lung cancer was predetermined. It 
appears that this view of lack of perceived control is not unique to non-attenders, but it 
might be the case that attenders of the ECLS trial are less avoidant than non-attenders. 
 
The emotional response to lung cancer was also found to be higher in those from deprived 




systematic review reported in Chapter 3, where there was not found to be any clear 
variation in fear across SES groups. Therefore, the ECLS results need to be interpreted 
with caution. ECLS trial participants from more deprived groups (SIMD 1 / SES 0) were 
more likely to feel emotional about their risk to lung cancer. The emotional response to 
lung cancer risk could perhaps be as a consequence of lower levels of lung cancer 
knowledge and higher fatalistic beliefs among those from more deprived groups. Those 
from more affluent groups were more likely to recognise that lung cancer would have a big 
impact on their life across both area- and individual-level SES. This could be a reflection 
of having an increased level of knowledge of lung cancer among more affluent groups. 
Those from more deprived groups have been found to have less knowledge of lung cancer 
and lung cancer screening compared to those from less deprived groups (Rutten et al., 
2009). Understanding the consequences of lung cancer, such as treatment types and high 
mortality rates, are inevitably associated with a person’s knowledge of cancer, and their 
overall health literacy level. The results of both Chapter 3 and 4 indicate that illness 
coherence (knowledge) of lung cancer is socially graded. Addressing lung cancer 
knowledge variation to increase screening participation could be a simple and potentially 
effective intervention for future development. 
 
Notably, univariate analysis reported in Chapter 4 indicated that there was no difference in 
belief that early detection of lung cancer can improve chances of survival in both area- and 
individual-level SES. There was a high level of agreement, which is in line with existing 
literature about attitudes towards cancer screening (Waller et al., 2015). This positive 
attitude towards lung cancer screening is also reflected among non-attenders (Chapter 6). 
This indicates that there is an overall positive attitude toward lung cancer screening across 
all groups, but that positive attitude is not enough to encourage participation in all cases. 
 
Trial participants from Glasgow were more likely to be from the most deprived groups 
(SIMD 1 / SES 0) compared to those recruited from Tayside and Lanarkshire. This is 
unsurprising and is a result of the trial recruitment strategy. However, it does indicate that, 
despite the shortcomings of area-based SES measures, the recruitment strategy 
predominately used in Glasgow was effective in reaching more deprived groups. As 
discussed in Chapter 5, those from Glasgow were more likely to be invited to participate 
via their GP and very few were recruited via the community. Conversely, a larger 
proportion of those from Tayside were more likely to have been recruited by community-




appear to reach high-risk deprived groups more successfully than community-based 
approaches regardless of how SES is measured. 
 
Chapter 3 highlighted the need for better, more consistent measures of SES that would 
allow for a more reliable comparison of results. The use of two measures of SES opened 
up further discussion about the most appropriate way to measure SES. This is also 
reflected upon in Chapter 4 and 5. Results indicated that the use of area-based measures of 
SES, such as SIMD, might not be the most effective measure of SES. When used as a 
recruitment tool to reach people who are at the highest risk of lung cancer, the use of 
SIMD in the ECLS trial appears to recruit predominately (60%) from the most deprived 
groups (SIMD 1 and SIMD 2). However, when individual measures of SES are applied, 
those who participated in the ECLS trial were not as deprived as initially believed, with 
more participants falling into the least deprived group (65% falling into SES 2 and SES 3). 
This indicates that they have greater access to wealth and services than their postcode 
suggests that they should. Area-based SES measures assume similar levels of deprivation 
across a geographical area but individuals within the area may be relatively affluent in 
terms of individual wealth and access to services. This can be seen in the ECLS trial 
sample. This discrepancy makes us consider how we should measure level of deprivation, 
particularly if it is used as a criterion in cancer screening. The use of area-based SES 
measures are more convenient, but do not correspond with the developing argument for 
individual-risk criteria for lung cancer screening. To ensure risk levels are accurate, it 
might be more prudent to use individual and individual composite measures of SES. 
 
The results of Chapters 3 and 4 indicate that variation in beliefs about lung cancer and lung 
cancer screening does exist across different SES groups. This provides us with insight into 
how to effectively reduce the social gradient of screening uptake that might occur if lung 
cancer screening is implemented in the UK. 
 
7.2.3 Do socioeconomic status, beliefs and attitudes towards 
lung cancer and lung cancer screening differ by invitation 
type? 
Those who respond to different types of invitation to lung cancer screening vary by SES, 





The results reported in Chapter 5 indicate that those who self-referred to the ECLS trial via 
the community-based recruitment were more likely to be from more affluent groups. This 
was the case for both area-level SES (SIMD) and individual-level SES, indicating a strong 
relationship between SES and recruitment methods. This somewhat contradicts the 
findings of pre-trial focus groups, which concluded that those who are high risk and from 
deprived groups might better engage with screening if recruited via alternative community 
methods such as local TV advertisement and posters placed in high footfall areas (such as 
GP practices and community centres) (das Nair et al., 2014). It was important that the 
ECLS trial acted upon the feedback from the pre-trial focus groups and proactively work 
with potential participants to optimise engagement with the trial. This was a positive 
approach to co-design, although, it was recognised at the time that community-based 
recruitment had not been systematically evaluated (das Nair et al., 2014). It does appear 
that GP-endorsed letters, such as those used in current UK national screening programmes, 
are the most effective means to invite deprived groups to participate in lung cancer 
screening (Brawarsky et al., 2004; Duffy et al., 2017). Existing literature indicates that 
interventions using GP-endorsed letters to increase screening uptake are based on the idea 
that people trust their healthcare provider to give recommendations and a letter from them 
provides a level of personalisation that encourages participation as well as informed choice 
(Duffy et al., 2017). Although the ECLS trial successfully recruited those living in 
deprived areas via their GP, more can be done to optimise this type of invitation. For 
example, GP endorsement letters should ideally be electronically signed by the GP, and on 
practice-headed paper, as letters sent on behalf of the practice are generally less effective 
(Hewitson et al., 2011). GP-endorsed invitations are a simple and effective way to 
encourage screening uptake which should be encouraged if a future lung cancer screening 
programmed is to be implemented in the UK. The use of community-based methods to 
invite people to participate in cancer screening may further exacerbate cancer screening 
inequality. 
 
There were some demographic differences between those who engaged in community-
based recruitment and those who were invited to participate via their GP. The sex of 
participants was found to be associated with recruitment type. Results indicated that men 
were more likely to be recruited via the community, when controlling for other variables. 
This is somewhat surprising as it would suggest that men were more proactive in their 
approach to screening which contradicts the general view that men are less likely to engage 




cancer screening such as bowel cancer screening, where men are more likely to screen than 
women (Wardle et al., 2005). Chapter 4 highlighted that there were no significant 
differences in sex across different SES groups when controlled for in the multivariable 
analysis and, as a result, we can infer that SES does not explain why the sex difference in 
recruitment type engagement exists. The variation is feasibly related to marital status, with 
those who are married or in a civil partnership being more likely to engage with 
community-based recruitment. It is possible that being in close relationships, such as 
marriage or civil partnerships, allow for spouses or partners to monitor each other’s health 
behaviours. Within heterosexual relationships, women have often been deemed ‘family 
health gatekeepers’ and are more likely to attempt to change their spouse’s behaviour, 
more so than men (van Jaarsveld et al., 2006). It is perhaps this relationship dynamic that 
led to more men engaging with community-based recruitment and being encouraged to 
attend by their spouse. 
 
Some components of illness perception varied by recruitment type. Unexpectedly, those 
recruited via the community were more likely to consider that they had no control over the 
development of lung cancer. This is surprising because this group were more proactive in 
their approach to lung cancer screening and, based on existing literature, would consider 
them to have greater perceived control over their risk. Having lower perceived personal 
control has previously been found to be incompatible with undertaking protective health 
behaviours (Martinez & Lewis, 2016). Those recruited via the community were also more 
likely to have smoked in the previous seven days. It is possible that they might not have 
perceived themselves to have the self-efficacy to stop smoking, or that they were more 
passive about their risk in general, believing their risk or the development of cancer was 
down to factors out with their control. Similar to the results discussed in Chapter 4, 
smokers recruited via the community might also appear more proactive because they 
considered screening as an opportunity to get reassurance that they do not have lung cancer 
and persist with the belief that they do not need to stop smoking (Tonge et al., 2018; van 
der Aalst et al., 2011; Young et al., 2018).  
 
People recruited via the community were also less likely to know what their risk of 
developing lung cancer is. This might be because, unlike the GP recruited participants, 
community recruited participants were never actively told that they are high risk of lung 
cancer. By being invited to participate by their GP, GP-recruited participants were actively 




at high risk of lung cancer receive invitations to attend. This is an explicit signal to them 
that they fall into an at-risk group. It could be posited that those recruited via the 
community might not be making a fully informed choice about taking part in the lung 
cancer screening trial when they make their initial decision to make contact. Future 
research could perhaps explore the drop-out rate between the initial contact after seeing 
community-based advertisement and undertaking the screening test. Chapter 6 highlighted 
that decision-making occurs in two stages; first, a quick intuitive decision based on 
existing knowledge, followed by a more reflective, informed decision.  
 
It is evident that the way in which we invite people to participate in cancer screening is of 
great importance when targeting high-risk groups. Optimising cancer screening invitations, 
by further exploring the level of personalisation required in GP-endorsed invitations will 
provide cost-effective and efficient means to improve uptake in at-risk groups, as well as 
improving informed decision-making. The use of community-based recruitment may 
exacerbate cancer screening inequality, with those from more deprived groups less likely 
to engage with this form of recruitment. As a result, this community-based recruitment 
should be avoided when attempting to target this population. 
 
7.2.4 What are the perceived barriers and beliefs about lung 
cancer and lung cancer screening held by screening non-
attenders? 
Non-attenders of the ECLS trial cited a number of different barriers that led them to cancel 
or not attend their initial appointment. Initially, all participants perceived there to be 
practical barriers to attending their appointments. Reasons such as ill-health, competing 
priorities or being unable to secure a suitable appointment resulted in non-attendance. 
These are commonly reported barriers to cancer screening, including lung cancer screening 
(Ali et al., 2015). The pre-trial qualitative work identified some practical barriers that 
might occur (e.g. travel and inconvenient appointment times) and as a result attempted to 
mitigate these barriers during the trial duration (das Nair et al., 2014). Mitigating actions 
included providing transport to the screening appointment and allowing participants to 
rearrange their appointment up to three times. However, pre-trial work did not account for 
other practical barriers such as ill-health, or the financial implications of having to take 
time off work to attend. Further, the mitigating actions put in place were not always 
sufficient enough to overcome barriers, which is made evident by the lack of attempts to 





Unlike the barriers to attending their initial appointment, participants were more likely to 
provide psychological barriers for not making or attending another appointment. 
Participants at this stage gave reasons such as low perceived risk of lung cancer, fear, 
worry and fatalism. There was also a high level of overt avoidance of lung cancer 
screening, with some not wishing to know if they had lung cancer. These are also 
commonly cited barriers to lung cancer screening in existing literature (Patel et al., 2012; 
Jonnalagadda et al., 2012). The recurring pattern of citing practical barriers, followed by 
psychological barriers, is of particular interest. It suggests that the underlying 
psychological beliefs about lung cancer might impact the way in which they approach the 
practical barriers they face when attending a scheduled appointment. When the practical 
barrier is removed (i.e. offered another appointment) the underlying beliefs still persist and 
are more difficult to overcome. This results in participants not remaking an appointment. 
 
The recurring pattern also provides us with key insights into the decision-making 
processes. It appears that non-attenders make an automatic decision to participate in lung 
cancer screening when they receive their invitation letter. This is an almost reflexive 
decision, based upon their previous screening behaviour. However, owing to the time 
between initial invitation and the eventual screening appointment, participants became 
more reflective in their decision-making, resulting in them not attending or remaking their 
appointment. This final decision not to attend or remake their appointment is based on their 
existing knowledge of lung cancer and lung cancer screening, as well as their emotional 
representations of lung cancer. This decision-making process corresponds to Dual Process 
Models of decision-making (Kahneman, 2003). It is hypothesised that participants engaged 
System 1 when first invited to take part in the trial; a decision to attend made quickly and 
based on their existing knowledge. Within the period of time between invitation and 
attending their appointment, they engaged the more reflective System 2. Making a 
deliberative decision not to attend their appointment, or make another for a later date, 
might be the result of having time to ruminate on their emotional representations of lung 
cancer. When faced with practical barriers, there is less inclination to put in place effective 
coping responses to overcome them and a deliberate decision was made not to make 
another appointment.  
 
Understanding how non-attenders make decisions to not attend a lung cancer screening 




programme implemented in the UK, but to existing cancer screening programmes. The 
insight gained will help to optimise interventions to increase uptake in cancer screening by 
targeting either System 1 or System 2 decision-making processes. In the case of screening 
non-attenders, it would be more helpful to capitalise on System 1, when people make fast 
decisions and are more positive towards screening. A key recommendation for this group 
would be to reduce the time between initial invitation and attending a screening 
appointment. This ensures that participants can still make an informed decision, but do not 
have time to engage with emotional representations of cancer. 
 
Alongside the emotional representations non-attenders hold about lung cancer, their beliefs 
also contribute to their non-attendance of lung cancer screening. Non-attenders tended to 
underestimate their own risk of getting lung cancer. Further, some also considered that 
they had little or no control over their risk of lung cancer. This is similar to the findings of 
the ECLS trial attenders discussed in Chapters 4 and 5, where those from more affluent 
groups and those recruited via the community where found to have lower perceived control 
over their own risk. It is unclear of the mechanisms behind the low perceived control of 
risk in attenders of the ECLS trial, however non-attenders considered lung cancer to be 
predetermined and outwith their control. In this group, it led them to believe that attending 
lung cancer screening was unnecessary. This is in line with existing literature on the 
barriers of lung cancer screening in the UK (Patel et al., 2012), as well as breast, cervical 
and bowel cancer screening (Lo et al., 2013). This belief appeared to be stronger in 
smokers in ECLS trial non-attenders, but also persisted in some past smokers. Smokers 
were more likely to minimise the risk of smoking and all non-attenders appear to 
underestimate their own personal risk. This was particularly evident when smokers 
compared their risk to that of non-smokers and considered there to be no difference in risk. 
This indicates that there might be a level of unrealistic optimism among non-attenders who 
smoke. Although, this risk perception bias might be a coping mechanism (denial and 
avoidance) adopted in order to deal with the emotional response they might feel if they 
confirmed their own risk. 
 
The perceived severity of lung cancer led non-attenders to hold fatalistic beliefs. They 
considered that lung cancer was severe, more so than other cancers. As a result, non-
attenders believed the survivability of lung cancer to be low. Both the uncontrollability of 
cancer risk and the severity of lung cancer induced emotional responses that acted as a 




among this group was common, alongside adopting a generally stoic attitude towards life 
and health. Fatalistic beliefs about lung cancer appear to be a common theme and persists 
across SES and ECLS trial attenders and non-attenders (Chapters 3, 4, 5 and 6). The 
difference between ECLS trial attenders and non-attenders could lie in how each group 
applies appropriate coping mechanisms. Non-attenders were more likely to employ 
maladaptive coping mechanisms, such as avoidance. Perhaps attenders were more 
successful at adopting coping mechanisms despite their feeling of risk or lack of control. 
 
Non-attenders beliefs were successfully mapped onto the CSM and HAPA model in an 
attempt to explain the processes behind non-participation in lung cancer screening, with 
the exception of the impact of comorbidity. There was found to be significant overlap 
between the constructs of the CSM, HAPA model and the themes developed in thematic 
analysis. Neither the CSM nor the HAPA model could fully explain non-attendance of lung 
cancer screening but each model included important components. The use of two models 
has highlighted areas of overlap and helped to identify gaps that should be the focus of 
future research. 
 
There was significant overlap between CSM and HAPA with regard to the role coping 
strategies play in a group of people who already have positive intentions. Non-attenders 
were unable to employ action-focused coping strategies that would help them overcome 
the initial practical and emotional barriers they faced when the time came to attend their 
appointment. They were also unable to appraise the maladaptive coping strategies adopted 
and realign in order to make another appointment. Coping planning and coping appraisal 
seem to be significant problem areas for non-attenders, with the time between invitation 
and appointment vital to whether or not they attend their appointment - this supports the 
knowledge that non-attenders use a two-system approach to decision-making (Kahneman, 
2003). 
 
Of interest, current health state significantly contributed to participants non-attendance. 
Often, those with comorbidities considered their current health conditions not only as a 
barrier to physically attending their appointment, but also as a cognitive barrier to 
screening. Participants with poor health were often more focused on their current health 
conditions, and did not have the capacity to worry about, or deal with having lung cancer. 




non-attendance. This is a clear gap in our theoretical knowledge, which could perhaps have 
practical implications to the implementation of cancer screening programmes in the UK. 
 
The use of theoretical frameworks in analysis has highlighted that in order for individuals’ 
experience of cancer screening to make sense we should not stick rigidly to one model to 
explain behaviour. It has been useful to explore more than one model in the context of non-
attendance of lung cancer screening and it has helped to identify themes in analysis that 
would otherwise not have been considered.  
 
Overall, exploring non-attenders’ barriers and beliefs have aided in developing our 
understanding of the decision-making processes inclined abstainers implement when 
invited to participate in screening. The two-system approach to decision-making adopted 
by this group will help us to identify appropriate interventions to increase screening uptake 
in not only lung cancer screening, but other forms of cancer screening.  
 
7.3 Strengths and limitations  
The research conducted for this thesis contained both a number of strengths and 
limitations, which will be outlined briefly in this section. 
 
7.3.1 Exploration of an unmet research need 
Lung cancer has been described as a cancer of substantial unmet need and is under 
researched compared to other forms of cancer. The novelty of the topic and the application 
of psychological methods and theories to the topic are a strength of the thesis. The research 
described in this thesis provides insight that has practical implications on existing cancer 
screening programmes, and future lung cancer screening programmes. 
 
7.3.2 Mixed methods approach  
An important strength of this thesis is the mixed methods approach taken to explore the 
factors associated with the participation in lung cancer screening. The thesis includes an 
integrative systematic review exploring both qualitative and quantitative literature (Chapter 
3), two quantitative analyses using a large trial dataset (Chapters 4 and 5) and qualitative 
interviews (Chapter 6). Each study has contributed to providing a holistic picture of lung 





Mixed methodologies are valuable to health research in a number of ways, including 
helping to address complex and multifaceted research questions, such as those explored in 
this thesis. The use of qualitative and quantitative methodologies has provided both deep 
and broad insights in answering the thesis research questions more so than if either 
methodology had been used in isolation. The use of both methodologies is considered to 
highlight the strengths of each, while counterbalancing the limitations of the individual 
approaches. For example, qualitative approaches help us to understand, in more detail, the 
mechanisms behind decision-making, while quantitative approaches are effective in 
producing generalisable findings. 
 
The approach to analysis in this thesis can be considered to be novel, particularly so with 
the integrative systematic review (Chapter 3) and qualitative analysis (Chapter 6). The 
systematic review presented in this thesis explored both quantitative and qualitative 
literature separately, at first, and then integrated them in an innovative way using thematic 
analysis and integrative matrices, in order to draw conclusions in a cohesive manner. 
Similarly, qualitative analysis used in Chapter 6 provided a unique approach by comparing 
themes - generated using framework analysis - to the constructs of two theoretical models 
of behaviour. This ‘bottom up’ methodology meant that the data was explored in a way 
that was comprehensive, providing helpful insight into the overlapping constructs and gaps 
that are not accounted for by the theoretical models.  
 
All of the studies in the thesis have been integrated in such a way that the findings have 
allowed for comprehensive discussion, conclusions to be drawn, and recommendations to 
be made. The use of novel approaches to analysis have provided interesting perspectives of 
the factors associated with lung cancer screening participation and have positively 
contributed to methodological discussion. 
 
7.3.3 Generalisability of screening trial  
The ECLS trial is central to this thesis. Data from the ECLS trial was used within Chapters 
4 and 5, and ECLS trial non-attenders were interviewed to explore barriers to lung cancer 
screening in Chapter 6. The UK does not routinely provide lung cancer screening via a 
national screening programme. Consequently, there is no opportunity to explore the uptake 
of true screening programmes. Lung cancer screening trials offer a unique opportunity to 





However, it is noted that participating in a screening trial is not the same as participating in 
a screening programme, which must be taken into account when considering 
generalisability of findings. For example, this might explain some of the variation in 
findings of the systematic review (Chapter 3), and the findings of the analysis in Chapter 4, 
both of which explored the differences in beliefs across different SES groups. Individuals 
participating in the lung cancer screening trial should be aware that the primary aim of the 
trial was to evaluate the effectiveness of a blood test to detect biomarkers that indicate the 
presence of lung cancer, which obviously varies from the true aim of real-world screening 
services, where the primary aim is to detect cancers. 
 
Despite this, there was significant overlap between the findings of the thesis with existing 
screening literature. Further, there was a high level of support for lung cancer screening 
among ECLS attenders, and the perceived effectiveness of the blood screening test. In the 
qualitative work presented in Chapter 6, only one participant discussed issues of the ECLS 
trial being an RCT and not a ‘real screening programme’, leading them to reconsider their 
participation.  
 
The trial has also successfully recruited high-risk people from deprived groups. This might 
be the result of more robust recruitment strategies but must not be overlooked. The 
recruitment strategies discussed in Chapter 5 have real-world applications and should not 
be reserved for the purposes of reaching optimal numbers required for screening trials. 
 
7.3.4 Secondary data set 
The thesis used a secondary data set to explore the beliefs of ECLS trial participants. There 
are some challenges when it comes to the use of secondary data. As the baseline 
questionnaire was not developed in order to answer the research questions of this thesis, it 
might be the case that more appropriate variables could have been used to explore the 
beliefs about lung cancer and lung cancer screening. The baseline questionnaire also used a 
number of single item measures and psychosocial variables. This was done in order to 
minimise the length of the questionnaire and therefore the burden on trial participants. The 
use of single item measures might not be as effective in exploring complex beliefs and 
attitudes associated with lung cancer, such as worry or fear. Single-item measures can also 
be less reliable than multiple item scales because measurement error can be reduced when 





Having no control over the development of the baseline questionnaire required a flexible 
approach to analysis and meant maximising the available data to gain as much insight as 
possible and adequately answer the research questions. This required extensive exploration 
of the ECLS data; how the data was collected by the ECLS team, and any potential gaps in 
the data. This was labour intensive but resulted in having a considerable understanding of 
the ECLS trial and the baseline questionnaire data.  
 
7.3.5 Recruitment challenges  
The qualitative work presented in the thesis (Chapter 6) involved recruiting non-attenders 
of the ECLS trial. This was a challenging process, with uptake in the study generally quite 
low. The initial pool available to draw from was determined by ECLS trial records. All of 
those identified as non-attenders were contacted and invited to participate in the 
interviews, however, only 15 indicated they would be interested in participating and a total 
of eight took part in the study. This was not entirely unexpected given that those targeted 
for the study had previously indicated their willingness to participate in the ECLS trial but 
ultimately did not. Time restraints of the study also meant that we could not recontact those 
who did not respond to the initial study invitation. As a consequence, the sample size was 
relatively small. 
 
There is much debate about appropriate sample size for qualitative research (Braun & 
Clark, 2019), for example if one should continue to sample until data saturation (Gentles et 
al., 2015) or use fewer participants with richer data collected (Morse, 2000). The small 
sample size allowed me to get to know each participant in greater detail than might have 
been the case if more participants had been recruited. This greatly assisted with the data 
that resulted from the interviews, which was rich, detailed and contributed to our 
understanding of cancer screening decision-making processes. 
 
7.4 Implications for future research, policy and practice  
The findings of this thesis have implications on future research, policy and practice. These 
implications are presented in the following section. 
 
7.4.1  Future research  
The findings of this thesis point toward several different avenues for further research. First, 




screening attenders, decliners and non-attenders. To my knowledge, a comparison of the 
lung cancer beliefs held by these distinct groups has not been investigated. Predominantly, 
research has focused on the views of lung cancer screening attenders. Both decliners and 
non-attenders are important groups to engage with and are key to optimising the uptake of 
lung cancer screening. In order to compare the views of these groups, we must use 
validated and comprehensive measures of the potential psychosocial and attitudinal 
barriers to lung cancer screening. The findings of this thesis indicate that the views of 
attenders and non-attenders are similar, but as indicated in Chapter 6, non-attenders do not 
adopt effective coping mechanisms. Previous research has concluded that these groups 
cannot be distinguished in terms of motivation to attend cancer screening (Orbell & 
Sheeran, 1998). However, in order to successfully compare the groups beyond motivation 
and intention, it would be prudent to compare them both quantitatively and qualitatively. 
On this basis, it might be possible to understand the nuances between attenders and non-
attenders in order to improve engagement with lung cancer screening in those with positive 
intentions.  
 
A second future direction for research could be to assess the differences observed between 
recruitment types in the ECLS trial by conducting an RCT. The results reported in the 
thesis (Chapter 5) indicate that GP-based invitations are more effective in the recruitment 
of high-risk deprived groups, compared to community-based recruitment. However, it has 
been noted that there was potential for ‘study contamination’ across the different 
recruitment groups, with those receiving GP invitations potentially exposed to community-
based advertisement. Those from the GP recruitment group could have been further 
influenced by seeing study advertisements in the community, on top of receiving their GP 
letter. In order to assess the true effectiveness of different recruitment methods on different 
SES groups, I propose an alternative study design. By using one recruitment method in 
different geographic areas we can explore the differences in uptake and the demographics 
of those engaging with each method. For example, if we take the geographical locations 
used in the ECLS trial - Glasgow, Tayside and Lanarkshire - it would be of particular 
interest to assign each a single recruitment method (GP-endorsed letter, community 
advertisement or standard screening invitation) and observe the differences in uptake. 
There is existing literature of the effectiveness of GP-based invitations on the uptake of 
bowel cancer screening in underserved groups (Duffy et al., 2017). However, because of 
the infancy of lung cancer screening programmes, little work has been done in this area, 




The work reported in Chapter 6 of this thesis indicates that non-attenders of lung cancer 
screening make their decision not to participate by implementing a two-system approach. 
First, making a fast and intuitive decision leading them to agree to participation (System 
1), followed by engaging a more reflective decision-making process (System 2), and with 
time not participating in screening despite their positive intentions. There are a number of 
potential interventions that can be developed in order to address non-attendance at 
screening trials, but given the insight gained from this thesis it would be appropriate to 
explore interventions that aim to optimise System 1 decision-making. This might include 
reducing the time between initial invitation and screening appointment, or by employing 
GP endorsement of screening that might result in people sticking with their default 
decision and removing the need for them to evaluate the risks and benefits themselves 
(Brawarsky et al., 2004). However, these interventions alone do not actively encourage 
informed decision-making. Another way to support uptake in non-attenders might be to 
provide them with further support to help them overcome the barriers they perceive. This 
could involve providing a patient navigation service that can give one-to-one tailored 
support by providing clear information and practical guidance, in an emotionally 
supportive context (McGregor et al., 2016). Patient navigators have been found to 
effectively increase uptake in other forms of screening, and it is hypothesised that it would 
be beneficial for non-attenders of lung cancer screening. Developing and testing of an 
intervention package that involved a combination of GP endorsement, patient navigation 
services, and reduced time between invitation and appointment might provide greater 
insight into which is most effective for increasing uptake of non-attenders. 
 
7.4.2 Implications on policy and practice  
The findings of this thesis point to several recommendations about increasing the uptake of 
lung cancer screening. First, it should be noted that there was a high level of positive 
attitude towards lung cancer screening across the ECLS trial studies conducted (Chapters 
4, 5 and 6). This highlights that there is an appetite for this type of screening among those 
who are at high risk of lung cancer, which has positive implications for any lung cancer 
screening programme implemented in the UK. Positive attitude towards lung cancer 
screening, as well as the perceived effectiveness of the screening test (in the case of the 
ECLS trial, a blood test), has been shown to be positively associated with greater cancer 
screening participation (Berkowitz et al., 2008). Even among non-attenders, there was a 
strong indication that lung cancer screening in the UK was necessary, and there was 




The thesis sets out that lung cancer rates are higher among those from more deprived 
groups and it is with this knowledge that lung cancer screening trials often aim to explore 
SES as a predictor of uptake, or as with the ECLS trial, use SES as a criterion for 
participation. However, as discussed in Chapters 3 and 4, there is no standardised measure 
of SES and this presents us with a number of challenges. First, if we are to use SES as a 
criterion for participation in lung cancer screening or screening trial, or as a contributing 
factor to individualised risk assessment, we must ensure we are truly identifying a person’s 
SES. Second, the use of a variety of measures of SES in screening research presents a 
challenge when trying to make comparisons across research. Both area-based, and 
individual measures of SES have their merits and shortfalls, with both measuring different 
aspects of SES. This thesis indicates that in the case of lung cancer screening, although the 
ECLS trial were successful in the recruitment of deprived groups using the area-based 
SIMD measure, the participants were not as deprived as first thought, with participants 
having greater access to wealth and resources than expected. As a result, it would be 
recommended that individual measures of SES are used to create a standardised composite 
measure in order to calculate individual SES. This individual risk score could contribute to 
the calculation of a person’s overall risk of developing lung cancer and, therefore, 
eligibility for lung cancer screening. Further work should be done to understand what 
components of a composite measure would create an effective measure of SES. 
 
The results of the thesis have also provided insight into how different types of screening 
influence screening uptake in different SES groups. Those from more deprived groups 
engage better with invitation via their GP, compared to community-based recruitment. 
Conversely, community-based recruitment was much more effective in engaging those 
from more affluent groups. This has clear implications on the invitation strategies we 
might want to employ in a future lung cancer screening programme, but there are also 
practical implications for other forms of cancer screening currently in existence. The 
results of the thesis indicate that the use of GP-endorsed invitation letters should be 
routinely employed by UK screening programmes in order to optimise screening uptake in 
under-screened deprived groups. The results also indicate that community-based 
invitations should be used sparingly, and not in isolation. Community-based invitations 
have the potential to widen screening inequalities among different SES groups as it would 
appear that those from low SES groups are less likely to engage with them. This group are 
already less likely to participate in cancer screening and the invitation strategies we 




The exploration of perceived barriers to lung cancer screening among non-attenders has 
provided us with some foresight into the potential barriers that might hinder a future lung 
cancer screening programme from reaching optimal uptake. Of note, the practical barriers 
faced by the non-attenders of the ECLS trial are also commonly cited by non-participants 
of other forms of screening programmes. These practical barriers are potentially easier to 
overcome with the right organisational changes, compared to the emotional barriers non-
attenders might face. If the non-attenders of the ECLS trial did not come up against 
practical barriers, it can be posited that they might have attended their appointment. The 
ECLS trial attempted to address some of the anticipated barriers to participation (e.g. 
transport), which was somewhat successful. However, providing paid transport to attend 
cancer screening might not be as practical in a ‘real-life’ context. The practical barriers 
cited in this thesis were primarily competing priorities (e.g. work) and comorbidities. Both 
of these barriers could be addressed by implementing simple changes to the organisation of 
screening programmes. For example, as recommended by Mike Richards in the recent 
review of screening programmes in England (NHS England, 2019), it would be possible to 
ensure that screening programmes that require physical attendance operate outside of 
traditional working hours. This would lessen the burden screening appointments might 
have on some working age people who either find it difficult to be absent from work, or 
there are financial implications to attending screening appointments within working hours. 
There are fundamental issues with the flexibility of appointments in cancer screening that, 
if addressed adequately, could help to reduce inequalities in screening uptake. Competing 
priorities are a valid barrier to cancer screening, particularly among deprived groups and 
those with other health conditions. Embedding accessibility into cancer screening, 
including location and flexibility of appointment times, would go some way to increase 
participation in those with positive intentions to attend. 
 
7.5 Conclusions  
This thesis set out to grow our understanding of lung cancer screening participation. In 
doing so I have explored the demographic and psychosocial factors associated with lung 
cancer screening.  
 
Lung cancer screening participation is lowest among those from more deprived groups, 
with these groups also more likely to be at high risk of lung cancer. This thesis identified 
variation in beliefs and awareness of lung cancer and lung cancer screening across SES 




those from more affluent groups, those from deprived groups are more likely to have a 
lower level of knowledge of lung cancer, lower perceived control of lung cancer risk and 
more pronounced emotional response to the thought of their own risk of lung cancer. It is 
considered that this might be evidence of greater fatalistic beliefs about lung cancer and, in 
the case of non-attenders, might result in the adoption of maladaptive coping strategies, 
such as avoidance. 
 
The thesis also looked to examine how different cancer screening invitation types might 
influence uptake of lung cancer screening. In doing so, it was found that there was 
variation in engagement across SES groups, with those from more deprived groups more 
likely to engage with GP-endorsed invitations, compared to community-based invitations. 
This insight not only has implications on lung cancer screening participation, but also 
existing cancer screening programmes. 
 
The thesis also provided opportunity to explore factors that contribute to non-participation 
in lung cancer screening. Non-attenders of lung cancer screening are likely to cite both 
practical and emotional barriers to lung cancer screening. It is believed that they employ a 
two-system approach to decision-making. This has provided a greater understanding of 
non-attendance in those with positive intentions, and the possible interventions that could 
be developed to encourage participation.  
 
This thesis has made a novel contribution to the literature by advancing understanding of 
the factors that might explain variation in lung cancer screening participation and has 
provided practical recommendations that could reduce screening inequalities among high-
risk deprived groups. The development of interventions to address the identified screening 
inequalities, and improve overall engagement with lung cancer screening, should remain a 

















International prospective register of systematic reviews
Public perceptions and awareness of lung cancer in different socioeconomic groups
Hannah Scobie, Katie Robb, Sara Macdonald
 
Citation
Hannah Scobie, Katie Robb, Sara Macdonald. Public perceptions and awareness of lung cancer in




What are the public perceptions and awareness of lung cancer, and do they vary by socioeconomic status?
 
Searches
The search strategy will include publishes literature.
Databases: MEDLINE/PubMed; EMBASE; CINAHL; PsycINFO; Web of Science Core Collection; and IBSS
Period: 1990 - 2015 
English language only
 
Types of study to be included
No restrictions on study design type eligible for inclusion.
 
Condition or domain being studied




Studies from any geographical location
Adults
Patients with lung cancer
Lay public
Exclusion:
Children (aged under 16 years)
 
Intervention(s), exposure(s)






An integrated synthesis of qualitative and quantitate studies that aim to describe the beliefs and awareness
of lung cancer amongst different socioeconomic groups.
 
Additional outcome(s)
The results from the review will inform the development of future interventions for improving early detection
of lung cancer.
 
Data extraction (selection and coding)
Title, abstract, and full paper screening will be carried out by the review team, aided by Distiller software.
Data analysis will be carried out using a formal data extraction instrument. Discrepancies will be reviewed by
a member of the research team.
 
Risk of bias (quality) assessment
The researchers will assess included studies for quality using Popay’s (2006) seven point scale. Studies will
not be excluded on the grounds of quality.
 






International prospective register of systematic reviews
Strategy for data synthesis
Intervention studies will, if appropriate, be synthesised to provide a meta-analysis. However, if aggregation is
not possible, a narrative review will be presented. Both qualitative and quantitative observational studies will
be presented as a narrative analysis. For qualitative studies in particular, findings will be first subject to initial
coding, classification into broad themes and then finally an addition ‘line of argument’ will be presented.
 
Analysis of subgroups or subsets
None planned
 




Organisational affiliation of the review
University of Glasgow ; Medical Research Council
http://www.gla.ac.uk ; http://www.mrc.ac.uk
 
Review team members and their organisational affiliations
Mrs Hannah Scobie. University of Glasgow
Dr Katie Robb. University of Glasgow
Dr Sara Macdonald. University of Glasgow
 





















Subject index terms status
Subject indexing assigned by CRD
 
Subject index terms
Awareness; Humans; Lung Neoplasms; Perception
 
Date of registration in PROSPERO
26 August 2015
 
Date of first submission
 
Stage of review at time of this submission
The review has not started












International prospective register of systematic reviews
 Stage Started Completed
Preliminary searches Yes Yes
Piloting of the study selection process No No
Formal screening of search results against eligibility criteria No No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
The record owner confirms that the information they have supplied for this submission is accurate and
complete and they understand that deliberate provision of inaccurate information or omission of data may be
construed as scientific misconduct.
The record owner confirms that they will update the status of the review when it is completed and will add





This information has been provided by the named contact for this review. CRD has accepted this information in good
faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission
is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any
associated files or external websites.
Powered by TCPDF (www.tcpdf.org)




Appendix 2: Systematic review search strategy  
 
Databases: Medline / Pubmed ; Embase ; Cinahl ; PsychInfo ; Web of Science Core 
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Participant Information Sheet 
 
Title: Exploring public perceptions of lung cancer screening. 
Introduction 
We would like to invite you to take part in a research study. Before you decide we would 
like to tell you why the research is being done and what it would involve for you. Please 
take time to read the following information carefully. Talk to others about the study if you 
wish. Ask us if there is anything that is not clear or if you would like more information. 
Who is conducting the research?  
The research is being carried out by a research team from the Institute of Health and 
Wellbeing at the University of Glasgow working in partnership with the Early Cancer 
detection test – Lung cancer Scotland (ECLS) research team. The research is part of a 
PhD project. 
What is the purpose of this study? 
We want to know what people think about lung cancer screening and find out why people 
decide not to take part.  This will help us improve the information we give to people about 
tests for lung cancer in the future. 
Why have I been invited? 
We are contacting men and women who were invited to take part in the ECLS study in 
Glasgow and Lanarkshire. We would like to talk to people who decided NOT to take part in 
the study. 
What will this study involve? 
This study will involve meeting one of our researchers either at your home or at our office 
at the University of Glasgow, or speaking with them on the telephone, whichever suits you 
best. If you choose for the researcher to come to your home to conduct the interview, the 
safety of the participant and researcher will be ensured by following the procedure in the 
University of Glasgow’s Lone Working policy. If you choose to come to our office at the 
University of Glasgow your travel expenses will be reimbursed.  
The researcher will ask you some questions about why you decided not to take part in the 
early cancer detection test study. You will have an opportunity to add any extra comments 
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that the researcher does not have to make notes during the session and can concentrate 
fully on listening to what you say. This will take up to 1 hour. 
After your meeting with the researcher you will not be required to do anything further but 
we will send you the results of the study if you wish. If you would like a summary of the 
results, your name and address will be taken after the interview is completed.  
Do I have to take part? 
No, it is up to you to decide whether or not to take part. If you decide to take part you are 
still free to withdraw at any time and without giving a reason. This will not affect the 
standard of care you may receive now or in the future. 
What do I do if I want to take part? 
If you are interested in taking part in this study, or have any questions about the study, 
please call or text Hannah Scobie on XXX XXXXXXX or email 
h.scobie.1@research.gla.ac.uk. 
Alternatively, please return the reply slip in the FREEPOST envelope. Once you have 
returned your reply slip, a member of the research team will call you to discuss the study 
with you and, if you are willing to take part, to arrange a convenient date and time for your 
interview. 
Confidentiality 
All the information you give us is strictly confidential. All audio-recordings will be stored 
securely and your name will not be held with the recording. Notes will be taken from the 
recording and the recordings will then be destroyed.  Your name will not be held with the 
notes.  Only the research team will have access to the information.  
What happens to the information that is collected? 
It is intended that the results of the research will be used within a PhD thesis and 
published in an academic journal.  
Data from interviews will be digitally recorded and recordings will be uploaded to password 
protected university computers.  The recordings will be assigned a unique ID number 
rather than the participant name. Thereafter paper copies of transcripts will also be stored 
in locked filing cabinets at the University of Glasgow. Any direct quotations that may be 
used with publications or reports will use the unique identifier. As such individual 
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The information collected should help to improve the information we give people about 
cancer screening in the future and help them make decisions about taking part in the 
screening programmes. It is important to point out that no volunteers included in the 
research will be able to be identified from any report or publication.  
What will happen if I don’t want to carry on with the study? 
At any time during the study, if you do not wish to carry on you may withdraw, without 
giving any reason. With your permission we will retain any data collected up until that 
point. However, if you do not wish for the data to be used in any way it will be destroyed 
and not included in the study. 
What are the possible benefits of taking part? 
We cannot promise the study will help you directly, although in previous studies 
participants have commented that they have enjoyed the opportunity to think about their 
health and express their views. We are able to offer you a £20 shop voucher as a token of 
our appreciation for your participation. 
What are the possible disadvantages of taking part? 
The study will take about an hour of your time. There are no right or wrong answers to the 
questions and you can talk about anything that you feel is relevant. It is possible that 
during the interview you may find a topic sensitive or upsetting and you are free to ask the 
interviewer to move on to another subject or stop the session altogether. If you wish to 
stop the interview, the information you have given up to that point will be retained with your 
permission. However, if you do not wish for the information to be used it will be destroyed. 
It is important for you to understand that you are not required to discuss anything that you 
do not want to and you should discuss only the things which you feel are relevant. If you 
have concerns you can discuss them fully with the research team.  
Who has reviewed this study? 
The East of Scotland Research Ethics Committee, REC 1, which has the authority to 
scrutinize proposals for medical research on humans, has examined this study and has 
raised no objections from the point of view of medical ethics. 
If you have a complaint about any aspect of the study 
If you are unhappy about any aspect of the study and wish to make a complaint, please 
contact the researcher in the first instance but the normal NHS complaint mechanism is 
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Feedback & Complaints Officer 
NHS Greater Glasgow and Clyde, 
J B Russell House, 
Corporate Headquarters, 
Gartnavel Royal Hospital, 
1055 Great Western Road, 
Glasgow, G12 0XH 
Telephone: 0141 201 4550 
 
Further information and contact details 
If you wish to obtain further information about this research, please do not hesitate to call 
or text Hannah Scobie on XXX XXXXXXX. If you would like to speak to someone outwith 
the research team please contact (person to be appointed).  
Thank you very much for considering taking part in our research. Please discuss 
this information with your friends, family or doctor if you wish. 
Hannah Scobie 
 
MRC PhD Student 
General Practice and Primary Care 
Institute of Health and Wellbeing 
University of Glasgow 
1 Horselethill Rd 
Glasgow G12 9LX 
Tel: +44(0)141 330 8214 
Email: h.scobie.1@research.gla.ac.uk  
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Participant Consent Form 
Title of Study: Exploring public perceptions of lung cancer screening. 
Name of Researcher: Hannah Scobie 
Please initial each box to the right of each statement   
I confirm that I have read and understood the participant information sheet 
(V4, 15th November 2015) and have had the opportunity to ask questions. 
 
I understand that my participation is voluntary and that I am free 
to withdraw at any time without having to give a reason.  
 
I understand that if I choose to withdraw from the study all data collected up to 
that point will be retained with my permission. If permission is not given, the 
data will be destroyed. 
 
I agree to my interview being audio recorded.  
I understand that information or quotes from the studies may be used in 
publications / reports, but that this will be completely anonymous so that I 
cannot be identified. 
 
I understand that data collected during the study will be used by researchers 
involved in the study and the data will be retained for 10 years after the study 
is completed. 
 
I understand that I can have a summary of the results if I provide the 
researcher with my name and address.   
 
I understand that the interview may be conducted either in my home, over the 
telephone, or at the University of Glasgow. 
 
I agree to take part in the study. 
                                     
 
Participant’s Name:  
………………………………………………………………………………………………………… 
Signature: ………………………………………………………………… Date: 
 




Appendix 7: Non-attender interview schedule  
 
Study Title: Understanding why people who are initially interested in lung 
screening fail to participate. 
1) General views about cancer screening 
What do they think about it, what do they feel about it 
How do they think people make decisions about whether to do 
screening – ‘know’ as soon as invited/think it over/don’t know  
2) Beliefs about cancer in general and lung cancer 
Are they aware of spouse/family/friends taking part in screening? 
What comes to mind when you think about: 
i. Cancer? 
ii. Lung cancer? 
Following elicitation of participants’ beliefs about, ask how fearful 
participants are of cancer in general and lung cancer and whether they 
believe they (lung or other types) can be successfully treated (if these have 
not come up in response to the first questions). 
3) Understanding of the lung screening test 
What comes to mind when you think about lung cancer screening? 
Following the elicitation of image, ask them to explain how they would 
explain this image and why they had it.  
What is their understanding of what the test involves?  
What is their understanding of the purpose of the test – 
detection/prevention? 
4) Personal decision about lung cancer screening participation (show 
example invitation letters and leaflets to prompt memory) 
Do they remember receiving an invitation for the screening test? 
As best they can remember, when invitation letter arrived in the post how 
did they think, how did they feel? 
How did they decide what to do next?  (e.g. Knew right away what they’d 




What did they do next?  (e.g. Acted immediately, acted after a reminder, 
forgot, changed mind, didn’t get round to it...) 
Did other things happen in life at the time influence decision?   
What did they think when decided not to attend the lung screening 
appointment?  How did they feel about it?  Were other things happening in 
their life that influenced their decision?  
5) Feelings of risk lung cancer 
What do they feel about their chances of getting lung cancer?  Do they feel 
equally at risk/not at risk/higher risk for lung cancer compared to other types 
of cancer? Do they feel their chances of getting lung cancer is the same or 
different for other types of cancer? Why?  
Who do they think would be at high risk of getting lung cancer and why? 
Conclusion 
Thank participant for time 






























Appendix 8: ECLS sub-study protocol submitted for NHS 
ethics 
 
Exploring public perceptions of lung cancer screening  
Researcher: Hannah Scobie 
Supervisors: Dr Katie Robb, Dr Sara MacDonald, Professor Sally Wyke, Dr Stephen 
Harrow. University of Glasgow 
Funder: Medical Research Council 
1. Introduction 
1.1 Rationale 
Lung cancer kills more people than any other cancer, with approximately 5,000 
people dying from lung cancer every year in Scotland. This is often because there 
are few symptoms until the cancer is at an advanced stage when the chance of 
cure is low. Lung screening offers the potential to detect lung cancers at an earlier 
stage when they are easier to treat. A recent trial in the US found that lung cancer 
mortality decreased by 20% among those receiving low dose computed 
tomography screening (Aberle, Adams, Berg, Black, Clapp & Fagerstrom, 2011). 
However, the benefits of cancer screening are only realised if people are willing to 
participate. Cancer screening participation rates remain suboptimal (Audit 
Scotland, 2012), and may be particularly challenging in the case of lung screening. 
Smokers are disproportionately represented among people living in more deprived 
areas who also have lower uptake of other cancer screening programmes 
(Scottish Household Survey, 2013). This means that the potential lung screening 
target population could be particularly hard-to-reach.   
1.2 Proposed research 
The proposed research consists of two further sub-studies within the Early Cancer 
detection test – Lung cancer Scotland (ECLS) Trial.  The first sub-study will 
qualitatively investigate why individuals decided not to take part in the ECLS Trial, 
after showing initial interest. This study (Study 1) will involve interviewing ECLS 
Trial ‘non-attenders’ – those who initially expressed an interest in having the test, 




that up to a total of 20 men and women non-attenders in the ECLS trial will be 
interviewed. The sample will be drawn from the NHS Greater Glasgow and Clyde 
and NHS Lanarkshire Health Boards. 
The second proposed sub-study (Study 2) will be a quantitative analysis of ECLS 
Trial attenders examining potential demographic and psychosocial differences by 
recruitment type. Participants in the ECLS Trial were recruited by two strategies: i) 
those who were invited to take part via their General Practice (GP) or; ii) those 
who ‘self-selected’ after seeing community advertisement/media releases or 
responded as a result of word of mouth. This study will examine potential 
differences in the demographic characteristics, beliefs about lung cancer and lung 
cancer screening, subjective health and risk perceptions among these two groups.  
The proposed studies will complement the embedded psychological sub-studies 
currently being conducted by researchers at the University of Nottingham including 
emotional and behavioural responses following screening; exploring why people 
declined to participate; understanding of screening results; and smoking cessation 
in participants of the lung screening Trial.  The proposed work therefore adds two 
new aspects to the ECLS Trial research by considering; i) why people change their 
mind about participating in the Trial; and ii) exploring any potential differences 
between participants recruited through GPs and ‘self-selectors’.   
2. STUDY 1 
2.1 Background & Literature Review 
While it is noted that participating in a screening Trial is not the same as 
participating in a screening programme, it is useful to draw from the literature on 
cancer screening programme participation in helping to understand screening 
behavior.  When participants make an appointment for cancer screening, it 
suggests they are motivated and intend to go to the screening appointment. 
However, this intention to attend does not always translate into action (i.e. 
attending the appointment) and ‘did not attend’ (DNA) and cancellations are 
frequent outcomes at screening clinics (Sheeran, 2002). Within the psychological 
literature. Orbell & Sheeran (1998) used the term inclined abstainers. To describe 




In the context of the present study, participants who initially make an appointment 
(positive intention) but go on to cancel or do not attend their appointment would be 
considered to be inclined abstainers. It is this group who are the primary interest of 
Study 1.  
Among the small number of studies on psychosocial barriers to lung cancer 
screening, cancer fatalism appears to play a significant role in uptake. A qualitative 
study in England exploring attitudes towards participation in lung cancer screening 
found themes of fatalism, worry, and avoidance in those who declined to be 
screened (Patel, Akporobora, Chinyanganya, Hackshaw, Seale, Spiro, & Griffiths, 
2012).  This conclusion was also supported by a quantitative study in the US, 
where participants who had fatalistic beliefs about lung cancer were less likely to 
undergo screening (Jonnalagadda, Bergamo, Lin, Lurslurchachai, Diefenbach, 
Smith, Nelson & Wisnivesky, 2012). Other barriers to lung cancer screening 
included: denial of risk, shame about smoking, fears about screening and 
embarrassment (Walton, McNeil, Stevens, Murray, Lewis, Aitken & Garrett, 2013). 
Understanding the socio-demographic characteristics of attenders and non-
attenders of cancer screening is crucial to ensure the introduction of a screening 
programme does not exacerbate health inequalities. For example, those from 
more deprived groups may be less likely to attend cancer screening (Weller & 
Campbell, 2009; Moser, Patnick & Beral (2009), but have a higher risk of cancer 
due to e.g. smoking, unhealthy diet, sedentary lifestyle. Other socio-demographic 
characteristics that may play a role in cancer screening attendance include age 
and gender.  
2.2 Potential Risks & Benefits 
Risks - This study is low risk, however there are a few areas to consider as 
potentially problematic.  Study 1 (invitation Strategy 2) will involve writing to 
potential participants in some cases 6 months or more after they did not attend 
their appointment.  It is possible that individual circumstances may have changed 
within this time. In some circumstances it is possible participants may have passed 
away or become unwell.  As a result, Health Informatics (HIC) University of 
Dundee will check against the patients CHI number through NHS health records to 




will include the sentence: ‘We apologise if this letter arrives at a particularly difficult 
time for you.’ 
Another potential area of risk could be the topic of the study. We are discussing a 
health issue and cancer in particular, which might upset some participants. This 
will be avoided by reminding the participant that they are under no obligation to 
answer all of the questions and may stop the discussion at any point. Moreover, 
the interview will be flexible enough to allow participants to introduce information 
that they feel comfortable with. If the participant appears hesitant or in doubt about 
responding, the interviewer will give them some time to proceed, alter the question 
or move on.  Finally, we will provide the telephone number and email address of 
the researcher at the end of the interview in case participants wish to talk about 
any of the issues raised in the interview. If necessary, the researcher will refer 
participants to one of the project supervisors to provided further information or 
support.  If required, the supervisor will provide details for professional 
organisations for people who feel they need to discuss issues further. 
Benefits –There are few potential benefits to research participants although in the 
past some participants in similar studies have reported enjoying the opportunity to 
take part in research. Those who participate in the interviews will be offered a £20 
voucher as a token of appreciation for their participation (Appendix A). Participants 
will be required to sign for the voucher received at the end of the interview. If the 
participant wishes to withdraw from the interview at any point during the interview, 
the participant will still receive the voucher. 
2.3 Aim 
The aim of Study 1 is to explore the beliefs and perceptions about lung cancer and 
lung screening among people who initially expressed an interest in screening, 
were appointed to be screened, but who later cancelled or did not attend their 
appointment, and in some cases did not attend a reappointment. 
Methodology  




Participants are required to have been invited and subsequently been eligible to 
participate in the ECLS Trial. Further, participants will have shown initial interest in 
the study, but at a later time, declined to participate. See Table 1 for further 
details. 
2.5 Exclusion Criteria 
Participants who were invited to take part in the ECLS trial and completed the 
study. Also, inability to speak, read or write English. The study involves 
understanding a Participant Information Sheet, completing a consent form and 
taking part in an interview in English. People who are unable to speak, read or 
write English will therefore be excluded most likely because they will not have 
responded to the initial invite to take part in the Trial.  See Table 1 for further 
details. 
Table 1: Study 1 Inclusion / Exclusion Criteria 
Inclusion Exclusion 
Invited to take part in the ECLS trial Inability to speak, read or write English 
Eligible to take part in ECLS trial on 
reassessment 
Individuals who contacted the team for 
information, but did not make an 
appointment 
Participants who made an appointment, 
but subsequently cancelled or DNA 
Individuals whose eligibility to take part 
in the ECLS trial was not established 
 
Participants who cancelled or DNA but 
rescheduled another appointment for a 





2.6 Study Design 
Interviews will be conducted face-to-face in the participants’ own homes or at the 
University of Glasgow, or over the telephone, whichever is most convenient to the 
participant. Participants’ travel expenses will be reimbursed if they choose to come 
to the University of Glasgow. It is recognised that the researcher will be working 
alone. As a result, the University of Glasgow’s policy on lone working will be 
followed to ensure the safety of the researcher and participant. 
Participants will receive the Participant Information Leaflet and informed consent 
form with their letter of invitation by post before the interview is conducted. Contact 
numbers are given to contact the study team to answer any questions they may 
have. In the case of telephone interviews being the preferred interview format, 
participants are invited to send their reply and completed consent form in the 
prepaid envelope. Prior to the telephone interview they will be asked to confirm 
their verbal consent.  Participants will be offered the opportunity to ask any 
questions about the study before informed consent is taken by the researcher. The 
researcher will seek consent in the first instance. Interviews will last approximately 
1 hour and will be based on a topic guide (Appendix B) developed from the 
existing screening literature with a particular focus on barriers to cancer screening. 
To avoid post-hoc rationalisations of their screening behaviour we will ask 
participants to discuss their general views on screening first before moving on to 
their personal experience. With the permission of the interviewee, interviews will 
be audio-recorded and transcribed verbatim. If the participant does not consent to 
be recorded, the participant can continue with the interview with the researcher 
taking detailed notes instead. Data from interviews will be anonymised during the 
transcription process. Thereafter paper copies of the transcripts will be stored in 
locked filing cabinets at General Practice & Primary Care, University of Glasgow. 
Interview transcripts will be assigned unique identifiers and any quotations that 
may be used with publications or reports will use the unique identifier. As such 
individual participants will not be identified.  
2.7 Researcher Effects 
Researcher effects will be kept to a minimum by using a topic guide to ensure 




qualitative research, supplementary questions may vary depending on the 
responses of the participants. 
2.8 Duration of Participation 
Participants will be asked to take part in one qualitative interview lasting 
approximately one hour. The research team will not contact the participant again, 
although study results will be disseminated to the individual following completion of 
the study if requested. If participant request the study results, their name and 
address will be noted. Participants requesting the results will be mailed a summary 
of the main findings. The study results will also be disseminated through the 
normal academic channels, including, publications and conference presentations. 
2.9 Criteria for Discontinuation 
Study 1 involves a one-off interview, and this will be the only contact with the 
research team. If informed consent is taken at the time of interview and the 
participant completes the interview, the research team will have no further contact 
with the research participant. If a participant decides part way through the 
interview to withdraw from this study the data collected would be retained if 
permission is given. If no permission is given, the data will be withdrawn. 
If participants make an appointment with the researcher and cancel or DNA the 
researcher will attempt to make contact again. Appointments will be rearranged up 
to three times. If a participant is unable to make the interview after the third 
attempt of rearranging an appointment, they will be removed from the invitation 
list. 
2.10 Procedure for collecting data 
This will be a difficult group to engage, as a result, three recruitment strategies will 
be used:  
1a. It is normal practice that the ECLS study team call participants the day before 
their appointment as a reminder in an attempt to reduce the number of DNAs. If 
during this call a potential participant states they wish to withdraw from the Trial 




research project for people who decide not to attend their appointment. If 
participants express an interest, they will be asked if they agree for a member of 
the research team to contact them directly to provide more information about the 
research. The participant will be reassured if they wish to decline and no further 
contact will be made by the research team.  
1b. Within the ECLS Trial protocol, if a participant DNA, the study team will call the 
participant to offer a new appointment time.  If during this call the participant states 
they wish to withdraw from the Trial, the study team will ask the participant if they 
would be interested in taking part in a research project and the procedure would 
be as described in 1a.   
2) We will retrospectively identify and contact people who booked an appointment, 
accepted an appointment, but cancelled or DNA initially within the previous 12 
months (i.e. 1 year from the commencement of the sub-study). If insufficient 
participants respond, we will contact people from the beginning of the Trial in 
Glasgow.  Participants will be identified from the Patient Management System 
used by the ECLS Trial. Eligible participants will be identified by the researcher, 
searching the additional text related to each case for key words such as, 
‘cancelled’, ‘did not attend’ or ‘DNA’. Once participants have been identified, the 
Health Informatics Centre (HIC at Dundee University) will extract the names and 
addresses of those eligible. 
Participants will be contacted by post after they have been identified as a suitable 
candidate via HIC.  Invitation letters will be sent out via a mail merge at HIC and 
those identified by HIC as having died will be excluded. Participants will be given a 
reply slip to return if they would like the researcher to contact them. Alternatively, 
they can contact the researcher by telephone or email. The researcher will not 
know the identity of the participant until the reply slip stating that they wish to 
participate is returned. 
2.11 Data Protection 
When potential participants express an interest, contact details will be stored in a 
locked filing cabinet at the University of Glasgow.  Consent forms will similarly be 




recordings will be uploaded to password protected university computers.  The 
recordings will be assigned a unique ID number rather than the participant name. 
Thereafter paper copies of transcripts will also be stored in locked filing cabinets at 
the University of Glasgow. Any direct quotations that may be used with 
publications or reports will use the unique identifier. As such individual participants 
will not be identified. Data will be retained for 10 years after the study is 
completed.  
Statistical Considerations 
2.12 Sample Size 
We will undertake interviews with a sample of approximately 20 ECLS Trial non-
attenders. Based on previous literature, this is the likely number required to reach 
'saturation' in terms of identification of new themes/ideas/issues. Based on 
previous experience, in order to obtain a sample of 20 participants, around 400 
people may need to be contacted although this may be less depending on the 
success of Strategies 1a and b. The study aims to interview a mix of males and 
females.  If possible, a sampling frame will be used so the balance of gender 
reflects the ratio of men to women among the DNA group overall.  However, we 
anticipate that it will be challenging to obtain 20 participants so this may not be 
possible.  
2.13 Method of Analysis  
The data will be analysed using the `framework approach´, a type of thematic 
analysis. Thematic analysis is a method for identifying, analysing, and reporting 
recurring patterns within data, which can then be reported in a detailed way.  The 
demographic characteristics of the participants including age, gender and Scottish 
Index of Multiple Deprivation score will also be described.  
3. STUDY 2 




The ECLS trial recruits participants in two distinct ways: i) invitation via GP or; ii) 
through community advertisement/ media releases/word of mouth and website 
review. As a result, it may be possible that there are sociodemographic and 
psychosocial differences between the participants who were invited by their GP 
and those who self-selected to participate. 
Previous research in lung cancer screening indicates that there are significant 
differences between participants who are invited to take part, and those who self-
select. Participants in the US National Lung Screening Trial, who were recruited by 
the media, appeared to be younger, higher educated and less likely to be current 
smokers (NLST, 2010). Similarly, in the Dutch–Belgian Lung Cancer Screening 
Trial (NELSON trial), respondents to the initial invitation were somewhat younger, 
and less likely to be current smokers (van der Aalst et al., 2012).  
Similar results can also be found outside lung cancer screening trials. In the Oslo 
Health Study, respondents to community and media advertisement were 
associated with older age, higher education levels, being married, and also not in 
receipt of benefits (Sogaard, Selmer, Bjertness & Thelle, 2004). A secondary 
analysis of the Malmo Diet and Cancer Study concurs with the results of Sogaard 
et al. (2004). When comparing the respondents of community invitations and 
personal invitations, Manjer et al. (2002) found that community respondents were 
older, and more often females, than participants recruited using personal 
invitations. Furthermore, participants recruited through community advertisement 
had a comparably more favourable situation with regard to sociodemographic and 
lifestyle factors. They also had a lower frequency of prevalent disease, lower 
incidence of cancer and lower mortality (Manjer, Elmsta, Janzon&Berglund, 2002).   
 
The present ECLS study will examine potential differences between the two 
invitation groups of the ECLS trial. This will assist with the future development of 
more efficient invitation strategies that will target the most high-risk groups.  
3.2 Aim 
The primary aim of Study 2 is to explore if there are any sociodemographic or 




participants of the ECLS study who were invited by GP or self-selected through 
community advertising. 
Methodology 
3.3 Inclusion Criteria 
In order to be included within the statistical analyses, participants are required to 
have taken part in the ECLS trial and completed the baseline study questionnaire.   
3.4 Exclusion Criteria 
Participants who took part in the ECLS trial but did not complete the study 
questionnaire will be excluded from the analysis. 
3.5 Procedure for identifying participants 
Participants will be identified from the patient management system (PMS) used by 
the ECLS trial. Eligible participants for the analyses will be identified by their 
invitation type group (GP or self-select). Once cases have been identified, the 
anonymised data required including demographic characteristics (age, gender, 
Scottish Index of Multiple Deprivation) and the responses to the psychosocial 
questionnaire will be extracted from OpenClinica.  Data will be extracted using 
participants’ cohort ID. 
3.6 Study Design 
The required anonymized data will be extracted from study data base; Open 
Clinica in order to complete the analysis. Data will be analysed at the University of 
Glasgow. The data will be transferred and stored as per the Data Sharing 
Agreement. The data will be analysed using Microsoft Excel 2010 and IBM SPSS 






3.7 Sample Size 
This sub study will analyse the data from all attenders of the ECLS Trial. 
3.8 Method of Analysis 
Statistical analysis will be conducted using IBM SPSS. Participants’ base-line data 
will be compared for the two groups of interest – GP invitation and self-selected. 
This will include demographic characteristics, beliefs about lung cancer and lung 
cancer screening, perception of general health and risk perception obtained from 
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